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Abstract 
Antibiotics are designed to inhibit the growth of or kill bacteria. Of the many classes of antibiotics 
that have been synthesized two particular classes of antibiotic have been frequently detected in the 
natural environment, namely the tetracyclines and sulfonamides. Following use, these compounds 
can enter the environment via the application of animal manures or domestic seawage sludge to 
land as a fertiliser or from wastewater treatment plant effluents. Once in the environment the 
compounds can persist and, depending on their properties, are distributed around the different 
environmental media (i.e. surface waters, groundwaters, soils and sediments).  Several studies have 
suggested that tetracyclines and sulfonamides may have significant impacts on microbial function 
in the natural environment. However most of these studies have used existing standardised test 
procedures and/or unrealistic exposure conditions. The aim of the current study therefore was to 
develop a more environmentally realistic test system for assessing the effects of antibiotics on 
aquatic microbial communities and to apply this to assess the potential impacts of a sulphonamide 
and a tetracycline antibiotic on aquatic microbial communities.  The developed system, which was 
an aquatic microcosm composed of fresh river water, return line treated sewage and OECD 
synthetic sewage, was initially used to assess the effects of 3, 5-dichlorophenol, an OECD 
reference toxicant. Effects of DCP were seen within the concentration range that is considered 
valid by other standard microbial toxicity tests, such as OECD method 209 (3.2-32 mg/L).  Since 
the developed system was able to quantify effects on aquatic microbial communities, it can be seen 
as being more environmentally relevant than existing standard tests, which rely on testing single 
microbial species or sludge communities. The test system was then used to test the effects of 
chlortetracycline (CTC) and sulfamethoxazole (SMX) on multisubstrate utilization. Following 
addition of the study antibiotics, effects were observed for both antibiotics on total substrate 
utilization and on the utilization of specific, ecologically relevant end-points (such as nutrient 
cycling and polymer degradation) also. Effects were also observed on the structure of microbial 
communities and on the functional diversity of substrate utilization (especially in the case of SMX 
exposure) and these effects generally persisted for up to 3 d after addition of the study compounds 
at a lower concentration of 0.1 mg/L for both compounds. The results indicate that both antibiotics 
were inhibiting various aspects of substrate utilization, most of which were related to ecologically 
relevant processes that occur in the aquatic environment. The results also suggest that SMX and 
CTC exposure result in changes in the community structure of ecologically relevant groups of 
microbes (such as bacteria involved in the nitrogen and carbon cycle bacteria).  Microbial 
communities that were exposed to CTC and SMX showed a varying degree of recovery, although 
more long term effects were seen in SMX exposures; functional effects were observed for the 
duration of the exposure. It was hypothesized that the observed recovery may have been caused by 
the selection of antibiotic resistance in the exposed communities. Culture based resistance studies 
showed that there was a significant temporal rise in CTC resistance at all CTC concentrations, but 
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not SMX resistance, across the dose range. In addition, a greater number of distinct microbial 
morphotypes could be isolated from combined microcosms on day 7 compared with day 1. An 
increase in CTC and SMX resistance in control exposures was also observed. In addition, distinct 
resistant morphotypes developed in both dosed and undosed microcosms on day 7 of the study. 
Furthermore, the results of a series of different culture based experiments suggested that multidrug 
resistance was present in morphotypes that were isolated from dosed and control microcosms. 
These data therefore suggest that multidrug resistance was present at the start of the exposure and 
may also have been co-selected by exposure to CTC and SMX.  In general, CTC and SMX show 
signs that they may pose a risk to the environment and possibly the wider health of humans and 
animals.  
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1. Introduction 
The problem of aquatic pollution is not a new issue. In 1961 legislation was passed to eliminate 
the use of branched surfactants due to cases of “foaming rivers,” which resulted from emissions of 
compounds such as alkyl benzene sulfates (Scheilbel, 2004). An emerging issue in the present day 
is the pollution of aquatic systems with active pharmaceutical ingredients (APIs) and the effects 
they exert on ecosystems.  
 
One class of pharmaceutical compound that has been detected in the aquatic environment (and 
other environmental compartments) is the antibiotics. Gustafson and Bowen (1997) describe 
antibiotics as a wide range of natural and semi-synthetic compounds that are used in the treatment 
and prevention of bacterial diseases. Alexander Fleming observed the first documented antibiotic 
activity in a laboratory setting in 1928 when he accidentally noticed that the Penicillium fungus 
inhibited the growth of Staphylococci sp. on agar plates (Fleming, 1929). During the next decade 
the sulfonamides became the first group of antibiotics to be administered therapeutically. A 
number of new antibiotic compounds have since been discovered (summarised in table 1.1). The 
most recent, tigecycline, was fast-tracked onto the market in 2005.  
 
Antibiotics can be separated into different classes. Compounds from each antibiotic class have a 
distinct cellular target (or targets) and therefore mechanisms of action (Table 1.2). Bacitracin is a 
mixture of related cyclic polypeptides and as such does not belong to a specific group. Antibiotic 
mechanisms of action can be sub-divided into four general mechanisms; protein synthesis 
inhibition, DNA synthesis inhibition, inhibition of RNA synthesis and inhibition of cell wall 
synthesis (Retsema and Fu, 2001).  
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Table 1.1: Chronology of antibiotic discovery. 
 
Discovery Event Discovery Date Country 
Penicillins (discovered) 1928 UK 
Sulfonamides (discovered) 1932 Germany 
Gramicidin (discovered) 1939 USA 
Penicillin (introduced) 1942 UK and USA 
Streptomycin (discovered) 1943 USA 
Bactiracin (discovered) 1943 USA 
Cephalosporins (discovered) 1945 Italy 
Chloramphenicol (discovered) 1947 USA 
Clortetracycline (discovered) 1947 USA 
Neomycin (discovered) 1949 USA 
Oxytetracycline (discovered) 1950 USA 
Erythromycin (discovered) 1952 USA 
Vancomycin (discovered) 1956 USA 
Kanamycin (discovered) 1957 Japan 
Methicillin (introduced) 1960 UK and USA 
Ampicillin (introduced) 1961 England 
Spectinomycin (reported) 1961 USA 
Gentamicin (discovered) 1963 USA 
Cephalosporin (introduced) 1964 UK 
Doxycycline (introduced) 1966 USA 
Clindamycin (reported) 1967 USA 
Tobramycin (discovered) 1971 USA 
Cephamycins (discovered) 1972 USA 
Minocycline (introduced) 1972 USA 
Tigelcycline (introduced) 2005 USA 
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Table 1.2: Mechanism of action of major antibiotic groups. 
    Antibiotic 
Group 
Example Mechanism of Action Reference(s) 
Aminoglycosides Streptomycin Competitive binding to 30S ribosomal subunit; causes codon misreading & failed translocation. Protein 
synthesis is halted. 
Davies et al., 1965; Davies & Davis, 
1968 
Bacitracin Bacitracin Inhibits dephosphorylation of C55-isoprenyl pyrophosphate preventing peptidoglycan transport across 
cytoplasmic membrane; results in inhibition of cell wall synthesis 
Anderson et al., 1966;  Stewart & 
Stromiger, 1967 
Beta-Lactams Dicloxacillin Act as analogues of the terminal D-alanyl-D-alanine terminal of the peptidoglycan precursor NAM/NAG-
peptide subunits. Cell wall biosynthesis is prevented. Also causes depolarisation of cell wall; acts as 
cellular signal to commence autlysis. 
Ghysen, 1991; Penyige et al., 2001 
Cephems Ceftobiprole Inhibit enzymes responsible for cross-linking of oligopeptides that form long chain peptidoglycan 
polymers in Gram positive cell wall. 
Smith, 1985 
Chloramphenicol Chloramphenicol Prevents peptidyl transfer activity by competitive inhibition of 23s ribosomal subunit; protein synthesis 
halted. 
Hansen et al., 2003 
Glycopeptides Vancomycin Bind to D-alanyl–D-alanine C-terminus of nascent peptidoglycan, stopping it from becoming cross-
linked by reactions catalysed by transglycosylases and transpeptidases. Cell wall is weakened and cell 
lysis occurs. 
Nieto & Perkins, 1971; Arthur & 
Courvalin, 1993; Walsh, 1993; Ge et 
al., 1999 
Macrolides Erythromycin Bind reversibly to the 50s ribosomal sub-unit preventing elongation of polypeptide chain and premature 
detachment from ribosomal binding site. Production of premature peptides causes cell death. 
Cocito et al., 1997 
Quinolones Trovafloxacin Inhibit type II Topoisomerase (DNA Gyrase & Topoisomerase IV) activity. Resultant build-up of double 
stranded breaks in chromosomes triggers SOS cellular response and subsequent cell death. 
Hooper, 1998 
Rifampins Rifampin E. Coli bacteriocidal activity thought to be additionally caused by apoptosis via activiation of suicide 
gene mazEF. 
Hartmann et al., 1985 
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Table 1.2 (cont). 
    
Antibiotic 
Group 
Example Mechanism of Action Reference(s) 
Sulfonamides Sulfamethoxazole Competitively inhibits the enzyme dihydropteroate synthetase (DHPS) by acting as a structrural analogue 
of Para-aminobenzoic acid (PABA). Folic acid therefore cannot be incorporated into essential nucleic 
acids and proteins and cell growth is inhibited. 
Henry, 1943 
Tetracyclines CTC Transiently bind to the ribosomal 30S sub-unit. Polypeptide elongation is therefore inhibited and protein 
synthesis cannot proceed normally. 
Gale et al., 1981 
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1.2. Antibiotic Usage 
 
The usage of antibiotic compounds can be split into two distinct categories, human and veterinary. 
Antibiotics are used to treat a wide array of infections caused by pathogenic bacteria such as 
Escherichia coli 0157 and Pneumonocystis pneumonia. Such drugs can be administered orally, 
topically or via an injection. Some countries also use antibiotics (such as tetracyclines) as dietary 
growth-promoting agents. Volumes of antibiotics that enter the environment can be estimated 
from sales data and information on metabolism in the treated human or animal. The British 
Veterinary Index provides veterinary sales data in the UK. As mentioned by Boxall et al. in 2002 
however, this data does not take into account sales by companies to veterinary surgeons, pet shop 
sales or sales made by the AHDA (Animal Health Distributors Association). Human sales figures 
in the EU are estimated from prescription data. This data is collated and published by IMS-
MIDAS. However, these figures do not take into account factors such as “over the counter” sales 
and illegal (and therefore unregistered) drug production (Boxall et al., 2001; Daughton and 
Ternes, 1999).  
 
Despite anomalies in data, antibiotic usage data is one of the best recorded in the EU compared 
with other pharmaceutical classes (Stege et al., 2003). There have been only limited attempts 
however to collate available data on total usage values. For example, Kools et al. (2008) were 
able to collate data from a wide array of sources to estimate antibiotic usage within Europe in 
2004. It was found that total veterinary antibiotic use (in 2004) was 4634 tonnes. This represented 
a 33% increase compared with 1997 figures and an 18% rise on 1999 usage data. These changes 
highlight the fact that antibiotic usage from year to year can be extremely variable due to 
changing usage profiles. For example, the use of antibiotics as growth promoters has dropped by 
50% whereas their therapeutic use in Denmark and the Netherlands increased between 1997 and 
2004 (KTBL, 2005; MANRAN, 2004). The most widely used veterinary antibiotics in the EU 
were the tetracyclines, followed by beta-lactam / cephalsporin mixtures.  
With regards to human antibiotic use, EU figures indicate that humans are medicated by 10 more 
days per year compared with animals. The total volume of antibiotics sold for human 
consumption was 7659 tonne in 1997. EU figures indicate that human antibiotic consumption was 
approximately 6.3 fold higher than veterinary usage; human usage was 342 mg antibiotic/kg body 
mass/year compared with 54 mg antibiotic/ kg body mass/year for animal usage (Ungemach et al., 
2006; Kools et al., 2008).  
1.3. Exposure Routes of Antibiotics into the Environment 
Antibiotics may enter the environment in a number of ways (Figure 1). Sewage treatment plants 
(STPs) represent the most significant point source of antibiotics in the aquatic environment. 
Human APIs are transported into STPs as domestic waste (in faeces, urine or from medicines that 
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have been discarded into toilets or sinks). If a drug entering the STP is hydrophilic it may pass 
through the sewage treatment process without being fully degraded. Drugs or partially 
metabolised drugs will then enter the aquatic environment when the sewage is discharged into 
surface waters (Fent et al., 2006). Lipophilic or very polar antibiotics tend to adsorb to particulate 
matter in STPs (ICON, 2001). This particulate matter is often spread onto fields as a source of 
nutrients with the only restrictions on this being the nutrient and heavy metal contents 
(86/278/EEC., 2000; Petrovic and Barcelo 2004).  
Antibiotics can also be directly emitted to fields and adjacent water bodies by medicated animals. 
Excreta from these animals may contain the parent antibiotic, metabolites of the antibiotic or a 
mixture of both (Kemper, 2008). Antibiotics that are applied topically (such as tetracycline and 
lincomycin) may also enter the terrestrial and aquatic environment via run-off from the animal 
skin during rainfall events (Armstrong and Phillips, 2008). Antibiotics entering the environment 
in this manner are generally in the form of parent compounds as they have not been in contact 
with phase I or phase II enzymes that metabolise the antibiotic in the body (Magnusson et al., 
2001). Phase 1 enzymes generally catalyse oxidative reactions or reactions which make a 
xenobiotic more polar, whereas phase II enzymes generally catalyse reactions which conjugate 
xenobiotic compounds with proteins (Akagah et al., 2008).  
 
Antibiotics may also be released on purpose to the aquatic environment when they are used as 
aquaculture treatments. For example, oxytetracycline and oxolinic acid are routinely administered 
to aquaculture sites as a preventative measure against microbial pathogens (Bjorkland et al., 1991; 
Primavera et al., 1993; Hirsch et al., 1999). Halling Sørensen et al (1998) calculated that 70-80% 
of drugs administered in aquaculture remain in the environment. Antibiotics that enter aquatic 
systems can also associate with freshwater and marine sediments where they have been shown to 
accumulate over time (Richardson and Bowron, 1985; Halling Sørensen et al., 1998).  
  
Effluent from drug production plants can also act as a point source of antibiotics into the aquatic 
environment. Despite claims that tight manufacturing processes would only result in minor levels 
of APIs being released into the aquatic environment, extremely high levels of antibiotics have 
been detected in effluent from drug manufacturing plants in India. Ciprofloxacin for example has 
been detected at levels of 31 mg/L in surface waters receiving effluent from drug manufacturing   
(Williams, 2005; Larsson et al., 2007). More recently, higher levels of pharmaceuticals have also 
been found in aquatic systems receiving industrial effluent in the USA (Phillips et al., 2010).  
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Figure 1.1: Exposure routes for antibiotics into the environment. 
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1.4. Reported Occurrence of Antibiotics in the Environment 
Much research has been conducted to quantify the extent to which antibiotics are present in the 
environment since Watts et al. (1983) first detected antibiotic compounds in the aquatic 
environment. This has been facilitated by the development of increasingly more sensitive 
analytical techniques in the last 40 years (Erikson, 2002). It has been estimated that over one 
million tonnes of antibiotics have been released into the biosphere (25 x10
6  
kg/year) between the 
start of antibiotic therapy and 1984 (Verma et al., 2007). Consequently, APIs have been detected 
in several environmental matrices at concentrations generally between 10
-5–10-9 g l-1 (Table 1.3).  
Antibiotics have been detected in several matrices, including soil (eg: Jacobsen et al., 2004), 
surface water (eg: Kolpin et al., 2002), sediment (eg: Lalumera et al., 2004) groundwater (eg: 
Karthikeyan and Bleam, 2003) and biota (eg: Chafer-Pericas et al., 2010). The majority of these 
monitoring studies have focused on detecting the occurrence of antibiotics in surface waters and 
groundwater, with only a small number of studies looking at soil, sediment or the marine 
environment. Across all environmental matrices the sulfonamides, tetracyclines, macrolides and 
fluoroquinolones represent major antibiotic groups that have all been frequently detected. The 
most commonly detected individual antibiotic compounds are sulfamethoxazole and 
trimethoprim.  
 
Studies that have investigated antibiotic occurrence upstream and downstream of an STP (sewage 
treatment plant) have often found higher concentrations downstream (Bendz et al., 2005; Ashton 
et al., 2004; Hilton and Thomas, 2003). Higher antibiotic concentrations have also been reported 
in groundwater and sediment below landfill sites (Holm et al., 1995). Water bodies near 
agricultural land and soils amended with manure have also been shown to contain higher 
concentrations of antibiotics than in more pristine environments (Yang and Carlson, 2004; 
Jacobsen et al., 2004; Hamsher et al., 2002).  
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Table 1.3: Reported occurrence of major antibiotic class representatives in various environmental compartments. Data in italics corresponds to limits of detection. 
      
Compound Matrix Location LOD/LOQ Reported Concentration Reference(s) 
      
tetracyclines 
     
chlortetracycline Soil amended with liquid manure Denmark 
0.6 x 10
-3 
mg/kg 
nd - 15.5 x 10
-3 
mg/kg Jacobsen et al., 2004 
1.1x 10
-3 
mg/kg 
 Soil amended with liquid manure Germany 
2 x 10
-3 
mg/kg 
4.6 - 7.3 x 10
-3 
mg/kg Hamsher et al., 2002 
 
5x 10
-3 
mg/kg 
 
Stream water USA 0.05 mg/kg 0.49 - 0.69 mg/kg  Yang and Carlson, 2004b 
 
Stream water USA 0.10 μg/L 0.16 μg/L Kolpin et al., 2002 
oxytetracycline Surface water Italy <0.0003 μg/L 0.01435 μg/L Calamari et al., 2003 
 
Surface water Italy <0.0003 μg/L nd – 0.01920 μg/L Calamari et al., 2003 
 
Stream water USA 0.10 μg/L 0.34 μg/L Kolpin et al., 2002 
 
Lake water (near agricultural land) USA 0.05 μg/L 0.13 μg/L Yang and Carlson, 2004b 
 
Lake water USA 0.05 0.09 μg/L Yang and Carlson, 2004b 
 
Marine sediment  Italy 0.061 μg /kg 246.3 μg /kg Lalumera et al., 2004 
tetracycline Soil amended with liquid manure Germany 
1 x 10
-3 
mg/kg  
(86.2 - 198.7) x 10
-3 
mg/kg Hamsher et al., 2002 (5x 10
-3
) mg/kg 
 
 
Surface water USA 0.05 μg/L 0.14 μg/L Yang and Carlson, 2004b 
 
Surface water USA 0.05 μg/L 0.06 and 0.12 μg/L Yang and Carlson, 2004b 
 
Stream water USA 0.10 μg/L 0.11 μg/L Kolpin et al., 2002 
 
Groundwater USA 0.05 μg/L 0.5 μg/L 
Karthikeyan and. Bleam, 
2003 
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Table 1.3 (cont). 
      
Compound Matrix Location LOD/LOQ Reported Concentration Reference(s) 
Doxycycline Lake water USA 0.05 μg/L 0.05 μg/L Yang and Carlson, 2004b 
Doxycycline Lake water USA 0.05 μg/L 0.05 μg/L Yang and Carlson, 2004b 
Doxycycline (cont) Surface water USA 0.05 μg/L 0.08 μg/L Yang and Carlson, 2004b b 
 
Surface water USA 0.05 μg/L nd and 0.05 Yang and Carlson, 2004b 
democlocycline Surface water USA 0.05 μg/L 0.12 μg/L and 0.32 μg/L Yang and Carlson, 2004b 
  Surface water USA 0.05 μg/L 0.44 μg/L  Yang and Carlson, 2004b 
      
sulfonamides 
     
      
sulfamerazine Surface water USA 0.05 μg/L nd and 0.05 μg/L Yang and Carlson, 2004b 
 
Lake water USA 0.05 μg/L 0.19 μg/L Yang and Carlson, 2004b 
sulfamethazine Stream water USA 0.02 μg/L - 0.12 μg/L 0.05 μg/L Kolpin et al., 2002 
 
Stream water USA 0.22 μg/L 0.05 μg/L Kolpin et al., 2002 
 
Lake water USA 0.22 μg/L 0.05 μg/L Yang and Carlson, 2004b 
 
Surface water USA 0.0010 μg/L < 0.0010 μg/L Skadsen et al., 2004 
 
Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 900 μg/L Holm et al., 1995 
 
Groundwater Germany 0.02 μg/L 0.16 μg/L Hirsch et al., 1999 
sulfamethoxazole Surface water Germany 0.02 μg/L 0.03 - 0.48 μg/L Hirsch et al., 1999 
 
Surface water (tributaries) Germany 0.030 μg/L < 0.030 μg/L & 0.040 μg/L Wiegel et al., 2004 
 
Surface water (in April 1998) 
Germany, Czech 
Rep. 
0.030 μg/L 0.030 - 0.070 μg/L Wiegel et al., 2004 
 
Surface water (upstream STP) 
discharge) 
Sweden NS < 0.001 Bendz et al., 2005 
 
Surface water (downstream STP 
discharge) 
Sweden NS 0 - 0.01 μg/L Bendz et al., 2005 
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Table 1.3 (cont). 
      
Compound Matrix Location LOD/LOQ Reported Concentration Reference(s) 
Sulfamethoxazole 
(cont) 
Surface water (upstream STP) UK <0.050 μg/L 0.050 μg/L Ashton et al., 2004 
 
Surface water (downstream STP) UK <0.050 μg/L 0.050 μg/L Ashton et al., 2004 
 
Surface water UK <0.050 μg/L 0.050 μg/L Hilton and Thomas, 2003 
 
Stream water USA  0.05 μg/L 0.15 - 1.9 μg/L Kolpin et al., 2002 
 
Stream water  USA 0.023 μg/L 0.066 μg/L - 0.52 μg/L Kolpin et al., 2002 
 
Surface water USA 0.0010 μg/L 0.010 ± 0.007 μg/L Skadsen et al., 2004 
 
Lake water  USA 0.05 μg/L 0.06 μg/L Yang and Carlson, 2004b 
  Surface water USA 0.007 μg/L 0.023 μg/L Heberer et al., 2001 
 
Surface water USA 0.05 μg/L 0.05 μg/L & 0.12 μg/L Yang and Carlson, 2004b 
 
Groundwater Germany 
0.0018 μg/L 
0.410 μg/L Sacher et al., 2001 
0.0062 μg/L 
 
Groundwater USA 0.023 μg/L 0.002 μg/L Heberer et al., 2001 
 
Groundwater Germany 0.025 μg/L 
< LOQ – 0.11 μg/L  ± 0.07 
μg/L 
Ternes et al., 2007 
 
Groundwater USA 0.05 μg/L 0.01 μg/L & 0.08 μg/L 
Karthikeyan and Bleam, 
2003 
 
Groundwater Germany 0.02 μg/L 0.47 μg/L Hirsch et al., 1999 
sulfathiazole Surface water USA 0.0010 μg/L < 0.0010 μg/L Skadsen et al., 2004 
sulfameththizole Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 330 μg/L Holm et al., 1995 
Sulfadiazine Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 1160 μg/L Holm et al., 1995 
sulfanilamide Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 300 μg/L Holm et al., 1995 
sulfaguanidine Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 1600 μg/L Holm et al., 1995 
sulfanilic acid Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 10440 μg/L Holm et al., 1995 
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Table 1.3 (cont). 
      
Compound Matrix Location LOD/LOQ Reported Concentration Reference(s) 
acetyl-
sulfamethoxazole  
Surface water (upstream STP) UK 0.050 μg/L < 0.050 μg/L Ashton et al., 2004 
 
Surface water (downstream  STP) UK 0.050 μg/L < 0.050 μg/L – 0.239 μg/L Ashton et al., 2004 
 
Surface water UK 0.050 μg/L < 0.050 μg/L - 0.240 μg/L Hilton and Thomas, 2003 
fluoroquinolones 
     
ciprofloxacin Soil amended with sludge Switzerland 0.05 mg /kg 
0.27 + 0.04 - 0.40 + 0.03 mg 
/kg 
Golet et al., 2002 
ciprofloxacin (cont)   0.18 mg /kg   
 
Stream water USA 0.02 μg/L 0.02 μg/L - 0.03 μg/L Kolpin et al., 2002 
 
Surface water Italy <0.0003 μg/L nd – 0.0262 μg/L Zuccato et al., 2005a 
 
Surface water Italy <0.0003 μg/L 0.01436 μg/L Calamari et al., 2003 
Norfloxacin Soil amended with sludge Switzerland 
0.05 mg /kg 0.27 + 0.01 mg /kg - 0.40 + 
0.03 mg /kg 
Golet et al., 2002 
0.18 mg /kg 
Flumequine Sediment (trout & Fsea-bass farms) Italy 0.012 mg /kg 578.8 mg /kg Lalumera et al., 2004 
Ofloxacin Surface water Italy <0.0003 μg/L 0.3061 μg/L Zuccato et al., 2005a 
 
Surface water Italy <0.0003 μg/L 0.0331 – 0.0370 μg/L Zuccato et al., 2005a 
      
ciprofloxacin + 
norfloxacin 
Surface water Switzerland 
0.0025 μg/L 
 nd - 0.015 μg/L ± 0.003 μg/L Golet et al., 2002a 
0.009 μg/L 
      
Macrolides 
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Table 1.3 (cont). 
      
Compound Matrix Location LOD/LOQ Reported Concentration Reference(s) 
clarithromycin Surface water Germany 0.02 μg/L nd - 0.26 μg/L Hirsch et al., 1999 
 
Surface water Italy <0.0003 μg/L 0.0016 μg/L – 0.0203 μg/L Zuccato et al., 2005a 
 
Surface water Italy <0.0003 μg/L 0.00831 μg/L Calamari et al., 2003 
 
Surface water 
Germany, Czech 
Rep. 
0.030 μg/L < 0.030 μg/L - 0.030 μg/L Wiegel et al., 2004 
 
Surface water (tributary) Germany 0.030 μg/L 0.030 μg/L & 0.040 μg/L Wiegel et al., 2004 
dehydrated 
erythromycin 
Stream water USA 0.05 μg/L 0.1 - 1.7 μg/L Kolpin et al., 2002 
 
Surface water 
Germany, Czech 
Rep. 
0.030 μg/L 0.030 - 0.040 μg/L Wiegel et al., 2004 
dehydrated 
erythromycin (cont) 
Surface water (tributary) Germany 0.030 μg/L 0.040 μg/L & 0.070 μg/L Wiegel et al., 2004 
 
Surface water Germany 0.02 μg/L 0.15 μg/L - 1.70 μg/L Hirsch et al., 1999 
 
Surface water USA 0.07 μg/L 0.17 ± 0.03 μg/L Yang and Carlson, 2004a 
 
Surface water Italy <0.0003 μg/L 0.00450 μg/L Calamari et al., 2003 
 
Surface water (upstream & 
downstream STP) 
UK 0.010 μg/L 0.057 μg/L & 1.000 μg/L Hilton and Thomas, 2003 
 
Surface water Italy <0.0003 μg/L 0.0032 μg/L – 0.0159 μg/L Zuccato et al., 2005a 
 
Surface water (upstream STP) UK 0.010 μg/L 0.010 μg/L - 0.057 μg/L Ashton et al., 2004 
 
Surface water (downstream STP) UK 0.010 μg/L 0.010 μg/L - 1.022 μg/L Ashton et al., 2004 
 
Groundwater Germany 
0.0042 μg/L 
0.049 μg/L Sacher et al., 2001 
0.014 μg/L 
Spiramycin Surface water Italy <0.0003 μg/L 0.0098 μg/L – 0.0438 μg/L Zuccato et al., 2005a 
 
Surface water Italy <0.0003 μg/L 0.07420 μg/L Calamari et al., 2003 
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Table 1.3 (cont). 
      
Compound Matrix Location LOD/LOQ Reported Concentration Reference(s) 
Lincomycin Surface water USA 0.0010 μg/L < 0.0010 μg/L Skadsen et al., 2004 
 
Surface water Italy <0.0003 μg/L 0.0326 μg/L – 0.2489 μg/L Zuccato et al., 2005 
 
Stream water USA 0.05 μg/L 0.06 μg/L – 0.73 μg/L Kolpin et al., 2002 
 
Surface water Italy 0.0003 μg/L 0.02440 μg/L Calamari et al., 2003 
roxithromycin Stream water USA 0.03 μg/L 0.05 μg/L - 0.18 μg/L Kolpin et al., 2002 
 
Surface water Germany 0.02 μg/L n.d. - 0.56 μg/L Hirsch et al., 1999 
 
Surface water (site 1) USA 0.03 μg/L 0.04 μg/L ± 0.001 μg/L Yang and Carlson, 2004a 
 
Surface water (site 2) USA 0.03 μg/L 0.06 μg/L ± 0.002 μg/L Yang and Carlson, 2004a 
 
Surface water (tributary) Germany 0.030 μg/L 0.030 μg/L & 0.30 μg/L Wiegel et al., 2004 
 
Surface water  
Germany, Czech 
Rep. 
0.030 μg/L 0.030 μg/L - 0.040 μg/L Wiegel et al., 2004 
      
chloramphenicol      
chloramphenicol Surface water Germany 0.02 μg/L n.d. – 0.06 Hirsch et al., 1999 
      
trimethoprim 
     
      
Trimethoprim Surface water Canada 0.001 μg/L – 0.010 μg/L 0.134 μg/L ± 0.008 μg/L Metcalfe et al., 2003 
 
Marine (harbour) Canada 0.001 μg/L – 0.010 μg/L 0.043 μg/L ± 0.004 μg/L Metcalfe et al., 2003 
 
Estuary (Tees River Estuary UK 0.004 μg/L < 0.004 μg/L - 0.017 μg/L Thomas and Hilton, 2004 
 
Estuary (Tyne River Estuary) UK 0.004 μg/L < 0.004 μg/L - 0.046 μg/L Thomas and Hilton, 2004 
 
Estuary (Mersey River Estuary) UK 0.004 μg/L < 0.004 μg/L - 0.569 μg/L Thomas and Hilton, 2004 
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Table 1.3 (cont). 
      
Compound Matrix Location LOD/LOQ Reported Concentration Reference(s) 
trimethoprim (cont) Surface water (tributary) Germany 0.030 μg/L < 0.030 μg/L & 0.040 μg/L Wiegel et al., 2004 
 
Surface water 
Germany, Czech 
Rep 
0.030 μg/L < 0.030 μg/L - 0.030 μg/L Wiegel et al., 2004 
 
Surface water (upstream STP) UK 0.010 μg/L < 0.010 μg/L - 0.036 μg/L Ashton et al., 2004 
 
Surface water (downstream STP) UK 0.010 μg/L < 0.010 μg/L - 0.042 μg/L Ashton et al., 2004 
 
Surface water (upstream STP) Sweden NS < 0.001μg/L Bendz et al., 2005 
 
Surface water (downstream STP) Sweden NS 0.01 μg/L - 0.02 μg/L Bendz et al., 2005 
 
Stream water USA 0.03 μg/L 0.15 μg/L - 0.71 μg/L Kolpin et al., 2002 
 
Stream water USA 0.014 μg/L 0.13 μg/L - 0.30 μg/L Kolpin et al., 2002 
 
Surface water USA 0.0010 μg/L <0.0010 μg/L Skadsen et al., 2004 
 
Surface water (Belfast Lough 
Estuary) 
UK 0.004 μg/L 0.024 μg/L - 0.032 μg/L Thomas and Hilton, 2004 
 
Surface water (Thames River 
Estuary) 
UK 0.004 μg/L < 0.004 μg/L Thomas and Hilton, 2004 
      
LOD = limit of detection; LOQ = limit of quantification; nd = not detected 
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1.5. Environmental Fate of Antibiotics 
1.5.1. Adsorption and Absorption 
The environmental compartment to which an antibiotic compound is transported, or the extent of 
transport, depends on the adsorption and absorption of an antibiotic (Boxall, 2004). Adsorption is 
the propensity for a molecule to sorb to the surface of soil, sediment structures, sludge, 
microorganisms and other particulate matter. In contrast, absorption involves the penetration of 
the antibiotic into the particulate matter (Ter Laak, 2005). This  degree of absorption or adsorption 
of an antibiotic will be dependent on the charge, hydrophobicity and polarity of the antibiotic 
molecule as well as the characteristics of the natural environment, including the pH, organic 
carbon content of particulate matter (e.g. suspended solids, soil particles, sediment particles) and 
the charge on the surface of the particulate matter (Ter Laak, 2005). The extent to which an 
antibiotic will be bound to particulate matter can be predicted from the physio-chemical 
characteristics of the antibiotic, particularly the octanol water distribution coefficient (Dow). (Dow) 
is defined as a concentration ratio of a compound between two distinct phases, n-octanol and 
water at a given pH. Dow is then modified to account for ionisable species at a given pH to give the 
octanol water coefficient (Log Kow). If the (Dow) of a compound is < 1 then a compound is not 
likely to sorb significantly. Values greater than 1 indicate sorption is likely (Kummerer, 2004).  
1.5.2. Environmental Transport 
Once antibiotics have entered the terrestrial environment they can be further transported to water 
bodies by three routes. The first of these, surface run-off, occurs when there is heavy rainfall or 
when additional water has been applied. Antibiotic residues (from soil amendment with manure, 
dung or slurry) on the soil surface can be carried into an adjacent water bodies after a rainfall 
event (Boxall et al., 2001). Antibiotics can also enter groundwater via leaching. During this 
process compounds are carried downward through soil horizons and are eventually carried into 
groundwater beneath soil or adjacent water bodies via drainage systems. If fissures exist within 
soil (due to dry weather or between rock formations for example) then preferential macropore 
flow may occur; antibiotics transported in this manner enter the aquatic environment more rapidly 
compared with leaching (Heberer, 2002).   
Leaching of antibiotic compounds into the environment has also been reported from landfill sites. 
Holm et al. (1995) for example detected sulfamethazine in groundwater under a landfill site in 
Denmark. Daughton (2003) has also reported the potential for APIs to leach into the environment 
from medicated corpses.  
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1.5.3. Degradation 
Antibiotics (and potential metabolites and transformation products of antibiotics) and other 
xenobiotic compounds can be subjected to a range of degradative processes in the aquatic and 
terrestrial environment, resulting in the dissipation of the parent compound. Degradative 
processes may result in the formation of one or more metabolites, one or more transformation 
products (such as R or S enantiomers) or the complete mineralisation of the compound into 
natural products. If a compound is recalcitrant to degradation then it is said to be persistent and 
will remain in the environment chemically unchanged (ECOTOC, 2005). Degradation can occur 
via either biotic or abiotic processes.  
1.5.3.1. Abiotic Degradation 
Abiotic degradation of antibiotics and other xenobiotic compounds occurs mainly via hydrolysis 
and photolysis. Hydrolysis reactions occur when a molecule reacts with the H3O
+ 
and OH
- 
in 
water. Hydrolysis reactions result in two products, one that has gained electrons from OH
- 
ions
 
and one that has donated electrons to H3O
+ 
ions. Hydrolysis reactions are generally pH dependent 
since they depend on the H3O
+
/OH
- 
ratio of an environment. Temperature can also affect 
hydrolysis rates as can the combined effects of temperature and pH. For example Loftin et al. 
(2008) observed increased rates of oxytetracycline, tetracycline and CTC hydrolysis as a result of 
increasing temperature and pH. Several antibiotics have been shown undergo hydrolysis in the 
environment. These include oxytetracycline (Loftin et al., 2008; Pouliquen et al., 2007), 
fluorfenicol (Pouliquen et al., 2007), oxolinic Acid (Pouliquen et al., 2007), flurnequine 
(Pouliquen et al., 2007), amoxicillin (Andreazzi et al., 2004), penicillin G (Li et al., 2008) and 
sulfadiazine (Yang et al., 2009).  
Photolysis of antibiotics and other xenobiotic compounds involves the dissociation of a molecule 
as the result of contact with photons. Since a photon’s energy is inversely proportional to its 
wavelength, photolysis can also involve electromagnetic waves with the energy of visible light or 
higher, such as ultraviolet light, x-rays and gamma rays. Two types of photolysis can occur in the 
environment, direct photolysis or indirect photolysis. Both reactions can occur simultaneously. 
Direct photolysis occurs when a molecule absorbs electromagnetic waves, causing decomposition 
of the excited state molecule. Indirect photolysis results from the chemical or electronic transfer 
from light-absorbing humic substances in natural water bodies. Iron compounds present in the 
environment can also result in indirect photolysis of antibiotics via the Photo-Fenton Process. 
Bautitz and Nogueira (2007) for example demonstrated that tetracycline photodegradation was 
favoured by the presence of an iron source under light conditions. 
 
Photodegradation of several antibiotic classes has been shown to occur in the environment, 
including sulfonamides (Sukul et al., 2008; Thiele-Bruhn and Peters, 2007; Boreen et al., 2004 ), 
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tetracyclines (Thiele-Bruhn and Peters, 2007; Bautitz and Nogueira, 2007; Sanderson et al., 
2005),  amoxicillin (Andreozzi et al., 2004), fluoroquinolones (Belden et al., 2007; Cardoza et al., 
2005; Knapp et al., 2005; Ferdig et al., 2005) and macrolides (Andreozzi et al., 2006; Di Paola et 
al., 2006). 
1.5.3.2. Biodegradation 
Biotic degradation (biodegradation) has been described as the “molecular degradation of a 
substance, resulting from the complex action of living organisms” (Leisinger et al., 1981). As a 
result, environmental microbes are able to utilise xenobiotic molecules as substrates within their 
metabolism (Limbert and Betts, 1996). Microbial communities in the environment play distinct 
roles in the decomposition of organic xenobiotics, acting as degradative consortia (Pelz, 1999). 
Some members of the consortia may not be able to degrade a particular molecule but may be able 
to biochemically transform it. Another member of the consortia may be able to degrade a 
transformation product via a biochemical pathway within its metabolism (ECETOC, 2003). Many 
biodegradative reactions are catalysed by constitutive enzymes and rely on xenobiotic molecules 
having structural homology to molecules that are metabolised naturally. Parent compounds or 
transformation products may also be degraded if a microbial species is able adapt or acquire 
enzymes capable of degrading particular molecules. This can occur when a gene coding for a 
degradative enzyme is horizontally transferred from another member of the microbial community. 
In terms of antibiotic biodegradation certain members of the microbial community may possess 
transferrable resistance genes that confer a phenotype for enzymes that can degrade a particular 
antibiotic (see table 1.5, this chapter). It has also been demonstrated that a microbial community is 
able to degrade xenobiotic molecules sensu stricto (alien to existing enzyme systems) by evolving 
new metabolic pathways (Springael and Top, 2003). This directional evolution strategy highlights 
the selective advantage that microorganisms gain by degrading as many substrates as possible.  
1.6. Microbial Function in the Environment 
Micro-organisms have an array of highly evolved biochemical pathways and physiological 
systems that represent broad microbial function. Many of these systems represent important stages 
during ecologically significant processes. A portion of these processes can be assigned to the 
global cycling of nutrients. Microbial action is required for the efficient cycling of carbon, 
nitrogen and phosphorus in their respective cycles. A healthy aquatic ecosystem relies upon major 
nutrients being in a delicate balance. The Redfield ratio is generally regarded as the perfect 
balance of carbon: nitrogen: phosphorus in an aquatic environment which is 106:16:1 (Redfield, 
1934). Liebergs’s law of minimum additionally states that the growth of an organism (or 
organisms) will be limited by the scarcest nutrient that is acting as a limiting factor (Brown, 
1942). The dynamic and continuous cycling of C, N and P to make nutrients available is therefore 
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essential to ensure the efficient growth of primary producers and other organisms within an 
ecosystem.  
1.6.1. The Nitrogen Cycle 
The nitrogen cycle involves the interaction of microbes, plants and animals during its seven major 
phases of biological activity. Micro-organisms are responsible for the cycling of inorganic 
nitrogen during this biogeochemical process (Payne, 1981). Micro-organisms contribute to 
nitrogen cycling in the terrestrial, aquatic and marine environment. 
The conversion of diatomic nitrogen gas to ammonia represents the major biological process by 
which nitrogen is made available to ecosystems. This process (called nitrogen fixation) is carried 
out by bacterial genera such as Rhizobium and Azobacter via nitrogenase metaloenzyme 
complexes (Quispel, 1974; Burns and Hardy, 1975). “Fixed” nitrogen can also enter the 
environment via lightning discharges or during the application of fertilizers that contain nitrogen 
that has been fixed by the Haber process. Biological fixation accounts for the majority of global 
nitrogen fixation however (85%). Of this, 60% occurs on land and 40% can be attributed to the 
aquatic environment (Brock et al., 1984).  
In the aquatic environment (marine and freshwater) nitrogen fixation may be conducted by a 
range of free-living aquatic bacteria. It is cyanobacterial taxa such as Anabaena and Nostoc sp. 
however that are responsible for the majority of aquatic nitrogen fixation, fixing up to ten times 
more nitrogen than other aquatic bacteria. They are able to do this by coupling the generation of 
ATP (via photosynthesis) with nitrogen fixation to produce nitrogen-containing compounds. 
Nitrogen fixation in the terrestrial environment is conducted by free-living symbionts of 
leguminous plants such as Rhizobium sp. and Bradyrhizobium sp. Symbionts of trees such as 
Actinomycetes also contribute to terrestrial nitrogen fixation. The mutuality of these relationships 
involves the transfer of metabolites between microbe and root nodules and is extremely important 
to maintaining soil fertility and therefore primary production (Atlas, 1988).  
 
Ammonia can then be used as a nitrogen source by organisms within an ecosystem. Excreted 
nitrogenous waste or decomposition of dead cells can then return nitrogen to the environment as 
ammonia, a process known as ammonification. Ammonification is an aerobic process that is 
conducted predominantly by soil- and sediment-dwelling micro-organisms. This source of 
ammonia along with ammonia already present in the environment can then undergo further 
biological processing. This occurs in the form of nitrification. Nitrification is the aerobic 
oxidation of ammonia to nitrite, then nitrite to nitrate.  These processes are performed by 
ammonia-oxidising bacteria (such as Nitrosomas and Nitrosospira) and nitrite-oxidising bacteria 
(such as Nitrobacter and Nitrococcus) respectively. Nitrification can also occur anaerobically in 
aquatic sediments via the ANAMMOX (ANaerobic AMmonia OXidation) reaction. Such 
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reactions are performed by Achaea species such as Crenarchaeota and ᵞ proteobacteria. These 
bacteria have often been shown to express specialised enzymes, such as ammonia 
monooxygenases (Lam et al., 2007).  
Nitrite and nitrate formed via nitrification can then enter the assimilatory pathway, where nitrite 
and nitrate reductase enzymes form ammonia from nitrite and nitrate respectively. Ammonia 
formed in this way can then be converted into nitrogenous compounds such as amino acids by 
organisms such as leguminous plants. Ammonia destined for this fate can also be produced by the 
dissimilatory pathway, during which certain bacterial species (such as Aeromonas and 
Enterobacter) grow anaerobically using nitrate as a terminal electron acceptor. Nitrite is formed 
as a result of nitrate reduction. Ammonia, diatomic nitrogen gas or nitrous oxide can be produced 
from further reduction of nitrite. The formation of nitrous oxide and diatomic nitrogen gas are 
performed by bacterial species such as Aquaspirillium and Paracoccus denitrificans respectively 
(Brock et al., 1984). 
1.6.2. The Carbon Cycle 
Carbon is an essential element in biological systems, composing an integral part of cellular 
components such as membranes, neurotransmitters and structural components. Cleavage of high-
energy carbon bonds (commonly C-H) is also an important energy production strategy for living 
organisms. Carbon-containing gasses such as carbon dioxide and methane are also important 
greenhouse gases. Cyclical concentrations of CO2 for example have been implicated in controlling 
the earth’s temperature over time (Berner, 1990).  The carbon cycle is a biogeochemical process 
where carbon is exchanged between the biosphere, atmosphere and hydrosphere. This represents 
the process of carbon recycling on planet earth.  
 
A number of non-biological processes contribute to the global cycling of carbon. Weathering of 
sedimentary rocks containing carbonate ions releases carbon dioxide gas via a hydrogen carbonate 
intermediate. Volcanic activity also releases carbon into the atmosphere as carbon dioxide, carbon 
monoxide and methane. In addition to these, carbon can be released into the atmosphere as carbon 
dioxide by the burning of fossil fuels and wood from forests.  
 
In the aquatic and terrestrial environment carbon is initially fixed into simple and complex 
carbohydrates (CH2O) by plants and algae that contain chlorophyll (via photosynthetic processes). 
Carbohydrates may then be respired by these organisms, in which case CO2 gas is released back 
into the atmosphere. Alternatively, plants and algae can be eaten by organisms living on a 
different trophic level and carbon is passed to these animals. Carbon can again be released into the 
atmosphere in the form of CO2 gas as carbohydrates are respired. Digested, partially undigested or 
undigested food can then be used as a carbon source by terretrrial and aquatic bacteria and fungi. 
Dead animals, plants or fragments of animals and plants that have been shed (detritus in aquatic 
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systems and humus in terrestrial sytems) can also be utilised in a similar manner. Carbon can 
come from autochthonous (within the ecosystem) and allochtonous (external) sources. Humus can 
therefore act as a carbon source for aquatic micro-organisms also (Naumann, 1918). Microbial 
metabolism of humus, detritus, digested or undigested food releases carbon containing gasses 
(such as carbon dioxide and methane) into the atmosphere. Within microbial communities 
interbacterial carbon cycling can also occur via viral lysing, bacterial bactivory and leakage from 
the carbon cycle (Cole and Caraco, 1993). 
 
In addition to detritus and humus, SOM in soil (soil organic matter) and DOC in aquatic systems 
(dissolved organic carbon) can be utilized as a carbon source by micro-organisms. Both forms of 
carbon are interchanged with POM (particulate organic matter) and can be quantified by bacterial 
biomass production (BBP) rates (how much carbon has been incorporated into microbial cells 
over a period of time). Alternatively, SOM and DOC can be mineralized to form carbon-
containing gases such as carbon dioxide and methane. SOM contains a wide array of structural 
and cellular components from a diversity of organisms. These substances can be humic or non-
humic. Humic substances (which make up around 60-80% of SOM) are composed of a wide 
range of organic molecules, including carbohydrates, amino acids and other nitrogenous 
compounds (such as amines and amides) as well as a range of carboxylic acids. Some of the most 
ecologically significant humic constituents are the carboxylated fulvic and humic acids. These not 
only provide buffering capacity but also act as an important carbon source to microorganisms. 
Non-humic substances (which make up around 20-30% of SOM) present in SOM include 
carbohydrates, proteins and other nitrogenous compounds and a vast and diverse array of 
polymers, such as lignin, fats, waxes and resins. Again, many of these compounds provide 
valuable carbon and nitrogen sources to environmental microorganisms (Nelson and Sommers, 
1982).  
DOC has also been reported to contain a wide range of organic molecules. Among the most 
prevalent of these are carbohydrates, carboxylic acids, amines and amino acids (McDowell and 
Likens, 1988). DOC has been shown to contain up to 50% humic substances, highlighting the 
importance of carboxylated DOC constituents. Humic DOC components have been shown to be 
important for bacterial production in the aquatic environment (Moran and Hodson, 1990).  
The ability of a wide array of bacteria and fungi to degrade (and therefore utilise) SOM 
components has been further demonstrated, with the soil community having enzymes such as 
celluases (degrade cellulose), chitinases (degrade chitin), peptidoglycan hydrolases (degrade 
peptidoglycan) and polyphenol oxidases (degrade polyphenols) (Ekschmitt et al., 2005). In the 
aquatic environment, microorganisms are capable of utilising a broad range of organic molecules 
contained within DOC (Jankhe and Craven, 1995). Whole-lake DOC addition experiments have 
shown that increased DOC results in increased bacterial production, highlighting the importance 
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of DOC to microbial communities (Blomqvist et al., 2001). Tranvik and Hofle (1987) have also 
demonstrated the high efficiency that organic molecules (glucose and phenol) are utilized (20% of 
DOC) based bacterial biomass calculations.  
A wide and diverse range of heterotrophic bacteria (such as bacterioplankton) play an important 
role in the recycling of carbon. In addition, aquatic aerobic anoxygenic phototrophic Bacteria 
(AAPBs) have been shown to be able to utilise sugars, tricarboxylic acids, fatty acids, amino 
acids, alcohols, gelatins, starch and even detergents such as tweens when light energy is 
unavailable to fix carbon (Shiba and Simidu, 1982; Yurkov and Gorlenko, 1990; Shiba, 1991; 
Yurkov and Gorlenko, 1993; Yurkov et al., 1994).  
Microorganisms also play an important role decomposing organic molecules of anthropogenic 
origin. Such compounds can occur in the environment as SOM or DOC. In the last fifty years a 
multitude of biodegradative pathways for organic pollutants have been mapped for a range of 
microbial species (Pelz, 1999), revealing the ability of environmental microbes to utilize 
anthropogenic organic compounds as a carbon and energy source (Mishra et al., 2001).  
1.7. Reported Effects of Antibiotics on Environmental Microbes 
The occurrence of antibiotics in the environment has led to a range of studies that have explored 
the effects of these substances on microorganisms. Effects have been observed in several matrices 
such as soil (e.g.: Chander et al 2005) surface water (eg: Schallenberg and Armstrong, 2004), and 
activated sludge (e.g.: Halling Sorenson, 2000). A diverse range of effects have been found 
following the exposure of microbes to a wide array of antibiotic classes with reported effects for 
each antibiotic differing greatly depending on which end-point is being evaluated. It is likely 
therefore that microbial end-points respond differently depending on the antibiotic that is being 
tested. It is also likely that different bacterial species and strains, as well as different microbial 
communities will respond differentially to specific antibiotics. This may be due to the fact that 
different bacteria and microbial communities have variable tolerances to the antibiotic or 
antibiotcs that are being tested.  
1.7.1. Effects of Antibiotics on Single Species  
Much of the work on effects of antibiotics on environmental bacteria has utilised single species 
testing. A popular organism for such testing has been the marine bacterium Vibrio fischeri which 
is the test organism in the commercially available bioluminescence inhibition test system, 
Microtox
©
. The test quantifies toxicity as a decrease in chemofluorescence produced by the 
bacterium compared with a control over a period of 30 minutes. The reduction in 
chemofluorescence can be the result of either the inhibition of the growth of the Vibrio fischeri 
population or by the inhibition of the organisms’ luciferase (the enzyme involved in 
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bioluminescence production) based biochemistry. The Microtox system has been used extensively 
as a standard test in recent years.  
Isidori et al. (2005) examined the potential toxicity of six antibiotics (erythromycin, 
oxytetracycline, sulfamethoxazole, ofloxacin, lincomycin and clarythromycin) using the Microtox 
test. It was found that three of the test compounds studied exerted an EC50 (the concentration of a 
chemical required to exert an effect equal to 50% of control values) value of below 100 mg/L. 
These were oxytetracycline (64.5 mg/L), sulfamethoxazole (23.3 mg/L) and ofloxacin (25% 
inhibition at 100 mg/L). The authors considered these effect concentrations to be higher than 
expected. When Christensen et al. (2006) tested the potential toxicity of various antibiotics 
(oxytetracycline, erythromycin, ofloxacin and oxolinic acid) and antibiotic mixtures 
(oxytetracycline plus flumequine, erythromycin plus flumequine and oxytetracycline plus 
erythromycin) using the Microtox system, relatively high acute EC50 values were observed. These 
values ranged from 66 to 560 mg/L. Of these values oxytetracycline exerted the highest EC50 
value (66 mg/L). Exposure to all antibiotic mixtures yielded scattered data that did not fit the 
analysis used by the authors. Relatively high EC50 values were also observed by Kim et al. (2007) 
when they used the Microtox assay to assess the toxicity of six widely used sulfonamides. In this 
study chemoluminescence was read after 5 and 15 minutes to determine the acute toxicity of the 
compounds tested. In the case of sulfamethoxazole EC50 values of 74.2 mg/L
 
and 78.1 mg/L
 
were 
observed after 5 and 15 minutes respectively. For sulfachlorpyridazine EC50 values were 53.7
   
and 
26.4 mg/L. When Lalumera et al. (2004) investigated the acute toxicity (30 minutes) of 
flumequine and oxytetracycline towards Vibrio fischeri they also observed relatively high EC50 
values of 12.1-15.3 mg/L and 121-139 mg/L respectively. The observed insensitivity of the 
Microtox test to the antibiotics may be a result of the short test duration (30 minutes). 
Several other studies that have conducted the Microtox assay over a longer exposure period. 
Froehner et al. (2000) exposed Vibrio fischeri to nalidixic acid, chloramphenicol and 
streptomycin sulphate for 24 hours. In the case of nalidixic acid and streptomycin sulphate, no 
EC50 values could be determined after 30 minutes. However EC50 values observed after 24 hours 
were 0.21 mg/L
 
for nalidixic acid and 21 mg/L
 
for streptomycin sulphate. Chloramphenicol had a 
30 minute EC50 value of 81 mg/L
 
compared with a 24 hour EC50 value of 0.07 mg/L. Backhaus et 
al. (1997) also observed significantly lower EC50 values using a chronic bioluminescence test 
compared with short term testing. In the case of nalidixic acid no effects were observed in acute 
testing but an EC50 value of 0.18 mg/L
 
was observed after a 24 hour exposure. When tetracycline 
was tested an EC50 value of 19.6 mg/L
 
was obtained in an acute (30 mins) test compared with a 
chronic (24h) EC50 value of 0.02 mg/L. In another study Backhaus and Grimme (1999) observed a 
24 hour EC50 value of 0.06 mg/L
 
for chloramphenicol. They also tested a range of other antibiotics 
and disinfectants in the same study. 24 hour EC50 values were found to be relatively lower than 
those that were obtained during a shorter exposure period. Indeed, of the antimicrobial 
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compounds tested, chloramphenicol, tetracycline, nalidixic acid, norfloxacin and ofloxacin all 
exerted EC50 values of < 1 mg/L.  It is interesting to note that agents that inhibit DNA/RNA were 
shown to be the most potent in this study, perhaps indicating the Microtox assay is suited towards 
testing the toxicity of compounds that are targeted to such mechanisms of action.  
 
Work has also been conducted to evaluate the impacts of antimicrobial compounds on other 
microbial test species. Kummerer et al. (2000) demonstrated that ciprofloxacin and ofloxacin 
inhibited the growth of the Gram-negative species Pseudomonas putida with EC50 values of 80 
μg/L (ciprofloxacin) and 10 μg/L (ofloxacin) being obtained. Since Pseudomonas putida is seen as 
being a model organism for Gram-negative environmental microbes it can be conferred these 
compounds may be toxic to a range of environmental microbes in general. The compounds 
studied were also broad-spectrum antibiotics, suggesting that wider effects may be seen with these 
compounds. Halling-Sorensen et al. (2002) also observed effects of antibiotics on pseudomonads. 
In this study, the growth rates of 15 pseudomonad strains (isolated from the soil microbial 
community) were observed in the presence of geometrical concentrations (0.25-32 mg/L) of 
chlortetracycline, oxytetracycline, tetracycline and tetracycline degradation products. Exposure to 
parent compounds resulted in MIC50 (minimum concentration of toxicant required to cause 50% 
inhibition, generally of microbial growth) values of 2 mg/L
 
(tetracycline), 0.5 mg/L
 
(CTC) and 1 
mg/L
 
(oxytetracycline). Degradation products of tetracycline were found to be generally less 
inhibitory to the growth of pseudomonads, with MIC50 values in the range of 12-32 mg/L. The 
same exposure conditions were also applied to four other soil isolates (Agrobacterium sp., 
Moraxella sp. and two strains of Bacillus sp.). These isolates were generally more sensitive to the 
parent compounds (all three compounds causing an MIC50 of 0.25 mg/L). In addition, they were 
generally more sensitive to tetracycline degradation products; MIC50 values were in the range of 
0.25-32 mg/L. These results highlight the fact that different species and strains show differential 
sensitivity to antibiotics. The also study highlights the fact that pseudomonads often show 
tolerance to a broad range of toxicants, explaining the higher MIC50 values that were obtained.  
 
Other studies have looked at more specific effects of antibiotics on pseudomonads. Linares et al. 
(2006) conducted experiments that could detect specific effects of tobramycin, tetracycline and 
norfloxacin at sub-inhibitory concentrations (determined from minimum inhibitory concentration 
experiments). In these experiments, the exposure of the pathogenic Pseudomonas aeruginosa to 
all three compounds resulted in increased biofilm formation and cell motility (in the case of 
tobramycin). Stimulation of these phenotypes may result in the antibiotic-susceptible pathogenic 
Pseudomonas aeruginosa having a selective advantage due to their ability to swarm at a greater 
rate and thus exploit new heterogenous habitats in the presence of the antibiotics. In addition, 
exposure to sub-inhibitory concentrations of tetracycline was found to stimulate a type III 
secretion system (a needle-like protein appendage that is released by Gram negative bacteria) 
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resulting in increased cytotoxicity. Increased cytotoxicity may result in an increased chance of 
survival of Pseudomonas aeruginosa due to an increased ability to survive predation.      
 
Single species tests have also been utilised to test the effects of tetracycline and tylosin that are 
bound to soil particles. Chander et al. (2005) inoculated two different soil types (Webster clay 
loam and Hubbard loamy sand) with three environmental species of bacteria (antibiotic resistant 
and sensitive Salmonella and Escherichia coli ATCC 25922). Dynamic and static conditions were 
simulated to represent effects in soils that had and hadn’t been mixed with manure or nutrients. A 
decline in CFUs (colony forming units) of 40-60% was observed in soils spiked with 
tetracyclines, with the greatest decline being recorded with Escherichia coli ATCC 25922 CFU 
counts. Exposure of the three microbial species to tylosin caused a 20-30% reduction in CFU 
counts. Sensitive Salmonella strains were found to be the most sensitive species studied. This 
investigation further highlights the potential for different antibiotic compounds to inhibit specific 
processes in single microbial species, in this case the number of original cells that are seeded onto 
an agar plate. The study also indicated that antibiotics retain at least some of their activity when 
bound to soil particles and are still bioavailable in such a scenario. 
The effects of antimicrobial compounds have also been tested on single species of cyanobacteria. 
Ando et al (2007) investigated the effect of seven antibiotic compounds (sulfadimethoxine, 
erythromycin, thiamphenicol, ampicillin, oxytetracycline, norfloxacin and trimethoprim) on the 
growth of eight species of cyanobacteria (Anabe thana cylindrical NIES-19, Anabena flos-aquae 
ATCC 29413, Anabena variabilis NIES-23, Microcystis aerugenosa NIES-44, Microcystis 
wesenbergii NIES-107, Nostoc sp. PCC 7120, Synechococcus leopoldensis IAM M-6, 
Synechococcus sp. and PCC 7002). Each species was grown in the presence and absence of 
antimicrobial compounds and the OD655 value (optical density at 655 nm) was taken as a measure 
of cellular growth. EC50 values for each exposure revealed that all nine cyanobacterial species 
were susceptible to most of the antimicrobial compounds tested at low concentrations (most EC50 
values were < 1 mg/L), with the exception of sulfadimethoxine and trimethoprim. Of the different 
cyanobacteria tested, Microcystis aerugenosa and Synechococcus sp. were found to be the most 
sensitive to the compounds tested, with EC50 values falling well below 1 mg/L
 
for five and four of 
the test compounds respectively. This study therefore illustrated the sensitivity of cyanobacteria to 
antimicrobial compounds in the aquatic environment. In another study by Robinson et al. (2004), 
Microcystis aerugenosa was shown to be sensitive to fluoroquinolone antibiotics. In five day 
growth tests, EC50 value of 7.9 μg/L (levofloxacin), 17 μg/L
 (ciprofloxacin), 21 μg/L (ofloxacin), 
49 μg/L (enrofloxacin), 51 μg/L (levofloxacin) and 1960 μg/L (flumequine) were recorded. Again, 
this study highlighted the tendency for cyanobacterial processes to be inhibited by antimicrobial 
compounds. Halling-Sorenson et al. (2000) further showed the susceptibility of Microcystis 
aerugenosa to antimicrobial compounds. In growth inhibition experiments in the presence of 
mecillinam and ciprofloxacin, EC50 values of 0.06
 
and 0.005 mg/L
 
(respectively) were reported. In 
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a second set of experiments Microcystis aerugenosa was shown to be extremely sensitive to a 
larger set of antimicrobial compounds (benzylpenecillin, CTC, olaquindox, spiramycin, 
streptomycin tetracycline, tiamulin and tylosin). With the exception of olaquindox, all compounds 
tested exerted an EC50 value of < 0.1 mg/L. The lowest EC50 value published was that of tiamulin 
(0.003 mg/L). The susceptibility of Microcystis aerugenosa to a wide range of antimicrobial 
compounds was therefore demonstrated.  
1.7.2. Effects of Antibiotics on Microbial Respiration 
Several authors have also reported toxicity of antimicrobial compounds towards microbial 
communities in the environment. One of the most studied effects has been on microbial 
respiration. Thiele-Bruhn and Beck (2005) for example conducted substrate-induced respiration 
(SIR) to test the effects of sulfapyridine and oxytetracycline. They conducted short-term (4 hour) 
and long-term (24 hour) incubations in the presence of various antibiotic concentrations and 
glucose (as a substrate). Experiments were conducted in two soil types (cambisol and luvisol). A 
significant inhibition of SIR occurred in 24-hour incubations in the case of both antibiotics tested 
and in both soil types. ED50 (dose that induces 50% inhibition) values of 6.2
 and 11.5 μg/L 
(cambisol and lumisol respectively) were detected for sulfapyridine and 19.1
 and 31.2 μg/L 
(cambisol and lumisol respectively) were detected for oxytetracycline. This study therefore 
showed the potential for various bacteriostatic agents to exert an inhibitory effect on microbes that 
are found in different soil types. It is interesting to note that no inhibitory effects were observed 
after a 4 hour incubation using SIR. These results are in agreement with variable time exposure 
results that have been detected with other assays (such as Microtox).  
In another experiment Zielezny et al. (2006) tracked SIR activity over a time period in soil 
microcosms that had been spiked with CTC and sulfadiazine. Varying levels of respiratory 
inhibition were detected. When microcosms were spiked with sulfadiazine and glucose a dose-
dependent decrease in microbial respiration was detected over time. It was observed that this 
inhibitory effect only occurred in the presence of glucose, indicating that microbial growth is a 
requirement for studies that track microbial activity over time in the presence of bacteriostatic 
antibiotics. When respiration in the presence of CTC was tracked over time no significant 
differences (compared with control microcosms) were observed (both with and without glucose 
addition). The lack of response by soil microbes to CTC was probably due to the compounds 
sorption to the orthic luvisol in which the experiment was conducted. In contrast to this study, 
Vaclavik et al. (2004) found that exposure to the antibiotics tylosin, tetracycline, CTC, 
sulfachloropyridazine and erythromycin increased SIR in soil microcosms. The increase was in 
the order of 1.3-1.7 times. When the tetracycline compounds were re-added into the microcosm 
system (days 36-100), a further increase in the soil respiration rate was observed (1.5-2.0 times 
the basal respiration rate). Further tylosin addition at the same time-point resulted in a reduction 
of respiration rate to basal levels. Addition of sulfachloropyridazine at day 36 resulted in a 0.8 
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fold decrease in respiration rate from day 36 to 100. These data therefore represented a variable 
temporal response of the microbial community to antibiotics. Schallenberg and Armstrong (2004) 
observed an increase in the microbial respiration rate when studying the effect of a mixture of 
antibiotics on microbial respiration in surface water. This significant (but undisclosed) increase in 
microbial respiration was observed after previous inhibition (significant but undisclosed value) 
was detected. The authors speculated that intermittent detoxification might explain these results. 
Vaclavik et al. (2004) theorised that three possible reasons could explain the observed increase in 
respiration rate. The first of these could have been that because of the specific mode of action of 
antibiotics, only a certain percentage of the microbial community were affected by the addition of 
antibiotics. Competing portions of the microbial community may therefore have been able to 
become more active (in terms of the measured respiration rate). In addition, dead cells may act as 
a carbon (and therefore energy) source for the living fraction of the microbial community and a 
corresponding rise in respiration rate may occur. Increased stress levels within the microbial 
community could also have caused an increase in respiration rate. Not all studies that have 
observed the effect of antibiotics on microbial respiration have amended their test system with a 
substrate such as glucose however. Landi et al. (1993) tracked CO2 evolution in different soils 
(arable and forest) that had been incubated in glass mesocosms. Arable soils that been exposed to 
streptomycin were shown to have a significantly lower level of CO2 evolution and therefore a 
lower respiration rate. In contrast, CO2 evolution in forest soils actually increased in the presence 
of streptomycin. Inhibition of respiration in arable soils is believed to be caused by the 
antimicrobial activity of streptomycin, suggesting that the compound has antimicrobial activity in 
arable soils. The study did not find similar effects in forest soils however. Possible reasons for this 
are the utilisation of streptomycin as a carbon source (and thus respiration mediated energy 
source) or the ability of forest soils to utilise an increased number of dead cells (caused by biocide 
activity) as a carbon (energy) source. This paper once again shows the variable effects of 
antibiotics that have been detected when investigating microbial respiration.  
1.7.3. Effects of Antibiotics on Microbial Growth 
Experiments that have tested the effects of antimicrobial compounds on the growth of microbial 
communities have also been conducted. Growth inhibition tests have been widely applied in a 
number of studies (sometimes in conjunction with other methods). The effects of antimicrobial 
compounds on the growth of activated sludge microbes have been studied the most extensively.  
Kummerer et al. (2000) for example determined CFU (colony forming unit) counts in test vessels 
containing wastewater in the presence of several antibiotics. Although no EC50 values were 
obtained a slight but significant effect on CFU counts was observed in activated sludge in the 
presence of ciprofloxacin. No effects on CFU counts were observed in the presence of ofloxacin 
or metronidazole. This study therefore suggested that ciprofloxacin slightly inhibits the growth of 
aquatic wastewater microorganisms.   
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Halling Sorensen et al. (2002) were also able to show effects of antimicrobial compounds 
(tetracycline, CTC, tetracycline degradation products and CTC degradation products) on activated 
sludge CFU counts (acting as a representative surrogate for environmental bacteria). Using 
percentage inhibition (of CFUs) to calculate EC50 values, the authors observed widespread 
inhibition of CFU counts. The lowest EC50 values that could be observed were 0.03 mg/L
 
(5a, 6-
anhydrotetracycline hydrochloride and CTC) compared with 6 mg/L for the toxicity reference 
compound 3, 5-dichlorophenol. Indeed all but two of the compounds tested (iso-CTC and ter-
oxytetracycline) had an EC50 value below that of the toxicity reference compound. The tendency 
for tetracyclines and tetracycline degradation products to inhibit bacterial colony formation (and 
therefore growth) on agar plates was therefore demonstrated.  Halling-Sorenson et al. (2002) 
showed a reduction in the potency of selected antibiotics (oxytetracycline, tylosin, sulfadiazine, 
streptomycin, ciprofloxacin and olaquindox) in activated sludge and soil interstitial water over 
time in both dark and light conditions by using CFU counts as a toxicity end-point. It was 
observed that the potency of most antibiotics tested generally declined over time (a reduction in 
CFU counts were was measured) in both soil interstitial water and activated sludge, except as the 
result of exposure to ciprofloxacin and oxytetracycline. In the case of ciprofloxacin the potency of 
the compound remained unchanged over time with all treatments. The potency of oxytetracycline 
in this study showed an increase over time in soil interstitial water. The cause of this effect was 
attributed to toxicity of degradation products, as removal of parent compound alone could not 
explain the increase in compound potency. A reduction in potency over time with other 
compounds tested was thought to be the result of degradation of the parent compound, formation 
of less toxic transformation and degradation products or due to the possibility that portions of the 
microbial community had become tolerant to antimicrobial compounds. Colinas et al. (1994) also 
investigated the effect of antibiotics and mixtures of antibiotics (oxytetracycline and penicillin) on 
soil CFU counts. In this study active CFU counts were also taken (by staining cells). Exposure to 
the two compounds resulted in active CFU counts being reduced by 20% compared with the 
control value and total CFU counts being reduced by 29%. Not only did these results provide 
another example of antibiotics inhibiting soil CFU counts, but also illustrated the potential for 
specific antimicrobial compounds to inhibit active CFU counts. These data suggest that the 
cultivable portion of the microbial community as well as the total cultivable portion of the active 
microbial community in soil are susceptible to an oxytetracycline-penicillin mixture.  
1.7.4. Effects of Antibiotics on Specific Cellular Function 
Many studies that have assessed the effects of antimicrobial compounds have focused on 
investigating more specific cellular functions. Thiele-Bruhn (2005) for instance tested the 
potential effects of a range of antibiotics (CTC, sulfadimethoxine, oxytetracycline, sulfadiazine, 
sulfadimidine and tetracycline) on iron (III) reductase activity (an important metabolic enzyme) of 
bacteria from different soil types. A wide range of ED50 (dose of test compound required to cause 
a 50% inhibition in end-point) values were recorded for each compound tested. Tetracycline 
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values for example ranged from 2.5–580 µmol/kg. It is thought that this range could be explained 
by differential sorption of test compounds to different soil types. Most significantly, three of the 
compounds tested showed sufficient inhibitory activity to cause ED10 values (dose of test required 
to cause 10% reduction in end-point activity) of < 100 µg/kg. These compounds were the 
sulfonamides sulfadiazine, sulfadimidine and sulfadimethoxine. This study therefore 
demonstrated the sensitivity of bacterial iron (III) reductase to sulphonamide exposure in certain 
soil types. The tendency for different soil types to display a variable iron (III) reductase response 
to antibiotics was also shown.  
Other effects on bacterial enzymes have also been reported. Boleas et al. (2005) examined the 
effects of oxytetracycline on dehydrogenase and phosphatase activity in a multi-species soil test 
systems. A significant inhibition in enzyme activity was observed at all concentrations in soils 
that had been amended with manure. The results from this study indicated that oxytetracycline 
concentrations as low as 0.01 mg/kg
 
can cause an inhibition in phophatase activity. As these levels 
are close to environmentally realistic concentrations, the compound has shown the ability to 
interfere with phosphorus cycling in soils that have been manured.   
 
The effect of oxytetracycline on dehydrogenase activity was found to vary, depending on whether 
or not manure was added to the system. In soil amended with manure a significant reduction in 
dehydrogenase activity was measured on day 7. Soils that had not been amended with manure 
however showed a significant inhibition in dehydrogenase activity after 21 days. In both cases 
these effects were seen at an oxytetracycline concentration of 100 mg/kg. As the dehydrogenase 
assay relates to carbon utilisation these results illustrated the ability of oxytetracycline to interfere 
with carbon cycling in soil at a relatively high oxytetracycline concentration.  
 
Other studies have also shown effects of antibiotics on processes that occur within carbon cycling. 
Maul et al. (2006) investigated the effect of ciprofloxacin on multi-substrate carbon utilisation by 
leaf-bound microbial communities. Using Principal Component Analysis (PCA), it was found that 
a significant variation in principle component (PC) scores could be observed at 100 μg/L 
ciprofloxacin (compared with other treatments). In addition, utilisation of carbohydrates was 
shown to be 2.7-3.5 times lower at the highest exposure concentration of ciprofloxacin (100 
μg/L). These data showed that ciprofloxacin significantly inhibited the ability of the microbial 
community (or at least part of it) to metabolise carbohydrates. The data also demonstrated that the 
cycling of certain macromolecules within the carbon cycle can be affected by 100 µg/L 
ciprofloxacin.  
 
Kong et al. (2006) assessed the effect of oxytetracycline on multi substrate utilisation by soil 
microbial communities. They reported that oxytetracycline concentrations as low as 1 μM/L 
resulted in a significant reduction in total carbon utilisation. They also reported a reduced onset of 
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carbon utilisation and less total carbon utilisation although this was not quantified numerically. 
When the team looked at how different substrate types were affected they found that 
oxytetracycline significantly reduced substrate utilisation at 1 μM/L and above, with polymer 
utilisation being the most affected. Oxytetracycline concentrations of greater than 1μM/L 
negatively affected substrate utilisation more than 0 μM/L and 1 μM/L; this was reflected by PCA 
analysis, with 0 μM/L and 1 μM/L oxytetracycline clustering close to each other but far apart 
from higher oxytetracycline concentrations. These data therefore suggested that an 
oxytetracycline concentration of more then 1 µM/L results in a change in microbial community 
structure.  
 
Schmitt et al. (2005) used multi-substrate carbon utilisation profiling to explore the effects of 
antibiotics (sulfachloropyridazine) on microbial function and community structure. Using a 
Pollution Induced Community Tolerance (PICT) approach (with Biolog plates inoculated from 
soil extracts) and generating community level physiological profiles (CLPP) data, they showed 
that sulfachloropyridazine shifted physiological fingerprints on the second PCA axis compared 
with controls. These results suggested that a toxicant-induced change in the manner in which the 
microbial community utilised various substrates occured. The authors also reported an increase in 
tolerance of the microbial community to sulfachloropyridazine as a result of fresh pig manure 
amendment. It was theorised that this could be an artefact of resistance gene transfer from 
microbial communities in the gastrointestinal tract of pigs.  
 
Effects of antibiotics on the breakdown of manure itself have also been tracked (Arikan et al., 
2006). In this study the production of biogas (methane) was monitored in manure from cattle that 
had been medicated with oxytetracycline. It was observed that total biogas production (from 
anaerobic digestion of manure) in medicated cattle was significantly lower than biogas production 
in non-medicated animals; a difference of 27 % was calculated. The results from this study are in 
agreement with other studies. Gamal-El-Din (1986) for example observed up to 49% inhibition of 
biogas production due to oxytetracycline exposure. Sankvist et al. (1984) found that 
oxytetracycline also inhibits the portion of the microbial community that anaerobically digest pig 
slurry; a 50% inhibition was observed for six consecutive days, although this occured at a 
relatively high oxytetracycline concentration of 100 mg/L. This reduction represents inhibition of 
the part of the microbial community that liberates carbon from manure. These studies have 
therefore shown that tetracyclines in medicated animal manure inhibit this part of the carbon 
cycle. As pointed out by Arikan et al. (2006) in their study, there are also economic implications 
for farmers. Reduced biogas production will in turn result in less energy generation or natural gas 
being sold to the public. Farmers may in addition have to rely on other forms of fuel, possibly 
resulting in increased prices of produce.  
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In addition to effects that have been observed on the carbon and phosphorus cycles, there have 
also been effects seen on the nitrogen cycle as a result of antibiotic exposure. Klaver and 
Matthews (1994) conducted aquaria experiments (spiked with oxytetracycline); aquaria water had 
been inoculated with two nitrifying microbial species, Nitrosomas and Nitrobacter. They 
observed almost complete inhibition of nitrification within seven days of the experiment. EC50 
values were reported to be between 8.6 and 29 mg/L
 
during the seven-day exposure. This 
disruption of the nitrification process could potentially lead to a build-up of toxicants (ammonium 
and nitrite) within an aquatic system. The potential for the ecology of aquatic systems exposed to 
tetracyclines to be adversely affected was therefore demonstrated. Campos et al. (2001) also 
observed a reduction in nitrification rates. In experiments that used sludge fermenters spiked with 
oxytetracycline, it was found that high concentrations of oxytetracycline (EC50 = 250 mg/L) 
resulted in a significant reduction in nitrification. Although high concentrations were used in this 
study, the results still show the potential for tetracyclines to disrupt the nitrification process and 
therefore disrupt nitrogen cycling in sludge. Halling-Sorensen (2000) looked at the effects of a 
range of antibiotic compounds (benzyl penicillin, CTC, oxytetracycline, olaquindox, 
streptomycin, tiamulin, tylosin, sulfadiazine, metronidazole and oxolinic acid) on nitrification in 
sewage sludge. It was found that oxytetraxycline, tetracycline, CTC and streptomycin inhibited 
measured nitrification rates. Conversely, sulfadiazine, oxolinic acid and tylosin were shown to 
increase nitrification rates. Although EC50 values were not published for these tests, values were 
given for follow up experiments that looked at growth inhibition of the nitrifying bacteria N. 
europaea. The compounds that exerted the greatest inhibitory effect were the tetracyclines and 
oxolinic acid, with EC50 values in the range of 0.002–0.5 mg/L. The study therefore illustrated the 
inhibitory effects of broad-spectrum antibiotics on sewage sludge microbes. As such microbes are 
often seen as being representative of aquatic bacteria (in the OECD 209 test, for example) the 
potential for the compounds tested to inhibit nitrification in rivers is revealed. In addition, the 
presence of broad-spectrum antibiotics in sewage treatment plants could potentially inhibit the 
integral process of nitrification (a key set of reactions which occur in sewage treatment works).  
 
There have also been reported effects of antibiotics on nitrification by soil microbial communities. 
Landi et al. (1993) explored the effect of streptomycin on nitrification rates in two different soil 
types (arable and forest). Although an initial increase in nitrification was noted (in arable soil) on 
day one, values decreased compared with the control value after this period. No effects on 
nitrification were observed in forest soils however. As nitrification is an important part of the 
nitrogen cycle in soils, these results presented the possible disruption of nitrogen cycling in arable 
soils as a result of streptomycin exposure. It should be remembered however that the dose of 
streptomycin that was applied to soils in this study was relatively high (3 mg/g).  
 
Other studies have explored the potential impacts of antibiotic exposure on other nitrogen cycle 
processes. Costanzo et al. (2005) for example explored the effect of a range of antibiotics 
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(ciprofloxacin, amoxicillin, clarithromycin, ampicillin, amoxicillin/clavaulinic acid and 
erythromycin) on the process of denitrification in aquatic sediments. At concentrations of 1000 
µg/L statistically significant effects were observed on denitrification due to exposure of the 
microbial community to clarithromycin, erythromycin and amoxicillin. The denitrification process 
was especially sensitive to amoxicillin exposure.  
 
The inhibition of another process which occurs within the nitrogen cycle, ammonification, was 
shown to be significantly inhibited in studies which had exposed microbial communities to 
ampicillin under laboratory conditions (Nimenya et al., 2000). In flask studies that tracked the 
formation of ammonium from cattle urine, ampicillin significantly inhibited the process in both 
the presence and absence of a urease enzyme (an enzyme that catalyses the breakdown of urea). 
From these results it was inferred that ampicillin inhibits the ammonification of urine by 
microbial communities. As this process is crucial in the environment (especially on land that 
supports livestock) any inhibition could lead to the build-up of toxic nitrogenous compounds 
(such as urea). Arikan et al. (2006) also studied ammonification rates from animal waste (cattle 
manure). A transient inhibition (but not statistically tested) in ammonification rates as a 
consequence of oxytetracycline exposure was observed. The inhibition was not sufficient to result 
in a toxic build-up of ammonia (that could potentially inhibit anaerobic digesters). 
The ability of environmental microbes to incorporate (rather than breakdown) nitrogenous 
compounds has also been shown to be affected by exposure of environmental bacteria to 
antibiotics. Verma et al. (2007) looked at the impact of tetracycline exposure on the ability of 
planktonic bacteria to incorporate the amino acid leucine. They found that free (unbound) 
tetracycline concentrations of 5 and 1000 µg/L
 
significantly affected leucine incorporation in river 
and wetland waters respectively. As leucine is an important amino acid that is required for 
bacterial protein production, any disruption in acquiring this nutrient could reduce the selective 
advantage of a (sensitive) microbe or microbial community. Protein production in planktonic 
bacteria was therefore shown to be extremely sensitive to tetracycline exposure in the aquatic 
systems that were investigated.  
1.7.5. Effects of Antibiotics on Xenobiotic Degradation 
The efficiency with which environmental microbes degrade xenobiotics in the presence of 
antibiotics has also been investigated. Chun et al. (2005) for example examined the effect of 
sulfamethazine, tylosin and CTC on the biodegradation and transformation of 17 β-Estradiol in 
soil (sequatchie loam). The authors reported a significant decrease in the transformation of 17 β-
Estradiol (to its metabolite estrone) in the presence of all antibiotics. Interestingly, the authors 
noted a significant inhibition in dehydrogenase activity as a result of antibiotic exposure. This led 
them to the conclusion that dehydrogenases may be responsible for transformation and partial 
degradation of 17 β-Estradiol in the environment. Moreover, the inhibition of dehydrogenases 
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results in reduced transformation/degradation of 17 β-Estradiol. Allen and Walker (1988) 
investigated the effect of antibiotics on the degradation of pesticides. They tracked the 
degradation of metamitron, metazachlor and metribuzin in two soils exposed to novobiocin. 
Although CO2 levels were found to be higher in both soils tested, novobiocin was found to inhibit 
the degradation of metazachlor and metribuzin significantly. In one soil novobiocin was also 
shown to inhibit the degradation of metamitron, although the extent to which this occured was 
minimal. The study highlighted the sensitivity of the portion of the microbial community that can 
degrade certain xenobiotics in different soil types. In another study by Montiero and Boxall 
(2009), the degradation of the anti-inflammatory drug naproxen by soil microbial communities 
was observed to be inhibited by the veterinary antibiotic sulfamethazine. The authors warned of 
the potential for mixtures of pharmaceuticals exerting a greater effect than single environmental 
toxicants.  
1.8. Antibiotic Resistance 
 
Antibiotic resistance is the ability of bacteria to grow and survive under normally inhibitory 
antibiotic concentrations (Davies, 2007). The prokaryotic kingdom has evolved specific and non-
specific responses to become resistant to the effects of anti-microbial compounds. Alexander 
Fleming observed this during initial observations with penicillin and warned of the tendency for 
microorganisms to become resistant (Fleming, 1928). In the 1950s Streptomycin resistance had 
been observed in clinical situations with the first multi-drug resistant strains being recorded in 
Japan in 1955. Since then antibiotic resistance has been observed for a wide array of anti-
microbial compounds (Davies, 2007). Indeed, Louise Pasture once commented, “the microbes 
will always have the last word,” highlighting the metabolic and evolutionarily diversity of 
prokaryotes in response to antibiotic chemotherapy. 
1.8.1. Mechanisms of Resistance  
Antibiotic resistance occurs via a range of cellular biochemical mechanisms. These mechanisms 
are the phenotypic expression of genetic determinats called antibiotic resistance genes. Resistance 
genes can arise either as a result of mutated DNA (plasmid or chromosomal) or can be acquired 
via horizontal gene transfer or gene induction. This is the process whereby foreign DNA can be 
introduced into a bacterial chromosome via a bacteriophage (bacterial virus). Some mechanisms 
of resistance can also be an artefact of natural cellular processes (intrinsic resistance). Table 1.4 
summarises the main types of resistance and how they occur. Table 1.5 summarises the specific 
genes and phenotypic mechanisms by which antibiotic resistance occurs. A more detailed 
description of the mechanism of resistance selection is provided in chapter 5.  
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Table 1.4: Main types of intrinsic, mutational and acquired resistance mechanisms. Mechanisms in italics indicate those mechanisms that are normally mutational 
(adapted from Davies, 2007). 
   
Category of Resistance Mechanism 
Intrinsic Mutational Acquired 
   
Inaccessibility of target Target site modification Target site modification 
Multi-drug efflux systems Target amplification Target amplification 
Drug inactivation Repair of damaged target Repair of damaged target 
 
Biofilm formation Biofilm formation 
 
Increased efflux Increased efflux 
 
Decreased influx Decreased influx 
 
Enzyme inactivation of antibiotic Enzyme inactivation of antibiotic 
 
Sequestration of antibiotic Sequestration of antibiotic 
 
Target bypass Target bypass 
 
Protection of target Protection of target 
 
Intracellular localisation of antibiotic Intracellular localisation of antibiotic 
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Table 1.5: Resistance mechanisms of major antibiotic classes. 
   Antibiotic Class Phenotypic Mechanism(s) Reference(s) 
Aminoglycosides Enzymatic modification of Aminoglycosides by acetyltransferases, nucleotidal transferases, 
adenylyltransferases and phosphotransferases. Modified Aminoglycoside molecules can no 
longer bind to the 30S ribosomal sub-unit allowing protein synthesis to occur normally. 
Shaw et al., 1993 
Bacitracin Cellular efflux of Bacitracin via ATP-binding cassette (ABC) transporter reducing intracellular 
Bacitracin concentration; increased phophorylation of C55-isoprenyl phophate allowing 
peptidoglycan synthesis to occur; secretion of exoploysacharride, thickening Gram-positive cell 
wall to act as increased physical barrier to Bacitracin entry to cell. 
Cain et al., 1993; Pollock et al., 1994; 
Tsuda et al., 2002 
Beta-lactams and Cephems >190 group 1-4 proteins and novel beta-lactamases hydrolyse beta-lactam ring structure. 
Modified beta-lactam molecules are then unable to act as analogues of the terminal peptide 
sequences of peptidoglycan precursor NAM/NAG-peptide. 
Bush, 1989a; Bush, 1989b; Medeioros, 
1989; Jacoby and Medeioros, 1991 
Chloramphenicol Acetylation of chloramphenicol molecules by chloramphenicol acetyltransferase enzymes. 
Modified chloramphenicol molecules are unable to bind to 23s ribosomal sub-unit and protein 
synthesis can proceed normally; reduced permeability of bacterial cells to chloramphenicol due 
to the loss of a 40 kDa protein. 
Shaw, 1967; Shaw and Unowsky, 1968; 
Burns et al., 1985 
Glycopetides Direction of peptidoglycan synthesis from precursors with C-terminus D-alanyl-D-lactate 
(VanA, VanB and Van D) or D-alanyl–D-serine (VanC, Van E and VanG). Modifications 
significantly reduce the affinity of peptidoglycan precursor to glycopeptides. Cell wall 
biosynthesis can therefore occur. 
Nieto and Perkins, 1971 
Macrolides Production of Macrolide methylase enzyme that catalyses N
6
-dimethylation a 23s ribosomal 
sub-unit adenosine. The resultant conformational change of the ribosomal P site prevents 
macrolide binding and protein synthesis can proceed; energy-dependent efflux of macrolides 
out of cytoplasm via efflux protein systems; degradation of Macrolides by EreA and EreB 
esterases renders Macrolides inactive. 
Lai and Weisblum, 1971; Nikaido, 1998; 
Wondrack et al., 1996 
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Table 1.5 (cont). 
Antibiotic Class Phenotypic Mechanism(s) Reference(s) 
Quinolones Mutations at codons 67, 81, 82, 83, 84, 87 and 106 of gyrA and at positions 426, 447 and 463 of 
gyrB confer quinolone resistance. The exact mechanism is unclear but suspected to involve 
conformational change in Topoisomerase IV and DNA Gyrase enzymes; efflux of Quinolones 
from bacterial cells via efflux pumps AcrAB, MexAB-OprM, MexCD-OprJ, MexEF-OprN, 
MexXY (reading frame not found), AdeABC, CmeABC, AcrAB
a
, AcrEF, EmrAB, MdfA, 
YdhE, SmeDEF, VceAB, NorM in Gram negative micro-organisms and Blt, BmrA, Bmr3, 
NorA and PmrA in Gram positive micro-organisms. 
Ruiz, 2003 
Rifampin Three mutations in bacterial RpoB (Rif
R 
cluster I, Rif
R 
cluster II and Rif
R 
cluster III) reduce 
affinity of RpoB for Rifampin; reduced permeability of microbial cells to Rifampin by as yet 
undescribed mechanism; energy-dependent efflux of Rifampin from intracellular matrix; 
enzymatic modification of Rifampin by phosphorylative enzymes and ADP-ribosylating 
transferase yielding inactive products. 
Yazawa et al., 1994; Dabbs et al., 1995; 
Abadi et al., 1996; Taniguchi et al., 1996; 
Chandrasekaran and Lalithakumari, 1998; 
Sulfonamides Production of alternative forms of DHPS (dihydropteroate synthase) with reduced affinity for 
sulfonamides caused by mutations in folP and acquisition of one of three genes SulI, SulII and 
SulIII. PABA can therefore be converted into dihydrofolate and tetrahydrofolate and normal 
cell function is restored. 
Scholz et al., 1989; Vedantam et al., 
1998; Perreten and Boerlin, 2003 
Tetracyclines Active efflux of tetracyclines from bacterial cells via membrane-bound efflux proteins therefore 
Tetracycline is not allowed to confer effects within cell. Reduced; ribosomal protection proteins 
(highly homologous to elongation factors EF-Tu and EF-G) prevent ribosomal binding of 
Tetracyclines. Aminoacyl tRNA is therefore allowed to bind to ribosomal A site and protein 
synthesis can occur normally; enzymatic modification of Tetracycline molecules by 44kDa 
protein in the presence of oxygen and NADPH. Modified product does not exert ant-microbial 
activity 
Speer et al., 1992 
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1.9. Current Testing Strategy Aimed at Protecting Environmental 
Microbes 
Before an antibiotic can be marketed by a company it now needs to be assessed to determine its 
potential risk to the environment. Guidance on the environmental risk assessment of human and 
veterinary antibiotics is provided by the European Medicines Agency. For veterinary antibiotics, 
additional guidance is also provided by VICH (Cooperation on Harmonisation of Technical 
Requirements for Registration of Veterinary Medicinal Products). Current testing strategies are 
broadly divided into two phases, Phase I and Phase II. Phase I assessment involves an initial 
assessment on the likelihood and level of environmental exposure, whereas in Phase II 
environmental fate and effects testing of the antibiotic is performed. The battery of standard 
bacterial tests that are performed within these frameworks is summarised in table 1.6. 
1.9.1. Testing Strategy for Human Antibiotics 
The first tests to determine a Predicted No Effect Concentration for microorganisms 
(PNECMICROORGANISM) is required in Phase II Tier A: Initial environmental fate and effects 
assessment. EMEA (2006) recognise that the microbial community most likely to be exposed to the 
highest concentrations is the activated sludge community.  Therefore in order to assess the impact 
on the microbial community the activated sludge respiration inhibition test, or ASRIT, is performed 
(OECD 209).  The PNECMICROORGANISM is then estimated from the NOEC value using an 
assessment factor of 10 which accounts for inter- and intra-species variability and laboratory to 
field extrapolation. The PNECMICROORGANISM is then compared to predictions of concentrations in 
surface water (PECSURFACEWATER). If the PECSURFACEWATER:PNECMICROORGANISM is > 0.1, further 
evaluation of the fate and effects of the medicine and/or its metabolites on microorganisms is 
required in Phase II Tier B. If the PECSURFACEWATER:PNECMICROORGANISM is < 0.1, then the risk to 
microorganisms is considered to be acceptable. The risks of the antibiotic to blue green algae will 
also be assessed during Phase II Tier A, using a s similar approach. 
 
Phase II Tier B of the EMEA ERA for human medicines, the risk quotient for the microorganisms 
to be refined.  In order to achieve this, a PEC is determined for the aeration tank of the activated 
sludge plant. If the PECAERATION TANK: PNECMICROORGANISM is > 1 then further microbial toxicity 
studies are required such the tests using single microbial species (e.g. Pseudomonas putida) as 
identified in the Technical Guidance Document (TGD, 2003). Finally, for medicines that are not 
readily biodegradable and have a KOC >10000 L/kg a terrestrial environmental risk assessment is 
required as part of Phase II Tier B.  For such medicines the impact on soil microorganisms needs to 
be evaluated using the OECD Nitrogen Transformation Test (OECD 216).  
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1.9.2. Testing Strategy for Veterinary Antibiotics 
For veterinary drugs, the EMEA guideline based on VICH Phase II distinguishes between test 
endpoints for the aquatic compartment (for drugs used in aquaculture, and for drugs used for mass-
rearing and pasture animals, if exposure of the aquatic environment is possible) and the terrestrial 
compartment (drugs used for intensively reared animals and pasture animals). In any case, effect 
testing of microbial species has only to be performed if the respective exposure triggers are 
exceeded. Exposure triggers are either a PEC (predicted environmental concentration) soil > 100 
ug/ kg in soil, or an aquatic EIC (initial environmental concentration) > 1 ug/L). 
For the freshwater environment, algae are one of the required test species in tier A. Drugs to be 
used in freshwater or saltwater should be tested with fresh - or saltwater algal species, respectively. 
In both cases, the endpoint is the EC50 for growth inhibition (according to OECD 201 guidelines for 
freshwater and ISO 10253 guidelines for salt water), and an assessment factor of 100 has to be 
applied to the results. The guidance notes that some agencies prefer blue-green algae (Cyanophyta, 
which are prokaryotic species) in place of green algae for freshwater testing due to their higher 
sensitivity for antimicrobial substances. For saltwater, no advice on the suitability of blue-green 
algae is included in the guideline. Tier B consists of the same algal growth inhibition testing 
(according to OECD 201 for freshwater and ISO 10253 for saltwater), but the NOEC has now to be 
used as endpoint with an assessment factor of 10. For freshwater, it is suggested to use the same 
species as in Tier A (e.g. testing with a blue-green algae). 
 
With respect to the terrestrial environment, testing inhibition of nitrogen transformation (according 
to OECD guideline 216) is required in Tier A for veterinary drug used for intensively reared 
animals and pasture animals. The assay has to be conducted at two concentrations, the maximum 
PEC and 10 times the maximum PEC. In Tier B, the nitrification inhibition assay has to be 
prolonged to 100 days in case > 25% inhibition is seen after 28 days.  
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Table 1.6: Description of the range of standard microbial tests that are available. 
 
Test Description End-point/validation Ecological Protection Offered Reference 
Activated Sludge Respiration 
Inhibition Test  (ASRIT) 
(OECD, 209) 
Measures the effect of a 
pharmaceutical on aerobic 
respiration rates of activated sludge 
microbes after 30 minutes, 3 hours 
or both 
% Mean respiration compared with 
control expressed as EC50. Validated 
against 3,5-dichlorophenol 
Protects microbes in STP; provides 
toxicity threshold for biodegradation 
studies 
OECD, 1984 
Nitrogen Transformation Test 
(OECD 216) 
Measures long-term effects of 
pharmaceuticals on nitrogen 
transformation rate in soils 
Nitrate production at days 0, 7 14 and 
28 and 100 days. Expressed as ECx 
values; no validity criteria required 
Protects ecologically important 
aspects of the nitrogen cycle 
performed by soil micro-organisms 
OECD, 2000 
Nitrification Inhibition Test 
(ISO 9509) 
Assesses short-term inhibitory 
effects of pharmaceuticals on 
nitrifying bacteria in activated 
sludge over a four-hour period at 5 
toxicant concentrations 
% Inhibition of nitrite production 
compared with control. Expressed as 
EC50; Validated against Allyl thiourea 
Protects nitrifying bacteria present in 
activated sludge 
ISO 2006 
Sewage Bacteria Growth 
Inhibition Test (ISO 15522) 
Assesses potential inhibition of 
growth of aerobic bacteria present 
in activated sludge by 5 
concentrations of pharmaceutical 
compound 
Increase in microbial cell density 
measured as absorbance at 530 nm; 
ECx values obtained; Validated 
against 3,5-dichlorophenol 
Offers protection to the growth of 
microbes found in STPs 
ISO, 1999 
Pseudomonas putida Cell 
Multiplication Inhibition Test 
(ISO 10712) 
Assesses potential inhibition of 
growth of a surrogate aquatic 
microbial species due to a toxicant 
Increase in medium turbidity at 
436nm over a 16-hour period; EC10 
and EC50 values are calculated by % 
inhibition compared with controls; 
validated against 3,5-dichlorophenol 
Offers inferred protection to aquatic 
bacteria against pharmaceuticals and 
other toxicants 
ISO, 1996 
Inhibition of Light Emission of 
Vibrio fischeri (ISO 11348) 
Assesses impact of chemicals on 
light emission from marine microbe 
Vibrio fischeri 
Decrease in bioluminescence 
compared with controls after 15 and 
30 minutes. Expressed as EC20 and 
EC50 values. Validated against 3,5-
dichlorophenol, Zn
2+ 
and Cr
6+
 
Offers inferred protection against 
pharmaceuticals and other toxicants to 
bacteria in surface waters, waste 
waters and soil pore waters 
ISO, 1994 
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1.9.3. Reported Shortcomings of Microbial Standard Tests and 
Testing Strategy 
There have been a number of reported and inherent shortcomings of current standard tests that 
have been reported. One such criticism relates to the recommended duration of standard tests. 
Kummerer et al. (2000) altered the test duration of the OECD 209 (activated sludge respiration) 
from the standard 30 minutes to 3 hours and 20 hours. They concluded that a period of 30 minutes 
was too short a timescale to adequately assess toxic effects based on comparison of published IC50 
values of the same toxicants on pathogenic bacteria. After a test duration of 20 hours however 
IC50 values fell to values nearer reported IC50s (concentrations which cause a 50% inhibitory 
effect). The study also reported differences in toxicity depending on specific properties and modes 
of action of individual toxicants, suggesting individual compounds or groups of compounds 
should be studied separately. Backhaus et al. (1997) also observed that the standard Vibrio 
fischeri bioluminescence assay (ISO 11348) duration was not adequate. The toxic effects of 
several antibiotics could not be determined after the standard 30-minute exposure period but could 
be determined when the assay duration was increases to 24-hours. Froehner et al. (2000) 
confirmed this, except toxic effects of antibiotics could be detected after 3 hours.  
Conversely, it has been suggested that the recommended sampling days of the Nitrogen 
Transformation Test (OECD 216) may underestimate the impact of a toxicant. In studies that 
sampled at days 7 and 14 as well as the recommended 0 and 28 it was found that short-term 
impacts of nitrapyrin (an inhibitor of nitrification) existed at days 7 and 14. If the standardised 
procedure were followed these effects would have been missed.  In addition, nitrate formation in 
control studies is extremely variable (between 1-7 mg nitrate/kg/day) (Snape et al., 2008). Despite 
the documented effects of Nitrapyrin on nitrification inhibition (eg: Abbasi et al., 2003) no 
reference toxicant is used in the OECD 216 test. As the assay is used to study chemicals that are 
applied directly to soil the test is also not suitable for studying chemicals that are applied to soil 
via sludge, manure or slurry. As this represents major exposure routes to soil the assay loses some 
relevance. 
 
The OECD 216 has also been shown to be less sensitive than other soil-based assays (that 
measure carbon turnover such as substrate induced respiration) when studying effects of 
antibiotics on soil microbes (Schmitt et al., unpublished data). The sensitivity of carbon turnover 
based assays in the study of antibiotic toxicology has been previously demonstrated (Thiele-
Bruhn and Beck, 2005; Zielezny et al., 2006). This may be because respiration-based assays 
measure a function of microbial growth, a physiological feature inhibited by the mode of action of 
some antibiotics (such as tetracyclines).  
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There are also some inherent shortcomings of the OECD 209. As the assay detects changes in 
respiration rate it will not be able to detect toxicity of chemical that uncouple oxidative 
phosphorylation or stimulate oxygen uptake. In addition, chemicals that react with the 
standardised medium, that are poorly soluble in water or are volatile are not suitable for testing 
with the OECD 209. At Phase II Tier A the PECSURFACEWATER: PNECMICROORGANISM is calculated 
using data from the OECD 209. The inoculum used in the test however is activated sludge. It 
therefore contains a microbial population that is more likely to exist in an STP rather than being 
representative of an aquatic community structure. Also, the inoculum used can never be 
standardised due to the fact that activated sludge is collected from various STPs and will be 
inherently variable in, for example biomass and microbial community structure.  
 
Single species tests aimed at the protection of aquatic microbes utilise Vibrio fischeri, 
Pseudomonas putida or algal species. Toxicity of a chemical to one microbe may not infer 
toxicity to another microbe. Chander et al. (2005) observed differential toxicity of tobimycin to 
different single soil isolates. Robinson et al. (2005) observed differential toxicity of a range of a 
range of antibiotics to various cyanobacterial species; demonstrating one cyanobacterial species 
may not be representative for all cyanobacterial species or strains either. In addition, Vibrio 
fischeri is a marine microorganism. It is therefore questionable if the Vibrio fischeri 
bioluminescence assay can be used as a surrogate for aquatic freshwater species as they will 
possess different microbial ecology.  
A general criticism of the testing strategy of antibiotics (human and veterinary) in all 
environmental compartments (and indeed between different matrices) is the fact that there are 
currently no standardised approaches for testing whether a compound will act as a selective agent 
for antibiotic resistance. Antibiotic resistance tests would likely test the extent to which a 
chemical caused members of the (environmental) microbial community to develop tolerance 
towards that compound. Bearing in mind that antibiotic resistance can spread (mainly via genetic 
determinants), there is not currently a standardised test which can quantify the extent to which this 
may occur in the environment. Such a test would ideally be able to track the spread of antibiotic 
resistance both within and between various environmental matrices, as resistance may be able to 
spread between environmental compartments.  
Another general criticism regarding the environmental risk assessment of human pharmaceuticals 
is that only an aquatic risk assessment is required (unless a compound has a high partitioning 
value). As human medicines can enter the terrestrial environment via a number of exposure routes 
risk assessment procedures are absent for identifying the toxicity of human medicines in the 
terrestrial environment.  
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1.10. Gaps in Knowledge and Major Concerns of Antibiotics in the 
Aquatic Environment 
From the previous sections, it is clear that antibiotics occur across a range of environmental 
media, including surface waters, groundwater, soils and sediment. These compounds have the 
capacity to cause a range of toxic effects on microbial populations (including effects on growth, 
nutrient cycling, biodegradation and respiration) in the natural environment and may also play a 
role in the selection of antibiotic resistance. While a number of good and thorough studies have 
been conducted into the interactions of antibiotics in soil and activated sludge systems (see 
section 1.7), our understanding of the effects in aquatic systems is less well developed. The 
studies that have been done also have many limitations. For example, they typically focus on one 
or two endpoints whose environmental relevance is often questionable. The role of waterborne 
antibiotics in resistance selection has not been extensively studied to date. The studies that have 
been typically performed using standard laboratory test systems and assays also use relatively 
high concentrations of antibiotics. There is therefore a need to perform more rigorous studies into 
the impacts of antibiotics on aquatic microbial communities, especially in terms of ecologically 
relevant end-points such as nutrient cycling. The findings of these studies will not only allow us to 
better establish the risks of antibiotics to ecosystems but also help inform the development of 
testing approaches for use in the environmental risk assessment process which needs to be done 
before a company can market a new pharmaceutical product.  
1.11. Choice of Test Compounds 
The two antibiotics that have been chosen for study in the current project are sulfamethoxazole 
and CTC. They belong to the antibiotic classes called the sulfonamides and tetracyclines 
respectively. Both classes of antibiotic have large usage profiles both as veterinary and human 
antibiotics. They have also been frequently detected in several environmental matrices, including 
the aquatic environment. It is clear therefore that aquatic microbial communities will be exposed 
to both sulfamethoxazole and CTC. Previous work has also shown that both test compounds have 
effects on the microbial function of environmental bacteria, mainly in studies that have focused on 
looking at such effects on soil and sludge microbial communities. Many of the end-points that 
have been studied in these investigations have been ecologically relevant ones, such as nutrient 
cycling and xenobiotic degradation. Investigation into similar effects which may be occurring in 
the aquatic environment is therefore merited. Both compounds also have several mechanisms of 
resistance. Moreover, the genetic determinants of such resistance mechanisms (resistance genes) 
have been detected in several environmental matrices. The possibility for exposure of microbial 
communities to the two test compounds to select for antibiotic resistance is therefore a possibility 
and also merits investigation.  
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1.12. Aims and Objectives 
The overall aim of this study was to explore the effects of commonly used antibiotics, with 
contrasting properties (mode of action, environmental fate characteristics) on aquatic microbial 
communities. This was achieved using the following specific objectives: 
1) To develop tests and a test system that are capable of determining specific, ecologically 
relevant effects of antibiotics in the aquatic environment and to evaluate the developed tests using 
a model reference toxicant (Chapter 2). 
 
2) To use the tests developed in 1) to determine the effects of antibiotics, with different 
modes of action and contrasting physico-chemical properties, on the functioning of aquatic 
microbial communities (Chapters 3 and 4). 
 
 3)       To determine the extent to which exposure of an aquatic system to antibiotics results in 
selection of antibiotic resistance, both single and multidrug (Chapter 5). 
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Chapter 2: General Method 
Development 
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2. General Materials and Methods 
2.1. Introduction 
Chapter 1 outlined the fact that antibiotic compounds may enter the environment where they have 
been frequently detected. When in the environment, antibiotics can exert a number of ecological 
effects on microbial communities. The following chapter will introduce the use of specific 
functional assays and which can be used to test the ecological impacts of toxicants on 
environmental microbial communities. The use of laboratory based test systems shall also be 
introduced. The chapter will ultimately describe experiments that will aim to develop these 
techniques so that they can be used to study the effects of antibiotics on environmemtal microbial 
communities.  
2.1.1. Environmental Microbial Function Assays 
Changes in microbial function in the environment are frequently quantified via the measurement of 
metabolically relevant end-points. These end-points generally relate to important aspects of cellular 
function (such as energy liberation and protein synthesis) and can be coupled with important 
environmental processes such nutrient cycling. Due to the fact that enzymes catalyse many of these 
reactions a vast array of functional assays also quantify enzyme activity within environmental 
microbes and microbial communities. Functional assays have been utilised in a range of 
environmental matrices to study the potential effects of antibiotics in the environment (Table 2.1).   
2.1.2. Multisubstrate Utilisation: The Biolog GN2 Assay 
 
The Biolog GN2 assay is a phenotypic microarray that is capable of quantifying the metabolism of 
95 distinct substrates by environmental Gram negative bacteria (shown in figure 2.1). The extent to 
which substrates are metabolised is gauged spectrally (at 595 nm) by the reduction of a tetrazolium 
dye which occurs via the gain of electrons that have been liberated from Biolog substrates (due to 
microbial metabolism). A blank value (water) is then subtracted from these values. The assay was 
first introduced as a tool to identify bacterial species and strains from pure cultures. In 1991 
Garland and Mills realised the assay’s potential for use in environmental science. Used in this 
respect, the Biolog GN2 assay is capable of tracking the catabolism of 95 distinct substrates 
containing a carbon source, nitrogen source or a source of both carbon and nitrogen. These 
substrate types can be further condensed into 6 distinct “guilds”: carbohydrates, carboxylic acids, 
amines and amides, amino acids, polymers and other. The substrates belonging to each substrate 
guild are outlined in table 2.2. A Substrate guild should not be confused with an ecological guild (a 
group of organisms which exploit similar resources) however. The Biolog GN2 assay quantifies 
actual and potential microbial function meaning it also tracks the metabolism of acclimated 
microbial populations (Preston-Mafham et al., 2002). 
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Table 2.1: Functional assays that have been used to study the effects of antibiotics in several environmental matrices. 
      
Assay 
Environmental 
Matrix Studied 
Assay Description Antibiotic(s) Studied 
Corresponding 
Environmental Process 
Reference(s) 
Dehydrogenase Soil 
Measures changes in reduction 
of a redox dye spectrally due to 
electron liberation from an 
organic substrate. Related to 
the Carbon Cycle 
Sulfamethazine, tylosin and 
CTC 
Carbon cycle 
Chun et al., 2005 
Oxytetracycline Boleas et al., 2005 
SIR Soil 
Measures changes in CO2 
production over time via pH 
change due to the oxidation of 
a single substrate (frequently 
glucose). Relates to the Carbon 
Cycle 
Sulfapyridine and 
oxytetracycline 
Thiele-Bruhn and 
Beck, 2005 
Tylosin, tetracycline, CTC, 
sulfachloropyridazine, 
eryhthromycin 
Vaclavik et al., 2004 
Antibiotic mixtures 
Scallenberg and 
Armstrong, 2004 
Streptomycin Landi et al., 2003 
CTC and sulfadiazine Zeilezny et al., 2006 
Biogas production 
Soil spiked with bovine 
manure and urine 
Measurement of methane 
production by microbial 
degradation of animal waste 
products 
Oxytetracycline 
Arikan Rital et al., 
2006 
Biolog  
Soil 
Measures changes in redox dye 
reduction spectrally over time 
due to oxidation of 96 distinct 
carbon sources 
Sulfadiazine 
Carbon cycle, nitrogen 
cycle, polymer degradation 
Schmitt et al., 2005 
Oxytetracycline Kong et al., 2006 
Surface water  Oxytetracycline Maul et al., 2006 
  
69 
 
Table 2.1 (cont). 
Assay 
Environmental 
Matrix Studied 
Assay Description Antibiotic(s) Studied 
Corresponding 
Environmental Process 
Reference(s) 
Nitrification assay Aquaria water 
Measures the conversion of 
nitrate to nitrite spectrally 
Oxytetracycline 
           Nitrogen cycle 
Klaver and Mathews, 
1994 
 Sewage sludge 
Tylosin, sulfadiazine, 
streptomycin, ciprofloxacin, 
olaquindox 
Sorensen, 2000 
 Soil 
Chloramphenicol and 
oxytetracycline 
Campos et al., 2001 
Denitrification assay Aquatic sediment 
Measures liberation of nitrogen 
gas or nitogen dioxide from 
inorganic nitrogenous 
compounds 
Ciprofloxacin, amoxicillin, 
clarithromycin, ampicillin, 
amoxicillin / clavaulinic acid 
and erythromycin 
Costanzo et al., 2005 
Ammonification 
assay 
Environmental urine 
Measures (spectrally) 
ammonium production from 
oxidation of amino acids such 
as arginine 
Ampicillin Nimenja et al., 2000 
Leucine incorporation 
assay 
Surface water  
Measures amino acid 
incorporation into biomass via 
isotopic labelling 
Tetracycline Verma et al., 2007 
Iron (III) reductase 
assay 
Soil 
Measures spectrally the extent 
to which iron compounds are 
reduced over time 
CTC, sulfadimethoxine, 
oxytetracycline, sulfadiazine, 
sulfadimidine, tetracycline,  
sufadimidine 
Iron cycle Thiele-Bruhn, 2004 
Phosphomonoesterase 
assay 
Soil 
Measures spectrally the 
conversion of phosphorus salts 
onto phenol 
Oxytetracycline Phosphorus cycle Boleas et al., 2005 
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Figure 2.1: The 95 distinct substrates and their schematic location on the Biolog GN2 Microplate (Biolog, 2007). 
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Table 2.2: Outline of substrates belonging to individual substrate guilds on the Biolog GN2 plate (Biolog, 2007). 
  Substrate Guild Substrates in Guild 
Amines and Amides 2-Amino ethanol, Glucuronamide, L-Alaninamide, Phenylethylamine, Putrescine, Succinamic acid 
Amino Acids 
ᵞ-Amino butyric acid, D,L-Carnitine, D-Alanine, D-Serine, Glycyl-L-aspartic acid, Glycyl-L-glutamic acid, Hydroxy-L-proline, L-
Alanine, L-Alanyl-glycine, L-Asparagine, L-Aspartic acid, L-Glutamic acid, L-Histidine, L-Leucine, L-Ornithine, L-Phenylalanine, 
L-Proline, L-Pyroglutamic acid, L-Serine, L-Threonine 
Carbohydrates 
α-D-Glucose, α-D-Lactose, β-Methyl-D-glucoside, Adonitol, D-Arabitol, D-Cellobiose, D-Fructose, D-Galactose, D-Mannitol, D-
Mannose, D-Melibiose, D-Psicose, D-Raffinose, D-Sorbitol, D-Trehalose, Gentiobiose, i-Erythritol, Lactulose, L-Arabinose, L-
Fucose, L-Rhamnose, L-Sorbose, Maltose, Methyl pyruvate, m-Inositol, Mono-methyl-succinate, N-Acetyl-D-galactosamine, N-
Acetyl-D-glucosamine, Sucrose, Turanose, Xylitol,  
Carboxylic Acids 
α-Hydroxy butyric acid, β-Hydroxy butyric acid, ᵞ-Hydroxy butyric acid, α-Keto butyric acid, α-Keto glutaric acid, α-Keto valeric 
acid, Acetic acid, Citric acid, Cis-aconitic acid, D,L-Lactic acid, D-Galactonic acid ᵞ-lactone, D-Galacturonic acid, D-Gluconic acid, 
D-Glucosaminic acid, D-Glucuronic acid, D-Saccharic acid, Formic acid, Itaconic acid, Malonic acid, p-Hydroxy phenylacetic acid, 
Propionic acid, Quinic acid, Sebacic acid, Succinic acid 
Polymers α-Cyclodextrin, Dextrin, Glycogen, Tween 40, Tween 80 
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2.1.3. Advantages and Disadvantages of the Biolog GN2 Assay 
A major advantage of the Biolog GN2 assay over existing risk assessment tools is that the Biolog 
GN2 assay can quantify the metabolism of a greater array of substrates than other assays such the 
ASRIT (which only quantifies glucose respiration). In addition, other types of substrate metabolism 
can be quantified (including glucose), such as amino acids, amines and amides. Several aspects of 
microbial function in the environment (such as nitrogen and carbon turnover) can therefore be 
studied simultaneously in one assay. The data that can be gained from the Biolog GN2 assay 
represent another advantage, as long as sufficient replication is applied to a study (Preston-Mafham 
et al., 2002). As well as having the ability to yield kinetic data, the Biolog GN2 assay can also be 
used to produce Community Level Physiological Profiles (CLPP) data by means of Principle 
Component Analysis (PCA). It has also been demonstrated that comparative data can be harvested 
for each substrate guild (eg: Kong et al., 2006).  
There have however been a number of criticisms expressed over the Biolog GN2 assay. The first of 
these relates to the inoculum density that is added to each Biolog well.  If the inoculum density is 
not equal across replicates (or individual well) then conditions will not be the same between 
samples. Garland and Mills (1991) showed that well colour formation was proportional to 
microbial density. It has been additionally demonstrated that reduced inoculum density has been 
correlated with a reduced lag time but not necessarily with the rate of colour development the 
maximum colour development possible (Haack et al., 1995). Garland (1996) further added that 
colour development also relies upon the proportion of actively respiring cells in the inoculum, so 
such populations must be standardised also. Another concern that has been raised has been that of 
nutrient carryover from environmental samples. If this is too high then the blank well may not be 
able to act as a control to substrate utilisation (Preston-Mafham et al., 2002).  
Despite these drawbacks a range of precautions can be implemented to reduce any disadvantages. 
These include allowing as much replication as possible, taking readings at multiple time points, 
taking into account inoculum density and having samples of equal weight, size or volume (Preston-
Mafham et al., 2002).  
2.1.4. Validity Criteria of Toxicity Tests 
Assays that yield data that is intended to provide toxicity information for environmental microbes 
must be validated against a reference toxicant. The EC50 of the reference toxicant is of known 
value. Any new tests that have been developed must therefore exert an EC50 value that is between 
the stated thresholds for the particular reference toxicant that is being utilised. Table 2.2 shows the 
range of reference toxicants that are currently used for microbial toxicity testing and their validity 
criteria. 
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Table 2.3: Reference toxicants and their toxicity thresholds for standard microbial toxicity tests. 
    Test Reference Toxicant Used Validity Criteria / EC50 Reference 
Activated sludge respiration inhibition test  (ASRIT) (OECD, 209) 3, 5-dichlorophenol 3–32 mg/L OECD, 1984 
Nitrification inhibition test (ISO 9509) allyl thiourea 3–32 mg/L ISO, 2006 
Sewage bacteria growth inhibition test (ISO 15522) 3, 5-dichlorophenol 4–12 mg/L ISO, 1999 
Pseudomonas putida cell multiplication inhibition test (ISO 10712) 3, 5-dichlorophenol 10–30 mg/L ISO, 1995 
Inhibition of light emission of Vibrio fischeri (ISO 11348) 3, 5-dichlorophenol, Zn
2+ 
and Cr
6+
 13–26 mg/L; 2.2–11 mg/L ISO, 1994 
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2.1.5. Use of Microcosms in Ecological Studies 
A microcosm is a laboratory based system that reproduces a natural habitat. They have been 
described as being a “bridge between theory and nature” (Fraser, 1999). Indeed data yielded from 
microcosm studies have produced data that have supported several important ecological theories, 
such as the effects of changing CO2 levels on ecosystem function (Bazzaz, 1990; Diaz et al., 1993).  
Microcosms can be composed of either a subset of a natural habitat (such as soil columns or 
watersheds) or can be fabricated from natural components in the laboratory. They can vary in size 
and complexity, spanning single test-tube experiments to entire biospheres (Fraser, 1999). The use 
of microcosms in ecotoxicology (in both fate and effects studies) began in the mid-1970s and their 
use in ecotoxicological studies have been cited as being especially widespread (Beyers and Odum, 
1993).  
Microcosm studies have several advantages over studying natural habitats in the field. In 
ecotoxicological studies the main advantage of using microcosms is the fact that microcosms can 
be easily manipulated in terms of contents (such as the environmental compartment that is studied 
and the type and concentration of a chemical that is added) and conditions (such as temperature and 
light intensity). Due to the ease of replicating microcosm studies (Fraser, 1999) they also provide a 
standardised approach; solid statistical analysis is therefore possible when data are being analysed. 
The use of microcosms in the study of the fate and effects of antibiotics in the environment has 
highlighted the added advantage that a number of end-points can be studied simultaneously in a 
particular environmental matrix. For example, samples can be removed and analysed chemically, 
biologically and physically. In practice, this allows for several aspects to be measured in a single 
test system. For example chemical concentrations and in vitro toxicity have been simultaneously 
studied in microcosms that had been spiked with antibiotics (e.g.: Zeilezny et al., 2006). For this 
reason a microcosm can potentially be seen as being a “one system fits all” solution. 
One of the main drawbacks of microcosm studies is the inherent lack of space afforded for study 
compared to a natural environment. Ingerslev et al. (2000) demonstrated the importance of test 
volume. They observed an increased lag time with regard to the biodegradation of 2, 4-
dichlorophenoxyacetic acid and p-nitrophenol (PNP). These data suggest that test volume is an 
important parameter to take into consideration when studying biological systems in microcosm 
studies and that test volume should be maximised as much as possible. The authors suggested that 
an increased microbial biodiversity is linked to higher test volumes. 
Microcosms have also been criticised for being too simplistic, due to the fact that only a subset of 
species are typically included. Another common criticism is the fact that microcosms do not reflect 
the complexity of natural ecosystems. As such, many believe that microcosms cannot provide 
reliable models for the ecosystems which they are attempting to study (Drake and Kramer, 2011). 
Other critics of microcosms point out that they are not subject to the variability of natural 
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conditions that real ecosystems are subject to, such as temporal aspects. These include diurnal and 
seasonal periodicities (such as weather and temperature changes) and environmental stochasticity 
(differences in growth rates of populations). In addition, physical processes are difficult to recreate 
in microcosms. Examples of how these can affect the realism of microcosm data include the effects 
of including a water-sediment interface and the mixing of a water column by wind (Carpenter, 
1996; Schindler, 1998). Bulling et al. (2006) point out that real ecosystems are subject to variable 
conditions that are extremely difficult to control in microcosm studies. From an ecotoxicological 
point of view, many microcosm systems also use artificially high concentrations of chemicals 
(compared with those found in natural ecosystems) so that the fate and effects of chemicals can be 
quantified.  
As such, microcosms which attempt to study microbial communities are unlikely to truly reflect 
natural populations of bacteria due to the fact that natural populations are subject to a huge array of 
variables and parameters. For these reasons, aquatic microbial microcosms will only provide a 
“snapshot” of what is occurring in natural environments. In addition, the increased complexity of 
natural environments mean that results of microcosm studies may be difficult to interpret in terms 
of what is actually occurring in nature.  
2.1.6. Rationale for Assay Choice  
One of the aims of this project was to track the effects of antibiotics on ecologically important end-
points. Many of the end-points that have been studied in the available literature have been those 
related to nutrient cycling, especially those that can linked to carbon and nitrogen turnover. As 
such, the bioassays that will be utilized in the current investigation will also aim to link the 
exposure of microbial communities to antibiotics with effects on nutrient cycling. Most assays that 
have been conducted with respect to looking at the effects of antibiotics on microbial communities 
rely on looking at a single end-point, as has been performed with ammonification, nitrification and 
denitrification assays. It was noted however that the Biolog GN2 assay could simultaneously track 
the utilization of a wide range of ecologically important substrates over time. The range of 
substrates that are potentially utilized also correlate to either the carbon or nitrogen cycle, or both 
in the case of substrates that have both carbon and nitrogen in their structures (such as amino 
acids). Additional information can also be collected regarding the microbial metabolism of 
polymers. This additional information may potentially give insights into how polymer degradation 
(in the aquatic environment) may be affected by antibiotics. Many pollutants are polymeric 
structures. As such, polymer degradation within a Biolog plate may provide clues as to how the 
exposure of a microbial community to antibiotics affects, for example, pollutant biodegradation. 
The fact that the Biolog GN2 assay can also yield information on how microbial communities may 
respond to antibiotics in terms of changes in community structure is also an attractive feature. As 
such, it was decided that all available time would be dedicated to developing a system that utilizes 
the Biolog GN2 system, including the development of suitable data analysis techniques. 
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2.1.7. Choice of Statistical Analyses for Project 
2.1.7.1 Biolog Kinetic Data 
Biolog kinetic data was chosen to be based upon a logistic growth model. This was in turn based 
upon a microbial Zwietering growth equation (Lee et al., 1992). The model can be programmed 
into statistical software (for example Sigmaplot) and a non-linear regression analysis can be 
performed. This allows for the visualisation of data over time via substrate utilization curves. This 
approach also allows for various parameters associated with microbial growth to be modelled, 
allowing for the analysis of how a toxicant may affect different aspects of substrate utilisation. The 
first modelled parameter which can be studied is the lag phase during the growth of a microbial 
community. During the lag phase, before substrate utilisation (analogous to the lag phase before 
microbial growth), bacteria adapt themselves to growth conditions. It is the period during which 
bacteria are maturing and not yet able to divide. During the lag phase of the bacterial growth cycle, 
synthesis of RNA, enzymes and other molecules occurs. The lag phase is therefore important for 
the microbial community as it prepares bacteria for the next phases of growth (exponential and 
stationary) and allows them to adapt to their environment. The second modelled parameter is the 
maximum rate of substrate utilisation (analogous to the maximum rate of growth of the microbial 
population). This parameter allows for the quantification of the maximum rate at which the 
microbial community is utilizing substrates. Using sample size and the margin of variation between 
samples, a one way analysis of variation (ANOVA) can be used to determine statistically 
significant differences between maximum rates and lag phases between different toxicant 
treatments compared with control values.  
2.1.7.2. Multivariate Analysis and Ordination of Biolog Data 
Biolog data can be thought of as having 95 different variables (representing individual substrates). 
These variables can be reduced into a smaller number of principle components by PCA (Principal 
Component Analysis). Principal components (PCs) are identified by taking eigenvalues of a 
covariance matrix, which is calculated from original data values (which are mean subtracted). 
Higher eigenvalues represent a greater degree of variation. The resulting numbers which are 
calculated account for a diminishing degree of variation within the dataset as the PC number 
increases. As such the first two PCs usually describe the greatest (if not all) degree of variation 
within a data set. The result of this analysis is to reduce the dimensionality of large datasets which 
can then be compared to each other more easily based on how similar they are to each other. This is 
achieved by comparing resultant PC scores. This process is called multidimensional scaling and is 
useful for analysing large, multidimensional datasets. As such, PCA can often show structure in 
such datasets (Randerson, 1993; Podani, 2000).  
When a PCA analysis of a data set has been completed, a visual representation of a dataset can be 
presented as a scatter plot. This is achieved by plotting the scores of the first two PCs for each 
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replicate of a treatment group on an x-y axis. Data points (replicates) that are ordinated on a scatter 
plot will appear to cluster together if their PC scores are similar on both axis of the scatter plot. Due 
to the fact that PCA followed by ordination of PC scores on a scatter plot can be used to visualise 
large datasets, this method of analysis is useful for visualising how similar large datasets are across 
different treatments. The method is also a useful tool for reducing the dimensionality of 
multidimensional datasets. However, PCA analysis cannot be considered as being a quantitative 
approach to analysing a dataset, but rather a useful exploratory tool for data mining.  
With regard to using PCA and scatter plot ordination to visualise Biolog data, the approach has 
been successfully used to form CLPPs (Community Level Physiological Profiles) of microbial 
communities. The concept behind this idea is that microbial communities which are more similar to 
each other will utilise a substrate utilisation profile which is more similar to each other as 
calculated by similarities in the first two PC scores between treatment groups. This approach has 
been utilised to visualise changes in the structure of microbial communities based upon how similar 
their substrate utilisation profiles are (Schmitt et al., 2005; Kong et al., 2006). In the context of this 
project PCA analyses of substrate utilisation profiles will therefore be used to visualise how 
changes in microbial community structure may result from the exposure of bacterial populations to 
antibiotics.  
2.1.7.3. Functional Analysis of Biolog Data 
As well providing kinetic and multivariate data, multi substrate utilisation data can be analysed to 
give insights into changes in the functional diversity of microbial communities (Preston-Mafham et 
al., 2002). A useful approach when discovering how the functional diversity of a microbial 
community has been altered is to employ the use of a diversity index, such as the Shannon-Weaver 
Diversity index (SWDI). The SWDI has previously been used as a measure of biodiversity, with a 
higher diversity index indicating a higher biodiversity. When studying changes in the functional 
diversity of substrate utilisation by a microbial community, an individual substrate acts as a 
surrogate for an individual species. Changes in the diversity of substrates that are utilised by the 
microbial community can therefore be tracked. The results of these analyses will therefore give an 
indication as to how the exposure of a microbial community to antibiotics may affect its ability to 
utilize a diversity of substrates.  
2.1.7.4. Data Transformation and Analysis of CFU (Colony Forming 
Unit) Data 
It is the aim of this project to generate relevant CFU data. Due to the non-parametric nature of 
these data a parametric statistical analysis of variation cannot be used to analyse this data due to the 
fact that the data are not normally distributed. As such, CFU data shall be log naturally 
transformed. This will result in the data being normally distributed. Once this has been completed 
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then the data shall be analysed using a parametric analysis of variation. This approach has the 
advantage of allowing a more statistically powerful analysis to be performed, rather than a non-
parametric test which would represent a more conservative approach. This would possibly 
underestimate statistically significant changes between treatment groups.  
2.2. Materials and Methods 
2.2.1. Chemicals and Equipment 
All chemicals were purchased from Sigma Aldrich (Poole, Dorset, UK). 5 litre microcosm vessels, 
Quickfit precision glassware, HEPA Filters and general laboratory equipment were purchased from 
Fisher Scientific (Loughbourgh, UK). Spectral analysis was performed by a Spectramax 
spectrophotometer (Molecular Solutions, MA, USA). Biolog GN2 Plates were purchased from 
Technopath (Limerick, Eire; on license from BIOLOG, CA, USA). Glass rods were prepared by 
glass-cutting equipment and smoothed by oxyacetylene flaming.  
2.2.2. Surface Water  
Surface water was collected from the River Dart, Buckfastleigh, Devon (grid reference SX7366). 
Weather conditions on the day of sampling were dry and temperatures were average for the time of 
year (15˚C). Temperature and pH readings were taken upon arrival to Brixham Environmental 
Laboratory. Surface water was sieved through a 1 mm mesh to remove large particles and stored at 
4°C in the site cold store until required.  
2.2.3. Activated Sludge and Preparation of Treated Sewage 
Activated sludge (return line) was collected from Buckland Sewage Treatment Plant, Newton 
Abbott, Devon, UK. Upon arrival to the laboratory activated sludge was aerated at 100 ml O2/min. 
Activated sludge was allowed to settle and the supernatant was siphoned off using a syringe. The 
supernatant represented treated sewage.  
2.2.4. Preparation of OECD Synthetic Sewage  
OECD synthetic sewage was prepared according to OECD 303a guidelines (Simulation Test- 
Aerobic Sewage Treatment: Activated Sludge Units). A 100 fold concentrate was prepared by 
dissolving the following components in 1 litre of water- 16 g peptone; 11 g meat extract; 3 g urea; 
0.7 g NaCl; 0.4 g CaCl2.2H2O; 0.2 g MgSO4.7H2O; 2.8 g K2HPO4. The synthetic sewage 
concentrate was then autoclaved for 15 mins at 121°C and stored in the dark at 0-4°C. 100 fold 
dilutions were prepared from the stock concentrate by mixing 10 ml concentrate with 1 litre of 
sterile water.  
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2.2.5. Microcosm Development 
2.2.5.1. Inoculum Type and Density 
2.2.5.1.1. Procedure 
An initial dilution of surface water was prepared by diluting 10% v/v river water with 90% v/v 
sterile water. Further 1 in 10 serial dilutions were prepared to obtain a river water dilution series of 
0, 10
-1
, 10
-2
, 10
-3
 and 10
-4
. A river water / treated sewage suspension was prepared by mixing 10% 
v/v treated sewage with 90% v/v river water. An initial dilution of this suspension was prepared by 
diluting 10% v/v river water with 90% sterile water v/v. Further 1 in 10 serial dilutions were 
prepared to obtain river water / treated sewage dilutions of 0, 10
-1
, 10
-2
, 10
-3
 and 10
-4
. Triplicate 
Biolog GN2 plates were then inoculated with 150 µl of each dilution and shaken on a micromixer 
in the dark for 10 minutes. Plates were then incubated at 20°C for 80 hours. The liquid in each well 
of the Biolog plate was periodically read spectrally at 595 nm.  
2.2.5.1.2. Initial Data Analysis 
Values in all wells were autoblanked using SoftMax Pro (Molecular devices). All data were then 
transferred to a Microsoft Excel spreadsheet where AWCD (average well colour development) and 
standard deviation values were calculated. All graphs for these experiments were compiled using 
Microsoft Excel.  
2.2.6. Initial Microcosm Studies  
Initial microcosm studies were conducted to examine how control microcosm data behaved over 
time using the Biolog GN2 assay. Microcosm contents were chosen based on previous experiments 
that had examined the type and density of inoculum Biolog GN2 plates should inoculated with.  
2.2.6.1. Microcosm Set-up 
It was concluded that a neat mixture of river water and treated sewage (9:1 v/v) was the optimum 
inoculum for functional studies and was therefore chosen as the microcosm contents. Advice from 
external communication (personal communication with Jose Tarazona, March 2006) had raised 
issues regarding the detergent concentration in 10% treated sewage however, so microcosm 
contents were amended to contain a final concentration of river water, treated sewage and OECD 
synthetic sewage (90:5:5 v/v). It was also concluded that this amendment would have the added 
advantage of providing a nutrient and energy source for the microbial community while also giving 
the environmental realism that treated sewage addition would bring.  
The final microcosm set-up is illustrated by figure 2.1. Individual microcosms were composed of 5 
litre fermentation vessels. Microcosms were sealed with Quickfit flanges and glass stoppers to 
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prevent external contamination but also allow access to the system as required for sampling. 
Aeration of the microcosms was achieved by the use of Quickfit aeration adapters that were 
connected to glass rods and PTFE tubing. Air flow under negative pressure was provided by a 
vacuum pump to achieve a nominal air flow rate of ~100 ml O2 / min. 0.22 µm HEPA filters were 
attached to glass tubing receiving external air to prevent infection from out-with microcosm 
vessels. All microcosms were incubated at 20°C +/- 2°C.  
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Figure 2.2: Annotated diagram of the final microcosm set-up. 
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2.2.7. Validation of the Microcosm-Biolog GN2 system 
2.2.7.1. Experimental Procedure 
Twelve microcosms were set-up as described in section 2.8.2.1. Nine microcosms were spiked with 
the OECD reference toxicant 3, 5-DCP. Three microcosms were spiked at 32 mg/L 3, 5-DCP, three 
were spiked at 3.2 mg/L
 
3, 5-DCP and three were spiked at 0.32 mg/L
 
3, 5-DCP. Three control 
microcosms were not spiked with any reference toxicant (0 mg/L).  
Following addition of the DCP, samples were taken from each microcosm every day for a week. 
Biolog GN2 plates were inoculated with 150 ųl of these microcosm liquid samples (as described by 
section 2.9.1) and shaken in the dark for 10 minutes using a micromixer. Triplicate Biolog GN2 
plates were inoculated for samples obtained on days 1, 4 and 7 and single Biolog GN2 plates were 
inoculated for samples taken on days 2, 3, 5 and 6. This strategy was seen being a compromise 
between practicality (time taken to read plates and inoculate more plates), statistical rigour and 
financial viability. Each plate was then incubated in the dark at 20°C for at least 80 hours with 
periodic readings taken spectrally at 595 nm using a spectrophotometer.  
2.2.8. Data Analysis 
2.2.8.1. Kinetic Analysis 
Biolog data were initially treated as described in section 2.6.1.2. A three parameter non-linear 
Zweitering logistic growth model (Lee et al., 1995) was then applied to control-normalised AWCD 
values for each 3,5-DCP treatment at each time point using Microsoft Excel and the Microsoft 
Excel solver function, such that a kinetic response over time could be plotted. The three parameter 
logistic growth function used was as follows- 
A = Amax / 1 + exp [4ųm / Amax (λ-t) +2] 
Where A= Absorbance at time, t 
Amax= Maximum absorbance recorded in Biolog GN2 plate wells 
ųm= Maximum rate of colour development in Biolog GN2 plate wells 
λ= Lag phase duration before onset of substrate utilisation 
Non-linear regressions were then performed on AWCD data using Sigmaplot (SYSTAT, IL, USA). 
Coefficient and standard error values for λ and ųm were then compared for statistical significance 
versus control values via a one way ANOVA (P < 0.05). This was performed by specifically 
designed Astrazeneca software (Alan Sharpe, Brixham Environmental Laboratories).  
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2.2.8.2. Principal Component Analysis (PCA) and Ordination of PCA 
Data 
Principal Component Analyses were performed on AWCDMAX values for each day of the exposure 
period. PCA analysis was performed using Minitab 15 (PA, USA). Data was ordinated by plotting 
the first principal components (PCs) on the x axis and the second set of PCs on the y axis (also 
using Minitab 15). This decision was taken due to the fact that the first two PCs frequently describe 
the majority of variation within a dataset, with PC 1 accounting for the vast majority of this 
(Randerson, 1993; Podani, 2000). Using this analysis, replicates with similar PC scores on each 
axis of the scatter plot (PC1 and PC2, or x and y) will appear to cluster together as they vary less 
from each other. Replicates which have been shown to vary greatly from each other will have 
different PC scores and will not cluster on a PC scatter plot. Indeed, the greater the variation 
between unrelated replicates, the greater the distance replicates will appear in the two dimensional 
space of the scatter plot. Replicates from different antibiotic treatments are represented by shapes 
of different colours. Replicates which appear to cluster were considered to have similar substrate 
utilisation profiles and therefore similar CLPPs (Community Level Physiological Profiles). Within 
the context of the microbial community, similar CLPPs will be used to tentatively indicate a 
change in microbial community structure.  
2.2.8.3. Analysis of the Functional Diversity of Substrate Utilisation 
Functional diversity of substrate utilisation was analysed by calculating the richness of substrate 
utilisation using the Shannon-Weaver Diversity Index (SWDI) according to the equation- 
H’ = -∑ pi ln (pi) 
Where H’ = the SWDI 
 
Pi = the relative abundance of each substrate given by the formula- 
Pi = AINDIVIDUAL SUBSTRATE / AWCDMAX 
Where AINDIVIDUAL SUBSTRATE = the control-corrected absorbance value for each well on the Biolog 
GN2 plate for each replicate in a treatment group 
 
AWCDMAX = the maximum average well colour development for each replicate in a treatment 
group 
 
The SWDI is then expressed as exponential raised to the power of the SWDI value, such that- 
 
e
 H’
 = EXP H’ 
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All calculations were performed using Microsoft Excel. Templates were designed and utilised 
which were capable of calculating the SWDI for exposure days which used three and nine replicate 
Biolog plates per dosing group. Values were then graphed using Microsoft Excel.  Student’s t Tests 
were then performed (using Sigmaplot) between e
 H’
 values from between each treatment group and 
the corresponding control value.  
2.3. Results 
2.3.1. Inoculum Type and Density 
Results from the studies into effects of inoculum density and inoculum type (figure 2.3) show that 
when river water and a river water/treated sewage suspension were diluted, the maximum colour 
development after 80 hours was markedly reduced. At all dilutions the colour production in plates 
containing river water only was visibly less than the maximum colour production in plates 
containing a river water/treated sewage suspension. In more dilute samples (10
-4
) there was a 
higher degree of variation between replicate Biolog plates. Conversely, where there had been no 
dilution there was very little variation between replicate plates. Due to the formation of suitable 
colour development across all treatments, there was no evidence of nutrient carryover posing a 
threat to the resolution of colour development. There did however seem to be an effect of inoculum 
dilution and type on lag phase time however; in general, colour development at lower dilutions and 
plates treated with river water only took visibly longer to develop. In all cases, an incubation period 
of ≥ 75 hours was adequate to resolve a clear trend. For future Biolog GN2 inoculations an 
exposure period of at least 75 hours was therefore selected. 
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a) 
 
b) 
 
 
Figure 2.3: Graphs with data illustrating the effect of inoculum type and density on total colour 
development (AWCD) over time in Biolog GN2 plates. a) 10
-1 
dilution b) 10
-2 
dilution c) 10
-3 
dilution d) 10
-4 
dilution e) No dilution. 
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c) 
 
d) 
 
Figure 2.3 (continued). 
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e) 
 
Figure 2.3 (continued). 
 
2.3.2. Validation of the Biolog GN2/Microcosm System with 3, 5-DCP 
The data in figure 2.4 show kinetic plots of total substrate utilisation on days 1, 4 and 6 for the 
different 3, 5-DCP treatments and the controls. PCA analysis of AMAX data is represented by score 
plots on days 1 and 4 in figure 2.5. The data in figure 2.6 represent maximum rate and lag phase 
duration versus exposure period duration. The information in table 2.4 shows significant and non-
significant changes in maximum rate and lag phase duration for the validation exposure duration. 
The data in figure 2.7 represent SWDI of substrate utilisation showing statistical significance over 
all days of the exposure.  
The data represented by kinetic model plots for days 1, 4 and 6 indicate an inhibition of total 
substrate utilisation as a result of exposing the microbial communities to 32 mg/L
 
3, 5-DCP. A 
significant increase in lag phase duration on days 1-4 could also be detected. When the max rate of 
substrate utilisation was analysed a significant reduction was detected (compared with control data) 
at the highest 3, 5-DCP concentration on all days of the exposure period. On day 1 of the exposure 
period a significant increase in lag phase duration could also be detected in microcosms exposed to 
3.2 mg/L
 
3, 5-DCP. At the same concentration a significant increase in the max rate of substrate 
utilisation was also detected. On day 6 of the exposure period a significant reduction in lag phase 
duration suggested the onset of a recovery at the highest 3, 5-DCP concentration.  
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PCA analyses of total substrate utilisation confirm that the multi substrate utilisation profile of the 
microbial community in microcosms exposed to 32 mg/L
 
was different to the control community. 
This was suggested by the unique clustering of data from control values. The data represented by 
scatter plots from all other days also suggested differential substrate utilisation profiles for 
replicates exposed to all other 3, 5-DCP concentrations. These data suggest that the multi substrate 
utilisation profile of dosed microbial communities was different to the control profile. It can be 
tentatively concluded therefore that the microbial community structure in all dosed microcosms 
was different to those that were present in control microcosms. There was some overlap between 
clustering of 0 and 0.32 mg/L 3, 5–DCP exposed replicates on days 1 and 4 however. This would 
suggest that there was a small degree of similarity between the multi substrate utilisation profile 
and thus the microbial community structure.  
Analysis of multi substrate utilisation data using the SWDI shows that the functional diversity of 
substrate utilisation was significantly reduced by 32 mg/L 3, 5-DCP on all days of the exposure 
period. The diversity of substrates that the microbial community was metabolising was also 
significantly inhibited by 3.2 mg/L 3, 5-DCP on day one of the exposure period. On all other days 
there were not any significant changes in the diversity of substrates that were being utilised. It is 
likely therefore that the microbial community that was present in microcosms that were spiked with 
this concentration of 3, 5–DCP had recovered by day 2 of the exposure period. In contrast, 
microbial communities that were exposed to 32 mg/L 3, 5-DCP did not show any signs of recovery 
during the exposure period.  
The results therefore suggest that 3, 5-DCP can exert an effect on total substrate utilisation down to 
a 3, 5-DCP concentration of 0.32 mg/L
 
when analysed by multivariate statistics on all days of the 
exposure period. When looking at the effects of 3, 5-DCP as detected by kinetic data however acute 
effects were only seen at a lower concentration of 3.2 mg/L at day. More chronic kinetic effects of 
the reference toxicant (after day 1) were observed at the highest dose of 3, 5-DCP.  
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a) 
 
b) 
 
Figure 2.4: Kinetic plots showing total substrate utilisation in control and 3,5-DCP exposed 
microcosms on a) Day 1, b) Day 2 and c) Day 4. 
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c) 
 
Figure 2.4 (cont). 
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Figure 2.5: Scatter plots of PC scores for the first two principle components for individual 
replicates from each 3, 5-DCP treatment group on a) Day 1 and b) Day 4. Day 1 (a) proportion of 
variability: PC1 = 75.1%, PC2 = 7.6%; Day 4 (b) proportion of variability: PC1 = 57.8%, PC2 = 
10.8%.  
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a) 
 
b) 
 
Figure 2.6: a) Log lag phase versus exposure period time for total substrate utilisation and b) Max 
rate of total substrate utilisation versus exposure period time following 3, 5-DCP exposure. 
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Table 2.4: Summary of one-way ANOVA results for lag phase values from Biolog data for 
inocula from microcosms following different exposure times to 3, 5-DCP in comparison with 
unexposed inocula.  
       
  
Day of Exposure / Statistical Significance of Lag Phase 
Duration
1
 
[3 , 5-DCP] / mg/L 1 2 3 4 5 6 
0.32 > * < ns < ns > ns n/a > ns 
3.2 > * > ns < ns > ns n/a > ns 
32 > * > * > * > * n/a < * 
       
Table 2.5: Summary of one-way ANOVA results for maximum rate of substrate utilization values 
from Biolog data for inocula from microcosms following different exposure times to 3, 5-DCP in 
comparison with unexposed inocula.  
       
  Day of Exposure / Statistical Significance of Max Rate
1 
[3 , 5-DCP] / mg/L 1 2 3 4 5 6 
0.32 > ns > ns > ns > ns n/a > ns 
3.2 > * > ns > ns > ns n/a > ns 
32 < * < * < * < * n/a < * 
       
 
  
                                                          
1
 <: Value was less than the control value, but statistical significance was not shown; >: Value was 
greater than the control value, but statistical significance was not shown; =: Value was equal to the 
control value; <*: Value was less than the control value and p < 0.05; >*: Value was greater than 
the control value and p < 0.05.   
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Figure 2.7: Bar graph illustrating richness of substrate of utilisation (e
H’
) versus exposure day at 
various [3, 5-DCP] compared with untreated data as analysed by the SWDI. Statistically significant 
changes in species richness are depicted by asterisk notation (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 
0.001; ****, P ≤ 0.0001). 
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2.4. Discussion 
An aquatic assay and microcosm system were developed to quantify the effects of a toxicant on the 
ecological functioning of aquatic microbial communities. The system had to act as a surrogate for 
the aquatic environment. To achieve this, natural river water and treated sewage were used in the 
microcosms. As such the microcosm system would act as a “bridge between theory and nature” 
(Fraser, 1999). The addition of treated sewage to the microcosm system posed the potential threat 
of nutrient carryover, possibly reducing the magnitude of the spectral response that could be 
detected in Biolog GN2 plates (Preston-Mafham et al., 2002). As such inoculum density 
experiments were conducted. The results of these studies revealed that natural waters amended with 
treated sewage gave a greater spectral response than river water alone. This suggested that the 
activity of the microbial community (in terms of substrate utilisation) was greater. Due to the 
reduced variation in undiluted samples and the greater functional response that was observed in a 
neat mixture of 9:1 river water: treated sewage, this was seen as being the optimum matrix for 
microcosm/Biolog GN2 studies. Due to concerns over detergent levels in treated sewage (and the 
toxicological effects they may exert on microbial communities) the system was amended with 5% 
treated sewage and 5% OECD synthetic sewage. The addition of OECD synthetic sewage had the 
dual function of acting as a nutrient source as it does in other regulatory test such as the OECD 
303A test for example.  The final microcosm system was also given a maximal volume in relation 
to available lab space and equipment (5 litre fermentation vessels). This allowed the most diverse 
microbial community to inhabit the microcosm system as possible. Ingerslev et al. (2000) had 
previously noted that a larger volume within a microcosm system increases the diversity of the 
microbial community in biodegradation studies. 
With the microcosm/Biolog system now developed it was then determined if the microbial 
community (within the microcosm system) could be inhibited by the OECD reference toxicant 3,5-
DCP in terms of a kinetic response. The effect of 3, 5-DCP on the community structure and 
functional diversity of the microbial community were also investigated. Time series experiments 
were therefore conducted at 3 different 3, 5-DCP concentrations and one control concentration (0 
mg/L
 
3, 5-DCP). Statistical analyses of kinetic data revealed that significant effects on lag phase 
duration and the max the rate of total substrate utilisation could be determined on all exposure days 
at the highest toxicant concentration that was tested (32 mg/L). The same data analysis of 
microcosms exposed to 3.2 mg/L
 
3, 5-DCP revealed that significant changes in lag phase duration 
and max rate could also be detected on day 1 of the exposure period. Kinetic plots and statistical 
analyses appeared to indicate that the current test system fell within the validity criteria of the 
ASRIT assay (EC50 value of between 3-32 mg/L) (OECD, 1984)
 
on all days of the exposure period. 
PCA analysis could resolve the effects of 3, 5-DCP down to a concentration of 0.32 mg/L
 
up to day 
6 of the exposure period. The mechanism of these effects remains unclear, so further analysis is 
necessary to ascertain this. These results infer that that the composition of the microbial community 
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is likely to have been altered by exposure to 0.32 mg/L 3, 5-DCP. The exact changes in microbial 
community structure could be confirmed by molecular techniques such as DGGE (Denaturing 
Gradient Gel Electrophoresis), TRFLP (Terminal Fragment Length Polymorphism) or DNA 
sequencing. It is clear though that multivariate statistics were able to resolve the effects of lower 3, 
5-DCP concentrations than was possible by a kinetic analysis. Kinetic analyses remain more 
specific however as both lag phase duration and the max rate of substrate utilisation can be tracked. 
Both analyses therefore exhibit strengths and weaknesses. As such it would be prudent to analyse 
data with both sets of statistical techniques in future studies. As such, a quantitative and semi-
quantitative approach can be taken.  
Functional diversity analysis (of multisubstrate utilisation) demonstrated that the microbial 
community was significantly inhibited by 32 mg/L 3, 5-DCP on all exposure days and was also 
inhibited by 3.2 mg/L 3, 5-DCP on day 1 of the experiment. These data suggest that the microbial 
community (or certain parts of the microbial community) were unable to utilise the same diversity 
(or range) of substrates that microbial communities exposed to 0 and 0.32 mg/L 3, 5-DCP were 
able to utilise. These results suggest that the microcosm/Biolog GN2 system may be able to 
identify similar effects when the microbial community is exposed to other toxicants, such as 
antibiotics. In terms of studying the effects of antimicrobial toxicants on the diversity of substrate 
utilisation therefore, the data from the present investigation suggest that the reference compound 3, 
5-DCP can be used a positive control for studies that have a duration similar to the one used in this 
study (6 days). The microcosms/Biolog GN2 system has therefore been shown to detect both acute 
and chronic effects on the functional diversity of substrate utilisation.  
Due to the small concentration range an exact EC50 value was difficult to derive for the present 
study. As such, future experiments of this nature could repeat current experiments with a greater 
number of concentrations. It is likely however that the EC50 of 3, 5-DCP in the current investigation 
lies between the range of 3 and 32 mg/L. For a regulatory test such as the ASRIT, the results of any 
test must show that the reference compound (3, 5-DCP) exerts an EC50 of between 3 and 32 mg/L 
for the study to be considered valid. The current investigation is therefore likely to be considered 
valid from a regulatory viewpoint. Other future work could compare the EC50 value of a repeated 
study (using more exposure concentrations) with some EC50 values that have been observed in a 
range of regulatory studies using standard tests such as the ASRIT. This would likely involve close 
collaboration with an institution such as a CRO (Contract Research Organisation). Such 
laboratories would have access to a huge array of such data as regulatory tests are conducted there 
on a daily basis.  
The results of this chapter point to the current microcosm/Biolog GN2 system showing promise as 
a risk assessment tool. The test could be used in place of the ASRIT assay in phase II, tier A of the 
environmental risk assessment procedure. Alternatively, the system could also act as a higher tier 
study, in phase II, tier B for example. In any case, the system has several advantages over existing 
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methods. The main advantage is that the system tests changes in microbial function in a simulated 
river water environment. No standard test currently offers protection to complex aquatic microbial 
communities. The current system also tracks the utilisation of a large array of substrates from a 
range of substrate types (guilds). Standard tests such as the ASRIT use only glucose as a metabolic 
substrate. But natural environments contain a much wider array of substrates. In addition, in many 
cases the specific mode of action of toxicity of a compound may be able to be related to a specific 
substrate utilisation profile. Kong et al. (2006) for example showed a decrease in utilisation of all 
substrate guilds as a result of exposing soil microbial communities to oxytetracycline. This could 
be attributed to the inhibition of protein synthesis and subsequent reduction in production of 
essential cellular proteins (such as enzymes and metabolic co-factors).  
The current system also offers a larger time scale to study the temporal effects of a toxicant, as 
Biolog plates are inoculated on each day of the exposure period. This allows for the effects of a 
toxicant (on microbial communities) to be tracked over a greater time period than is possible with 
other tests such as the ASRIT. This offers the advantage that the effects of a toxicant can be 
identified over a longer exposure period. In addition, this provides the opportunity to study any 
potential recovery of the microbial community which may occur. Also, as Biolog plates are 
incubated for ≥ 75 hours, a kinetic response can be calculated for each day of the exposure period. 
This is not possible using tests such as the ASRIT, which only measures oxygen consumption (of 
the microbial community) over a ~15 minute period at the end of a 3 hour exposure period. Several 
authors have raised concerns over the brevity of standard test such as the ASRIT and Microtox 
(Backhaus and Grimme, 1997; Kummerer et al., 2004). A longer exposure period may be required 
when studying the effects of certain compounds that inhibit the growth of aquatic microorganisms 
such as bacteriostatic antibiotics (e.g.: tetracyclines).  
Due to the potential for guild (related to specific substrate types) data to be analysed, the 
microcosm/Biolog GN2 system can also be used a tool to study distinct aspects of the carbon and 
nitrogen cycle. Specifically, amine/amide and amino acid utilisation can be linked to the nitrogen 
cycle and carbohydrate/carboxylic acid utilisation can be linked to the carbon cycle. Analysis of 
polymer utilisation data can also be used to quantify how polymers are degraded in the 
environment in the presence of a toxicant. With a lack of standardised systems/assays to quantify 
the potential toxicity of antibiotics (or other toxicants) in the aquatic compartment in terms of 
specific microbial function the current results show promise of this being achieved with the 
methods that have been developed within this chapter.  In the next two Chapters, the developed 
methods are applied to two ‘model’ antibiotics: chlortetracycline and sulfamethoxazole. 
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Chapter 3: Effects of Chlortetracycline 
on Microbial Functioning in Aquatic 
Systems 
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3. Effects of CTC on Microbial Function 
3.1. Tetracyclines 
Benjamin M. Duggar first isolated chlortetracycline from the soil-dwelling bacterium Streptomyces 
aureofaciens in 1945  The discovery of CTC heralded the discovery of the first broad-spectrum 
antibiotic, with the compound capable of treating infections from both Gram positive and Gram 
negative bacteria, as well as well as atypical infections such as chlamydiae and rickettsiae (Chopra 
and Roberts, 2001). It is thought to be effective against approximately fifty diseases. The discovery 
of the next tetracycline, oxytetracycline soon followed. The compound was isolated from another 
soil bacterium, Streptomyces rimosus, in 1950 (Finlay et al., 1950). The structure of 
oxytetracycline was determined shortly after by Robert Burns Woodward, paving the way for 
Lloyd H. Conover to produce the first synthetic tetracyline in 1953 (Bhattacharya, 2003). A 
number of natural and semi-synthetic tetracyclines have been discovered since, with the newest 
group (the tigilcyclines) having recently gone through phase II clinical trials (Chopra and Roberts, 
2001). The chronology of tetracycline discovery is summarised in table 3.1. 
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Table  Table 3.1: Chronology of tetracycline discovery (modified from Chopra and Roberts, 2001). 
 
 
Chemical Name  Generic Name Trade Name Year of Discovery 
     
 
7-CTC CTC Aureomycin 1948 
 
5- hydroxytetracycline tetracycline oxytetracycline Terramycin 1950 
 
tetracycline tetracycline Achromycin 1953 
 
6-demethyl-7-CTC demethylchlortetracycline Declomycin 1957 
 
2- N-pyrrolidinomethyltetracycline rolitetracycline Reverin 1958 
 
2-N-lysinomethyltetracycline limecycline Tetralysal 1961 
 
N-methylol-7-CTC  clomocycline Megaclor 1963 
 
6- methylene-5-hydroxytetracycline methacycline Rondomycin 1965 
 
 
6-deoxy-5-hydroxytetracycline doxycycline Vibramycin 1967 
 
7-dimethylamino-6-demethyl-6-deoxytetracycline minocycline Minocin 1972 
 
9-(t-butylglycylamido)-minocycline tertiary-butylglycylamidominocycline Tigilcycline 1993 
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3.1.2. Chemistry of Tetracyclines 
 
Having an octahydrotetracene-2-carboxamide skeleton, tetracyclines are a sub-class of the 
polyketides and are known collectively as derivatives of polycyclic naphthacene carboxamide. 
Tetracyclines are composed of four linearly fused tetracyclic rings (named A, B, C and D). A 
number of functional groups can be covalently bonded to the 4 tetracycline rings to form specific 
members of the tetracycline group. The structure of the linear fused tetracycline ring is subject to 
the naturally occurring conversion of keto and enol forms on positions 11, 12 and 12a of the D ring 
and stereochemical configurations at the ring A/ring B interface at positions 4a and 12a. An 
additional stereochemical conformation can also be found at position 4. Tetracylines are 
zwitterionic. In addition, tetracyclines can exist in an extended or folded form (Jin et al., 2007). 
Tetracyline, oxytetracycline and CTC exhibit reversible epimerisation at the C4 position. 4-epimers 
(epi-CTC, epi-oxytetracycline and epi-tetracycline) of these compounds are formed as a result of 
epimerisation reactions (Doershuck et al., 1955). Epimerisation of tetracyclines has been shown to 
occur between pH 2 and 6 although epimerisation has been found to occur at pH 7 in the case of 
epi-tetracycline. A molar ratio of between 0.4 and 0.6 exists for the epi-tetracycline: tetracycline 
equilibrium (McCornick et al., 1957). Hussar et al. (1968) have reported that CTC and tetracycline 
tend to epimerise to a greater extent than oxytetracycline. This has been attributed to the binding of 
the C5 hydroxyl and dimethylamino groups. 
The chemical behaviour of tetracyclines is pH dependent. Respective iso-tetracyclines may be 
formed by cleavage of the C6 hydroxyl group under alkaline conditions (Mitscher, 1978). CTC is 
especially vulnerable to C6 hydroxyl cleavage and is irreversibly transformed into iso-CTC under 
alkaline conditions (Waller et al., 1952; Stephens et al., 1954). If oxygen is present under alkaline 
conditions desmethyl or didesmethyl analogs of tetracyclines can be formed, such as N-desmethyl-
tetracycline (Waller et al., 1952; Stephens et al., 1954).  
Tetracycline chemistry is also affected by lower pH. Dehydration of a hydrogen atom at position 
C5a and of the hydroxyl group at position C6 occurs under acidic conditions with CTC, 
oxytetracycline and tetracycline. Respective epimers of each compound are subject to the same 
reactions. In the case of oxytetracycline the process is irreversible. The resultant products of these 
reactions are apooxytetracycline, apoepioxytetracycline, apochlorterracycline, apo-epi-CTC, 
apotetracycline and apo-epitetracycline. Due to their relative instability, apooxytetracycline and 
apo-epioxytetracycline can be further transformed into α and β phtalides due to scission of ring B at 
the C5 hydroxyl position (Hochstein et al., 1953).  
Another important aspect of tetracycline (and epi-tetracycline) chemistry is their tendency to form 
keto and enol tautomers in aqueous solution. Under alkaline conditions, CTC and 4-epi-CTC can 
undergo keto/enol-tautomerism between position C11a and C12 (Noidong et al., 1990). There are a 
reported 64 tautomer permeations existing for tetracycline considering the five possible 
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protonations (H4Tc
+
, H3Tc, H2Tc
−
, HTc
2−
and Tc
3−
) and four acid dissociation constants (pKas at pH 
3.2, 7.6, 9.6, and 12) that can occur (Duarte et al., 1998; Jin et al., 2007). The specific combination 
of tautomers depends on physiochemical factors such pH and the dieclctric constant of a solution. 
There has not however been keto/enol tautomerism reported for oxytetracycline (Halling-Sørensen 
et al., 2002).  
The tendency for tetracyclines to chelate with divalent and trivalent metal ions at positions C11 and 
C12 represent another important aspect of tetracycline chemistry. Most work in this area has 
focused on chelation with Ca
2+
 and Mg
2+
, due to their physiological significance (Jin et al., 2007). 
Binding stoichoimetries of 1:1, 1:2, and 2:1 bound ions per tetracycline molecule have been 
calculated for both ions between pH 6.5 and 6.8 (Lambs et al., 1984; Berthon et al., 1983; Newman 
and Frank, 1976; Martin, 1979; Wessels et al., 1998; Schmitt  and Schneider, 2000). The binding of 
tetracyclines with minerals, such as aluminium and iron hydrous oxides has also been demonstrated 
(Cheng and Karthikeyan, 2005). Several chelation sites can be found on the tetracycline molecule. 
These include the β-diketone system on positions C11 and C12 and at the enol systems of C1 and 
C3. A chelating carboxamide group can also be found at position C2 of the tetracycline A-ring 
(Blackwood, 1985). 
3.1.3. Tetracycline Mode of Action 
The first aspect of tetracycline mode of action is the mechanisms by which they enter the Gram-
positive and Gram-negative cell (Chopra and Roberts, 2001). In Gram-negative enteric species 
tetracycline crosses the outer membrane by passive diffusion. The molecule does so by passing 
through the porin membrane channel proteins OmpF and OmpC. Tetracycline molecules enter 
porin channels as positively charged co-ordination complexes, probably with Mg
2+ 
ions (Chopra 
and Ball, 1982; Chopra, 1985; Schnappinger and Hillen, 1996). The Donnan potential (the 
formation of electric potential between two solutions) of the outer membrane draws the cationic 
tetracycline-Mg
2+ 
into the cellular periplasm. It is thought that tetraycline molecules accumulate in 
the cell as uncharged, weakly hydrophilic molecules (having now dissociated with Mg
2+ 
ions). It is 
this species that can then be transported across the inner cytoplasmic membrane. In Gram-positive 
bacteria it is an electroneutral lipophillic tetracycline species that passes through the outer 
cytoplasmic membrane. The passing of tetracyclines into microbial cells is energy dependent. The 
energy is supplied by a ΔpH-dependent proton motive force (Yamaguchi et al., 1991a; 1991b; 
Nikaido and Thanassi, 1993; Chnappinger and Hillen, 1996). Due to the divalent metal 
concentration and pH within the cytoplasm it is likely that the tetracycline molecule becomes 
chelated once more before exerting its mode of action (Chnappinger and Hillen, 1996). 
Once in the cytoplasm tetracyclines exert their bacteriostatic (growth is prevented, but cells are not 
killed) action primarily by transient inhibition of protein synthesis at the ribosomal level (Tritton, 
1977; Gale et al., 1981; Chopra, 1985; Rasmussen et al., 1991). Inhibition of protein synthesis 
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occurs mainly when tetracycline molecules preferentially bind to the ribosomal A (acceptor) site of 
prokaryotic 70S ribosomes, reducing tRNA binding efficiency to 20% of normal levels (Epe et al., 
1987). Since the A site binds aminoacyl tRNA during the translation stage of protein synthesis, 
codon-anticodon matching is disrupted. Tetracyclines exert this effect by binding to six binding 
sites on the 30S sub-unit of the 70S ribosome (Pioletti et al., 2001). Tet-1 represents the aminoacyl 
tRNA docking site and is the major (or “primary”) tetracycline-binding site (Epe et al., 1987). 
Tet-1 is located between the distorted minor groove of H34 and the stem–loop of H31 (Cate et al., 
1999). Tetracycline molecules are held in place by a clamp formed by bases 1196 and 1054 of 30S 
sub-unit rRNA (ribosomal RNA). The binding of tetracyclines to this region is Mg
2+ 
- dependent 
(Pioletti et al., 2001). Tetracyclines are also known to inhibit the binding of release factors RF1 and 
RF2 to the ribosomal small sub-unit A-site. Release factors are responsible for the binding to 
ribosomes when certain stop signals appear at the A site (UAG and UAA (for RF-1) or UGA and 
UAA (for RF-2). Peptides are released from the A site when these sequences are recognized 
(Brown et al., 1993). If a tetracycline is bound to these sites then peptidyl formation will be greatly 
disadvantaged. A further five tetracycline binding sites (Tet-2–Tet-6) have also been identified. 
With the exception of Tet-2, all binding sites are located within the 16S rRNA structure. 
The binding of tetracyclines at loop 970 of the ribosomal P site has consequences for correct 
positioning of tRNA molecules during protein synthesis, since this site is thought to be essential for 
correctly positioning tRNA (Saraiya et al., 2008). The high affinity binding of tetracyclines to the 
ribosomal protein S7 (near the anti-codon loop at the ribosomal P site) represents another 
mechanism by which tetracyclines inhibit protein synthesis. Protein S7 has been shown to be in 
close contact with the anticodon loop of P site-bound tRNA and with mRNA upstream of crucial 
decoding regions (Wower et al., 1993; Doring et al., 1994). Protein S7 also has important cross-
linking properties with 16S rRNA (Moller et al., 1978; Urlaub et al., 1997). The interaction of 
tetracyclines with protein S7 therefore has effects on ribosomal codon binding and on the 
conformational structure of the ribosomal small sub-unit. 
Another binding site (Tet-6) is located on the ribosomal E (or “exit”) site, where deacylated 
peptides leave the ribosome. Although the exact function of the E site has remained controversial 
recent studies have shown that it is essential for avoiding frameshift mutations and for efficient 
translocation of polypeptide chains. It has also been shown to have a role in GTPase turnover 
activity (Sergiev et al., 2005). Binding of tetracyclines to the E site might also further affect 30S 
ribosomal functioning. The binding of tetracyclines to ribosomal sites A, P therefore has several 
direct effects on protein synthesis with inferred effects on the ribosomal E-site.  
Tetracyclines have also been shown to have other binding targets that help explain its mode of 
action. One of these is the binding of tetracyclines to elongation factor Tu (Ef-Tu) (Gordon, 1969; 
Lucas-Lenard and Raenni, 1969; Ravel et al., 1969; Shorey et al., 1969; Skoultchi et al., 1970; 
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Spirin and Asatryan, 1976; Semenkov et al., 1982). EF-Tu-GTP is the most abundant protein in E. 
coli cells and is responsible for the binding and delivery of an aminoacyl-tRNA complex to the A 
site on the ribosome. The process is dependent on the binding of GTPase and ATPase. The binding 
of EF-Tu-Tetracycline was recently crystalised, revealing Mg
2+ 
dependent binding domains that are 
shared by all GTPases and many ATPases. The binding of tetracyclines to Ef-Tu therefore 
represents a pre-translational process that inhibits microbial protein synthesis (Heffron et al., 
2006).  Interestingly, Werner et al. (1975) had previously reported the inhibition of the 
translocation process by tetracylines. It is thought this may occur via the targeting of an elongation 
factor that is homologous to Ef-Tu, Eg-G (Heffron et al., 2006).  
Several tetracycline analogs also exist that can act as bactericidal (i.e they kill cells) agents. These 
compounds (also termed “atypical tetracyclines”) include anhydrotetracycline, anhydroCTC, 6-
thiatetracycline, chelocardin and 4-epi-anhydro-CTC. Anhydro-CTC and 6-thiatetracycline do still 
possess some ribosomal inhibition properties however (protection of base A892) (Chopra, 1994). 
Enzyme leakage studies have revealed that tetracycline analogs target the cytoplasmic membrane. 
Cell lysis occurs and cells subsequently die (Oliva et al., 1992). It has also been shown that atypical 
tetracyclines prevent nucleic acids being incorporated into DNA and RNA (Rasmussen et al., 
1991). Although the exact mechanism of action of atypical tetracyclines is not fully understood, it 
is believed that the lipophillic compounds become trapped in the hydrophobic cytoplasmic 
membrane where they exert their effect (Rasmussen et al., 1991). This theory is galvanised by 
studies that have shown that atypical tetracyclines can still exert an anti-microbial effect in the 
presence of tetracycline efflux pumps and ribosomal protection proteins (Oliva and Chopra, 1992). 
Due to side effects in clinical trials (possibly due to indiscriminate mode of action in prokaryotes 
and eukaryotes) atypical tetracyclines are not used therapeutically (Chopra and Roberts, 2001).  
3.1.4. Tetracycline Usage 
Tetracyclines are broad-spectrum antibiotics and are therefore used to treat a wide range of 
microbial infections (Chopra and Roberts, 2001). Tetracyclines can be applied as either a topical, 
oral or intravenous application, both in human and veterinary medical practice. Tetracyclines are 
also used for non-anti-infective purposes. In some countries for example tetracyclines are used as 
growth-promoters in husbandry, cattle swine and poultry (Sanderson et al., 2005). However, the 
use of tetracyclines as growth promoters was phased out in the EU in 2000. Tetracyclines have also 
been utilised as prophylactics in fish farming (Primavera et al., 1993). Tetracyclines also have a 
number of alternative uses in human medicine. The compounds have been utilised clinically as 
chelating ionophores, inhibitors of inflammation, in proteolysis, angiogenesis and as anti-apoptotic 
agents (Ross et al., 1998; Sapadin and Fleischmajer, 2006).  
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Despite the use of tetracyclines as growth promoters in Denmark and the Netherlands being 
reduced by 50% between 1997 and 2004 they were still among the most widely used antibiotics in 
the EU (KTBL, 2005; MANRAN, 2004).  
3.1.5. Occurrence of Tetracyclines in the Environment 
Tetracyclines have been detected in several environmental matrices such as surface water (e.g.: 
Calamari et al., 2003), soil (e.g.: Hamscher et al., 2002), groundwater (e.g.: Karthikeyan and. 
Bleam, 2003) and marine sediment (e.g.: Lalumera et al., 2004). Reported occurrences of 
tetracycline residues in the environment are summarised in table 3.1. Table 3.1 illustrates the fact 
that tetracyclines have been found mainly in water bodies. The data also suggest that tetracyclines 
have been detected in soils that have been amended with liquid manure. This would make sense as 
manure represents a major exposure route of antibiotics into the soil environment.  
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Table 3.2: Reported occurrences of tetracyclines in several environmental matrices. Data in italics indicates limit of quantification.  
      Compound Matrix Location LOD/LOQ  Reported Concentration Reference 
      
CTC Soil amended with liquid 
manure 
Denmark 0.6 x 10-3 mg/kg nd - 15.5 x 10-3 mg/kg Jacobsen et al., 2004 
1.1x 10
-3 
mg/kg 
 Soil amended with liquid 
manure 
Germany 2 x 10-3 mg/kg 4.6 - 7.3 x 10-3 mg/kg Hamsher et al., 2002 
5x 10
-3 
mg/kg 
 Stream water USA 0.05 mg/kg 0.49 - 0.69 mg/kg Yang and Carlson, 2004b 
 Stream water USA 0.10 μg/L 0.16 μg/L Kolpin et al., 2002 
oxytetracycline Surface water Italy <0.0003 μg/L 0.01435 μg/L Calamari et al., 2003 
 Surface water Italy <0.0003 μg/L nd – 0.01920 μg/L Calamari et al., 2003 
 Stream water USA 0.10 μg/L 0.34 μg/L Kolpin et al., 2002 
 Lake water (near 
agricultural land) 
USA 0.05 μg/L 0.13 μg/L Yang and Carlson, 2004b 
 Lake water USA 0.05 0.09 Yang and Carlson, 2004b 
 Marine sediment Italy 0.061 μg /lg 246.3 μg /kg Lalumera et al., 2004 
tetracycline Soil amended with liquid 
manure 
Germany 1 x 10-3 mg/kg 
(86.2 - 198.7) x 10
-3 
mg/kg 
Hamsher et al., 2002 
(5x 10
-3
) mg/kg 
 Surface water USA 0.05 μg/L 0.14 μg/L Yang and Carlson, 2004b 
 Surface water USA 0.05 μg/L 0.06 and 0.12 μg/L Yang and Carlson, 2004b 
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Table 3.2 (cont). 
 
Compound Matrix Location LOD/LOQ 
 
Reported Concentration Reference 
tetracycline (cont) Groundwater USA 0.05 μg/L 0.5 μg/L Karthikeyan and. Bleam, 
2003 
doxycycline Lake water USA 0.05 μg/L 0.05 μg/L Yang and Carlson, 2004b 
 Surface water USA 0.05 μg/L 0.08 μg/L Yang and Carlson, 2004b 
 Surface water USA 0.05 μg/L nd and 0.05 Yang and Carlson, 2004b 
democlocycline Surface water USA 0.05 μg/L 0.12 and 0.32 μg/L Yang and Carlson, 2004b 
 Surface water USA 0.05 μg/L 0.44 μg/L Yang and Carlson, 2004b 
      LOD = Limit of detection; LOQ = Limit of quantification; nd = not detected. 
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3.1.6. Fate and Behavior of Tetracyclines in the Environment 
The behavior of tetracyclines in soil, manure, sewage treatment plants and the aquatic environment 
(surface water and sediment) have been reported. Such is the complexity of tetracycline behavior in 
the environment it has been suggested that the traditional approach of linking log Kow and organic 
carbon content with sorption alone are not sufficient (Tolls, 2001). Due to three environmentally 
relevant pKa values, tetracyclines can exist as cations, zwitterions or as net negatively charged 
anions (Sassman and Lee, 2005). Additional reported aspects of tetracycline behavior can be 
attributed to the chelation of tetracycline residues with metallic ions that are present in the 
environment, such as metal percholates (Mikulski et al., 1988), aluminium (De Almeida et al., 
1998; Dos Santos et al., 2000; Gu and Karthikeyan, 2005), magnesium (Wessels et al., 1998; 
Schmitt and Schneider, 2000) and iron oxides (Gu and Karthikeyan, 2005). It is noteworthy that 
quite often contradictory data can be found with regard to the fate of tetracyclines in the 
environment. It is likely that specific environmental conditions (such as soil organic matter content 
for example) govern the fate of tetracyclines in the environment. As such, each environmental 
matrix and its specific physiochemical and biological properties should be taken into consideration 
when studying the fate of tetracylines in the environment. The same assertion is also likely to be 
true for other complex and ionisable antibiotics that are present in the environment, such as 
sulfonamides, which will also be investigated during this study.  
3.1.6.1. Fate of Tetracyclines in Soil  
Sorption of tetracyclines to a range of soil types has been investigated. Pils and Laird (2007) 
reported 96% sorption of CTC and tetracycline to clay components in soil and whole soils that 
contain high proportions of clay in laboratory based studies. Allaire et al. (2006) also observed 
sorption of CTC to clay and sandy loam soils in laboratory studies. They concluded that CTC 
sorption was significantly greater in clay soils than in sandy loam soils. This data is in agreement 
with another study that reported CTC binding twice as much to clay soils than sandy loam soils 
(Chander et al., 2005).  Rabolle and Spliid (2000) reported that oxytetracycline sorbed almost twice 
as much to sandy loam soils than it did to sandy soils, with observed Kd values of 1026 and 417 
respectively. Allaire et al. (2006) additionally showed that 95% of CTC sorption occurs within the 
first ten minutes following CTC addition. Kulshrestha et al. (2004) investigated the sorption of 
oxytetracycline to clay soils as a function of pH. They found that oxytetracycline sorption 
decreases with increasing pH, revealing a pH dependent sorption to clay soils. Laboratory studies 
have also revealed that sorption of oxytetracycline to clay soils can be reduced by the presence of 
humic substances, suggesting organic matter in soils interferes with tetracycline binding 
(Kulshrestha et al., 2004). Sithole and Guy (1987) had previously demonstrated biphasic 
tetracycline sorption to humic acid and peat, suggesting the presence of two distinct tetracycline 
binding sites on organic matter. Jones et al. (2005) observed higher oxytetracycline sorption to 
109 
 
soils with an organic matter content of between 4 and 9% than those with less than 4%, suggesting 
tetracyclines sorb to soils with higher organic matter content or different types of organic content.  
Modeling the sorption of three tetracyclines (tetracycline, oxytetracycline and CTC) to clay soils 
has revealed a proton uptake mechanism at acidic pH and a surface binding mechanism at alkaline 
pH (Figueroa et al., 2004). Jones et al. (2005) further suggested that cation exchange may explain 
sorption between soils and the positively charged tertiary amine group of oxytetracycline occur at 
pH 5.5. The sorption of tetracyclines to soil organic matter (such as humic substances) is likely to 
occur via H-bonding between phenolic and carboxyl groups (Sithole and Guy, 1987).  
Laboratory and field studies have been conducted to investigate the movement of tetracyclines 
through soil horizons. Kay et al. (2004) tracked the movement of oxytetracycline through a 
macroporous tile drained clay soil over a two-year period. Oxytetracycline was found mainly in the 
topsoil, with some movement to deeper soil layers and drainage water. In another soil column 
study, tetracycline could be detected up to 6 feet belowthe soil surface. Tetracycline could also be 
detected in a river adjacent to spiked soil columns (2% of tetracycline in applied manure). The soil 
type in this study was lower in clay and higher in organic matter, indicating that soils lower in clay 
matter and higher in organic matter can facilitate the movement of tetracycline through soil and 
into surface water (Aga et al., 2003).  A laboratory-based study by Kay et al. (2005) found that the 
breakage of macropores (by tilling) significantly reduced the concentration of oxytetracycline 
found in soil drainage water, implicating the role of preferential macropore flow in oxytetracycline 
movement through soil where it has been shown occur.  
Several studies that have investigated the movement of tetracyclines through soil have only 
detected the compounds in upper soil layers. Two studies conducted could not detect 
oxytetracycline or CTC transport below 30 cm soil depth over a two-year period. Although one soil 
had high clay content, the other had relatively low clay content, suggesting tetracyclines can sorb to 
lower clay content or to other soil components. Both studies therefore suggested that tetracyclines 
are not transported to surface water in certain soils (Kay et al., 2005; Hamscher et al., 2002; 
Hamscher et al., 2005). These findings are in agreement with an earlier study that did not detect 
oxytetracycline in the leachate of a soil column (Rabolle and Spliit, 2000). In general however the 
movement of tetracyclines through soils has yet to be fully elucidated (Pils and Laird, 2007).  
The impact of run-off on tetracyline movement from soil to surface water has also been 
investigated. Yang and Carlson (2003) reported higher levels of tetracyclines in streams near 
agricultural land compared to pristine locations. The authors attributed this to run-off from soil due 
to the fact that the areas studied were known to be prone to run-off. Another study reported 
extremely low levels of tetracyclines in surface water due to run-off compared with other 
veterinary medicines however (Davis et al., 2006), suggesting such events are dependent on 
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individual areas. Kim and Carlson (2007) also found higher concentrations of CTC in water bodies 
adjacent to agricultural activity, suggesting the role of surface run-off.  
In terms of tetracycline degradation in soils, studies have revealed varying results. Hamscher et al. 
(2002) for example observed no significant change in tetracycline concentration during a seven-
month period of a field study in which tetracycline was applied to soil from manure. Another study 
however reported significant losses of tetracycline from soil columns that had also received 
tetracyclines via manure application. The authors attributed some tetracycline loss to degradation 
processes (Aga et al., 2003). Soeberg et al. (2004) investigated the degradation of CTC and its 
transformation products and epimers at various pHs, temperatures and light conditions in soil 
interstitial water. It was observed that the presence of solar irradiation and higher temperatures 
shortened half-lives of all compounds at all temperatures and pHs tested, with the exception of 4-
epi-CTC (solar irradiation did not affect its degradation). It was also observed that all compounds 
tested were generally more persistent under acidic conditions compared with neutral conditions 
suggesting that CTC, epimers of CTC and transformation products of CTC will be more persistent 
in acidic soils.  
The degradation of oxytetracycline has also been investigated in soil. In clay soil column studies, 
oxytetracycline could not be detected after 52 days after application of oxytetracycline-spiked 
manure (Kay et al., 2005). In another investigation, oxytetracycline had been fully removed from a 
clay loam soil lysimeter 4 months after application of oxytetracycline (Kay et al., 2005). 
Conversely, Aga et al. (2005) could not detect any significant removal of oxytetracycline in 
manure-amended soil five months after treatment (using ELISA analysis), but could detect 50% 
removal of parent compound after three-months using LC-MS analysis. As ELISA detects total 
tetracyclines, tetracycline epimers and tetracycline tautomers (Aga et al., 2003) it is possible that 
these were being detected in soils five-months after amendment and were not detected by LC-MS. 
Halling Sorensen et al. (2003) investigated the abiotic formation and degradation of 
oxytetracyclines in soil interstitial water. The formation of epi-oxytetracycline, N-DM-
oxytetracycline and N-DDM-oxytetracycline were shown to initially increase, suggesting abiotic 
processes (such as hydrolysis and oxidation) transform oxytetracycline in the soil environment.  In 
terms of degradation, half-lives of between 2.3 days (epi-oxytetracycline) and 270 days (β-apo-
oxytetracycline) were observed. It was also found that α- apo- oxytetracycline degraded faster 
under light conditions and epi- oxytetracycline degraded faster under dark conditions. Thiele-Bruhn 
and Peters (2007) observed two fractions of oxytetracycline and CTC with differing (biphasic) 
photodegradability, agreeing with Halling Sorensen et al. (2003) that only some tetracyclines (or 
tetracycline species) undergo photodegradation. Oka et al. (1989) had previously identified two-
membered ring structures as a result of tetracycline photodegradation. The literature therefore 
suggests some aspects of tetracycline degradation, but not all, are significantly influenced by the 
presence of light. 
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3.1.6.2. Fate of Tetracyclines in the Aquatic Environment 
The behavior of tetracyclines has also been investigated in aquatic systems.  Just like in soil 
systems, tetracyclines have been reported to adsorb to organic matter (such as humic acids and 
peat) in different types of clay and sediments. Tetracyclines form polar interactions with divalent 
cations in clay as well as H bonds present in tannic acids in clay. Tetracycline sorption to clays in 
aquatic systems has been shown to decrease as ionic strength and pH increase (Sithole and Guy, 
1987). Tetracyclines have also been shown to adsorb to both freshwater and marine sediments. 
Pouliquen and Le Bris (1996) observed that oxytetracycline sorption was greater in marine 
sediments with higher mineral content and higher organic matter content. They also found that 
smaller particle size (< 63μm) resulted in increased tetracycline sorption due to a larger surface 
area being available. Tetracyclines have also been shown desorb from aquatic sediment. Simon 
(2005) conducted oxytetracycline desorption studies in various rivers. It was reported that between 
0.6-3.3 μg/g oxytetracycline (per dry sediment weight) was easily desorbed. Higher concentrations 
of easily desorbed oxytetracycline were found upstream of a sewage treatment plant. Smith and 
Samuelsen (1996) also demonstrated that a small fraction of oxytetracycline (between 0.04 and 
3.82%) is lost from marine sediment as a result of washout into the aqueous phase (seawater).  
The movement of tetracyclines in the aquatic environment has also been investigated. Rose and 
Pederson (2005) conducted computer simulations to predict oxytetracycline (from aquacultural 
discharge) movement through rivers. Higher oxytetracycline concentrations were expected to occur 
in sediment that were downstream (4 mg/kg) than were found in sediments that were upstream of 
aquacultural activity (≤ 0.2 mg/kg). Kerry et al. (1996) directly measured oxytetracycline 
concentrations below fish farms and in areas adjacent to fish farm cages. They detected 
oxytetracycline concentrations of between 0.65 and 1.26 μg/kg (directly under cages) and 4.2 μg/kg 
in areas that were 10 m from cages (in the direction of the water current). These results suggested 
that oxytetracycline distribution was confined to a small area of sediment under or adjacent to cage 
areas in the direction of the prevailing water current.  
The dissipation of tetracyclines in the aquatic environment has also been studied. Verma et al. 
(2007) measured the dissipation of tetracycline in river and wetland waters. They observed half-
lives of 2 and 3 days for river and wetland waters respectively in the presence of light. When the 
experiment was conducted in the absence of light significantly higher half- lives of 18 and 13 days 
(for river and wetland waters respectively) were observed. The results of this study therefore 
implicate the role of photodegradation in the rapid dissipation of tetracyclines. The results also 
indicated the role of microbial degradation, hydrolysis or a mixture of both in the dissipation of 
tetracyclines in natural water systems. Sanderson et al. (2005) investigated the dissipation of 
tetracycline, oxytetracycline, CTC and doxycycline in outdoor aquatic mesocosms. Half-lives of 
between 1 and 4 days were observed. When the dissipation of higher concentrations of 
tetracyclines were tested, it was observed that the parent compounds could still be detected in 
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mesocosms 4 weeks into the exposure period, with doxycycline dissipating fastest followed by 
tetracycline, oxytetracycline then CTC. 
3.1.7. Reported Effects of Tetracyclines on Environmental Microbes 
There have been several reported effects of tetracyclines on various aspects of microbial growth 
and cellular function. Much of this work has focused on single species testing. The Microtox test 
has yielded significantly different results depending on the test duration. Short-term testing using 
oxytetracycline as a test compound has yielded EC50 values of between 64.5 and 139 mg/l 
(Lalumera et al., 2004; Isidori et al., 2004; Christensen et al., 2006).  Backhaus and Grimme 
(1999) extended the Microtox test duration to 24 hours using Tetracycline as a test compound. 
They observed an EC50 value of < 1 mg/l suggesting tetracyclines may exert differential toxicity on 
Vibrio fischeri during prolonged exposures.  
Halling-Sorenson et al. (2002) tested a variety of tetracyclines and tetracycline degradation 
products on the growth rates of 15 pseudomonad strains. EC50 values of between 0.5 and 32 mg/l 
were observed, with degradation products of tetracyclines exerting a lesser toxic effect. Linares et 
al. (2006) investigated the effects of tetracycline on the pathogenic environmental bacterium 
Pseudomonas aeruginosa. At sub-inhibitory concentrations of tetracycline exposure they observed 
increased biofilm formation and an increase in a type III secretion system. This causes elevated 
cytotoxicity. These observations suggest that tetracycline exposure may result in an increase in 
swarming behaviour a response to avoid predation.  
Other tests have shown the effects of tetracyclines on the growth of other single species. Halling -
Sorenson et al. (2002) tested the effect of various tetracyclines and tetracycline degradation 
products on the growth rate of three soil isolates (Agrobacterium sp., Moraxella sp. and two strains 
of Bacillus sp.). EC50 values ranged from 0.25–32 mg/l, with the lowest EC50 values being 
observed for the parent compounds (all were 0.25 mg/l). In another study Chander et al. (2005) 
observed declines in CFU counts of soil bacteria of between 40-60% as a result of exposure to 
tetracyclines, with the isolate Escherichia coli ATCC 25922 being affected the most.  
The most significant effects exerted on single species by tetracyclines have been observed using 
cyanobacteria as single test species. Both Robinson (2007) and Halling-Sorensen (2000) observed 
low EC50 values when cyanobacterial growth was measured optically. Halling Sorensen (2000) 
observed an EC50 value of < 0.1 mg/l due to tetracycline exposure while Robinson et al. (2007) 
observed an EC50 of < 1 mg/l as a result of oxytetracycline exposure.  These studies highlight the 
sensitivity of aquatic cyanobacteria to tetracycline exposure.  
Tetracyclines have also been reported to effects the growth of whole microbial communities. 
Halling Sorensen et al. (2002) observed inhibition to growth of activated slugged bacteria as a 
result of exposure to tetracycline, CTC, tetracycline degradation products and CTC degradation 
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products. EC50 values as low as 0.03 mg/l (for 5a, 6-anhydrotetracycline hydrochloride and CTC 
respectively) were observed, with all but two compounds tested having EC50 values less than that 
of the reference toxicant. Halling-Sorensen et al. (2002) showed that the toxicity of tetracyclines to 
activated sludge bacteria decreases over time however, as suggested by results obtained using 
oxytetracycline as test compound. In the same study, the antibiotic activity of oxytetracycline 
increased over time in soil interstitial water studies, suggesting a possible toxic effect of 
oxytetracycline degradation products over time 
Several authors have also reported changes to microbial respiration as a result of exposure to 
tetracyclines. Thiele-Bruhn and Beck (2005) observed inhibitory ED50 values of 19.1 and 31.2 μg/l 
for oxytetracycline in two different soil types. In contrast, other studies have reported no significant 
changes in microbial respiration rates as a result of tetracycline exposure. Zielezny et al. (2006) 
concluded CTC had no effect on respiration substrate induced respiration. Vaclavik et al. (2004) 
observed a 1.5-2 fold increase in substrate induced respiration rates as a result of exposure to CTC 
in soil microcosms. These conflicting results suggest that factors other than the presence of 
tetracyclines may be having an effect on the results of these experiments. Vaklivic et al. (2004) for 
example theorised that dead microbial cells may being degraded by the microbial community, 
which had potentially resulted in higher respiration rates due to cellular material being respired.   
Tetracyclines have also been shown to have significant effects on specific microbial function. 
Thiele-Bruhn demonstrated lower end ED50 values of 1.2 mg/kg for CTC, 5.3 mg/kg for 
oxytetracycline and 3 mg/kg for tetracycline. Boleas et al. (2005) tested dehydrogenase activity of 
microorganisms from manured and non-manured soils following oxytetracycline addition. They 
observed a significant reduction in dehydrogenase activity after 7 days in manured systems and 
after 21 days in non-manured microcosms. In the same study oxytetracycline concentrations as low 
as 100 mg/kg caused a significant decrease in phosphomonoesterase activity in soils that had 
fertilised with manure.  
Kong et al. (2006) examined the effects of oxytetracycline on multisubstrate carbon utilization (the 
ability of microbes to degrade a range of organic substrates). A significant reduction in substrate 
utilisation could be observed at oxytetracycline concentrations as low as 0.46 mg/l. When the 
authors looked at effects on specific substrate utilisation they observed a significant reduction in 
the utilization of all substrate guilds at an oxytetracycline concentration of above 0.46 mg/l. These 
results were also reflected multivariate analysis, with oxytetracycline concentrations of above 0.46 
mg/l clustering distinctly from control data.  
Several studies have investigated the effects of tetracyclines on biogas production (from the 
degradation of manure). Arikan et al. (2006) and Gamal-El-Din (1986) demonstrated reductions in 
biogas production of 27% and 49% respectively in fields inhabited by medicated animals. Sankvist 
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et al. (1984) tracked the effects of oxytetracycline on the anaerobic digestion of manure. They 
observed a 50% reduction in carbon cycling over a period of six consecutive days.  
Other studies have reported effects of tetracyclines on processes which occur within the nitrogen 
cycle. In aquaria experiments for example, Klaver and Matthews (1994) reported significant effects 
of oxytetracycline on the growth of two nitrifying microbial species Nitrosomas and Nitrobacter; 
EC50 values of between 8.6 and 29 mg/l were observed during the seven-day exposure period. 
3.1.8. Aims and Objectives of Chapter 
The overall aim of the work described in this Chapter was to assess the potential effects of 
chlortetracycline on aquatic microbial communities. This was achieved using the following specific 
objectives; 
1) To utilize the methods developed in Chapter 2 as well as measures of colony forming units to 
assess the effects of CTC on microbial population numbers and the ecological functioning of 
microbial communities in aquatic systems. 
2) To explore the potential for recovery of microbial communities following CTC exposure in 
terms of ecological functioning. 
3) To link functional data to effects of CTC in terms of the likely effect CTC may be exerting and 
to link these data to how these effects may be affecting wider ecological processes in the aquatic 
environment. 
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3.2. Materials and Methods 
3.2.1. Chemicals 
All materials and chemicals were purchased and prepared according to section 2.7.1. R2A agar was 
purchased from Oxoid (Cambridge, UK). CTC hydrochloride was purchased from Sigma Aldrich 
(Poole, UK).  
3.2.2. Surface water 
Surface water was collected and prepared according to section 2.2.2. 
3.2.3. Activated Sludge and Preparation of Treated Sewage 
Activated sludge was collected and prepared according to section 2.2.3. 
3.2.4. Preparation of OECD Synthetic Sewage 
OECD synthetic sewage was prepared according to section 2.2.4. 
3.2.5. Preparation of R2A Plates 
11.5g R2A agar was weighed on a calibrated balance and mixed with 1 litre of deionised water. 
The R2A agars / deionised water suspension was then slowly heated while being stirred on a 
magnetic infrared hotplate. When the mixture was completely melted it was autoclaved at 121°C 
for 15 minutes. Melted R2A agar was then poured into sterile Petri dishes leaving an air space of 
~0.25 cm.  
3.2.6. CTC Exposure Experiments 
Twelve microcosms were set-up as described in section 2.2.6.1. Nine microcosms were spiked with 
an aqueous CTC solution. Three microcosms were spiked to a nominal CTC concentration of 1 
mg/l, three to a nominal CTC concentration of 0.32 mg/l and three to a nominal CTC concentration 
of 0.1 mg/l. Three control microcosms received no CTC solution. A time series experiment was 
then conducted as described in sections 2.2.7.1. 
3.2.7. CFU (Colony Forming Unit) Counts 
Serial dilutions (0, 10
-1
, 10
-2
 and 10
-3
) of microcosm contents were prepared using sterile water. 
Triplicate R2A and R2A-CTC agar plates were spread-plated with each 0.1 ml of each dilution 
factor using a sterile plate spreader.  Plates were then incubated at 20°C for 72 hours. After 
incubation, the numbers of individual CFUs on each plate were enumerated by eye on each agar 
plate. Only CFU counts of between 30 and 300 were accepted for further analysis.  
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3.2.8. Data Analysis 
Initial Biolog AMAX values were treated as in section 2.2.5.1.2. A kinetic model was applied to 
AWCDMAX values as described in section 2.2.8.1. Max rate and lag phase duration values were 
plotted using Microsoft Excel.  
Non-linear regression of AWCD data was performed by SigmaPlot 4.01 (SYSTAT, IL, USA). Co-
efficient and standard error values for λ and ųm were then compared for significance (P < 0.05) 
using an Excel macro (Alan Sharpe, Brixham Environmental Laboratory).  
Principle Component Analysis (PCA) was performed using Minitab 15 (PA, USA). PCA was 
performed on maximum absorbance (AMAX) values from each corresponding time point. All data 
treatment was then performed on AMAX AWCD values from Biolog guild data (amines and amides, 
amino acids, carbohydrates, carboxylic acids and polymers). Analysis of the functional diversity of 
total substrate utilisation was conducted as described in section 2.2.8.3.  
 
CFU count data was transferred onto an Excel spread sheet that had been previously manipulated to 
calculate CFU dilution data. On the same spread sheet, data were then log-transformed so that a 
parametric analysis could be performed. Data were then tested for analysis of variance using a one 
way analysis of variance (ANOVA). Statistical significance was at the P < 0.05 level. This was 
performed using Sigmaplot.  
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3.3. Chapter 3 Results 
3.3.1. Effects of CTC on Organic Multi-Substrate Utilisation 
The data in figure 3.1 illustrate total organic substrate utilisation as kinetic model plots on days 
one, two and three of the six day exposure period. Figure 3.2 shows PCA score plots for the first 
two principle components (normally associated with the greatest variation) on exposure days one 
and four. The data in figure 3.3 illustrate lag phase duration and the maximum rate of substrate 
utilisation on exposure days 1-6. The information in tables 3.3 and 3.4 show the statistical 
significance of lag phase and max rate values compared with control data. 
3.3.1.1. Kinetic Model Plots 
Total substrate utilisation plots for day 1 (fig 3.1a) show that the highest absorbance occurred in 
control microcosms, followed by microcosms containing 0.32, 0.1 and 1 mg/l CTC. Although this 
trend continued in microcosms containing 1 mg/l on exposure day 2 (fig 3.1b) the magnitude of 
trend was not as great, with the plot becoming more similar to that of the control. Other CTC 
treatment plots became more similar to control curves. In addition, a higher maximum absorbance 
value was observed for microcosms containing 0.1 mg/l, with the two treatments above this 
approaching the maximum absorbance level of the control microcosm; day 2 plots therefore 
suggest the beginning of a recovery in microcosms that contained 0.1 and 0.32 mg/l CTC with 
reduced effects at the upper CTC concentration. Kinetic model plots therefore seem to illustrate an 
acute effect of CTC, with an apparent recovery immediately after an acute effect has been exerted.  
3.3.1.2. Lag Phase versus Exposure Time 
When lag phase duration was plotted against exposure time plots showed that all CTC 
concentrations resulted in a longer lag phase duration; this increase was statistically significant 
across all CTC treatments (table 3.3). On day two of the exposure, the lag phase duration decreased 
at all treatments and in control microcosms also. The lag phase was still significantly higher than 
the control treatment in microcosms containing 1 mg/l CTC however. 48 hours after exposure saw 
no significant increase or decrease in lag phase for any CTC treatment. After 72 hours however a 
statistically significant decrease in lag phase was recorded for all CTC treatments. This trend 
continued for the duration of the exposure period (until 120 hours) in microcosms containing 1 
mg/l CTC. In microcosms that had been exposed to 0.32 mg/l CTC a significant decrease in lag 
phase was also observed 120 hours after exposure.  
3.3.1.3. Max Rate versus Exposure Time 
On days 1 and 2 of the exposure a reduction in the max rate of total organic substrate utilisation 
was seen with increasing CTC concentration. On day 1 the difference were statistically significant 
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at all CTC treatments (table 3.4). On day 2 max rate values were again lower than control values at 
all CTC treatments, although values were higher than day 1 readings for all CTC concentrations. A 
statistically significant reduction in max rate values was only observed in microcosms containing 1 
mg/l however. 72 hours after CTC exposure max rate values at the highest two CTC concentrations 
rose above the control value, although not significantly. For the rest of the exposure period max 
rate values remained lower than control readings. On the final day after exposure this decrease was 
statistically significant in microcosms treated with 1 mg/l.  
3.3.1.4. PCA Analysis 
Data shown as PCA plots of the second versus the first principle components 0 hours after 
exposure (day 1) showed that control replicates and 0.1 mg/l replicates clustered closely together, 
suggesting that the microbial community was similar in microcosms exposed to these CTC doses. 
Replicates from microcosms containing 0.32 mg/l and 1mg/l clustered independently from both 
each other and the control-0.1 mg/l cluster. These data suggests that higher CTC concentrations 
caused differences in mulisubstrate utilisation profiles in microcosms spiked with the two highest 
CTC concentrations. Microbial communities exposed to higher doses were therefore likely to be 
different than communities that were present at lower and control doses of CTC. These data also 
suggest that microbial communities present in microcosms exposed to higher CTC doses tended to 
be less similar to both each other and control and communities, as well as to communities that had 
been exposed to a lower CTC dose. It is likely that the microbial community structure was also 
different in microcosms that had been exposed to these doses of CTC.  
Day 4 PCA score plots also show clustering of 0.1 mg/l and control microcosm (0 mg/l) replicates, 
again suggesting carbon utilisation profiles (and therefore microbial communities) were similar. 
Distinct clustering occurred in replicates from the top two CTC concentrations. In addition, these 
clusters were completely separate from any other clusters in terms of distance. This suggests that 
0.32 and 1 mg/l CTC treatment alter the carbon utilisation profile of the microbial community. Day 
4 PCA results also suggest that higher CTC doses result in changes in microbial community 
structure.  
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a) 
 
b) 
 
 
Figure 3.1: Kinetic plots of total substrate utilisation following CTC exposure on a) day 1, b) day 2 
and c) day 3. 
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c) 
 
 
Figure 3.1 (cont). 
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Figure 3.2: Scatter plots of PC scores for the first two principle components for individual 
replicates from each CTC treatment groups representing total substrate utilisation on a) day 1 and 
b) day 4. Day 1 (a) proportion of variation: PC1 = 41.3%, PC2 = 6.9%; Day 2 (b) proportion of 
variation: PC1 = 31.4%, PC2 = 12.4%.  
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a) 
 
b) 
 
 
Figure 3.3: a) Lag phase duration versus exposure period time for total substrate utilisation 
and b) Max rate of total substrate utilisation versus exposure period time following 
exposure to CTC. 
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Table 3.3: Summary of one-way ANOVA results for lag phase values before total substrate 
utilization from Biolog data for inocula from microcosms following different exposure times to 
CTC in comparison with unexposed inocula.  
        
 
 
Day of Exposure / Statistical Significance of Lag Phase Duration
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 >* < ns < ns < * < ns < ns 
 
0.32 >* > ns < ns < * < ns < * 
 
1 >* >* < ns < * < * < * 
       
 
       
Table 3.4: Summary of one-way ANOVA results for maximum rate of total substrate utilization 
values from Biolog data for inocula from microcosms following different exposure times to CTC in 
comparison with unexposed inocula.  
 
       
 
 
Day of Exposure / Statistical Significance of Max Rate
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 < ns <ns <ns <ns <ns >ns 
 
0.32 <* <ns >ns <ns <ns <ns 
 
1 <* <* >ns <ns <ns <* 
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3.3.2. Effect of CTC on Amine and Amide Utilisation 
The data shown in figure 3.4 illustrate amide and amine utilisation on exposure days 1, 2 and 3 that 
were plotted using a kinetic model. Data in figure 3.5 show PCA plots for the first two principle 
components scores on days 1 and 4. The information in figure 3.6 illustrates lag phase and 
maximum rate data on exposure days 1-6. Tables 3.5 and 3.6 show the statistical significance of lag 
phase and max rate values compared with control data.  
3.3.2.1. Kinetic Model Plots of Amine and Amide Utilisation 
The data in kinetic plots on day 1 (0 hours) show a negative correlation between amine and amide 
utilisation and increasing CTC concentration. At all concentrations a longer incubation period was 
required to produce colour development and colour development levels was not as high as levels 
that were seen in the control plot. The magnitude of colour that had been developed at the end of 
the incubation period in treated Biolog plates was lower than control plates. In addition, control 
plots followed a steeper gradient.  
In plots that represent data for 24 hours after exposure to CTC, a similar trend continued at all CTC 
concentrations. An increase in slope and maximum colour formation were observed at CTC 
concentrations of 1 mg/L
 
and 0.32 mg/L
 
and the onset of colour formation appeared shorter than in 
day 1 plots of the same treatments. In plots illustrating data of a 0.1 mg/L
 
CTC treatment, the onset 
of colour development appeared to occur faster than was shown by day 1 plots. 
The data shown by day 3 kinetic plots show fewer differences between exposure concentrations. 
The data in all plots show similar times of colour production onset. The slope of each curve also 
appeared similar across the concentration range. The maximum level of colour production appeared 
to be either equal to or greater than control values with the exception of the highest CTC treatment 
(1 mg/L). 
3.3.2.2. Lag Phase of Amine and Amide Utilisation versus Exposure 
Time  
On day 1 lag phase duration was higher than control values for all CTC treatments. A (statistically) 
significantly higher lag phase duration was only observed in microcosms spiked with 0.1 mg/L
 
CTC
 
however (Table 3.5). A similar trend was observed 24 hours after exposure to CTC, although 
lag phases had shortened compared with day 1 values. A statistically significant increase in lag 
phase duration was observed in microcosms containing 1 mg/L
 
CTC on day 2 however. From days 
3 to 5 no significant difference in lag phase duration was observed at any dose compared with 
control data, although values for all CTC concentrations gradually decreased to values that were 
less than that of the control value. On day 6 of the exposure period lag phase values were 
significantly lower than those of control microcosms at all CTC treatments.  
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3.3.2.3. Max Rate of Amine and Amide Utilisation versus Exposure 
Time 
 
Max rate values on day 1 were generally less than the control value for all concentrations of CTC 
(3.3b). A significantly lower max rate value compared with control data was observed at 0.1 mg/L
 
CTC (Table 3.6). 24 hours after exposure to CTC max rates values had increased compared to day 
0 values, although they were still below control levels. No statistical differences were observed 
compared with control data however. There was no significant statistical difference between the 
control max rate and the max rate of any CTC treatments until day 5 after exposure. At this point 
the max rate value in microcosms containing 1 mg/L CTC
 
was significantly less than the max rate 
value that was recorded in control microcosms. A similar but not statistically significant trend was 
seen with max rate values at all other CTC treatments.  
3.3.2.4. PCA Analysis of Amine and Amide Utilisation 
 
Data shown by PCA score plots of the first two principle components on day 1 show that replicates 
treated with 0.32 and 1 mg/L
 
cluster together, suggesting that amine and amide utilisation had a 
similar metabolic fingerprint. These data also suggest that the portions of the microbial community 
that were utilising amines and amides (likely to be microbes involved with nitrogen cycling) had a 
similar community structure in microcosms that had been spiked with these CTC concentrations. 
There was also a slight overlap of replicate clustering between the 0.32 and
 
0.1 mg/L groups
 
suggesting that a small degree of similarity between these two treatments. These data suggest that 
these portions of the microbial community that were utilising amines and amides had some 
structural similarity. Replicates from microcosms treated with 0.1 mg/L
 
CTC generally clustered 
with control replicates however, suggesting that amine and amide utilisation followed a similar 
pattern in these microcosms. This points to the likelihood that members of the microbial 
community that were utilising amines and amides at these doses were likely to have had a similar 
community structure.  
 
On day 4 of the exposure a similar trend to day 1 was apparent in terms of replicate groups that had 
clustered. The two clusters (0/ 0.1 mg/L and 0.32 /1 mg/L) were however closer together on day 4, 
suggesting that all treatments were becoming more similar to each other. These data suggest that 
the community structure of the portion of the microbial community that was utilising amines and 
amides in these microcosms was becoming more similar on day 4. In addition, a greater degree of 
clustering had occurred between the control / 0.1 mg/L
 
cluster and replicates from microcosms 
spiked with 0.32 mg/L
 
CTC. This would suggest that the portion of the microbial community that 
was utilising amines and amides at these CTC concentrations were becoming more structurally 
similar. 
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a) 
 
b) 
 
 
Figure 3.4: Kinetic plots of amine and amide utilisation following exposure to CTC on a) day 1, b) 
day 2 and c) day 3. 
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c) 
 
 
Figure 3.4 (cont). 
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Figure 3.5: Scatter plots of PC scores for the first two principle components for individual 
replicates from each CTC treatment group representing amine and amide utilisation on a) Day 1 
and b) Day 4. Day 1 (a) proportion of variation: PC1 = 54.2%, PC2 = 16.2%; Day 4 (b) proportion 
of variation: PC1 = 35.2%, PC2 = 28.9%.  
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a) 
 
b) 
 
 
Figure 3.6: a) Lag phase duration versus exposure period time for amine and amide substrate 
utilisation and b) Max rate of amine and amide utilisation versus exposure period time following 
exposure to CTC. 
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Table 3.5: Summary of one-way ANOVA results for lag phase values before amine and amide 
utilization from Biolog data for inocula from microcosms following different exposure times to 
CTC in comparison with unexposed inocula. 
        
 
 
Day of Exposure / Statistical Significance of Lag Phase Duration
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 >* >ns >ns <ns <ns <ns 
 
0.32 >ns >ns <ns <ns <ns <* 
 
1 >ns >* <ns <* <* <* 
       
 
       
Table 3.6: Summary of one-way ANOVA results for maximum rate of amine and amide utilization 
values from Biolog data for inocula from microcosms following different exposure times to CTC in 
comparison with unexposed inocula.  
 
       
 
 
Day of Exposure / Statistical Significance of Max Rate
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 <ns <ns >ns >ns <ns <ns 
 
0.32 <ns <* <ns <ns <ns <ns 
 
1 <ns <ns <ns >ns <ns <* 
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3.3.3. Effect of CTC on Amino Acid Utilisation 
The data that are shown in figure 3.7 illustrates amino acid utilisation on exposure days 1, 2 and 3 
plotted using a kinetic model. The data that are shown by figure 3.8 shows PCA plots for the first 
two principle components scores on days 1 and 4. The data in figure 3.9 illustrate lag phase and 
maximum rate on exposure days 1-6. The information in tables 3.7 and 3.8 show the statistical 
significance of lag phase and max rate values compared with control data.  
3.3.3.1. Kinetic Model Plots of Amino Acid Utilisation 
Amino acid utilisation, in terms of slope, onset of colour development and maximum colour 
development was inhibited by all CTC doses on day one of the exposure (figure 3.7a).  
On day 2 (24 hours after exposure) the time taken for onset of colour development was slower in 
all treated microcosms than in control microcosms. Although it is difficult to distinguish the slopes 
the kinetic plots merely by eye, it is clear that the maximum absorbance was greater than control 
values at all CTC concentrations (figure 3.7b). 
Day 3 kinetic plots (figure 3.7c) show a reduction in the onset of colour formation for all CTC 
treatments compared to control kinetic plots. In addition, treated and control slopes appeared to be 
similar. The maximum level of colour development was also comparable for all plots, with the 
exception of those representing an exposure of 0.32 mg/L
 
CTC; a greater final absorbance was 
reached in Biolog plates that were seeded from these microcosms.  
3.3.3.2. Lag Phase of Amino Acid Utilisation versus Exposure Time 
On day 1 lag phase durations were higher than control values at all concentrations of CTC. 
Significantly higher lag phase durations were observed at CTC concentrations of 0.1 and 0.32 mg/L 
CTC.  
Lag phase values then dropped sharply between days 1 and 2, with no lag phase being observed in 
microcosms that had been exposed to 1 mg/L
 
CTC. Lag phases for all CTC treatments on day 2 
were statistically significant compared with control values (table 3.7). This trend continued on day 
3. A rise in lag phase duration was observed compared with day 2 values, although no statistical 
significance was observed. A significant decrease in lag phase duration did occur however for the 
rest of the exposure period in microcosms containing 1 mg/L
 
CTC. This trend was mirrored at all 
other concentrations, with a significant decrease in lag phase duration being observed 120 hours 
after exposure at a CTC concentration of 0.32mg/L
 
(figure 3.9a and table 3.7).  
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3.3.3.3. Max Rate of Amino Acid Utilisation versus Exposure Time 
On day 1 of the exposure period treatments of 0.32 and 1 mg/L
 
CTC caused a decrease in max rate 
values. A statistically significant decrease in max rate was only observed at 0.32 mg/L
 
CTC. On 
exposure day 2 all treatments had resulted in a max rate value that was significantly lower than that 
of the control. In the case of the highest two CTC concentrations max rate values had dropped since 
day 1. Max rate values at a CTC concentration of 0.32 mg/L
 
had increased since day 1 however. 
This trend continued until day 4 of the exposure, after which max rate values dropped below 
control readings; no statistically significant changes were observed after day 1. A rise in the max 
rate of colour production was also observed between days 2 and 3 and days 3 and 5 for CTC 
concentrations of 1 and 0.1 mg/L
 
respectively. After these periods, max rate values fell to levels 
nearer control readings. On the final day of the exposure a significant decrease in the max rate of 
colour production was observed at 1 mg/L
 
CTC (figure 3.9b and table 3.8).  
3.3.3.4. PCA Analysis of Amino Acid Utilisation 
At 0 hours after CTC exposure (day 1) replicates from the 1 mg/L
 
exposure clustered in a manner 
that was distinct from all other exposure concentrations. This suggests that the amino acid 
utilisation profile at the highest test concentration was distinct from the profile of other treatment 
groups. This finding supports the theory that exposure to 1 mg/L CTC alters the community 
structure of microbes that are utilising amino acids. The majority of replicates from the 0.32 mg/L
 
exposure also clustered separately. These data suggest that the portion of the microbial community 
that was utilising amino acids was altered by 0.32 mg/L CTC. A separate cluster was formed by 
replicates from the control and 0.1 mg/L
 
groups, suggesting that these treatments formed a similar 
amino acid utilisation profile. These data suggest that the portion of the microbial community that 
was utilising amino acids was not altered structurally by 0.1 mg/L CTC. There was also some 
limited overlap between this cluster and the 0.32 mg/L
 
cluster, suggesting that some replicates from 
the 0.32 mg/L
 
group had a similar amino acid utilisation profile (figure 3.8a). These data point the 
fact that the community structure of amino acid utilising bacteria had a degree of similarity.  
On day 4 (72 hours after exposure) control and 0.1 mg/L replicates
 
again clustered together, 
suggesting that a similar amino acid utilisation profile had resulted from these two treatments. 
These data again suggest that the microbial community structure in these microcosms was similar 
to those present in microcosm treated with other CTC concentration. Two distinct clusters were 
formed by replicates from the 0.32 and 1mg/L
 
groups, suggesting distinct amino acid utilisation 
profiles (figure 3.8b). Day 4 PCA data therefore suggests that the respective portions of the 
microbial community that were utilising amino acids had a similar community structure.  
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a) 
 
b) 
 
 
Figure 3.7: Kinetic plots of amino acid utilisation following CTC exposure on a) day 1, b) day 2 
and c) day 3. 
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c) 
 
 
Figure 3.7 (cont). 
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Figure 3.8: Scatter plots of PC scores for the first two principle components for individual 
replicates from each CTC treatment group representing amino acid utilisation on a) Day 1 and b) 
Day 4. Day 1 (a) proportion of variation: PC1 = 54.2%, PC2 = 16.2%; Day 4 (b) proportion of 
variation: PC1 = 23.4%, PC2 = 18%.  
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a) 
 
b) 
 
 
Figure 3.9: a) Lag phase duration versus exposure period time for amino acid utilisation and b) 
Max rate of amino acid utilisation versus exposure period time following CTC exposure. 
 
  
-10
0
10
20
30
40
50
60
70
80
90
1 2 3 4 5 6
L
a
g
 P
h
a
se
 D
u
ra
ti
o
n
 (
h
o
u
rs
) 
Time (Days) 
0 mg/L CTC
0.1 mg/L CTC
0.32 mg/L CTC
1 mg/L CTC
0.06
0.08
0.1
0.12
0.14
0.16
0.18
0.2
1 2 3 4 5 6
M
ax
 R
a
te
 (
a
b
s 
u
n
it
s 
/h
o
u
r)
 
Time (Days) 
0 mg/L CTC
0.1 mg/L CTC
0.32 mg/L CTC
1 mg/L CTC
137 
 
Table 3.7: Summary of one-way ANOVA results for lag phase values before amino acid utilization 
from Biolog data for inocula from microcosms following different exposure times to CTC in 
comparison with unexposed inocula. 
        
 
 
Day of Exposure / Statistical Significance of Lag Phase Duration
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 >ns <* <ns <ns <ns <ns 
 
0.32 >* <* <ns <ns <ns <ns 
 
1 >* <* <ns <* <* <* 
 
       
Table 3.8: Summary of one-way ANOVA results for maximum rate of amino acid utilization 
values from Biolog data for inocula from microcosms following different exposure times to CTC in 
comparison with unexposed inocula.  
 
       
 
 
Day of Exposure / Statistical Significance of Max Rate
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 <* <* <ns <ns >ns >ns 
 
0.32 <ns <* >ns <ns <ns <ns 
 
1 <ns <* <ns <ns <ns <* 
 
  
138 
 
3.3.4. Effect of CTC on Carbohydrate Utilisation 
The data that are shown in figure 3.10 illustrates carbohydrate utilisation on exposure days 1, 2 and 
3 that were plotted using a kinetic model. The data in figure 3.11 show PCA plots for the first two 
principle components scores on days 1 and 4. The data that are shown in figure 3.12 illustrate lag 
phase duration and the maximum rate of substrate utilisation on exposure days 1-6. The 
information in tables 3.9 and 3.10 show the statistical significance of lag phase and max rate values 
compared with control data. 
3.3.4.1. Kinetic Model Plots of carbohydrate Utilisation 
Carbohydrate utilisation, in terms of slope, onset of colour development and the maximum rate of 
colour development (and therefore carbohydrate utilisation) was inhibited by all CTC 
concentrations on day one of the exposure period (figure 3.14a).  
On day 2 of the exposure, the plot representing carbohydrate utilisation for 0.32 mg/L
 
CTC 
exposure resembled the control plot in terms of slope and onset of colour development. Maximum 
colour development at the end of incubation period was also higher than the control value. 
Although similar maximum colour development levels (to the control plot) were reached by 0.32 
and 1 mg/L
 
curves, a negative effect on carbohydrate utilisation was still visible at these CTC 
concentrations. 
 
On exposure day 3, plots representing both 0.32 and 1 mg/L
 
showed a quicker onset of colour 
development and a higher maximum colour development was reached. These data therefore 
suggested that carbohydrate utilisation was stimulated at these CTC concentrations. Carbohydrate 
utilisation was still inhibited by CTC in microcosms that had been dosed with 0.1 mg/L
 
CTC 
however. 
3.3.4.2. Lag Phase of Carbohydrate Utilisation versus Exposure Time 
On day 1 of the exposure, the lag phase duration was significantly higher as a result of exposure to 
all CTC doses. In the case of exposure to 1 mg/L
 
CTC, lag phase duration was also significantly 
higher than the control value on day 2 of the exposure period. On the same day, lag phase duration 
decreased compared with the control value as a result of exposure to 0.1 and 0.32 mg/L
 
CTC. After 
day 2, lag phase duration was generally lower than control values at all CTC treatments. At CTC 
exposures of 0.32 and 1 mg/L,
 
lag phases were significantly lower than control values for the rest 
of the exposure period.  
3.3.4.3. Max Rate of Carbohydrate Utilisation versus Exposure Time 
On day 1 of the exposure, the max rate of carbohydrate utilisation was inhibited by all CTC doses. 
With the exception of microcosms that were exposed to 0.1 mg/L
 
CTC a statistically significant 
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decreases in the max rate of carbohydrate utilisation was observed for all CTC exposures 
concentrations. This trend continued on exposure day 2 with a significant reduction in max rate of 
carbohydrate utilisation having been observed in microcosms that had been exposed to 0.1 mg/L 
CTC. Max rate did not differ significantly at any CTC concentration until day 6 of the exposure 
period. At this time, significant decreases in the max rate of carbohydrate utilisation were observed 
as a result of exposure to 0.32 and 1mg/L
 
CTC.  
3.3.4.4. PCA Analysis of Carbohydrate Utilisation 
The data shown by PCA score plots of the first two principle components on day 1 of the exposure 
period show three distinct replicate clusters. The first cluster is composed of replicates representing 
the 1mg/L
 
CTC group. Another distinct cluster depicts replicates exposed to 0.32 mg/L CTC. These 
data therefore suggest an effect of CTC on carbohydrate utilisation at these two concentrations, in 
terms of substrate utilisation profile. From these results, it can be suggested that the top two CTC 
doses caused a change in the community structure of microbes that were utilising carbohydrates. A 
third cluster is composed of replicates from control and 0.1 mg/L
 
CTC exposure groups suggesting 
these two treatments result in a similar carbohydrate utilisation profile. It is likely therefore that the 
portion of the microbial community that was utilising carbohydrates had a similar community 
structure in microcosms exposed to these CTC concentrations.  
A similar trend is apparent on day 4 PCA score plots, suggesting that similar carbon utilisation 
profiles to day 1 were observed. As such, CTC concentrations of 0.32 and 1 mg/L were still 
causing changes in the carbohydrate utilisation profile of the microbial community. These data 
suggest that the portion of the microbial community that could utilise carbohydrates had different 
community structures from unexposed microbial communities. Day 4 data also suggested that the 
portion of the microbial community that was able to utilise carbohydrates had a similar community 
structure in microcosms that had exposed to 0 and 0.1 mg/L CTC.  
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a) 
 
b) 
 
 
Figure 3.10: Kinetic plots of carbohydrate utilisation following exposure to CTC on a) day 1, b) 
day 2 and c) day 3. 
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c) 
 
 
Figure 3.10 (cont). 
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Figure 3.11: Scatter plots of PC scores for the first two principle components for individual 
replicates from each CTC treatment group representing carbohydrate utilisation on a) day 1 and b) 
day 4. Day 1 (a) proportion of variation: PC1 = 49.3%, PC2 = 8.6%; Day 4 (b) proportion of 
variation: PC1 = 37.3%, PC2 = 14.6%.  
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a) 
 
b) 
 
 
Figure 3.12: a) Lag phase duration versus exposure period time for carbohydrate utilisation and b) 
Max rate of carbohydrate utilisation versus exposure period time following CTC exposure. 
 
  
0
10
20
30
40
50
60
70
1 2 3 4 5 6
L
a
g
 P
h
a
se
 D
u
ra
ti
o
n
 (
h
o
u
rs
) 
Time (Days) 
0 mg/L CTC
0.1 mg/L CTC
0.32 mg/L CTC
1 mg/L CTC
0.06
0.08
0.1
0.12
0.14
0.16
0.18
0.2
0.22
0.24
0.26
0.28
1 2 3 4 5 6
M
ax
 R
a
te
 (
a
b
s 
u
n
it
s 
/h
o
u
r)
 
Time (Days) 
0 mg/L CTC
0.1 mg/L CTC
0.32 mg/L CTC
1 mg/L CTC
144 
 
Table 3.9: Summary of one-way ANOVA results for lag phase values before carbohydrate 
utilization from Biolog data for inocula from microcosms following different exposure times to 
CTC in comparison with unexposed inocula.  
        
 
 
Day of Exposure / Statistical Significance of Lag Phase Duration
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 >ns <* <ns <ns <ns <ns 
 
0.32 >* <* <ns <ns <ns <ns 
 
1 >* <* <ns <* <* <* 
 
       
Table 3.10: Summary of one-way ANOVA results for maximum rate of carbohydrate utilization 
values from Biolog data for inocula from microcosms following different exposure times to CTC in 
comparison with unexposed inocula. 
 
       
 
 
Day of Exposure / Statistical Significance of Max Rate
1
 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 <* <* <ns <ns >ns >ns 
 
0.32 <ns <* >ns <ns <ns <ns 
 
1 <ns <* <ns <ns <ns <* 
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3.3.5. Effect of CTC on Carboxylic Acid Utilisation 
The data that are shown shown by figure 3.13 illustrate carboxylic acid utilisation on exposure days 
1, 2 and 3 plotted using a kinetic model. The data in figure 3.14 show PCA scatter plots for the first 
two principle components scores on days 1 and 4. The data in figure 3.15 illustrate lag phase and 
maximum rate on exposure days 1-6.  The information in tables 3.11 and 3.12 show the statistical 
significance of lag phase and max rate values compared with control data. 
3.3.5.1. Kinetic Model Plots of Carboxylic Acid Utilisation 
Carboxylic acid utilisation, in terms of colour production onset time and maximum colour 
development, was inhibited by all CTC concentrations. At CTC concentrations of 0.32 and 1 mg/L,
 
the slopes, when compared with the control slope, also indicated that inhibition of carboxylic acid 
utilisation had occurred as the result of exposure to CTC (fig 3.13a).  
The data shown by day 2 kinetic model plots illustrate a continuing trend from day 1 data. 
Inhibition of carboxylic acid utilisation was still detected at all CTC concentrations in terms of 
colour production onset. Slopes of treated plots on day 2 were more similar to control slopes 
however. Maximum colour development on day 2 was either similar to or higher than control 
values (fig 3.13b) 
The data in day 3 kinetic plots indicate that colour development onset at all CTC concentrations 
was occurring more rapidly than was shown by control plots. There were also no observable 
differences in the gradient of plots representing exposed microcosms compared with control data. 
In addition, the maximum colour development on day 3 was higher at all CTC concentrations 
compared with control values (fig 3.13c). 
3.3.5.2. Lag Phase of Carboxylic Acid versus Exposure Time 
On day 1 of the exposure, an increasing lag phase duration was negatively correlated with 
increasing CTC concentration. The decrease in lag phase duration was shown to be statistically 
significant. Although lag phase values could still be negatively correlated with increasing CTC 
concentration on day 2 of the exposure, the increase in lag phase that was statistically significant 
was caused by exposure to 1 mg/L
 
CTC. Between days 1 and 3 of the exposure period, lag phase 
values had dropped. The only lag phase value that was significantly higher than the control lag 
phase duration was at a dose of 1mg/L CTC.  
For the remainder of the exposure period (days 3 to 6), lag phase durations remained lower than 
that of the control. The only lag phase value that was statistically less than the control value was at 
1 mg/L
 
CTC (fig 3.15a; table 3.11).  
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3.3.5.3. Max Rate of Carboxylic Acid Utilisation versus Exposure 
Time 
On day 1 of the exposure, a reduction in the max rate of carboxylic acid utilisation was negatively 
correlated with increasing CTC concentration. Statistically significant reductions in max rate values 
were only detected at the two highest concentrations of CTC however. A general rise in the max 
rate of carboxylic acid utilisation was observed at all exposure concentrations (and in control 
microcosms) between days 1 and 4, although the max rate of carboxylic acid utilisation was still 
consistently lower than the control value. It was observed that max rate was significantly lower 
than the control value in microcosms exposed to 1 mg/L CTC
 
on day 4. On the final day of the 
exposure period (day 6) significantly lower max rate values (compared with the control max rate) 
were observed at CTC concentrations of 0.32 and 1 mg/L (figure 3.15b; table 3.12). 
3.3.5.4. PCA Analysis of Carboxylic Utilisation 
Data illustrated by PCA scatter plots of the first two principle components on day 1 shows a 
distinct cluster composed of replicates from the 1 mg/L
 
CTC exposure. At this CTC concentration 
the utilisation profile of carboxylic acids had therefore been altered compared with control profiles. 
It is likely that the portion of the microbial community that was able to utilise carboxylic acids had 
a different community structure from the unexposed microbial community. A cluster of five 
replicates resulted from exposure to 0.32 mg/L. However, four replicates from the 0.32 mg/L
 
grouping were also associated with a cluster that contained replicates from the control and 0.1 
mg/L
 
group.  
It can therefore be inferred that the carboxylic acid utilisation profile of control and 0.1 mg/L
 
exposed microbial communities had similar carboxylic acid utilisation profiles. Microcosms 
exposed to 0.32 mg/L had a less distinct carboxylic utilisation profile that could sometimes be 
associated with control and 0.1 mg/L
 
profiles. These data suggest that the portion of the microbial 
community that was utilising carboxylic acids on day 1 had similar community structures in 
microcosms exposed to 0 and 0.1 mg/L CTC. The carboxylic acid utilising microbial community 
that was exposed to 0.32 mg/L was likely to have a less similar community structure to unexposed 
communities, although separate clustering would indicate that exposure to this CTC concentration 
did result in a degree of change in community structure.  
Day 4 data indicates that 0.32 mg/L CTC replicates tended to cluster more distinctly from control 
and 0.1 mg/L replicates but more closely to replicates from the 1 mg/L group. This would suggest 
that the carboxylic utilisation profile of the microbial community present in microcosms that were 
exposed to 0.32 mg/L was being altered compared to the microbial community that was present in 
control microcosms. It is therefore likely that the community structure had changed and had also 
become more similar to the microbial community that was present in microcosms spiked with 1 
mg/L CTC. Replicates from the control and 0.1 mg/L CTC groups continued to cluster on day 4, 
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suggesting that their carboxylic utilisation profile (and therefore microbial community structure) 
were similar. Replicates from the 1 mg/L CTC group continued to cluster on day 4. Therefore the 
carboxylic acid utilisation profile and subsequently the microbial community structure remained 
distinct from the unexposed group.  
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a) 
 
b) 
 
 
Figure 3.13: Kinetic plots of carboxylic acid utilisation following CTC exposure on a) day 1, b) day 
2 and c) day 3. 
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c) 
 
 
Figure 3.13 (cont). 
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Figure 3.14: Scatter plots of PC scores for the first two principle components for individual 
replicates from each CTC treatment group representing carboxylic acid utilisation on a) Day 1 and 
b) Day 4. Day 1 (a) proportion of variation: PC1 = 36%, PC2 = 12%; Day 4 (b) proportion of 
variation: PC1 = 34.8%, PC2 = 16.8%.  
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a) 
 
b) 
 
 
Figure 3.15: a) Lag phase duration versus exposure period time for carboxylic acid utilisation and 
b) Max rate of carboxylic acid utilisation versus exposure period time following CTC exposure. 
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Table 3.11: Summary of one-way ANOVA results for lag phase values before carboxylic acid 
utilization from Biolog data for inocula from microcosms following different exposure times to 
CTC in comparison with unexposed inocula. 
        
 
 
Day of Exposure / Statistical Significance of Lag Phase Duration
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 >ns <ns <ns <ns <ns <ns 
 
0.32 >* >ns <ns <ns <ns <ns 
 
1 >* >* <ns <* <* <* 
 
       
Table 3.12: Summary of one-way ANOVA results for maximum rate ofcarboxylic acid utilization 
values from Biolog data for inocula from microcosms following different exposure times to CTC in 
comparison with unexposed inocula. 
 
       
 
 
Day of Exposure / Statistical Significance of Max Rate
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 <ns <ns >ns <ns <ns <ns 
 
0.32 <* <* <ns <* <ns <ns 
 
1 <* <* <ns <* <ns <ns 
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3.3.6. Effect of CTC on Polymer Utilisation 
The data shown by figure 3.16 illustrate carboxylic acid utilisation on exposure days 1, 2 and 3 
plotted using a kinetic model. Data in figure 3.17 show PCA plots for the first two principle 
components scores on days 1 and 4. The data in figure 3.18 illustrate lag phase and maximum rate 
on exposure days 1-6.  The information in tables 3.13 and 3.14 show the statistical significance of 
lag phase and max rate values compared with control data. 
3.3.6.1. Kinetic Plot Models of polymer Utilisation 
The data in day 1 kinetic model plots illustrate a trend of polymer utilisation being inhibited by all 
CTC concentrations. At all concentrations the time of colour production onset, slope gradient and 
maximum colour development were inhibited compared with data in control kinetic plots (figure 
3.16a). 
On day 2 of the exposure, data in plots representing polymer utilisation in microcosms exposed to 
0.32 mg/L CTC show a steeper gradient and a higher maximum colour development (and therefore 
polymer utilisation) than illustrated by data in control plots. Plots showing data for l
 
mg/L
 
on the 
same exposure day
 
point towards an inhibition of colour development onset (figure 3.16b). 
On day 3, data from all plots of CTC exposure concentrations show a higher maximum rate of 
colour development. Inhibition of polymer utilisation was no longer inhibited by 0.32 or 1mg/L 
CTC exposure. It is unclear as to whether any inhibitory effects were still being observed at 0.1 
mg/L CTC exposure on day 3 (figure 3.16c). 
3.3.6.2. Lag Phase of Polymer Utilisation versus Exposure Time 
On day 1 of the exposure, the lag phase duration increased as a result of exposing microcosms to 
all CTC concentrations. The longest lag phase duration was observed at 1mg/L
 
CTC exposure, 
although this reduction was not significantly different from the control lag phase duration. 
Significant differences in lag phase duration were however observed at 0.1 and 0.32 mg/L CTC 
exposure.  
On the second exposure day, lag phases shortened at all CTC treatments (including control values). 
Only an exposure concentration of 1mg/L
 
resulted in a statistically shorter lag phase duration 
however. Lag phases at all CTC doses (not including the control dose) remained similar to the 
control lag phase duration until the end of the exposure period (day 6). The only exception to this 
trend was a significant lag phase reduction compared to the control value at 1 mg/L CTC on day 6 
being been observed (figure 3.18a). 
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3.3.6.3. Max Rate of Polymer Utilisation versus Exposure Time 
On day 1 of the exposure, a statistically significant decrease in the max rate of polymer utilisation 
was observed in microcosms that had been spiked with 0.1 and 0.32 mg/L
 
CTC. Conversely, the 
max rate of polymer utilisation in microcosms that were exposed to 1mg/L
 
increased, although this 
increase was not statistically significant. On day 2 of the exposure, the max rate of polymer 
utilisation increased as a result of exposing microbial communities to 0.1 and 0.32 mg/L
 
CTC. The 
latter exposure concentration resulted in a significantly higher max rate of polymer utilisation 
compared with the control value. Max rate values for all CTC treatments remained similar to the 
control max rate until the end of the exposure period (day 6) with the exception of microcosms that 
had been exposed to 1mg/L
 
CTC on day 4; a significantly higher max rate of polymer utilisation 
was observed at this time-point and CTC concentration. 
3.3.6.4. PCA Analysis of Polymer Utilisation 
Data illustrated by PCA scatter plots of the first two principal component scores on day 1 show two 
distinct replicate clusters. The first cluster shows distinct grouping of replicates from the control, 
0.1 and 0.32 mg/L groups, suggesting that the polymer utilisation profile was similar for these CTC 
treatments on day 1. In another cluster group, replicates that had been exposed to 1mg/L also 
cluster closely. This suggests that exposure to the highest CTC concentration results in a distinct 
polymer utilisation profile also. Some replicates from the 0.32 mg/L
 
CTC group also clustered with 
this group suggesting that there was some similarity between the polymer utilisation profile of 
microcosms exposed to 0.32 and 1 mg/L
 
CTC (figure 3.17a). 
It can be suggested therefore that the portion of the microbial community that was utilising 
polymers on day 1 of the exposure had a different community structure than microcosms that were 
exposed to 1 mg/L CTC. It is also likely that exposure of the polymer-utilising microbial 
community that was exposed to 0.32 mg/L CTC caused a smaller difference in microbial 
community structure compared with the unexposed microbial community structure. The results also 
suggest that this microbial community structure shared some similarity with the microbial 
community that exposed to 1 mg/L CTC.  
The polymer utilisation profile of day 1 is mirrored by the data shown in day 4 PCA scatter plots, 
although more replicates from the 0.32 mg/L
 
CTC exposure cluster with replicates from the 1mg/L 
cluster. These data would suggest that the microbial community structure of carboxylic utilising 
bacteria that were exposed to 0.32 and 1 mg/L CTC were more similar on day 4 (figure 3.17b).  
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a)  
 
b) 
 
 
Figure 3.16: Kinetic plots of polymer utilisation following CTC exposure on a) day 1, b) day 2 and 
c) day 3. 
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c) 
 
 
Figure 3.16 (cont). 
 
  
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
2.2
0 10 20 30 40 50 60 70 80 90
A
b
so
rb
a
n
ce
 a
t 
5
9
5
 n
m
Time (hours)
Predicted 0 mg/L CTC
Predicted 0.1 mg/L CTC
Predicted 0.32 mg/L CTC
Predicted 1 mg/L CTC
Measured 0 mg/L CTC
Measured 0.1 mg/L CTC
Measured 0.32 mg/L CTC
Measured 1 mg/L CTC
157 
 
a) 
3210-1-2-3-4
2
1
0
-1
-2
First Component
S
e
c
o
n
d
 C
o
m
p
o
n
e
n
t
0 mg/L CTC
0.1 mg/L CTC
0.32 mg/L CTC
1 mg/L CTC
 
b) 
3210-1-2-3-4
2
1
0
-1
-2
-3
First Component
S
e
c
o
n
d
 C
o
m
p
o
n
e
n
t
0 mg/L CTC
0.1 mg/L CTC
0.32 mg/L CTC
1 mg/L CTC
 
 
Figure 3.17: Scatter plots of PC scores for the first two principle components for individual 
replicates from each CTC treatment group representing polymer utilisation on a) Day 1 and b) Day 
4. Day 1 (a) proportion of variation: PC1 = 72%, PC2 = 10.1%; Day 4 (b) proportion of variation: 
PC1 = 59.8%, PC2 = 24.3%.  
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a) 
 
b) 
 
 
Figure 3.18: a) Lag phase duration versus exposure period time for polymer utilisation and b) Max 
rate of polymer utilisation versus exposure period time following CTC exposure. 
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Table 3.13: Summary of one-way ANOVA results for lag phase values before polymer utilization 
from Biolog data for inocula from microcosms following different exposure times to CTC in 
comparison with unexposed inocula. 
        
 
 
Day of Exposure / Statistical Significance of Lag Phase Duration
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 >* >ns <ns <ns <ns >ns 
 
0.32 >* >ns <ns <ns <* <ns 
 
1 >ns >* <ns <* <* <* 
 
       
Table 3.14: Summary of one-way ANOVA results for maximum rate of polymer utilization values 
from Biolog data for inocula from microcosms following different exposure times to CTC in 
comparison with unexposed inocula. 
 
       
 
 
Day of Exposure / Statistical Significance of Max Rate
1 
 
[CTC] / mg/L 1 2 3 4 5 6 
 
0.1 <* >ns <ns <ns <ns >ns 
 
0.32 <* >* >ns >ns <ns >ns 
 
1 <ns >ns >ns >* >ns >ns 
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3.3.7. Effect of CTC on Total CFU Counts 
 
There were no statistically significant changes in CFU counts compared with control values as a 
result of exposing microbial communities to any CTC dose on day 1 or day 7 (figure 3.19). These 
data would suggest that the total number of cells that were being produced by the microbial 
community was not significantly affected by exposure to any CTC concentration. It can therefore 
be concluded that microbial communities in general exhibited similar growth regardless of which 
CTC treatment they were exposed to.  
 
 
 
Figure 3.19: Bar graph representing total log CFU counts versus [CTC] on days one and seven of 
the exposure period. Any statistically significant changes are indicated by asterisk notation (*, P ≤ 
0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001).  
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3.3.8. Effect of CTC on the Functional Diversity of Multisubstrate 
Utilisation 
 
The data shown by figure 3.20 indicate changes in the functional diversity of substrates that were 
being utilised by microbial communities on each day of the exposure. On day 1 of the exposure the 
functional diversity of substrate utilisation was significantly inhibited (P < 0.001) by the two 
highest CTC concentrations (0.32 and 1 mg/L) as shown by these two treatment groups having a 
lower diversity index value. These data would suggest that microbial communities that had been 
exposed to these CTC concentrations were not able to utilise the same range of substrates as 
communities that were exposed to 0 and 0.1 mg/L CTC were able to utilise.  
Data from other days of the exposure show that microbial communities that had been exposed to 
the two highest CTC concentrations were no longer inhibited on day 2 onwards in terms of the 
diversity of substrates that they were able to utilise. On days two and three of the exposure, 
microbial communities at all treatment concentrations showed a similar functional diversity of 
substrate utilisation. On day 4 however, communities that had been exposed to the two highest 
CTC doses were able to utilise a significantly greater (P < 0.001) diversity of substrates, as shown 
by a higher diversity index. This trend continued to the end of the exposure in the case of the 1 
mg/L CTC treatment group.  
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Figure 3.20: Bar graph showing values of the Shannon-Weaver Diversity Index (e
H’
) on each day of 
the exposure period for each CTC treatment group. Statistical significance is indicated by asterisk 
notation (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001).  
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3.4. Discussion 
3.4.1. Effects of CTC on Total Organic Substrate Utilisation 
The microcosm/Biolog GN2 phenotype microarray assay-system (which was developed by work 
described in Chapter 2) was used to explore the potential effects of a candidate tetracycline 
antibiotic (CTC) on aquatic microbial communities. It was first tested if any inhibition or 
stimulation of total organic substrate utilisation could be detected in terms of a general trend and by 
analysis of lag phase duration (following onset of substrate utilisation) and the maximum rate of 
total substrate utilisation. Data transformed using a 3-parameter kinetic model suggested that an 
inhibition of total substrate utilisation had occurred on exposure day 1 at all CTC concentrations. 
Statistical analysis of lag phase duration before onset of total substrate utilisation revealed a 
significant increase in lag phase duration compared with the control lag phase duration at all CTC 
doses. A significant decrease in the maximum rate of total substrate utilisation was also observed as 
a result of exposing microcosms to 0.32 and 1 mg/L CTC.  
It is likely that CTC was taken up by bacterial cells rapidly. McMurry et al. (1981) for example 
showed that E. coli cells had accumulated 9.5 mg/L tetracycline in just 5 minutes following 
exposure. It is known that once tetracyclines enter microbial cells they are accumulated (Chopra, 
1985). Subsequently, increasing intracellular tetracycline levels exert an antimicrobial effect. The 
main mode of action of tetracyclines is the inhibition of protein synthesis at the ribosomal level 
(Tritton, 1977; Gale et al., 1981; Chopra, 1985; Rasmussen et al., 1991). The binding of 
prokaryotic tRNA to the 70S ribosome is reduced to around 20% of normal levels (Epe et al., 
1987). Using cell-free extracts, Holmes and Wild (1967) demonstrated that CTC can exert this 
effect within 2 hours of exposure to CTC. As a result, it probably took longer for members (or 
some members) of the microbial community present in microcosms and Biolog GN2 plates to 
synthesise essential proteins (such as enzymes and transporter proteins) that would have been 
required to efficiently utilise a range of organic substrates. This most likely explains why an 
increase in lag phase duration and a reduction in the max rate of substrate utilistion were observed 
on day 1 at all CTC concentrations. In addition, due to the bacteriostatic effect of CTC, it is 
possible that the growth of at least a portion of the microbial community present in treated 
microcosms was inhibited. As a result, potentially fewer bacteria were present in microcosms. CFU 
data did not show a significant difference in cell numbers (compared with control data) that would 
have supported this theory however. CFU count data do in fact suggest that no significant changes 
in cell density occurred as the result of exposing the microbial community to any CTC dose. The 
possibility that CTC was exerting a growth-independent effect cannot be ruled out therefore. One 
should bear in mind though that culturing techniques may not be able to detect the majority of the 
total microbial community; this is due to “the great plate count anomaly.” Accordingly, it has been 
estimated that less than 1% of the total microbial community can be cultured on (or in) synthetic 
and semi-synthetic media (Jannasch and Jones, 1959; Staley and Konopka, 1985). As such, there is 
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a great deal of uncertainty as to whether CFU counts truly represent what is occurring on a whole 
community level. Also, in 1982 the concept of “viable but non-culturable bacteria” (VBNC) was 
proposed, whereby microbial cells may be metabolically active but do not reproduce; this portion 
of the microbial community is not detectable by traditional cell culture techniques (Bogosian and 
Bourneuf, 2001). A suggestion for future studies therefore would be to use a range of techniques 
capable detecting distinct portions of the microbial community, such as molecular based techniques 
(such as detection of total 16S RNA).   
It should also be noted that R2A media and the media that is present in Biolog GN2 plate wells 
(modified LB, or lysogeny broth media) are likely to target different portions of the microbial 
community. R2A media has a low nutrient formulation which targets slower growing oligotrophic 
bacteria that are likely to occupy a niche which has a low nutrient level (such as surface waters). 
Such bacteria generally display relatively slow growth rates. Although Biolog have not published 
the exact constituents of their growth media, they have revealed that it is a modified LB Medium 
(Biolog, 2007). LB medium is much richer in nutrients than R2A agar. As a result of this, LB 
medium is likely to promote the growth of faster growing bacteria which are adapted to exploit 
more nutrient rich niches. This has also been suggested experimentally by work that has analysed 
Biolog plates by molecular techniques (Smalla et al., 1998). It is therefore unclear whether CFU 
counts obtained in the current investigation equate to cell densities that may be found in individual 
Biolog GN2 wells. Future experiments could be designed to address these issues. Firstly, plates 
from which CFU counts are calculated could contain the same growth medium as is present in 
Biolog GN2 plates. Both media would therefore be targeting the same (or more similar) portions of 
the microbial community. A sub-experiment could compare the difference between CFU counts 
that were obtained by inoculation of both R2A and LB media to see whether R2A media could be 
used to estimate cell densities in Biolog plates. The type of isolates that were cultured by both 
methods could also be compared by a molecular technique such as DNA sequencing. Alternatively, 
Biolog plates could be recreated using R2A broth and commercially available empty (and 
sterilised) microplates. If this method was tested then all bacteria would be growing on the same 
substrate. Alternatively, microbial cell densities in both microcosms and Biolog plates could be 
enumerated using an alternative method, such as measuring total DNA present a given sample (of 
equal volume).  
This also leads one to question of whether R2A plate CFU counts can be used to form the 
assumption that total cell densities in the inoculum that was used to seed Biolog plates throughout 
the exposure period were equal. Addressing this issue would be of interest. In particular, if 
inoculum cell densities are not normalised, then any functional effects that are seen using Biolog 
data might just be an artefact of there being more or less bacteria present (in individual Biolog GN2 
plate wells) that are able to utilise a particular substrate. On the other hand, one could also argue 
that differences in cell numbers due to exposure (of a microbial community) to a toxicant would 
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inherently result in differential substrate utilisation between doses, so substrate utlilisation might be 
expected to be different because of this toxicant-induced reduction in growth. Selecting a method 
would therefore depend on whether one wished to look at purely growth-independent functional 
effects or whether one wanted growth-dependent effects to be considered also.  
Due to the fact that Biolog plates utilise high nutrient modified LB as a growth media, it is likely 
that the functional activity of faster growing bacteria was detected during the current study. In 
addition, such bacteria are also likely to be more abundant at the start of the exposure period as 
nutrients will be relatively more available compared with a later time point, when a large 
proportion of nutrients have been consumed by the microbial community (or a portion of the 
microbial community). It is also worth mentioning that the effect of CTC on slower growing 
oligotrophic bacteria may not be detected by the current system due to the fact that they may not 
grow quickly enough to allow their substrate utilisation to be measured by the Biolog GN2 assay. 
In addition, an exposure period of 7 days may not represent an adequate time frame during which 
such organisms can be studied. The results presented in the current investigation are likely to better 
detect relatively acute effects of antibiotics. If future studies wanted to study more relatively 
chronic effects then a microcosm and assay system that was deigned to be used for a longer time 
period would have to be employed. When devising future experiments however, one must also bear 
in mind that previous investigations which have looked at the effects of bacteriostatic antibiotics 
have concluded that inhibitory effects can only be observed when a relatively high nutrient load is 
added to a system (Schmitt et al., 2005). The design of any future study needs careful consideration 
of these points.  
In addition to kinetic effects, CTC doses of 0.32 and 1 mg/L caused a statistically significant 
reduction in the functional diversity of substrates that were being utilised by the microbial 
community (or portion of the microbial community) that were present in corresponding 
microcosms. It is possible that the growth or physiological function of certain members of the 
microbial community was being inhibited by the upper two CTC doses. In such a scenario, it is 
possible that certain members of the inhibited microbial community (present in microcosms spiked 
with 0.32 and 1`mg/L CTC) had their growth rates reduced to the point that their contribution to the 
utilisation of certain substrates was not detectable on Biolog GN2 plates. In such a scenario, it is 
possible that uninhibited members of the microbial community (for example members of the 
microbial community that were expressing CTC resistance mechanisms) could not exploit the same 
range of substrates as those that were inhibited (for example bacteria that were present in 
microcosms spiked with 0 and 0.1 mg/L CTC). It is also possible that certain members of the 
microbial community in affected microcosms were not able to synthesise the same range of cellular 
proteins, especially catabolic enzymes, which would have been required to efficiently utilise a 
more broad range of substrates. This would have occurred due to the inhibition of protein synthesis 
by CTC. Kong et al. (2006) investigated the effect of exposing a soil microbial community to 
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oxytetracycline at similar concentrations to the present investigation. They observed a general 
decrease in the diversity of Biolog substrates that could be utilised by the microbial community (or 
at least a portion of the microbial community). The results are however in general agreement with 
the current study, suggesting that CTC can have a negative impact on the range of substrates that 
soil and aquatic microbial communities are able to utilise.  
PCA analysis of functional data revealed changes in the pattern of total substrate utilisation at the 
highest two CTC doses (0.32 and 1 mg/L). This would suggest that the microbial community 
structure was different in microcosms that had been exposed to these CTC doses. Moreover, these 
effects could still be observed after effects on kinetic and functional diversity of substrate 
utilisation could be seen. In fact, changes in the microbial community structure were observed on 
all days of the exposure period. There are several possibilities why this could be occurring. Firstly, 
it is likely that previously inhibited bacteria will be able to grow when the system is in recovery. 
This could be because CTC has been degraded or such bacteria have developed a degree of 
resistance to CTC. It is also known that the bacteriostatic effect of CTC is transient, meaning that 
the effect of CTC will eventually stop (Chopra, 1985). There are no prior studies indicating the 
time-frame this may occur within in the context of aquatic microbial communities however. As 
time progresses, bacteria with different growth rates could be thriving at different time points 
compared to when they would have done in an unexposed system. Or indeed resistant members of 
the microbial community may be exploiting nutrients within the system. As members of the dosed 
(with 0.32 and 1 mg/L CTC) community appear at different times, their pattern of substrate 
utilisation is likely to be different. Alternatively, if resistant bacteria are present in dosed but not 
unexposed microcosms, they could also exhibit a different pattern of substrate utilisation. It could 
also be the case that the same resistant and susceptible bacteria are present in both exposed and 
unexposed systems, but in exposed microcosms the resistant community members are more able to 
compete for the available resources. In such a scenario, substrate utilisation patterns (and 
subsequent microbial community structures) could also be different in affected and unaffected 
systems.  
Although patterns of substrate utilisation suggest that differences in community structure have 
occurred between dose groups, future work should validate these findings using molecular 
approaches such as PCR-DGGE. Other investigations have used this approach to good effect 
previously. Nelson et al. (2011) for example analysed V3 regions of bacterial 16S rRNA 
(ribosomal RNA) which was extracted from soil microbial communities that had been exposed to 
CTC.  
Day 1 results are in agreement with other studies that have tracked the effects of tetracyclines on 
total substrate utilisation. Kong et al. (2006) observed a significant reduction in total substrate 
utilisation by soil microbial communities as a result of exposure to oxytetracycline. A lowest 
oxytetracycline concentration of 0.46 mg/L was found to significantly reduce the maximum colour 
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development that was formed in Biolog GN2 plates over time. The authors also reported an 
increased onset of colour production. Although this was not numerically or statistically quantified 
the observation is in agreement with the data that were obtained during this study. Stone et al. 
(2011) observed that aged manure application which contained 11.6 mg/L CTC reduced overall 
substrate utilisation by soil microbial communities at certain depths in soil columns (30 cm).  
 
Kong et al. (2006) used PCA score plots of the first two principal components to look at the 
clustering of different oxytetracycline exposure groups compared with an unexposed control group. 
All oxytetracycline exposure groups clustered independently from the control group, with the top 
three oxytetracycline concentrations forming a separate cluster. In the present study separation of 
the two highest CTC concentrations was observed. The data in both studies therefore illustrate 
changes in total substrate utilisation profiles by environmental microbes a result of exposure to 
tetracycline antibiotics. In another investigation, Stone et al. (2011) found that manure containing 
aged antibiotic residues (tylosin and CTC) caused changes in substrate utilisation patterns at 
different soil depths (10 and 30 cm). The authors speculated that exposure of the soil microbial 
community to antibiotics had caused a shift in the structure of the microbial community. Other 
studies have also investigated changes in microbial community as indicated by substrate utilisation 
profiles. Maul et al. (2006) exposed leaf-bound microbial communities to the antibiotic 
ciprofloxacin. A significant variation in PC1 (principal component 1) and PC2 (principal 
component 2) scores were observed at a dose of 0.1 mg/L ciprofloxacin, suggesting that a change 
in total carbon utilisation profiles occurred compared with controls. Schmitt et al. (2005) reported a 
shift in PCA scores on the second axis, suggesting a change in the total substrate utilisation profile 
as result of exposing soil microbial extracts to the antibiotic sulfachloropyridazine. The results of 
these and the present study suggest that a range of antibiotics can affect the metabolic physiology 
of microbial communities in a range of environments.  
 
The inhibitory effects of CTC that were observed the on the max rate of total substrate utilisation 
and lag phase duration were also observed on day 2 of the exposure period at the highest CTC 
concentration (1 mg/L). It is likely the same reasons that were mentioned previously were 
responsible for these prolonged effects. There was no effect on either lag phase duration or the max 
rate of substrate utilisation as result of exposure to 0.1 and 0.32 mg/L CTC on day 2. These data 
suggest that the microbial community in microcosms exposed to CTC concentrations below 1 mg/L 
were recovering from the inhibitory effects of intoxication. By day 3 of the exposure period no 
inhibitory effects were being observed at the top CTC exposure concentration in terms of either 
increased lag phase durations or a reduction in the max rate of total substrate utilisation. These data 
suggest that microcosms exposed to 1 mg/L were also recovering by day 3. By day 4 lag phases for 
all CTC treatments were lower than control values, suggesting microbial function had actually been 
stimulated. This could potentially be explained by less toxic waste products being present (such as 
ammonia) and more nutrients (essential for microbial growth and cellular function) being available 
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due to the previously reduced uptake and metabolism of macromolecules, salts etc. due to CTC 
intoxication. This could have potentially occurred due to the fact that inhibition of the microbial 
community (or a portion of the microbial community) may have resulted in less metabolism of 
nutrients within the microcosm and therefore less potentially toxic by-products (such as ammonia) 
of metabolism being formed. Alternatively, previously inhibited bacteria may have been growing 
and exploiting nutrients now that they had potentially recovered from the toxic effects of CTC. As 
a result, it may have taken longer for these community members to become abundant enough to 
have a measurable kinetic impact on substrate utilisation. Also, some members of the microbial 
community could have formed resistance (by horizontal gene transfer, for example) earlier in the 
exposure due and were now present in sufficient numbers to utilise a measurable level of 
substrates. 
 
The recovery of the system was also mirrored by diversity index data, with no inhibition of the 
functional diversity of substrate utilisation being witnessed after day 1. On days 2 and 3 of the 
exposure period the functional diversity of substrate utilisation was similar at all CTC doses before 
an increase could be observed later on in the exposure period (on day 4 at 0.32 and 1 mg/L CTC). 
These data provide evidence that the portion of the microbial community that was being 
investigated was able to utilise a greater number of substrates during the recovery period. This 
could have been caused by previously inhibited members of the microbial community being able to 
exploit a greater number of substrates as they recovered from the effects of CTC intoxication. Such 
bacteria may have already thrived then died in exposure scenarios during which their growth or 
physiological functioning was not inhibited, in control microcosms for example. It is possible that 
no other member (or members) of the microbial community could utilise the same range of 
substrates once such members of the community had died. As such, the utilisation of a reduced 
range of substrates would have lowered the value of the diversity index.  
 
The recovery of the microbial community observed from day 2 onwards can possibly be attributed 
to one or more mechanisms of antibiotic resistance being expressed by a portion of the microbial 
community. A number of intrinsic, mutational and acquired mechanisms of resistance exist which 
result in aquatic microbes being protected from the toxic effects of tetracyclines (and other 
antibiotics). This is usually dependent on bacteria possessing one or more resistance genotypes. 
Tetracycline mechanisms of resistance include drug efflux, ribosomal protection and biochemical 
modification of tetracycline molecules (Speer et al., 1992; Davies, 2007). Members of the 
microbial community could potentially be able to thrive in an environment containing CTC if they 
possessed one or more of these resistant phenotypes. This leads to the possibility that a resistant 
member (or resistant members) of the microbial community that would normally be out-competed 
(during a non-exposed scenario) by a susceptible member could start to compete for the resources 
that the inhibited member cannot now utilise. In such a scenario, it is possible that the cell density 
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within a microcosm system would not necessarily change. In such a scenario, CFU data from the 
current investigation would support such a theory.  
 
In addition, the possibility for microbes to pass resistance genes to other members of the microbial 
community that did not previously possess copies of that specific gene has been reported (e.g.: 
Droge et al., 1999). If members of the microbial community are becoming resistant at the start of 
the exposure period, it is likely that the faster growing members of the microbial community 
(which are able to utilise the relatively large abundance and diversity of nutrients that are present 
nearer the beginning of the exposure period) are forming resistance. If tetracycline resistance was 
spreading throughout the microbial community (or at least a portion of it) then it is highly likely 
that at least one member of the community possessed a resistant genotype at the start of the 
exposure. Chapter 5 will address the issue of antibiotic resistance in more depth.  
 
It is also possible that the parent compound (CTC) is being degraded. It is difficult to evaluate this 
due to the conflicting nature of the results that have been generated by previous studies. For 
example, Verma et al. (2007) have reported a degradation half-life of CTC of between 13-18 days 
in the aquatic environment. Sanderson et al. (2005) on the other hand reported a shorter 
degradation half-life of 1-4 days. In the scenario that the shorter half-life is correct, then the 
recovery of the microbial community may have been at least in part facilitated by the dissipation of 
CTC from the microcosm system. The likelihood of this occurring is reduced somewhat in the 
scenario that a longer degradation half-life was required to remove CTC from microcosm. 
Tetracycline degradation would likely have been more rapid in the presence of light (Verma et al., 
2007), but the current investigation was conducted under dark conditions.  During the course of the 
current study, time constraints did not allow for CTC analysis. As the merits of such an analysis are 
clear, future investigation should allow for this. In any case, it is noteworthy that at least two of the 
reported tetracycline mechanisms of resistance correspond to the biochemical alteration of the CTC 
molecule, which would result in biodegradation or biotransformation of the tetracycline molecule. 
Tet X for example codes for a flavoprotein that catalyses the monohydroxylation of the 
Tetracycline-mg
2+
 binding domain. After several hours the tetracycline molecule degrades into 
several degradation products (Wright, 2005). The enzymatic activity of tet (37) is very similar to tet 
(X) in that a monohydroxylation reaction is catalysed which is NADPH-dependent (Diaz-Torres et 
al., 2003).   
 
Despite the fact that total substrate utilisation had recovered by day 2 in terms of functional 
diversity and day 3 in terms of the lag phase duration and max rate of substrate utilisation, a 
reduction in the max rate of substrate utilisation was observed at 1 mg/L CTC on day 6 of the 
exposure. A possible explanation for this could be that a toxic metabolite of CTC was exerting a 
toxic effect upon (at the very least) a portion of the microbial community. A number of CTC 
metabolites (5a, 6-anhydrochlortetracycline, isochlortetracycline, N-desmethylchlortetracycline, 
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apochlortetracycline, apo-epichlortetracycline, or possible a 64 combinations of keto and enol 
tautomers) could have been formed by the biochemical action of certain members of the microbial 
community Halling-Sorensen (2002) investigated the toxicity of tetracycline degradation products   
on single species (Pseudomonas, Agrobacterium sp., Moxella sp. and Bacillus sp.) growth tests. 
Although Pseudomonas was not very sensitive to tetracycline degradation products (MIC50 values 
ranged from 0.25-32 mg/L), it was found that soil isolates were more sensitive, with MIC50 values 
ranging from 0.25 mg/L). Halling-Sorensen et al. (2002) also observed inhibition of CFU counts of 
activated sludge microorganisms as a result of exposure to tetracycline degradation products. At the 
lower end of the results scale an EC50 value of 0.03 mg/L
 
were observed as a result of exposure to 
5a, 6-anhydrotetracycline hydrochloride, an identical value to that obtained as a result of exposure 
to CTC. Given the low toxicity values of tetracycline degradation products (which are in the same 
order of magnitude of effects that have been observed in the present investigation) it is possible that 
these could be exerting a toxic effect on day 6 of the exposure.     
 
Tetracyclines are the most used veterinary antibiotics in the EU (Kools et al., 2008). They can 
enter the aquatic environment via a number of routes, such as surface run-off and aquaculture 
chemotherapy effluent (Halling-Sorensen et al., 1998; Yang and Carlson, 2003). Consequently, 
the occurrence of tetracyclines in the aquatic environment has been reported in several 
publications (eg: Koplin et al., 2002).  The present study has shown the inhibitory effects of CTC 
on the ability of aquatic microbes to utilise an average of 95 distinct substrates. Jankhe and 
Craven (1995) reported the ability of aquatic microorganisms to utilise a broad range of molecules 
contained within DOC (dissolved organic carbon). DOC has been reported to contain a wide 
range of organic molecules. Among the most prevalent of these are carbohydrates, carboxylic 
acids, amines and amino acids (McDowell and Likens, 1988). DOC has been shown to contain up 
to 50% humic substances, highlighting the importance of carboxylated DOC constituents. Humic 
DOC components have been shown to be important for bacterial production in the aquatic 
environment (Moran and Hodson, 1990). Biolog GN2 plates also contain carbohydrates, 
carboxylic acids, amino acids, amines and amides, all of which have been shown to be important 
constituents of DOC in the aquatic environment.  
The results of the present study therefore suggest that the presence of CTC may inhibit the ability 
of aquatic microbes to utilise and degrade this broad range of molecules contained within DOC. 
Tranvik and Hofle (1987) commented on the high efficiency with which microbes normally 
achieve this. If CTC inhibits the ability of aquatic microbes to utilise DOC then this could result 
in a reduced microbial biomass in aquatic environments. Although this may potentially increase 
oxygen levels in the aquatic environment (potentially making more oxygen available to aerobic 
organisms), the absence of certain bacteria may also result in key processes within nutrient cycles 
not being performed as efficiently. For example, a reduction in key nitrifying, denitrifying and 
xenobiotic-degrading bacteria may have adverse effects on nitrogen cycling and on the removal of 
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pollutants from the aquatic environment. In addition to this, bacteria provide a key food source for 
aquatic organisms such as heterotrophic flagellates and protozoa. In turn, these organisms are 
preyed upon and so on until energy is ultimately transferred to an apex predator (an organism that 
has no predator of its own). A reduction in bacterial numbers may therefore affect the normal 
transfer of energy through aquatic food chains. Blomqvist et al. (2001) demonstrated the 
importance of DOC in terms of its conversion into microbial biomass. This also means that, via 
the incorporation of DOC into bacterial biomass, aquatic bacteria act as important carbon sink. 
Carbon sinks play an important role in carbon sequestration from the atmosphere (removal or 
reduction in carbon dioxide levels). As such, bacterial biomass plays an important biogeochemical 
role in regulating the earth’s climate.    
The degradation of a wide array of autochthonous and allochtonous organic matter (such as 
humus, undigested food and dead animal material) in the aquatic environment requires microbial 
communities to be efficient organic multi substrate utilisers. Within the carbon cycle, bacterial 
breakdown of DOC can be liberated back into the environment via the release of carbon dioxide, 
which is commonly regarded as being the most critical greenhouse gas on the planet (Siegenthaler 
and Sarmiento, 1993). DOC degradation therefore plays an important role in releasing gasses 
which regulate the planet’s temperature over time (Berner, 1990). Other inorganic nutrients (such 
as nitrates and phosphates) are also liberated during microbial degradation of DOC. These may be 
taken up as nutrients by, for example, aquatic plants, or they may enter another nutrient cycle 
(such as the nitrogen cycle) for further processing. Any effect on DOC degradation in the aquatic 
environment therefore has the potential to interfere with climate and nutrient cycling.  
Previous studies have shown that oxytetracycline inhibits the ability of bacteria to break down the 
broad range of volatile organic substances in manure.  Biogass production was therefore reduced. 
Inhibition of biogass production (both aerobic and anaerobic) as a result of exposing microbial 
communities to oxytetracycline ranged from 27-50% across three studies (Sankvist, 1984; Gamal-
El-Din, 1986; Arikan Rital et al., 2006).  In one study, methane production was inhibited for six 
consecutive days, although oxytetracycline was doesd at a high rate (100 mg/L) (Sankvist et al., 
1984). Landi et al. (1993) also reported a significant decrease in soil respiration rates as a result of 
exposure to streptomycin. As the substrate being respired was SOM (soil organic matter), this 
pointed to the inhibition of multisubstrate utilisation by soil microbial communities. The inhibition 
of organic substrate utilisation by different antibiotics has therefore been reported in both the 
aquatic and terrestrial environment. It should be pointed out however that the exposure 
concentrations were higher during these studies (the minium exposure was 9.8 mg/kg).  
 
The current investigation has taken the approach of looking at how aquatic environmental bacteria 
utilise component parts of DOC (substrates from each Biolog guild) in the presence of a toxicant, 
rather than looking at how environmental bacteria may metabolise a mixture of often more 
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complex molecules.  As such, the current investigation has concentrated on looking at how the 
component parts of organic matter may be metabolised by the microbial community in the aquatic 
environment in the presence of an antimicrobial toxicant. A possible line of future investigation 
therefore may be to investigate how CTC affects the degradation/utilisation of a range of more 
complex molecules that may be found in the environment.  
Microbial consortia are also responsible for the degradation (and therefore utilisation) of a wide 
range of organic substrates in the aquatic environment (Pelz, 1999; Mishra, 2001). The tendency 
for CTC to inhibit multi substrate utilisation could also have implications for the degradation of 
anthropogenic organic compounds. The potential for this to occur has been previously observed in 
soil studies. Chun et al. (2005) observed that CTC (as well as sulfamethazine and tylosin) reduced 
the ability of a soil microbial community to degrade the synthetic hormone 17 β-estradiol into its 
transformation product estrone. In another study conducted in soil, Allen and Walker (1987) 
reported that the degradation of three pesticides was inhibited by the antibiotic novobiocin.  
Montiero et al. (2009) have also reported the inhibition of naproxen biodegradation as the result of 
exposing microbial communities to the veterinary antibiotic tylosin. Based on the results of these 
studies, it is possible that CTC could inhibit the degradation of xenobiotic compounds by microbial 
communities (or portions of microbial communities).  
3.4.2. Effect of CTC on Amine and Amide Utilisation 
 
Although day 1 kinetic plots (figure 3.8a) would suggest an inhibition of amine and amide 
utilisation across all CTC exposure concentrations, the only statistically significant inhibitory effect 
was observed as result of microcosms being exposed to 0.1 mg/L (tables 3.5 and 3.6). It is likely 
that statistical significance was not observed in the case of max rate and lag phase duration due to 
the high standard deviation (and therefore variation) among replicate Biolog plates. Future studies 
of this type that incorporated a larger number of samples (to increase n) would reduce inter sample 
variability and increase the likelihood of gaining a higher degree of statistical significance.  
A significant increase in lag phase duration was however observed on day 2 of the exposure period 
in microcosms exposed to 1 mg/L CTC (table 3.5). A significant decrease in the max rate of amine 
and amide utilisation was also observed in microcosms exposed to 0.32 mg/L
 
CTC (table 3.6). As 
with total substrate utilisation, the reasons behind these inhibitory effects of CTC are likely to 
result from the compounds mode of action (as discussed in the previous section).  
PCA analysis (figures 3.5a and 3.5b) of amine and amide utilisation revealed that a similar profile 
was shared by control/0.1 mg/L
 
and 0.32/1 mg/L
 
microcosm replicates on day 1. A similar trend 
was observed on day 4 suggesting amine and amide utilisation followed a similar profile. These 
results suggest that exposure to CTC alters amine and amide utilisation profiles even after a 
recovery had been detected by data from other end-points. It is likely that the action of CTC (or its 
metabolites and transformation products) is having an effect on the structure of the microbial 
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community which are responsible for the degradation of amines and amides in the aquatic 
environment.   
Amines and amides enter the nitrogen cycle where bacteria convert them into nitrite and nitrate via 
the processes of ammonification and nitrification (Paul and Clark, 1996). CTC concentrations of 
0.32 and 1 mg/L are therefore causing changes in the microbial community structure of aquatic 
bacteria that are responsible for these processes. This would explain a change in the metabolic 
fingerprint that was expressed by exposed (to CTC) microbial communities. This would have 
occurred because different microbial communities are likely to possess differential metabolic 
systems. Indeed, the Biolog GN2 system was originally designed to differentiate microbial species 
and strains based on differential substrate metabolism (Preston-Mafham et al., 2002). To confirm 
these changes in the community structure of amine and amide utilisation bacteria, future studies 
should apply a molecular technique such as PCR-DGGE. This would confirm any changes in the 
community structure of amine and amide utilisers within the nitrogen cycle. Furthermore, 
sequencing on DGGE bands would reveal more about which particular bacteria were present in 
dosed and control (unexposed) communities. One could therefore make some conclusions on which 
biogeochemical mechanisms were present or missing from each community.  
After day 2 of the exposure period there were no statistically significant inhibitory effects on amine 
and amide utilisation observed with the exception of a significant reduction in max rate of amine 
utilisation on day 6 as the result of exposure of microcosm to 1mg/L
 
CTC. The general recovery 
associated with amine and amide utilisation could be explained by the emergence of members of 
the microbial community that possess resistant phenotypes. A possible reason for day 6 inhibition 
of max rate of amine and amide utilisation could be the toxicity of one or more degradation product 
of CTC. Halling-Sorensen (2002) investigated the toxicity of CTC degradation products on single 
species (Pseudomonas, Agrobacterium sp., Moxella sp. and Bacillus sp.) growth tests. Although 
Pseudomonas was not very sensitive to CTC degradation products (MIC50 values ranged from 
0.25-32 mg/L), it was found that soil isolates were more sensitive, with MIC50 values ranging from 
0.25 mg/L). Halling-Sorensen et al. (2002) also observed inhibition of CFU counts of activated 
sludge microorganisms as a result of exposure to tetracycline degradation products. At the lower 
end of the results scale EC50 values of 0.03 mg/L
 
were observed as a result of exposure to 5a, 6- 
anhydrotetracycline hydrochloride, an identical value to that obtained as a result of exposure to 
CTC. It is possible that the significant reduction of the max rate of amine and amide utilisation was 
caused by a toxic degradation or transformation product of CTC considering their potential to exert 
toxicity upon environmental microorganisms at similar (and lower) concentrations to those that 
were tested in the current study.   
Kong et al. (2006) also observed a decrease in amine and amide utilisation (quantified by 
maximum colour development) as a result of exposing Biolog GN2 plates (inoculated with soil 
extract) to different oxytetracycline concentrations. At the highest concentration amine and amide 
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utilisation was almost completely inhibited, although significant effects were observed between 1 
and 5μM. CTC concentrations of between 2.8 and 28 μM were used in the present study. Effects of 
tetracycline were therefore observed at similar exposure concentrations in both studies.  
Amines and amides can be utilised in a number of ways by environmental bacteria. They may enter 
the nitrogen cycle where they are first subject to the process of ammonification. When ammonia 
has been produced via this reaction it is then subject to further biogeochemical processing in the 
process of nitrification, whereby nitrite and nitrate are formed. Nitrogen in these forms can be 
utilised by bacteria (Paul and Clark, 1996). Amines and amides can therefore act as an important 
nitrogen source for environmental microbes.  
Inhibition of amine and amide utilisation as a result of CTC exposure could indicate a potential 
inhibitory effect on the ammonification and nitrification in the aquatic environment. Previous work 
has detected inhibitory effects of specific aspects of the nitrogen cycle as a result of exposure to 
tetracyclines. Halling Sorensen et al. (2000) detected inhibition of the growth of the aquatic 
nitrifying cyanobacterial species Microcystis aerugenosa as a result of exposure to CTC and 
tetracycline. In the case of both compounds an EC50 value of < 0.1 mg/L
 
was observed. Halling 
Sorensen (2000) also detected significant inhibition of nitrification as a result of exposing activated 
sludge communities to CTC, oxytetracycline and tetracycline. In the same study, tetracyclines were 
found to inhibit the growth of cyanobacteria, with EC50 values of between 0.002 and 0.5 mg/L
 
being observed. The data in these studies provide a link between the inhibition of nitrogen 
utilisation and exposure to tetracyclines. The findings of this study therefore provide support for 
some of the results of the current investigation.  
Another study (Klaver and Mathews, 1994) detected almost complete inhibition of nitrification in 
aquaria experiments as a result of exposure to oxytetracycline, observing EC50 values of between 
8.6 and 29 mg/L. Although the concentration of tetracycline used was much higher than in the 
current study potential effects of tetracyclines on nitrification were still observed.  
3.4.3. Effects of CTC on Amino Acid Utilisation  
 
Amino utilisation lag phase was found to be significantly inhibited by exposure to 0.32 and 1 mg/L
 
CTC on exposure day 1. The max rate of amino acid utilisation was significantly reduced as the 
result of exposure of microbial communities to 0.1 mg/L
 
CTC on day 1 and by all CTC 
concentrations on day 2  (figure 3.4; tables 3.7 and 3.8).  The high variation between samples may 
again explain why a statistical significance was not observed in microcosms exposed to higher 
CTC concentrations. There are various reasons that can explain the reduced rate and increased lag 
phase duration observed on days 1 and 2. Firstly, amino acids can be utilised as a nitrogen-based 
energy source by heterotrophic environmental microbes in the aquatic environment (Flores and 
Herrroro, 1994). For them to achieve this they must process amino acids via ammonification and 
nitrification reactions. Due to the inhibition of protein synthesis (as a result of CTC exposure) 
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production of enzymes (such as nitrogenases and amino acid dehydrogenases) that are required for 
these processes may be inhibited and the utilisation of nitrogenous compounds such as amino acids 
may be inhibited. The inhibition of an important stage in amino acid utilisation in the nitrogen 
cycle, deamination, as the result of exposure of chick ruminal microbes to CTC has been 
previously observed (Broderick and Balthrop, 1979). It is therefore a possibility that the same 
process is occurring in aquatic microbial communities that are likely to share some enzymatic 
homology with chick ruminal bacteria. In terms of effects on the nitrogen cycle, similar effects 
could be potentially observed as described for amine and amide utilisation.  
Secondly, amino acid uptake may be reduced due to the fact that CTC has inhibited amino acid (in 
the form of aminoacyl tRNA) binding to the 70S ribosomal subunit (Epe et al., 1987) and amino 
acids will therefore not have an intracellular binding target. Wheeler and Kirchman (1986) had 
previously reported a > 58% decrease in amino acid uptake as a result of exposing marine bacteria 
to the protein synthesis inhibitor chloramphenicol. Verma et al. (2007) observed a significant 
reduction in leucine incorporation rates by river water microbial communities as result of exposure 
to 5 μg/L tetracycline (compared with a lower CTC exposure concentration of 100 μg/L during the 
present study). In another study, Kong et al. (2006) observed a significant reduction in amino acid 
utilisation as the result of exposing soil microbial communities to oxytetracycline. The 
concentrations range they used was in the same order of magnitude as was tested in the present 
study. These results are in agreement with the current investigation, with results from other studies 
suggesting that antibiotics that inhibit protein synthesis may also inhibit amino acid uptake. 
Although a significant reduction in the max rate of amino acid utilisation was observed on days 1 
and 2, the lag phase duration on day 2 of the exposure period was significantly lower than control 
values at all levels of CTC exposure (table 3.7). The reduction was greatest at a CTC concentration 
of 1mg/L, followed by 0.32 mg/L then 0.1 mg/L. In the case of 1 mg/L CTC
 
exposure, no lag phase 
was recorded at all. In terms of lag phase duration, the recovery observed in the case of amino acids 
was extremely fast compared with the recovery that was observed for other substrate guilds. It 
would benefit the microbial community if they were able to recover amino acid utilisation as 
quickly as possible, as they are required to synthesise essential proteins such as enzymes that are 
necessary to utilise other substrate guilds.  
The formation of resistant members of the microbial community being able to utilise amino acids 
may explain the reduction in lag phase duration.  The short onset of amino acid utilisation could 
also be explained by a rapid uptake of amino acids that were required to bind with intracellular 
tRNA. Holmes and Wild (1967) observed an initial increase in RNA synthesis during E. coli 
exposure to CTC. In addition, this RNA was stable and stored intracellularly. During the recovery 
period following CTC-mediated inhibition of protein synthesis, RNA remained stable and 
ribosomes were synthesised. It is this increase in RNA and ribosomal synthesis that may explain 
the reduced lag phase during the recovery period following the inhibition of protein synthesis.  
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A significant reduction in the max rate of amino acid utilisation however would suggest that a 
certain amount of inhibition was still occurring. This may be reflect the fact that only a certain 
portion of the microbial community can  tolerate the inhibitory effects of CTC and some of the 
community was still inhibited. As was seen in the case of amine and amide synthesis, there was 
also a significant reduction in the max rate of amino acid utilisation at the highest CTC 
concentration (1 mg/L) on day 6 of the exposure period (table 3.8). Again, this could possibly be 
explained by the potential toxicity of CTC metabolites or transformation products (Halling-
Sorensen et al., 2002).  
PCA analysis of amino acid utilisation profiles on day 1 (figure 3.5a) revealed that control/0.1 
mg/L and 0.32/1 mg/L microcosm replicates shared a similar profile as suggested by the presence 
of two distinct clusters on PCA score plots. A similar trend was observed on day 4 (figure 3.5b), 
suggesting that amino acid utilisation followed a similar profile. The results suggest that exposure 
of microbial communities to 0.32 and 1 mg/L CTC alters amino acid utilisation profiles even after 
a recovery has been detected by data from other end-points. It is likely however that PCA data in 
the present study is representative of the action of CTC (or its metabolites and transformation 
products) having an effect on the structure of the microbial community due to the effect it is having 
on the metabolic profiles of the microbial community. In particular, the portion of the microbial 
community that is likely being affected is certain bacterial species that are involved in nitrogen 
cycling. Broderick and Balthrop (1979) have previously shown that CTC can interfere with 
deamination of amino acids in chick ruminal bacteria. Due to the presence of conserved 
biochemical mechanisms between different bacteria, it is possible that certain portions of the 
microbial which perform deamination reactions are also being affected in aquatic microcosms and 
therefore the aquatic environment in general. From the data provided in this study, it is not clear 
which particular bacteria are present in microbial communities from each dose group. The extent to 
which discrete biogeocheical processes were being performed by distinct microbial communites 
(within different microcosms) is therefore not known. Future studies should therefore utilise 
molecular techniques to confirm community shifts (eg: PCR-DGGE) and whole genome 
sequencing to establish the identity and biogeochemical functioning of community members.  
3.4.4. Effects of CTC on Carbohydrate Utilisation 
Carbohydrate utilisation was significantly inhibited on day 1 in terms of an increase in lag phase 
duration at all CTC exposure concentrations (Table 3.9). There was also a significant decrease in 
the max rate of carbohydrate utilisation on day 1 in microcosms exposed to 0.32 and 1 mg/L
 
CTC.  
A significant reduction in max rate of carbohydrates was also observed on day 2 in microcosms 
exposed to 0.1 mg/L
 
CTC (Table 3.10). These inhibitory effects can be explained by the mode of 
action of CTC in terms of the inhibition of protein synthesis. Many carbohydrates require 
transporter proteins to enter the cytoplasm of microbial cells. Examples of such proteins are the 
ABC carbohydrate uptake transporters family 1 (MalF and MalG) and carbohydrate uptake 
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transporters family 2 (RbsC and RbsD).  It is therefore possible that inhibition of the synthesis of 
these proteins is caused by exposure of the microbial community to CTC. Certain carbohydrates 
could therefore not enter the cytoplasm of microbial cells. It is also a possibility that the synthesis 
of oxidative enzymes that are responsible for the transfer of electrons from carbohydrates to ADP 
(to from ATP) as an energy liberating system are being inhibited by CTC. Examples of these 
enzymes include α-galactosidases, glucoamylase and lactase.  
There has been a body of work that has been conducted into the effects of tetracyclines on 
carbohydrate metabolism. Thiele-Bruhn and Beck (2005) examined the effect of oxytetracycline on 
glucose-induced respiration. They observed 24-hour ED50 values of between 19.1 and 31.2 µg/L. 
Values gained were statistically significant. In contrast, Zielezny et al. (2006) observed no 
significant in glucose-induced respiration rates as a result of exposing soil microbial communities 
to CTC. Vaclavik et al. (2004) observed an increase in glucose-induced respiration rates in the 
order of 1.3-1.7 times as a result of exposure to tetracycline and CTC in soil studies. In a study that 
quantified enzyme activity associated with glucose utilisation it was observed that oxytetracycline 
significantly reduced dehydrogenase activity in soil mesocosms after 7 days exposure (Boleas et 
al., 2005).  
 
Kong et al. (2006) tracked carbohydrate utilisation in Biolog plates that had been inoculated with 
soil extracts and oxytetracycline. They observed an inhibition in the maximum level of 
carbohydrates utilised as a result of increasing CTC concentration. The results from the literature 
therefore portray a mixed picture in terms of the effects of CTC on carbohydrate metabolism and 
utilisation. Maul et al. (2006) observed a 2.7-3.5-fold reduction in carbohydrate utilisation as a 
result of exposing leaf-bound microbial communities to the antibiotic ciprofloxacin (100 μg/L). 
This work demonstrated the inhibitory effects of antibiotics to microbial communities in the 
environment and provides data in support of some of the findings from the present study. 
 
The main consequence of a reduction in carbohydrate utilisation is the inability of the microbial 
community to gain energy from preferred organic sources. In the absence of a suitable energy 
source the growth of certain portions of the microbial community will likely be inhibited. This has 
been demonstrated by whole-lake DOC addition experiments, in which a significant increase in 
aquatic microbial biomass was observed as a result of adding increased DOC (Blomqvist et al., 
2001). The high degree with which aquatic microbes are able to convert glucose into biomass (20% 
of total DOC) highlights the importance of carbohydrate utilisation to aquatic microbial 
communities (Tranvik and Hofle, 1987).  It has previously been discussed within the current 
chapter the importance of microbial biomass in terms of food chains and acting as a carbon sink. In 
addition, a wide range of biochemical processes are reliant upon the energy that microbial 
communities gain from carbohydrates, such as active transport of molecules in and out of cells and 
maintenance of buoyancy systems in cyanobacterial cells (Chu et al., 2007).  
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After day 2 of the exposure period carbohydrate utilisation data exhibited a recovery in terms of a 
decrease in the lag phase duration (table 3.9). As has been see with the utilisation of other 
substrates during this study, this recovery may be the result of several factors, such as formation of 
tetracycline resistance or degradation of CTC for example. In the case of max rate data however 
significant reductions compared with control data were still seen on day 4 (at 0.1 mg/L
 
CTC) and 
day 6 (at 0.32 and 1mg/L CTC). It is a possibility therefore that carbohydrate metabolism was 
being inhibited by toxic metabolites and transformation products of CTC (Halling-Sorensen et al., 
2002).  Due to the relatively low CTC concentration that was inhibiting the max rate of 
carbohydrate utilization at periods throughout the exposure period, carbohydrate metabolism was 
one of the sensitive end-points that was used in the present study (in terms of looking at the effects 
of CTC).  
 
PCA analysis of carbohydrate utilisation profiles on day 1 and (figure 3.11a) of carbohydrate 
utilisation revealed that control/0.1 mg/L and 0.32/1 mg/L day 1 replicates shared a similar profile 
as represented by their distinct clustering. A similar trend was also observed on day 4 (figure 
3.11b), suggesting that carbohydrate utilisation shared a similar profile at this time-point. These 
data suggest that exposure to CTC alters carbohydrate utilisation profiles even after a recovery has 
been detected by data from other end-points. It is possible that the action of CTC (or its metabolites 
and transformation products) is having an effect on the structure of the microbial community as 
shown by the effect that it is having on the pattern of metabolic profiles of the microbial 
community. In such a scenario, a specific portion of the microbial that utilises carbohydrates as an 
energy source (which is likely to be performing their metabolic action within the carbon cycle) may 
be inhibited at a particular CTC concentration but not at lower doses. In the absence of this 
particular carbohydrate utiliser (or utilisers in the case that more than one member of the microbial 
community is inhibited at a certain CTC dose) other members of the microbial (which may have 
been outcompeted previously) may be able now utilise carbohydrates. If different member of the 
microbial community are present at different CTC doses, then it probable that at least a portion of 
the respective microbial communities will have display a different carbohydrate utilisation profile.  
3.4.5. Effect of CTC on Carboxylic Acid Utilisation  
 
Carboxylic acid utilisation was shown to exhibit an inhibitory effect on lag phase duration on day 1 
of the exposure period in microcosms that had been exposed to 0.32 and 1 mg/L
 
CTC (table 3.11). 
An inhibitory effect on lag phase duration was also observed on day 2 as a result of exposure to 1 
mg/L CTC. An identical pattern of inhibition was also observed on the max rate of carboxylic acid 
utilisation (table 3.12).  
 
Kong et al. (2006) also observed an inhibition of carboxylic acid utilisation as a result of exposing 
soil extracts to oxytetracycline (similar concentrations to the present study). Inhibitory effects were 
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also observed at a similar oxytetracyline concentration as used in the current study. This indicates 
that carboxylic acid utilisation can be inhibited in both the terrestrial and aquatic environment at 
similar concentrations.  
 
Carboxylic acids represent an important energy source for environmental microbes. Molecules such 
as citric acid, pyruvic acid, succinic acid and lactic acid can enter energy liberating biochemical 
pathways such as the tricarboxylic acid cycle, directly (Reactome, 2010). Carboxylic acids are also 
formed from the cleavage of fatty materials in the environment in the form of fatty acids. Naumann 
(1918) first showed the utilisation of humic materials by aquatic microorganisms. Humic acids 
contain high carboxylic acid content (Kawahigashi and Sumida, 2006). These form an important 
part of the carbon cycle in terms of the recycling of dead animal and plant material. Inhibition of 
carboxylic acid utilisation as result of CTC exposure in the environment could therefore inhibit the 
ability of environmental microbes to produce energy and degrade certain molecules within the 
carbon cycle.  
Guven et al. (2005) demonstrated the ability of certain Archaea species (such as Candidatus 
Brocadia and Canditus Kuenenia) to utilise organic acids (such as propionate) using nitrite/nitrate 
instead of oxygen as terminal electron acceptor. The important role of these organisms in the 
nitrogen cycle was therefore shown. Inhibition of carboxylic acid utilisation could possibly affect 
this part of the nitrogen cycle, although it is unclear if these types of reactions are taking place on 
Biolog GN2 plates. Analysis of microbial by molecular techniques (such as DNA sequencing) may 
be able to give an insight into the portion of the microbial community that is present within CTC-
dosed microcosms however.  
Carboxylic acid utilisation showed a recovery (in terms of lag phase duration and max rate of 
utilisation) at all CTC concentrations on day 3 of the exposure period. As with the recovery 
observed with the utilisation of other substrates, the increased appearance of resistant phenotypes 
and the subsequent synthesis of enzymes capable of utilising carboxylic acids is a possible 
explanation for this. In such a scenario, members of the microbial community which are not 
affected by CTC may be now be able to exploit resources that they not previously able to due to 
them being outcompeted. Alternatively, populations of slower growing or resistant bacteria which 
were able to significantly utilise carboxylic acids (which were present from the start of the 
exposure period) could now be sufficiently abundant to utilise the carboxylic acids.  
PCA analysis was conducted with regard to carboxylic acid utilisation. Day 1 replicates exposed to 
1 mg/L
 
and some replicates from the 0.32 mg/L
 
group clustered independently. Replicates from the 
control group clustered with replicates from the 0.1 mg/L
 
group. These data indicate that on day 
1of the exposure, the carboxylic acid utilisation profile of microbial communities was altered 
mainly as the result of exposure to 1 mg/L
 
CTC and to a lesser extent by exposure to 0.32 mg/L 
CTC. The carboxylic utilisation profile was not altered by exposure of microcosms to 0.1 mg/L
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CTC. Day 4 data illustrated a similar picture with regard to the 0.1 mg/L / control cluster, although 
1 mg/L
 
replicates clustered closer to these groups. The carboxylic acid utilisation profile was 
therefore changed as a result of exposure to 1 mg/L
 
CTC, but had become more similar to 0.1 
mg/L/control treatments by day 4. The majority of 0.32 mg/L
 
replicates clustered closer to 1 mg/L
 
replicates on day 4, although some were separately clustered from all other treatments. These data 
indicate that microbial communities exposed to 0.32 mg/L
 
and 1 mg/L
 
shared similar carboxylic 
utilisation profiles, with some replicates from the 0.32 mg/L
 
group having a unique carboxylic 
utilisation profile. It can be therefore be inferred that the microbial community structure was 
different as result of exposure 1 mg/L
 
CTC and (to a lesser extent) 0.32 mg/L
 
CTC. At these time 
points, it is likely therefore that the community structure of carboxylic utilising bacteria was 
different at these doses.  
3.4.6. Effect of CTC on Polymer Utilisation  
Polymer utilisation was significantly inhibited in terms of lag phase duration as a result of exposing 
microcosms to CTC concentrations of 0.1 and 0.32 mg/L CTC. A significant reduction in the max 
rate of polymer utilisation was also detected due to exposure of microcosms to the same CTC 
concentrations. Although exposure of microcosms to 1 mg/L CTC did not result in significant 
effects to lag phase, a high increase was still recorded. A high increase in the max rate of polymer 
utilisation was also observed. It is likely that these values were not found to be significant due to 
the high standard deviation of regression values calculated by the 3-parameter kinetic model. 
Future studies should therefore repeat similar exposure studies with a higher degree of sample 
replication in to reduce any possible variation. Significant inhibitory effects were also seen on day 
2 in terms of lag phase (in microcosms exposed to 1 mg/L CTC) and max rate of polymer 
utilisation (in microcosms exposed to 0.32 mg/L CTC).  
Kong et al. (2006) exposed soil extract inoculated Biolog plates with oxytetracycline at similar 
concentrations to the present study. They observed a significant reduction in maximum colour 
production (and therefore polymer utilisation) as a result of exposure to oxytetracycline. The results 
of this study are therefore in agreement with the current study.  
 
Environmental microorganisms are responsible for the degradation of polymers within ecosystems 
as the result of biosynthesis of lipases, ureases, esterases and proteases (Fleming, 1998; Lugauskas, 
2003). Microorganisms also secrete enzymes into their environment to progressively reduce their 
molecular weight, producing oligomers, dimmers and monomers (Lucas et al., 2008). They have 
also been shown to be capable of degrading polymers that are widely regarded as being recalcitrant 
to degradation (Shimano, 2001; Howard, 2002; Szostac-Kotowa, 2004; Shah et al., 2008). 
Microrganisms ultimately assimilate polymers as cellular biomass and energy (Lucas et al., 2008). 
Any inhibition of the microbial community in terms of polymer utilisation could therefore result in 
the reduced functioning of such processes within the aquatic environment.  
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A recovery in lag phase duration was observed in microcosms exposed to 0.1 and 0.32 mg/L CTC. 
A recovery in lag phase duration was not observed until one day later, indicating that aquatic 
systems take longer to recover from higher CTC exposures. In terms of the max rate of polymer 
utilisation a recovery was observed on day 2 at the lowest and highest CTC concentration. Effects 
were still being seen in microcosms exposed to 0.32 mg/L CTC. It could be that significant effects 
were again not detected due to the high degree of variation between samples however. By day 3 all 
microcosms had recovered, suggesting polymer utilisation is back to normality at this time point. 
At this point a large proportion of the microbial community is likely to have become resistant to the 
effects if CTC via one or more resistance mechanisms (Speer et al., 1992).  
The data in PCA score plots on day one revealed that a change in the polymer utilisation profile 
was only caused by exposure of microbial communities to 1 mg/L CTC. All other groups clustered 
with control replicates, with the exception of two replicates from the 0.32 mg/L group (that 
clustered with 1 mg/L replicates). On day 4 a similar pattern emerged except more 0.32 mg/L 
replicates clustered with 1 mg/L replicates.  This data indicates that the polymer utilisation profile 
was only altered by exposure of microbial communities to 1 mg/L CTC, with some changes caused 
by exposure to 0.32 mg/L CTC. Although there is no president to these results in the available 
literature, it is likely that aquatic microbes in 1 mg/L microcosms form a different community 
structure to other microcosms. These data may suggest therefore that exposure to relatively high 
CTC concentrations may alter the manner in which aquatic environmental microbes to degrade 
polymers of natural and anthropogenic origin. For example, CTC exposure may reduce the 
diversity of microbes which are able to degrade a range of polymers. This could be investigated 
further with the use of molecular tools such DNA sequencing with BLAST analysis.  
3.4.7. Effect of CTC on CFU Counts  
In the present study no significant effects were seen on CFU counts as a result of exposing Aquatic 
microbial communities to three concentrations of chortetracycline. In other studies, Halling 
Sorensen et al. (2002) observed an EC50 values of as 0.03 mg/L for CTC and 5a, 6-CTC when 
studying the effect of these compounds on CFU counts. During this study activated sludge 
microbial communities were exposed to tetracyclines, indicating that the growth of activated sludge 
communities may be more sensitive to tetracyclines than river water communities. Colinas et al. 
(1993) also showed a significant decrease in CFU counts in soils exposed to oxytetracycline, with a 
20% reduction in the CFU count having been observed. It is possible that the growth of soil 
microbial communities is more sensitive to tetracyclines. Alternatively, it may be the case that the 
portion of the aquatic microbial community that is affected by tetracyclines is not culturable using 
traditional culturing techniques. A final possibility for not seeing any inhibition of microbial 
growth in the present study could be the presence of more resistant members of the aquatic 
microbial community than in other studies. One piece of evidence that supports this view is the 
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relatively high increase in CFU between days 1 and 7 as a result exposure to 1 mg/L CTC. 
Although this change was not statistically significantly different compared with CFU changes in 
the control, the variation between agar plates was extremely high. This reduces the chances of 
gaining a significantly different value. 
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Chapter 4: Effect of Sulfamethoxazole 
on Microbial Functioning in Aquatic 
Systems 
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4. Effects of Sulfamethoxazole on Microbial Function 
4.1. Sulfonamides 
In the early 1930s it was observed that certain azo group containing dyes had antibacterial 
properties. Further research into these properties by the German pathologist and bacteriologist 
Gerhard Johannes Paul Domagk led to the synthesis of the first commercially available antibiotic, 
prontosil. This 1939 Nobel Prize winning discovery was the beginning of the modern antimicrobial 
therapy revolution and heralded the first in a series of commercially available sulfonamide 
compounds (table 4.1). The importance of Domagk’s initial research was highlighted by the 
treatment of Tuberculosis post World War II by the sulphonamides thiosemicarbazone and 
isoniazid. The success of sulfa drugs led to the unregulated manufacture of hundreds of tons of 
sulfa-containing drugs worldwide until the “Elixir Sulfonamide Disaster” (during which hundreds 
of people were poisoned by ethylene glycol impurities that were present in sulfonamide drugs) led 
to the first regulation of antibiotic production (Carpenter, 2010).  
Table 4.1: Chronology of sulfonamide drug discovery. 
   
Chemical name Generic Name 
Year of 
Discovery 
4-[[2, 4-diaminophenyl) azo] 
benzenesulfonamide 
prontosil 1935 
4-aminobenzenesulfonamide sulfanilamide 1936 
N-[(4-aminophenyl) sulfonyl] acetamide sulfacetamide 1939 
2-(p-aminobenzenesulphonamide)-4, 6-
dimethylpyridine 
sulfadimidine/sulfamethazine 1942/1943 
N1-2-pyrimidinylsulfanilamide sulfadiazine 1947 
4-amino-N-(5-methyl-1, 2-oxazol-3-yl) 
benzenesulfonamide 
sulfamethoxazole 1961 
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4.1.2. Chemistry of Sulfonamides 
Sulfonamide antibiotics are composed of a sulfonyl group covalently bonded to an amine group 
with the general formula RSO2NH2, where R represents an organic group. Sulfonamides are 
synthesised from a sulfonic acid precursor by replacement of a hydroxyl group with an amine 
group. Sulfonamide chemistry is often affected by pH. Sulfonamides are ionogenic compounds. As 
such they are subject to pH-dependent ionisation. The two ionisable groups on sulfonamide 
molecules are the anilinic amine and amide moieties. A cationic species (SA
+
) is mainly formed at 
low pHs and an anionic species (SA
-
) being mainly formed at higher pHs. Between the two pka 
values (pka1 and pka2), a neutral sulfonamide species can exist (SA
0
). The neutral species is in 
tautomeric equilibrium with another zwiterionic sulfonamide species (SA
±
) although this form is 
only reported to account for < 0.2% of speciation in favourable conditions (Gao and Pederson, 
2005). 
4.1.3. Sulfonamide Mode of Action 
The enzyme 6-hydroxymethyl-7, 8-dihydropteroate synthase (DHPS) catalyzes the condensation of 
para-aminobenzoic acid (pABA) with 6-hydroxymethyl-7, 8-dihydropterin-pyrophosphate to form 
6-hydroxymethyl-7, 8-dihydropteroate and pyrophosphate. DHPS is essential in the synthesis of 
folate in prokaryotes and plants. Sulfonamide antibiotics act as a structural analogue of pABA and 
the folate pool is therefore reduced in inhibited organisms. As a result, cells are not able to grow 
and occasionally cell death is recorded also (Baca et al., 2000).  
The action of sulfonamides has been reported to be pH-dependent. Mengelers et al. (1997) for 
example showed that the toxicity of several sulfonamides was dependent on the pka2 values and the 
extracellular pH of which the bacteria inhabit. Based on the fact that the intracellular bacterial pH 
does not normally exceed 8 there is a pka2 limit of 6.5 on the sulfonamide species that can enter the 
bacterial cell. Therefore sulfonamides with a pka2 of greater than 6.5 will not enter the bacterial 
cell.  
Changes in the intracellular pH of the bacterial cell will also affect the uptake of sulfonamides. 
Even a small shift in intracellular pH can cause an increase in sulfonamide uptake (assuming an 
optimum pka2 for uptake). However, if intracellular and extracellular pHs are similar, no significant 
changes in sulfonamide uptake will be recorded and the greater the pH difference between intra- 
and extracellular space the greater the uptake of sulfonamides will be. The extracellular pH 
therefore has an effect on sulfonamide uptake also. In general, the uptake of sulfonamides with low 
pka2 values is highly dependent on extracellular pH, assuming that intracellular bacterial pH is 
within the normal range of between 5 and 9. Considering an environmental pH optimum of 7, the 
sulfonamides with the potential for the most effectiveness are sulfisoxasole and sulfamethoxazole 
(Zarfl et al., 2008; Madigan et al., 2003; Roland et al. 1979).  
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Tappe et al. (2008) tested these concepts further and investigated two bacteria with a good and 
poor ability to regulate pH. They observed that bacteria with a strong ability to regulate pH would 
be strongly inhibited by sulfonamides in low pH environments. Conversely, they observed that 
bacteria that are poor regulators of pH are likely to be mildly inhibited by sulfonamides at low pH 
and affected more at a pH of 7 or 8. This study showed the importance of internal bacterial pH 
(pHi) in evaluating the antibiotic activity of sulfonamides. 
4.1.4. Sulfonamide Usage 
Sulfonamide antibiotics are used in both human and veterinary antimicrobial chemotherapy. In 
human medicine, sulfonamides are mainly used to treat urinary and upper respiratory tract 
infections. They can also be used to treat bacterial pneumonia, shigellosis and Nocardia infection 
(Connor, 1998). Sulfonamide antibiotics are mainly used to treat coccoidal infections in both 
commercial farm animals and pets. Veterinary sulfonamide antibiotics are controlled under the EC 
directive 1831/2003 (European Union Register of Feed Additivies).  
4.1.5. Occurrence of Sulfonamide Antibiotic in the Environment 
Sulfonamides have been detected in several environmental matrices including soil (e.g.: Shelver et 
al., 2010) surface water (e.g.: Young and Carlson, 2004) and groundwater (e.g.: Holm et al., 1995). 
Reported occurrences of sulfonamides are summarized in table 4.2. The data in table 4.2 show that 
sulfonamides have detected mainly in aquatic environments. All reported detection of sulfonamides 
in the soil environment has been in areas that have been amended with manure from sulfonamide – 
treated animals. As with tetracycline detection in the soil environment this makes sense as manure 
is a major exposure route of veterinary antibiotics.  
It can also be seen from table 4.2 that sulfonamides have been detected at levels that are very close 
to LOD or LOQ levels. This would suggest that detectable levels of sulfonalides in the environment 
are on the edge of what can be detected. As with other antibiotcs that have been detected in the 
environment, sulfonamide levels are extremely low.   
 
187 
 
Table 4.2: Reported occurrence of sulfonamide antibiotics in various environmental compartments. Data in italics indicates limit of quantification.  
      Compound  Matrix Location LOD/LOQ Reported Concentrations  Reference (s) 
sulfamerazine Surface water USA 0.05 μg/L nd and 0.05 μg/L Yang and Carlson, 2004b 
 
Lake water USA 0.05 μg/L 0.19 μg/L Yang and Carlson, 2004b 
sulfamethazine Stream water USA 0.02 μg/L - 0.12 μg/L 0.05 μg/L Kolpin et al., 2002 
 
Stream water USA 0.22 μg/L 0.05 μg/L Kolpin et al., 2002 
 
Lake water USA 0.22 μg/L 0.05 μg/L Yang and Carlson, 2004b 
 
Surface water USA 0.0010 μg/L < 0.0010 μg/L Skadsen et al., 2004 
 
Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 900 μg/L Holm et al., 1995 
 
Groundwater Germany 0.02 μg/L 0.16 μg/L Hirsch et al., 1999 
sulfamethoxazole Surface water Germany 0.02 μg/L 0.03 - 0.48 μg/L Hirsch et al., 1999 
 
Surface water (tributaries) Germany 0.030 μg/L 
< 0.030 μg/L & 0.040 
μg/L 
Wiegel et al., 2004 
 
Surface water (in April 1998) Germany, Czech Rep. 0.030 μg/L 0.030 - 0.070 μg/L Wiegel et al., 2004 
 
Surface water (upstream 
STP) discharge) 
Sweden NS < 0.001 Bendz et al., 2005 
 
Surface water (downstream 
STP discharge) 
Sweden NS 0 - 0.01 μg/L Bendz et al., 2005 
 
Surface water (upstream 
STP) 
UK <0.050 μg/L 0.050 μg/L Ashton et al., 2004 
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Table 4.2 (cont). 
 
Compound  Matrix Location LOD/LOQ Reported Concentrations  Reference (s) 
sulfamethoxazole 
(cont) 
Surface water (downstream 
STP) 
UK <0.050 μg/L 0.050 μg/L Ashton et al., 2004 
 
Surface water UK <0.050 μg/L 0.050 μg/L Hilton and Thomas, 2003 
 
Stream water USA  0.05 μg/L 0.15 - 1.9 μg/L Kolpin et al., 2002 
 
Stream water  USA 0.023 μg/L 0.066 μg/L - 0.52 μg/L Kolpin et al., 2002 
 
Surface water USA 0.0010 μg/L 0.010 ± 0.007 μg/L Skadsen et al., 2004 
 
Lake water  USA 0.05 μg/L 0.06 μg/L Yang and Carlson, 2004b 
  Surface water USA 0.007 μg/L 0.023 μg/L Heberer et al., 2001 
 
Surface water USA 0.05 μg/L 0.05 μg/L & 0.12 μg/L Yang and Carlson, 2004b 
 
Groundwater Germany 0.0018 μg/L 0.410 μg/L Sacher et al., 2001 
 
Groundwater USA 0.023 μg/L 0.002 μg/L Heberer et al., 2001 
 
Groundwater Germany 0.025 μg/L 
< LOQ – 0.11 μg/L  ± 
0.07 μg/L 
Ternes et al., 2007 
 
Groundwater USA 0.05 μg/L 0.01 μg/L & 0.08 μg/L Karthikeyan & Bleam, 2003 
 
Groundwater Germany 0.02 μg/L 0.47 μg/L Hirsch et al., 1999 
sulfathiazole Surface water USA 0.0010 μg/L < 0.0010 μg/L Skadsen et al., 2004 
sulfathiazole Surface water USA 0.0010 μg/L < 0.0010 μg/L Skadsen et al., 2004 
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Table 4.2 (cont). 
      
Compound  Matrix Location LOD/LOQ Reported Concentrations  Reference (s) 
sulfameththizole Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 330 μg/L Holm et al., 1995 
sulfadiazine Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 1160 μg/L Holm et al., 1995 
sulfadiazine Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 1160 μg/L Holm et al., 1995 
sulfanilamide Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 300 μg/L Holm et al., 1995 
sulfaguanidine Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 1600 μg/L Holm et al., 1995 
sulfanilic acid Groundwater (landfill site) Denmark 20 μg/L < 20 μg/L – 10440 μg/L Holm et al., 1995 
acetyl-
sulfamethoxazole  
Surface water (upstream 
STP) 
UK 0.050 μg/L < 0.050 μg/L Ashton et al., 2004 
 
Surface water (downstream  
STP) 
UK 0.050 μg/L < 0.050 μg/L – 0.239 μg/L Ashton et al., 2004 
  Surface water UK 0.050 μg/L < 0.050 μg/L - 0.240 μg/L Hilton and Thomas, 2003 
      LOD = Limit of Detection
LOQ = Limit of Quatification 
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4.1.6. Fate and Behaviour of Sulfonamides in the Environment  
4.1.6.1. Sorption 
Several studies have investigated the fate and behaviour of sulfonamides in several environmental 
matrices, although the vast majority of these studies have concentrated on the terrestrial 
environment.  
The environmental behaviour of sulfonamides has been shown to be affected by sorption to soil 
mineral constituents such as montmorillomite, illite, and ferrihydrite and metal oxides; studies have 
also shown these processes to be pH-dependent (Khale and Stamm, 2007; Thiele-Bruhn et al., 
2004). The sorption of sulfonamides to micelle–clay systems has further highlighted the 
importance of sulfonamide sorption to inorganic particles (Polubesova et al., 2006).  
The tendency for sulfonamides to interact with phenolic, carboxylic and N-heterocyclic compounds 
has also been investigated, highlighting the importance of compounds found in SOM to the 
sorption of sulfonamides (Thiele-Bruhn et al., 2004). Bialk et al. (2005) demonstrated the sorption 
of sulfonamides to natural organic matter (NOM), showing that the compounds sorbed to the model 
NOM constituents that weer investigatd. Kahle and Stamm (2007) showed that this process was 
also highly pH-dependent as well as being affected by higher ionic strength (due to multiple 
ionisation sites of sulfonamides). In general, sulfonamides tend to form “unextractable fractions” 
with environmental matrices which has made studying the fate and behaviour of sulfonamides (and 
their chemical species) difficult (Huschek et al., 2008). Indeed, data from sorption and transport 
studies have provided data which suggests that permanently bound sulfonamide-soil complexes 
have been formed (Kruezig et al., 2005; Hamscher et al., 2005).  
The sorption of sulfonamides to a variety of different soil types has been investigated. Heise et al. 
(2006) observed that a high proportion of sulfadiazine and sulfamethoxazole represented 
unextractable bound residues (93%) when added to whole soils. Forster et al. (2009) showed that 
residual fractions of both sulfadiazine and its N-acetylated metabolite were trapped in whole soils 
where they were likely to persist for several years. Thiele-Bruhn et al. (2004) observed a greater 
degree of sorption of sulfonamides to soils with finer particles compared to soils with a relatively 
more coarse structure. The authors linked higher SOM with an increased adsorption of 
sulfonamides. Another study however found no significant differences between sulfonamide 
sorption behaviour in a silt and sandy loam (Acclinelli et al., 2007).  
4.1.6.2. Transportation of Sulfonamides 
Several studies have also looked at the movement of sulfonamides through different soils.  
Burkhardt and Stahm (2007) investigated the movement of sulfonamides (sulfadimidine, 
sulfadiazine and sulfathiazole) through an undisturbed loamy grassland soil. They found that all 
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three compounds studied were highly mobile through the soil column via preferential flow in pore 
water with as much test compound being detected 50 cm down as was detected 5 cm from the top.  
Blackwell et al. (2007) investigated the movement of sulfonamides through a sandy loam soil. The 
authors reported that sulfachloropyridazine was highly motile through the soil column, with a 
relatively high concentration (0.78 µg/L)
 
being detected at a depth of 40 cm after 20 days. The 
same authors conducted another study (in 2009) to investigate the movement of 
sulfachloropyridazine through a clay soil into drainage water. They were able to detect a 
considerable sulfachloropyridazine concentration in drainage water (613 µg/L
 
in year 1 and 6.1 
µg/L in year 2), indicating that the compound had moved through the soil column.  
Lapen et al. (2008) also investigated the movement of two sulfonamides (sulfamethoxazole and 
sulfapyridine) from sewage sludge through a soil column following a series of simulated 
precipitation events. The two compounds could only be detected at levels above the LOQ in tile 
drainage water following the first tile drain event but not after subsequent simulated rainfalls. The 
results from this study would therefore suggest that sulfonamides had moved rapidly through the 
soil column into drainage water.  
Weiss et al. (2008) also studied the movement of a sulfonamide (sulfamethazine) through soil 
following simulated precipitation events. In this study the test compound was contained within 
seepage water rather than sewage sludge. Two different soil environments were tested (grassland 
versus arable cropping sites). The authors observed losses (of sulfamethizine) to drainage water of 
between 2.8 and 5.4% in arable cropping soils compared with 10% losses in grassland areas. The 
results were hypothesised to have been caused by an increase in preferential macropore transport in 
grassland soils due to the increased presence of undisturbed macropores in grassland soils. Werhan 
et al. (2007) also observed significant leaching of a sulfonamide compound (sulfadiazine) through 
a soil column. This study additionally demonstrated that leaching of sulfonamide residues is 
increased if the compound is frequently applied at higher concentrations. There would appear to be 
a general agreement therefore that sulfonamides show a degree of motility through a variety of soil 
columns despite the sorptative properties that are displayed by the compounds. As result, 
sulfonamides can be transported to drainage waters with the possibility that further transport to 
adjacent water bodies will also take place. Another potential exposure route of sulfonamides into 
the aquatic environment is surface runoff. Blackwell et al. (2009) demonstrated this under field 
conditions. During the experiment they observed a sulfachloropyridazine concentration of 25.9 
µg/L in surface runoff water. These data suggest that these dissolved sulfonamide residues could 
enter the aquatic environment.  
Although the movement of sulfonamides through soil has been well reported in the literature, 
transport within the aquatic environment has been less well documented. One report that 
investigated sulfonamide (sulfachloropyridazine, sulfadimethoxine and sulfamethoxazole) 
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movement from sewage effluent downstream through a receiving river however found that the 
compounds travelled kilometre scale distances with relatively low uptake velocities. This one study 
therefore suggested that sulfonamides are very mobile in the aquatic environment.  
4.1.6.3. Dissipation of Sulfonamide Antibiotics - The Terrestrial 
Environment 
The degradation of several sulfonamides has been investigated in the terrestrial environment. Heuer 
et al. (2008) applied 
14
C sulfadiazine-spiked manure to a soil system. Although no mineralisation 
was shown to have taken place, rapid deacetylation of the major metabolite (N-acetyl sulfadiazine) 
occurred in soil. Forster et al. (2009) also observed significant deactylation of N-acetyl sulfadiazine 
in soils spiked with sulfadiazine and fresh manure. They also observed that the subsequent product 
of this (sulfadiazine) was further transformed to 4-OH-sulfadiazine. In terms of total dissipation, a 
DT25 of 16.8 days was observed in cambisol compared with a DT50 of 250 days in luvisol.  
The degradation of sulfachloropyridazine in soil has also been studied. Blackwell et al. (2007) 
tracked the dissipation of sulfachloropyridazine in spiked sandy loam soils. DT50 and DT90 values 
of 3.5 and 18.9 days were observed respectively, indicating that the compound had dissipated 
relatively quickly. Accinelli et al. (2007) also measured dissipation rates of sulfachloropyridazine 
in a sandy loam soil. The authors of this study reported a DT50 of 21.3 days. A slightly lower DT50 
value (18.6 days) was observed for sulfachloropyridazine dissipation in a silt loam soil although 
dissipation was further increased by the addition of fresh manure to the soil system.  
Another study has looked at the degradation kinetics of sulfadimethoxine in soils spiked with 
manure-containing sulfonamides. Using a kinetic model it was observed that the degradation rate 
constant increased with decreasing initial concentration. The authors attributed this to the 
antimicrobial action of sulfadimethoxine at higher concentrations. Higher degradation rates were 
also observed with increasing manure and moisture contents; the former is therefore in agreement 
with other results (Accinelli et al., 2007; Wang et al., 2006).  
4.1.6.4. Dissipation of Sulfonamide Antibiotics - The Aquatic 
Environment 
Although the transport of sulfonamide antibiotics in aquatic systems has not been extensively 
studied, there is a body of literature that describes their dissipation in the aquatic environment. 
Many of these investigations have measured sulfonamide dissipation in rivers. Bendz et al. (2005) 
studied the dissipation of sulfamethoxazole in a Swedish river. Sulfamethoxazole was shown to be 
relatively persistent, with a concentration  of just below 0.03 µg/L being measured at the furthest 
point downstream of an STP compared with an STP effluent concentration of 0.05 µg/L. Tamtam 
et al. (2008) also investigated sulfamethoxazole dissipation downstream of an STP in a French 
river. They observed 50% removal of sulfamethoxazole during the study. This was attributed to a 
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40% river dilution due to a high tributary flow rate. It was concluded therefore that 
sulfamethoxazole was likely to be persistent. Haggard and Bartsch (2009) observed similarly low 
removal rates of seven sulfonamide antibiotics (sulfachloropyridazine, sulfadiazine, 
sulfadimethoxine, sulfamerazine, sulfamethazine, sulfamethoxazole and sulfathiazine) down an 
aquatic gradient of several kilometres. In addition, low uptake levels from the water column were 
observed, suggesting that minimal degradation had occurred. Conkle et al. (2008) also tracked the 
dissipation of sulfamethoxazole (and sulfapyridine) from STP effluent through a wetland and 
ultimately a lake. The study detected no changes in the concentration of either sulfonamide 
antibiotic in STP effluent compared with wetland and lake water. These data would suggest that the 
sulfonamides tested are persistent in the aquatic environment. 
Benotti and Brownawell (2008) have conducted the sole study that has investigated sulfonamide 
degradation in the marine environment. Of the broad range of pharmaceuticals tested, 
sulfamethoxazole was one of the most persistent tested, with a lower half-life of 85 days having 
been measured.  
Other studies have attempted to decipher the possible mechanisms which may be responsible for 
sulfonamide degradation / transformation. Radke et al. (2009) for example investigated 
sulfamethoxazole and sulfamethoxazole metabolite dissipation in water and water sediment 
systems. They found that the compounds tested were only significantly removed by systems that 
included sediment, apart from the metabolite, sulfamethoxazole-N1-glucuronide, which was 
significantly removed in water alone. Due to the lack of significant sorption taking place, the 
authors concluded that the sulfonamides tested were removed by the degradative action of sediment 
microorganisms.  
Lai and Hou (2008) investigated the influence of light and microbial activity on the degradation 
rates of four sulfonamides (sulfamethoxazole, sulfadiazine, sulfadimethoxine and sulfamethazine) 
in eel pond water and sediment. All compounds were shown to be transformed by light treatment 
alone. Light and non-sterile conditions resulted in a reduction in half-lives in both water and 
sediment suggesting a possible role of microbes in the biotransformation of sulfonamides. 
However, only sulfamethoxazole was shown to undergo biotransformation in non-sterile dark 
controls in both water and sediment. This result was particularly interesting given that a number of 
other studies have concluded that sulfamethoxazole is not biodegraded in conventional closed 
bottle tests (Alexy et al., 2004; Al-Amad et al., 1999).   
4.1.7. Reported Effects of Sulfonamide Antibiotics on Microbial 
Function in the Environment 
The effects of sulfonamide antibiotics on various aspects of microbial function in the environment 
have been investigated. Single species testing has accounted for many of these studies. Isidori et al. 
(2005) observed an EC50 value of 23.3 mg/L when exposing the Microtox system to 
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sulfamethoxazole. Kim et al. (2007) also used the Microtox test to study the effects of 
sulfonamides. They reported EC50 values (5 and 15 minutes) of 26.4 mg/L
 
53.7 mg/L
 
for 
sulfachlorpyridazine and 74.2mg/L and 78.1mg/L
 
for sulfamethoxazole.  
Ando et al. (2007) investigated the effect of sulfadimethoxine on the growth of eight 
cyanobacterial species. Interestingly, the sulfonamide antibiotic was shown to be much less toxic 
than the other compounds tested. It exerted an EC50 value of between 2.3 and >2000 mg/L. All 
other antibiotics tested exerted EC50 values of < 1 mg/L.  
Other studies have looked at the effect of sulfonamides on microbial respiration. Thiele-Bruhn and 
Beck (2005) for example tracked the effect of sulfapyridine on substrate induced respiration (SIR). 
They observed EC50 values of 6.2 and 11.5 μg/L
 
for two soils. In another experiment, Zielezny et 
al. (2006) tracked SIR in soils spiked with sulfadiazine. They observed an inhibition of respiration 
rates in the presence of glucose only, highlighting the importance of nutrient addition when 
studying bacteriostatic compounds. Vaclavik et al. (2004) recorded a 0.8 fold decrease in 
respiration rate as a result of exposing soil mesocosms to sulfachloropyridazine.  
Halling-Sorenson et al. (2002) studied the effect of sulfadiazine activity over time in activated 
sludge and soil pore water. They showed this by demonstrating a reduction in CFU counts. This 
study was the only investigation that utilized CFU counts as an end point in the detection of 
sulfonamide toxicity in the environment. Brandt et al. (2009) also showed a reduction in bacterial 
growth using 
3
H leucine incorporation. This was significantly reduced by exposure of the microbial 
community to 0.1 µg/g sulfadiazine.  
Other teams have investigated the effect of sulfonamides on specific cellular function. Thiele-
Bruhn (2005) for instance tested the effect of sulfonamides on iron metabolism. All of the 
sulfonamides that were tested (sulfadimethoxine, sulfadiazine, sulfadimidine and sufadimidine) 
tested exerted ED10 values of < 100 mg/kg. Schmitt et al. (2005) tested the effect of 
sulfachloropyridazine on multisubstrate utilisation. The authors reported that sulfachloropyridazine 
shifted physiological fingerprints on the second PCA axis compared with controls, suggesting that 
a change in community structure had occurred. Loftin et al. (2005) investigated the effect of three 
sulfonamide antibiotics (sulfathiazole, sulfamethazine and sulfadimethoxine) on anaerobic 
metabolism. They found that two of the sulfonamide antibiotics significantly inhibited methane 
production after 72 hours and all three compounds inhibited methane production after 336 hours. 
Two studies have also investigated the impact of sulfonamide on the biodegradation of xenobiotics. 
Chun et al. (2005) found that sulfamethazine significantly inhibited the dissipation of the synthetic 
hormone 17 β-Estradiol in soil. More recently, Monteiro and Boxall (2009) observed a reduction in 
naproxen dissipation as the result of exposing microbial communities to sulfamethazine.  
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4.1.8. Aims and Objectives of Chapter 
The overall aim of the work described in this Chapter was to assess the potential effects of SMX on 
aquatic microbial communities. This was achieved using the following specific objectives; 
1) To utilize the methods developed in Chapter 2 as well as measures of colony forming units to 
assess the effects of SMX on microbial population numbers and the ecological functioning of 
microbial communities in aquatic systems. 
2) To explore the potential for recovery of microbial communities following SMX exposure in 
terms of ecological functioning. 
3) To link functional data to effects of SMX in terms of the likely effect SMX may be exerting and 
to link these data to how these effects may be affecting wider ecological processes in the aquatic 
environment. 
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4.2. Materials and Methods 
4.2.1. Study outline 
The literature explored in previous chapters has revealed that sulfonamide antibiotics have been 
detected in the aquatic environment. Moreover, despite a range of reported effects having been 
detected in several environmental matrices there is still a lack of knowledge regarding the 
effects of sulfonamide antibiotics in the aquatic environment. In this chapter methods developed 
in Chapter 2 will be utilised to investigate the effects of sulfonamide antibiotics on microbial 
function in aquatic environment. The effects of sulphonamide exposure on CFU (colony 
forming units will also be assessed.  
4.2.2. Chemicals 
All materials and chemicals were purchased and prepared according to section 2.2.1. R2A agar 
was purchased from Oxoid (Cambridge, UK). Sulfamethoxazole was purchased from Sigma 
Aldrich (Poole, UK).  
4.2.3 Surface water 
Surface water was collected and prepared according to section 2.2.2. 
4.2.4. Activated Sludge and Preparation of Treated Sewage 
Activated sludge was collected and prepared according to section 2.2.3. 
4.2.5. Preparation of OECD Synthetic Sewage 
OECD synthetic sewage was prepared according to section 2.2.4. 
4.2.6. Preparation of R2A Plates 
R2A plates were prepared according to section 3.8.5. 
4.2.7. Sulfamethoxazole Exposure Experiments 
Twelve microcosms were set-up as described in section 2.2.6.1. Nine microcosms were spiked 
with an aqueous sulfamethoxazole solution. Three microcosms were spiked to a nominal 
sulfamethoxazole concentration of 1 mg/L, three to a nominal sulfamethoxazole concentration 
of 0.32 mg/L and three to a nominal sulfamethoxazole concentration of 0.1 mg/L. Three control 
microcosms received no sulfamethoxazole solution. A time series experiment was then 
conducted as described in sections 2.2.7.2.  
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4.2.8. CFU (Colony Forming Unit) Counts 
CFU counts were performed according to section 3.9.1. 
4.2.9. Data Analysis 
Data were analysed according to section 3.9.2. 
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4.3. Results 
4.3.1.1. Effect of Sulfamethoxazole on Total Substrate Utilisation 
The data in figure 4.1 (a, b and c) show kinetic model plots of total substrate utilisation on days 1, 4 
and 7 of the exposure. These graphs were included as they illustrated the main events during the 
exposure period at regular intervals. Figure 4.2 (a and b) shows PCA score plots representing 
multivariate data on days 1 and 7. The data in figure 4.3 (a and b) show lag phase and maximum 
rate graphs on all days of the exposure period. Tables 4.3 and 4.4 show statistical analyses of 
modelled max rate and lag phase duration values on days 1-7.  
4.3.1.2. Kinetic Model Plots 
Kinetic plots showing day 1 exposure data for total substrate utilisation shows that maximum 
absorbances reached their highest levels on 0 mg/L SMX plots 
 
and their lowest levels on 1 mg/L 
SMX plots. Plots depicting day 4 kinetic data show that microcosms that had been treated with 1 
mg/L
 
SMX had recovered slightly as far as a visual trend can tell. However, the two middle 
treatments had now showed more of an inhibition compared with the highest treatment in terms of 
an increased visual lag phase (0.1 and 0.32 mg/L SMX) and the maximum absorbance that plots 
had reached (0.32 mg/L SMX). All treatments still showed an inhibitory trend compared with 
control plots. Plots showing day 7 data reveal that all treatments had shown a further recovery in 
terms of the absorbance maxima, slope steepness and apparent lag phase. Inhibition was still 
observable with plots depicting data for 0.1 and 0.32 mg/L SMX showing the greatest inhibition.  
4.3.1.3. Lag Phase Duration versus Exposure Time 
The data shown by figure 4.4a and table 4.3 shows that the lag phase duration following total 
substrate utilisation was significantly increased as a result of exposing aquatic microcosms to 0.32 
and 1 mg/L
 
SMX. On day 2 of the exposure, microcosms that had been exposed to 1 mg/L SMX
 
still displayed a significantly higher lag phase duration. However these microcosms had showed a 
recovery by day 3 and even a significantly reduced lag phase duration by day 5. The lag phase 
following total substrate utilisation as a result of exposure to 0.32 mg/L
 
SMX showed a complete 
recovery by day 2. A significant increase in lag phase duration was observed on day 4 of the 
exposure in microcosms that had been exposed to 0.1 mg/L
 
SMX. No further effects were seen at 
this concentration for the remainder of the exposure period however.  
4.3.1.4. Max Rate versus Exposure Time 
The data shown by figure 4.4b and table 4.4 show significant widespread effects of SMX on the 
max rate total substrate utilisation. On day 1 of the exposure a significant reduction in the max rate 
of total substrate utilisation was observed as a result of exposure to 0.32 and 1 mg/L SMX, 
although no significant effect was observed in microcosms exposed to the lower SMX 
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concentration (0.1 mg/L). On days 2 and 3 of the study significant reductions in the max rate of 
total substrate utilisation were seen at all SMX concentrations. After this, a recovery was observed 
in 1 mg/L
 
SMX-treated microcosms. Significant reductions in the max rate of substrate utilisation 
were seen until the end of the investigation in microcosms that had been treated with 0.32 mg/L 
SMX. This was also the case with microcosms that were exposed to 0.1 mg/L SMX, except no 
effects were observed on days 5 or 6.  
4.3.1.5. PCA Analysis of Total Substrate Utilisation 
PCA plots depicting day 1 exposure data show that replicates from each treatment clustered almost 
exactly by SMX dose, with minimal mixing of replicates between treatments. This would indicate 
that total substrate utilisation had resulted in 4 distinct microbial community structures, based on 
their individual “metabolic fingerprint.”  
By day 4 of the exposure, a different picture had been formed according to PCA score plots. These 
plots show a higher degree of mixing between replicates from all SMX treatments, including 
between control and 1 mg/L
 
doses. A distinct replicate cluster containing only 0.1 mg/L replicates 
could also be observed, suggesting that this treatment had caused the most change in the total 
substrate utilisation pattern of the microbial community. 
By day 7 of the exposure, replicates from the two highest SMX treatments were relatively well 
separated, with some slight mixing between replicates representing 1 and 0.32 mg/L
 
and 0.1 and 
0.32 mg/L. There was significant replicate mixing between day 7 clusters representing control and 
0.1 mg/L SMX
 
treatments, suggesting that the total substrate utilisation profile was similar at these 
doses. It can be inferred from this that the microbial communities within microcosms treated with 
these treatments utilised total substrates in a similar manner.  
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a) 
 
b) 
 
 
Figure 4.1: Kinetic plots of total substrate utilisation following SMX exposure on a) day 1, b) day 4 
and c) day 7. 
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c) 
 
Figure 4.1 (cont). 
 
  
-0.2
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
0 5 10 15 20 25 30 35 40 45 50 55 60 65 70 75 80 85 90 95 100 105
A
b
so
rb
a
n
ce
 a
t 
5
9
5
 n
m
Time (hours)
Predicted 0 mg/L SMX
Predicted 0.1 mg/L SMX
Predicted 0.32 mg/L SMX
Predicted 1 mg/L SMX
0 mg/L SMX
0.1 mg/L SMX
0.32 mg/L SMX
1 mg/L SMX
202 
 
a) 
1050-5-10
5.0
2.5
0.0
-2.5
-5.0
-7.5
First Component
S
e
co
n
d
 C
o
m
p
o
n
e
n
t
0 mg/L SMX
0.1 mg/L SMX
0.32 mg/L SMX
1 mg/L SMX
 
b) 
7.55.02.50.0-2.5-5.0
5.0
2.5
0.0
-2.5
-5.0
-7.5
First Component
S
e
c
o
n
d
 C
o
m
p
o
n
e
n
t
0 mg/L SMX
0.1 mg/L SMX
0.32 mg/L SMX
1 mg/L SMX
 
 
Figure 4.2: Scatter plots of PC scores for the first two principle components for individual 
replicates from each SMX treatment groups representing total substrate utilisation on a) day 1 and 
b) day 7. Day 1 (a) proportion of variation: PC1 = 69.3%, PC2 = 14.8%; Day 4 (b) proportion of 
variation: PC1 = 42.9%, PC2 = 23.4%.  
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a) 
 
b) 
 
 
Figure 4.3: a) Lag phase duration versus exposure period time for total substrate utilisation and b) 
Max rate of total substrate utilisation versus exposure period time following exposure to SMX. 
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Table 4.3: Summary of one-way ANOVA results for lag phase values before total substrate 
utilization from Biolog data for inocula from microcosms following different exposure times to 
SMX in comparison with unexposed inocula. 
         Day of Exposure / Statistical Significance of Lag Phase Duration
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 >ns <ns >ns *> >ns <ns <ns 
 
0.32 >* <ns >ns >ns <ns >ns >ns 
 1 >* >* >ns >ns <* <ns <ns 
 
       
 Table 4.4: Summary of one-way ANOVA results for maximum rate of total substrate utilization 
values from Biolog data for inocula from microcosms following different exposure times to SMX 
in comparison with unexposed inocula.  
 
       
 Day of Exposure / Statistical Significance of Max Rate
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 = <* <* <* <ns <ns <* 
 
0.32 <* <* <* <* <* <* <* 
 1 <* <* <* <ns <ns <ns <ns 
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4.3.2. Effect of SMX on Amine and Amide Utilisation 
The data in figure 4.4 show kinetic plots for amine and amine utilisation on days 1 (a), 4 (b) and 7 
(c). Data shown in figure 4.5 show PCA score plots of amine and amide utilisation for the first two 
principle components on days 1 (a), 4 (b) and 7 (c). Figure 4.6 shows data representing lag phase 
duration and max rate values on days 1-7 of the exposure period. Tables 4.5 and 4.6 show 
statistical analysis of lag phase duration and max rate values of amine and amide utilisation in 
aquatic microcosms.  
4.3.2.1. Kinetic Model Plots of Amine and Amide Utilisation 
Kinetic model plots showing amine and amide utilisation show that SMX exposure resulted in an 
apparent inhibition of amine and amide utilisation on day 1 of the exposure in terms of lag phase, 
rate and the maximum absorbance that was recorded. The only exception was the maximum 
absorbance that was reached by 1 mg/L SMX plots; this exceeded the maximum absorbance 
reached by plots depecicting microcosms that had been exposed to 0.32 mg/L SMX. An apparent 
recovery by microcosms exposed to 1 mg/L SMX can be seen in plots depicting day 4 kinetic data, 
with slopes closely resembling those of control plots. On day 4, kinetic plots show that inhibitory 
effects can be seen at 0.1 and 0.32 mg/L SMX,
 
with the most inhibition being observed at 0.32 
mg/L SMX. On day 7, kinetic plots show that microcosms that had been treated with 0.1 and 0.32 
mg/L SMX
 
show no inhibition, with both curves showing a steeper slope and a higher maximum 
absorbance compared with the control slope. A recovery was therefore suggested at these two SMX 
concentrations. However, an inhibitory effect could still be observed in microcosms exposed to 
0.32 mg/L
 
SMX in terms of lag phase duration, maximum absorbance and slope steepness.  
4.3.2.2. Lag Phase Duration: Amines and Amides 
In terms of lag phase duration no significant increases could be observed as a result of exposing 
aquatic microcosms to 0.1 or 0.32 mg/L SMX
 
on any day of the exposure period. However, a 
significantly higher lag phase duration was observed in microcosms that had been exposed to 1 
mg/L SMX on days 1 and 2 of the study. A recovery started on day 3 onwards in these microcosms 
however, as shown by reuced lags times. In general, there was a trend for lag phase duration to 
decrease over time at all SMX concentrations. No apparent trend could be detected in control 
treatments. 
4.3.2.3. Max Rate of Amine and Amide Utilisation 
Although the graph showing max rate data on days 1-7 of the study shows the max rate of amine 
and amide utilisation was generally lower in treated microcosms, a statistically significant 
reduction in the max rate of amine and amide utilisation was only observed on day 4 of the 
exposure. These were observed in microcosms that had been exposed to 0.1 and 0.32 mg/L SMX. 
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No significant effects were observed as a result of treating microcosms to 1 mg/L SMX on any day 
of the study. In general, there was a trend of max rate of amine and amide utilisation increasing 
with time as result of all treatments.  
4.3.2.4. PCA Analysis of Amine and Amide Utilisation  
PCA score plots of amine and amide utilisation illustrating day 1 substrate utilisation shows that 
there was a large degree of replicate mixing from different SMX treatments. Mixing of replicates 
could also be observed at all SMX treatments and with control replicates also. However, there was 
another large replicate cluster that grouped treated replicates from all SMX treatments but no 
control replicates. This would suggest that a portion of the microbial community was utilising 
amines and amides slightly differently at all SMX doses but a portion of the microbial community 
was also utilising amines and amides in a similar manner. These data suggest that the microbial 
community structure for microbes that were utilising amines and amides was slightly different in 
microcosms exposed to all SMX concentrations.  
On day 4 of the exposure, replicates from treated microcosms tended to cluster together with only 
minimum mixing with control replicates. There was however a large degree of mixing between 
replicates from microcosms that had been exposed to all SMX concentrations. These results would 
suggest that the microbial community in all treated microcosms were utilising amines and amides 
differently form the microbial community that was present in control microcosms. It is therefore 
possible that the community structure of amine and amide utilising microbes was different as the 
result of exposing microcosms to SMX.  
A similar picture was observed on day 7 of the study; again, replicates from treated microcosms 
tended to cluster. There was however a greater degree of mixing between control and treated 
replicates on day 7, suggesting that the amine and amide utilising microbial community became 
slightly more similar to control replicates in terms of amine and amide utilisation.  
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a) 
 
b) 
 
 
Figure 4.4: Kinetic plots of amine and amide utilisation following SMX exposure on a) day 1, b) 
day 4 and c) day 7. 
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c) 
 
 
Figure 4.4 (cont). 
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Figure 4.5: Scatter plots of PC scores for the first two principle components for individual 
replicates from each SMX treatment groups representing amine and amide utilisation on a) day 1 
and b) day 7. Day 1 (a) proportion of variation: PC1 = 52.5%, PC2 = 9.2%; Day 7 (b) proportion of 
variation: PC1 = 20.8%, PC2 = 14.6%.  
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a) 
 
b) 
 
 
Figure 4.6: a) Lag phase duration versus exposure period time for amine and amide utilisation and 
b) Max rate of amine and amide utilisation versus exposure period time following exposure to 
SMX. 
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Table 4.5: Summary of one-way ANOVA results for lag phase values before amine and amide 
utilization from Biolog data for inocula from microcosms following different exposure times to 
SMX in comparison with unexposed inocula. 
         Day of Exposure / Statistical Significance of Lag Phase Duration
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 ns< ns> >ns >ns >ns >ns <ns 
 
0.32 ns> ns< <ns <ns <ns >ns >ns 
 1 *> *> >ns >ns <ns >ns >ns 
 
       
 Table 4.6: Summary of one-way ANOVA results for maximum rate of amine and amide 
utilization values from Biolog data for inocula from microcosms following different exposure 
times to SMX in comparison with unexposed inocula.   
 
       
 Day of Exposure / Statistical Significance of Max Rate
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 ns< = ns< *< = ns< ns< 
 
0.32 ns< ns< ns< *< ns< ns< ns< 
 1 ns< ns< ns> ns> ns< ns< ns> 
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4.3.3. Effect of SMX on Amino Acid Utilisation 
The data in figure 4.7 shows kinetic plots representing amino acid utilisation on days 1 (a), 4 (b) 
and 7 (c). PCA score plots of amino acid utilisation fingerprints are shown in figure 4.8 a, day 4 
and b, day 7. Figure 4.9 (a and b) shows lag phase durations and max rate values of amino acid 
utilisation for all SMX treatments versus time. Table 4.7 show a statistical analysis of lag phase 
duration before amino acid utilisation as a result of SMX exposure. Table 4.8 shows a statistical 
analysis of the max rate of amino acid utilisation as result of SMX exposure. 
4.3.3.1. Kinetic Model Plots of Amino Acid Utilisation 
Kinetic plots of amino utilisation on day 1 show that SMX had an inhibitory effect at all SMX 
concentrations. This was evident in terms of the slope of plots as well as an apparent increase in lag 
phase duration and the maximum absorbance that was reached by plots. Day 4 kinetic plots show a 
recovery in terms of amino acid utilisation in 1 mg/L SMX-treated microcosms. An inhibition in 
amino acid utilisation could still be observed at the two lower SMX treatments in terms of lag 
phase duration and maximum absorbance. By day 7 of the study, maximum absorbances (for all 
SMX doses) were lower than the control value and the rate of amino acid utilisation seemed to be 
lower in microcosms treated with 0.32 mg/L SMX. 
4.3.3.2. Lag Phase Duration: Amino Acid Utilisation 
On day 1 of the investigation all treated microcosms displayed a longer lag phase duration before 
amino acid utilisation occurred. These increases were shown to be statistically significant for SMX 
treatments of 0.32 and 1 mg/L. In the case of the 1 mg/L
 
treatment, a further significantly higher 
lag phase duration was observed on day 2 also. Lag phase durations were generally higher at all 
SMX doses until day 4, although not significantly so. After day 4, lag phases were reduced to 
values either near or less than the control.  
4.3.3.3. Max Rate of Amino Acid Production 
On day 1 of the exposure, a significant reduction in the max rate of amino acid utilisation was 
observed as a result of exposing the microbial community to 1 mg/L
 
SMX. The only other 
statistically significant reduction in the max rate of amino acid utilisation could be observed on day 
4 of the study at 0.1 mg/L SMX. There was however no clear trend in terms of the max rate of 
amino acid utilisation over time. 
4.3.3.4. PCA Analysis of Amino Acid Utilisation 
Day 1 of the exposure period revealed a large degree of mixing between replicates from different 
SMX treatments, suggesting a degree of similarity in amino acid utilisation between treatments. 
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This further suggests that the amino acid utilising microbial community structure was also similar 
between doses. On day 4 however replicates treated with SMX could be separated from control 
replicates, suggesting a difference in amino acid utilisation between treated and non-treated 
microbial communities. 0.1 and 1 mg/L
 
SMX treatments could also be separated with mixing of 
0.32 mg/L
 
replicates in between. These data suggest that on day 4 of the exposure period the 
portion of the microbial community that was utilising amino acids had been altered (compared with 
control communities) in 0.1 and mg/L SMX dosed microcosms and that these communities shared 
some structural similarity with communities that had been exposed to 0.32 mg/L SMX.  
On day 7 of the study, the control and 0.1 mg/L
 
groups were utilising amino acids in a similar 
manner with some similarity to 0.32 mg/L
 
treated microbial communities as shown by a degree of 
mixing. Replicates treated with 1 mg/L SMX clustered separately however, indicating that this 
treatment had resulted in a microbial community that were utilising amino acids differently from 
the control/0.1 mg/L
 
SMX dosed communities. There was however some mixing with 0.32 mg/L
 
SMX replicates, indicating some similarity between the amino acid utilisation profile (and 
therefore community structure) of microbial communities exposed to these SMX doses.  
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a) 
 
b) 
 
 
Figure 4.7: Kinetic plots of amino acid utilisation following SMX exposure on a) day 1, b) day 4 
and c) day 7. 
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c) 
 
 
Figure 4.7 (cont). 
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Figure 4.8: Scatter plots of PC scores for the first two principle components for individual 
replicates from each SMX treatment groups representing amino acid utilisation on a) day 4 and b) 
day 7. Day 4 (a) proportion of variation: PC1 = 42.3%, PC2 = 18.5%; Day 7 (b) proportion of 
variation: PC1 = 19.9%, PC2 = 16.7%.  
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a) 
 
b) 
 
 
Figure 4.9: a) Lag phase duration versus exposure period time for amino acid utilisation and b) 
Max rate of amino acid utilisation versus exposure period time following exposure to SMX. 
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Table 4.7: Summary of one-way ANOVA results for lag phase values before amino acid 
utilization from Biolog data for inocula from microcosms following different exposure times to 
SMX in comparison with unexposed inocula. 
         Day of Exposure / Statistical Significance of Lag Phase Duration
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 ns> ns< ns> ns> ns< ns< ns< 
 
0.32 *> ns< ns> ns> ns< ns> ns> 
 1 *> *> ns> ns> ns< ns< ns< 
 
       
 Table 4.8: Summary of one-way ANOVA results for maximum rate of amino acid utilization 
values from Biolog data for inocula from microcosms following different exposure times to SMX 
in comparison with unexposed inocula. 
 
       
 Day of Exposure / Statistical Significance of Max Rate
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 = ns< ns< *< ns< ns< ns< 
 
0.32 ns< <ns ns< ns< ns> ns< ns< 
 1 *< = ns< ns< ns< ns> ns< 
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4.3.4. Effect of SMX on Carbohydrate Utilisation  
The data in figure 4.10 illustrate kinetic plots of carbohydrate utilisation on days 1 (a), 4 (b) and 7 
(c). Figure 4.11 shows PCA score plots of carbohydrate utilisation on days 1 (a) and 7 (b). The data 
in figure 4.12 show lag phase duration before carbohydrate utilisation (a) and the max rate of 
carbohydrate utilisation (b). Tables 4.9 and 4.10 show statistically significant changes in 
carbohydrate utilisation in terms of lag phase duration and max rate respectively. 
4.3.4.1. Kinetic Plots of Carbohydrate Utilisation 
Day 1 kinetic plots suggest that carbohydrate utilisation was inhibited by all doses of SMX. The 
inhibition was visually apparent in terms of lag phase, rate and the maximum absorbance that was 
reached by plots. On day 4, a similar pattern was visible, with SMX inhibiting carbohydrate 
utilisation in an almost identical fashion to day 1. On day 7, microcosms treated with 1 mg/L SMX
 
showed a general recovery; kinetic plots representing these microcosms became very similar to 
control plots. There was still an apparent inhibition of carbohydrate utilisation in microcosms 
treated with 0.1 and 0.32 mg/L SMX however. This could be visually observed in terms of lag 
phase duration, steepness of curves and maximum absorbance reached by these plots.  
4.3.4.2. Lag Phase Duration: Carbohydrate Utilisation 
All lag phase values apart from the highest SMX treatment showed a general increase over time. 
Day 1 values represented a statistically significant rise in lag phase duration as the result of 
exposing microbial communities to all SMX concentrations. At the highest SMX treatment, no 
significant effects could be detected after day 1and a significant reduction was shown on day 5. A 
recovery in lag phase duration in microcosms treated with 1 mg/L SMX was therefore suggested. 
In microcosms that had been treated with 0.32 mg/L SMX, significant effects were still being 
observed on days 3, 4 and 7, suggesting that a recovery had not occurred. There was however 
intermittent periods (days 2, 5 and 6) when no significant effects on lag phase duration could be 
shown. An increase in lag phase duration was also observed on day 4 of the study in microcosms 
that had been treated with 0.1 mg/L SMX, although no significant effects were seen after this time-
point. These microcosms were therefore likely to have been showing a recovery in terms of lag 
phase duration. 
4.3.4.3. Max Rate of Carbohydrate Utilisation 
Graphs depicting the max rate of carbohydrate utilisation versus time show that max rate values 
representing all SMX treatments were lower than the control value for the duration of the exposure. 
The exception to this was observed in microcosms that had been exposed to 1 mg/L SMX. At this 
dose the max rate of carbohydrate utilisation was either equal to or higher than the control value on 
day 6 and 7 of the exposure. On day 1 at 0.32 and 1 mg/L SMX, the
 
max rate of carbohydrate 
utilisation was significantly lower than the control. At the highest SMX treatment, further 
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significant reductions were witnessed on days 2, 4 and 5. At the lowest SMX concentration, a 
significant reduction in the max rate of carbohydrate utilisation could be seen on days 2, 3, 4 and 7. 
In microcosm treated with 0.32 mg/L SMX, the max rate of carbohydrate utilisation was 
significantly reduced during the entire exposure period.  
4.3.4.4. PCA Analysis of Carbohydrate Utilisation 
On day 1 of the exposure, PCA score plots indicate that the two highest SMX concentrations 
resulted in distinct clustering of replicates and that 0.1 mg/L
 
replicates were mixed with control 
replicates. These data would suggest that the microbial community that had been exposed to 0.32 
and 1 mg/L
 
SMX utilised carbohydrates in a similar manner as did microbial communities present 
in 0.1 mg/L
 
SMX-treated and control communities. Based on these data, it is likely that an altered 
community structure resulted form exposure to 0.32 and 1 mg/L SMX.  
Day 4 PCA score plots show that the microbial community that had been exposed to 0.32 mg/L 
SMX clustered in a distinct manner from other treatments. Other treatments also clustered 
distinctly; minimal mixing with control replicates was observed. Some mixing was also observed 
between 0.1 and 1 mg/L
 
replicates. SMX treatment on day 4 had therefore resulted in differential 
utilisation of carbohydrates by microbial communities exposed to all SMX concentrations. It is 
likely therefore that the microbial community structures were different in treated and control 
microcosms also.  
Day 7 plots reveal that the exposure of the microbial community to all SMX concentrations 
resulted in a complete separation of treated and control replicates. There was only minor mixing (1 
replicate) between 0.1 and 1 mg/L SMX-treated replicates. These observations would suggest that 
on day 7 of the exposure microbial communities that had been exposed to all SMX concentrations 
resulted in differential utilisation of carbohydrates. It is also likely therefore that the microbial 
community structures were different at these SMX treatments.  
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a) 
 
b) 
 
 
Figure 4.10: Kinetic plots of carbohydrate utilisation following SMX exposure on a) day 1, b) day 
4 and c) day 7. 
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c) 
 
 
Figure 4.10 (cont). 
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Figure 4.11: Scatter plots of PC scores for the first two principle components for individual 
replicates from each SMX treatment groups representing carbohydrate utilisation on a) day 1 and 
b) day 7. Day 1 (a) proportion of variation: PC1 = 72.1%, PC2 = 6.9%; Day 7 (b) proportion of 
variation: PC1 = 22.3%, PC2 = 21.9%.  
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a) 
 
b) 
 
 
Figure 4.12: a) Lag phase duration versus exposure period time for carbohydrate utilisation and b) 
Max rate of carbohydrate utilisation versus exposure period time following exposure to SMX. 
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Table 4.9: Summary of one-way ANOVA results for lag phase values before carbohydrate 
utilization from Biolog data for inocula from microcosms following different exposure times to 
SMX in comparison with unexposed inocula. 
         Day of Exposure / Statistical Significance of Lag Phase Duration
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 *> ns< ns> *> ns> ns> ns> 
 
0.32 *> ns> *> *> ns> ns> *> 
 1 *> ns> ns> ns< *< ns< ns< 
 
       
 Table 4.10: Summary of one-way ANOVA results for maximum rate of carbohydrate utilization 
values from Biolog data for inocula from microcosms following different exposure times to SMX 
in comparison with unexposed inocula.  
 
       
 Day of Exposure / Statistical Significance of Max Rate
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 ns< *< *< *< ns< ns< *< 
 
0.32 *< *< *< *< *< *< *< 
 1 *< *< ns< *< *< ns>  = 
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4.3.5. Effect of SMX on Carboxylic Acid Utilisation 
The data represented by figure 4.13 show kinetic plots for carboxylic acid utilisation on days 1 (a), 
4 (b) and 7 (c) of the study. Figure 4.14 shows PCA score plots representing data for days 1 (a) and 
7 (b). The data in figures 4.15 show lag phase duration following carboxylic acid utilisation on 
days 1-7 (a) and max rate of carboxylic acid utilisation on day 1-7 (b). Tables 4.11 and 4.12 show 
statistically significant changes in lag phase duration and max rate respectively.  
4.3.5.1. Kinetic Model Plots of Carboxylic Acid Utilisation 
Day 1 kinetic plots show that there was an initial inhibition of carboxylic acid utilisation in terms 
of the visual increase in lag phase duration, slope and the maximum absorbance that was reached 
by plots illustrating all SMX doses.  
On day 4 of the exposure, inhibition could still be observed at all SMX concentrations, with the lag 
phase, slope and maximum absorbance still showing signs of inhibition compared with the control 
kinetic plot. The greatest effects were seen as a result of exposing microcosms to 0.32 mg/L SMX. 
Plots representing 0.1 and 1 mg/L SMX exposures
 
were more similar in terms of slope, lag phase 
duration and the maximum absorbance that was reached by the plot.  
At the end of the exposure (day 7), there were signs of a slight recovery compared with plots from 
previous days. There were still some visible signs of the inhibitory effects of SMX however. Plots 
representing 0.l and 1 mg/L
 
were not as steep as the control plot slope indicating a possible slower 
rate of carboxylic acid utilisation. The maximum absorbance that was reached by these two plots 
was below also that of the control. In addition, although the steepness of the curve representing 0.1 
mg/L SMX
 
was comparable to the control plot in terms maximum steepness, the maximum 
absorbance that was reached was not as high. 
4.3.5.2. Lag Phase Duration: Carboxylic Acid Utilisation 
The data in graphs depicting lag phase duration versus time do not follow a trend at any SMX dose 
(including the control). However, on days 1, 3 and 4 of the exposure lag phase durations for all 
exposures were higher than the lag phase duration that was observed in control microcosms. In 
terms of statistically significant increases in lag phase duration, a significant increase was observed 
on day 1 at 0.32 and 1 mg/L SMX. After this, there was an apparent recovery at these SMX 
concentrations. A significant increase in lag phase duration was also observed on day 4 as a result 
of exposing the microbial community to 0.1 mg/L
 
SMX.  
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4.3.5.3. Max Rate of Carboxylic Acid Utilisation 
On all days of the exposure period every treatment of SMX caused a reduction in the max rate of 
carboxylic acid utilisation, with the exception of 0.1 mg/L SMX,
 which didn’t cause any inhibition 
on day 2. There was no apparent trend to each plot over time. 
Statistically significant reductions in the max rate of carboxylic acid utilisation were observed on 
days 1 and 2 as a result of exposing microcosms to 1 mg/L SMX. There was no further inhibition 
after this, suggesting that a recovery had taken place after day 2. Although no effects on the max 
rate of carboxylic acid utilisation were observed on day 1 of the study in microcosms spiked with 
0.32 mg/L, a significant reduction was observed on all subsequent days. No significant effects on 
the max rate of carboxylic acid utilisation were observed in microcosms spiked with 0.1 mg/L on 
days 1, 2, 5 or 6, although significant effects were observed at this SMX concentration on days 3, 4 
and 7.  
4.3.5.4. PCA Analysis of Carboxylic Acid Utilisation 
On day 1 of the exposure, PCA score plots show that there was a clustering of 1 mg/L SMX  
replicates with some mixing of 0.32 mg/L
  
replicates. There was considerable mixing of all other 
replicates with control replicates. The results of day 1 PCA analysis would therefore suggest that 
SMX treatments of 0.32 mg/L and, to a greater extent, 1 mg/L caused a change in the carboxylic 
acid utilisation profile. It can also be suggested that microbial communities that had been exposed 
to these SMX concentrations had altered community structures compared with control microcosms.  
On day 4 of the exposure there was considerable mixing of replicates representing SMX treatments 
of 0, 0.1 and 1 mg/L
 
and replicates representing 1, 0.1 and 0.32 mg/L SMX also. These data would 
suggest that there were some changes in carboxylic acid utilisation as a result of exposing 
microbial communities to SMX, especially 0.32 mg/L
 
SMX. It is possible therefore that an SMX 
concentration of 0.1 mg/L and above caused a shift in microbial community structure compared 
with unexposed communities.  
On day 7 PC score plots there were two clusters containing replicates from microcosms treated 
with all SMX concentrations. All replicates from microcosms treated with 0.32 mg/L
 
were in one 
of these two groups. The majority of the replicates representing SMX treatments of 0.1 and 1 mg/L
 
clustered away from control replicates. This would suggest that on day 7 of the exposure period 
SMX concentrations of 0.1 and 1 mg/L
 
were still causing differential carboxylic acid metabolism 
compared with control microbial communities.  These SMX concentrations were likely to be 
causing a shift in microbial community structure compared with control community structures.  
  
228 
 
a) 
 
b) 
 
 
Figure 4.13: Kinetic plots of carboxylic acid  utilisation following SMX exposure on a) day 1, b) 
day 4 and c) day 7. 
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c) 
 
 
Figure 4.13 (cont). 
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Figure 4.14: Scatter plots of PC scores for the first two principle components for individual 
replicates from each SMX treatment groups representing carboxylic acid utilisation on a) day 1 and 
b) day 7. Day 1 (a) proportion of variation: PC1 = 51.2%, PC2 = 22.8%; Day 7 (b) proportion of 
variation: PC1 = 22.4%, PC2 = 14.7%.  
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a) 
 
b) 
 
 
Figure 4.15: a) Lag phase duration versus exposure period time for carboxylic acid utilisation and 
b) Max rate of carboxylic acid utilisation versus exposure period time following exposure to SMX. 
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Table 4.11: Summary of one-way ANOVA results for lag phase values before carboxylic acid 
utilization from Biolog data for inocula from microcosms following different exposure times to 
SMX in comparison with unexposed inocula. 
         Day of Exposure / Statistical Significance of Lag Phase Duration
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 ns> ns< ns> *> ns> ns< ns< 
 
0.32 *> ns< ns> ns> ns< ns> ns> 
 1 *> ns> ns> ns> *< ns< ns< 
 
       
 Table 4.12: : Summary of one-way ANOVA results for maximum rate of carboxylic acid 
utilization values from Biolog data for inocula from microcosms following different exposure 
times to SMX in comparison with unexposed inocula.  
 
       
 Day of Exposure / Statistical Significance of Max Rate
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 ns< ns< *< *< ns< ns< *< 
 
0.32 ns< *< *< *< *< *< *< 
 1 *< *< ns< ns< ns< ns< ns< 
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4.3.6. Effect of SMX on Polymer Utilisation  
The data in figure 4.16 show kinetic plots of polymer utilisation on days 1 (a), 4 (b) and 7 (c). 
Figure 4.17 shows PCA score plots of polymer utilisation on days 1 (a) and 7 (c). Figure 4.18 
shows the lag phase duration before polymer utilisation (a) and the max rate of polymer utilisation 
(b). Tables 4.13 and 4.14 show statistically significant changes in lag phase duration and max rate 
of polymer utilisation respectively.  
4.3.6.1. Kinetic Plots of Polymer Utilisation 
Day 1 kinetic plots of polymer utilisation show that polymer utilisation was inhibited at all SMX 
concentrations. This trend was visible in terms of lag phase duration, slope and the maximum 
absorbance that was reached by plots representing each SMX treatment.  
On day 4 of the exposure, inhibition of polymer utilisation was still visible in terms of lag phase 
duration, slope and the maximum absorbance that was reached by plots, although the slope for each 
plot had exhibited some visual recovery. The maximum absorbance that was reached by each plot 
had increased also, which also suggests that a recovery was occuring in terms of polymer 
utilisation.  
By day 7, kinetic plots representing microcosms exposed to 1 mg/L
 
were visually more similar to 
control plots in terms of curve shape. These data would suggest that a full recovery of the microbial 
community in terms of polymer utilisation had occurred at this SMX concentration. There was a 
degree of recovery apparent in curves representing microcosms that had been exposed to 0.l and 
0.32 mg/L SMX in terms of the maximum absorbance that was reached by kinetic plots. Different 
slopes still suggested that an effect on polymer utilisation was still taking place however. 
4.3.6.2. Lag Phase Duration: Polymer Utilisation  
Graphs representing lag phase durations following carboxylic acid utilisation as a result of 
exposing microcosms to SMX reveal no temporal trend at any SMX treatment. On day 1 however 
lag phase durations were significantly higher at all SMX treatments compared with control values. 
There were no further statistically significant increases as a result treating microcosms with 1 mg/L 
during the exposure.
 
These data suggest that a recovery in terms of lag phase duration was 
occurring in microcosms that had been exposed to 1 mg/L from day 2 onwards. There were 
significant increases in lag phase durations on day 3 as a result of exposing microcosms to 0.1 and 
0.32 mg/L SMX. After this there were no further increases in lag phase duration suggesting that 
these microcosms were showing a recovery in terms of lag phase from day 5 onwards. 
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4.3.6.3. Max Rate of Polymer Utilisation 
Although graphs illustrating the max rate of polymer utilisation over time do not show any 
temporal trends, they do show that there was an inhibition of the max rate of polymer utilisation. In 
general, the max rate of polymer utilisation was lowered as a result of exposing microcosm to all 
SMX concentrations. The only exceptions to this were seen on days 1 and 5, when microcosms 
exposed to 0.1 mg/L SMX were not inhibited in terms of the max rate of polymer utilisation.  
Statistically significant decreases in the max rate of polymer utilisation were seen at 1 mg/L
 
SMX 
on days 1, 2 and 4 of the exposure, after which no more significant effects were observed. On days 
2, 3, 4, 6 and 7 a significant reduction of the max rate of polymer utilisation was observed at 0.32 
mg/L SMX. An SMX concentration of 0.1 mg/L
 
caused significant changes in the max rate of 
polymer utilisation on days 2 and 4.  
4.3.6.4. PCA Analysis of Polymer Utilisation   
PCA analysis of polymer utilisation on day 1 of the exposure showed that control replicates tended 
to cluster near replicates from microcosms that had been treated with 0.1 mg/L SMX, although 
some replicates from the other two SMX treatments clustered with control replicates also. However 
most replicates representing microcosm treated with 0.32 and 1 mg/L
 
clustered separately from 
control replicates. These data suggest that the top two SMX concentrations had resulted in the 
microbial community utilising polymers differently on day 1 of the study. It can therefore be 
inferred that exposure to 0.32 and 1 mg/L resulted in changes in the microbial community structure 
that was present in corresponding microcosms.  
This trend continued into day 4 of the exposure period, with the most pronounced separation 
apparent for replicates from microcosms treated with 0.32 mg/L SMX. By day 7 of the study, PCA 
plots were much more mixed. As a result, separate clusters were hard to visualise indicating that 
the microbial communities present in all microcosm were behaving in a similar manner in terms of 
polymer utilisation. It is therefore likely that, by day 7, microbial community structure was similar 
in all microcosms (treated and control).  
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a) 
 
b) 
 
 
Figure 4.16: Kinetic plots of polymer utilisation following SMX exposure on a) day 1, b) day 4 and 
c) day 7. 
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c) 
 
 
Figure 4.16 (cont). 
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Figure 4.17: Scatter plots of PC scores for the first two principle components for individual 
replicates from each SMX treatment groups representing polymer utilisation on a) day 1 and b) day 
7. Day 1 (a) proportion of variation: PC1 = 80.2%, PC2 = 12.3%; Day 7 (b) proportion of variation: 
PC1 = 43.4%, PC2 = 35.6%.  
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a) 
 
b) 
 
 
Figure 4.18: a) Lag phase duration versus exposure period time for polymer utilisation and b) Max 
rate of polymer utilisation versus exposure period time following exposure to SMX. 
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Table 4.13: Summary of one-way ANOVA results for lag phase values before polymer utilization 
from Biolog data for inocula from microcosms following different exposure times to SMX in 
comparison with unexposed inocula. 
         Day of Exposure / Statistical Significance of Lag Phase Duration
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 ns> ns< *> ns> ns> ns> ns> 
 
0.32 *> ns< *> ns> ns> ns> ns> 
 1 *> ns> ns> ns> ns< ns< ns< 
 
       
 Table 4.14: Summary of one-way ANOVA results for maximum rate of polymer utilization values 
from Biolog data for inocula from microcosms following different exposure times to SMX in 
comparison with unexposed inocula. 
 
       
 Day of Exposure / Statistical Significance of Max Rate
1 
  [SMX] / mg/L 1 2 3 4 5 6 7 
 
0.1 = *< *< *< ns> ns< <ns 
 
0.32 *< *< ns< *< ns< *< *< 
 1 *< *< ns< *< ns< ns<  = 
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4.3.6. Effect of SMX on Total CFU Counts 
There were no statistically significant changes in CFU counts compared with control values as a 
result of exposing microbial communities to any SMX dose on day 1 or day 7 (figure 4.19). These 
data would suggest that the total number of cells that were being produced by the microbial 
community was not significantly affected by exposure to any SMX concentration. It can therefore 
be concluded that microbial communities in general exhibited similar growth regardless of which 
SMX treatment (including control microcosms) they were exposed to.  
 
 
Figure 4.19: Bar graph representing total log CFU counts versus [SMX] on days one and seven of 
the exposure period. Any statistically significant changes are indicated by asterisk notation (*, P ≤ 
0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001).  
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4.3.7. Effect of Sulfamethoxazole on the Functional Diversity of 
Multisubstrate Utilisation 
The data shown by figure 4.20 indicates changes in the functional diversity of substrates that were 
being utilised by microbial communities, as shown by changes in the SWDI value. The data show 
the effect that exposure to various concentrations of SMX had on this on each day of the exposure 
period. It can be seen that the functional diversity of substrate utilisation (as shown by SWDI 
values) was significantly reduced at all SMX concentrations (P < 0.001) on day 1 of the exposure. 
This trend continued throughout the exposure period, with a lower SWDI value being observed at 
all SMX concentrations on every day of the study. Significantly lower effects were observed in at 
least one SMX dose group on every exposure day. On day 4, every SMX concentration had again 
caused a statistically significant reduction in the SWDI value (0.1 mg/L, P < 0.001; 0.32 mg/L, P < 
0.001; 1mg/L, P < 0.05). On day 7 of the exposure a recovery (in terms of the functional diversity 
of substrate utilisation) could still not be observed. Indeed a significant reduction could still be 
detected at the two lower SMX concentration (0.1 and 0.32 mg/L; P < 0.01). These lower SWDI 
values at each SMX concentration (compared to control values) on each day of the exposure period 
therefore indicate that the functional diversity of substrate utilisation was severely impacted with 
no sign of recovery.  
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Figure 4.20: Bar graph showing values of the Shannon-Weaver Diversity Index (e
H’
) on each day 
of the exposure period for each SMX treatment group. Statistical significance is indicated by 
asterisk notation (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001).  
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4.4. Discussion 
Sulfonamide antibiotics are widely used chemotherapeutic agents in both human and veterinary 
medicine. The parent compound is excreted (90%) and can enter the aquatic environment via a 
number of exposure routes. When they enter the environment, sulfonamide antibiotics have been 
shown to cause a number of effects on environmental bacteria. There are very few standard tests 
that offer protection to environmental microbes in terms of ecologically relevant end-points 
however. Moreover, there is a gap in knowledge as to what effects sulfonamide antibiotics may 
have on the ecological function of microbial communities in the environment. The data described 
in this chapter therefore aim to use techniques and systems that had been developed earlier in the 
study to answer some of these questions.  
4.4.1. Effects of Sulfamethoxazole on Total Organic Substrate 
Utilisation 
The first part of work in this chapter aimed to evaluate the temporal effects of a candidate 
sulfonamide, sulfamethoxaole (SMX) on the ability of the aquatic microbial community to utilise a 
wide array of distinct metabolically diverse carbon and nitrogen sources. The data shown in kinetic 
plots on day 1 of the exposure (figure 4.1a) show that total substrate utilisation was inhibited at all 
SMX concentrations. Statistical analysis revealed that a significant increase in the lag phase 
duration had occurred as a result of exposing microbial communities to 0.32 and 1 mg/L SMX. 
There was also a significant decrease in the max rate of total substrate utilisation at these SMX 
concentrations on day 1 of the exposure. It is likely that these effects were caused by the specific 
mode of action of SMX. The compound inhibits the biosynthesis of folate by the microbial 
community (Brown, 1962). Folate is an integral part of many biochemical systems in bacteria, 
acting as both a promoter of growth and as a micronutritive compound (Jenkins and Spector, 1976; 
Shane and Stockstad, 1975).  
More specifically, in the form of 5, 6, 7, 8-tetrahydrofolic acid/tetrahydrofolate (THFA or THF), 
folate acts as a co-factor in one carbon transfer reactions related to growth. THFA has been shown 
to play an important role as a co-factor in several metabolic reactions. Many of these concern 
amino acid catabolism and biosynthesis. THF donates carbon atoms during the synthesis of serine 
to glycine. In addition THF is also required for the catabolism of histidine and glycine. 
Importantly, THF plays a crucial role in the formation of the amino acid methionine and 
consequently S-adenosyl methionine (SAM). Methionine is an important molecule in its own right, 
most notably in the formation of N-Formylmethionine (fMet) start codons during protein synthesis. 
SAM is also an important molecule; the synthesis of creatine, polyamines, glutathione, and 
proteoglycans are all SAM-dependent. SAM also provides the methyl group on DNA molecules 
that comprise its methylated cap. This is an important process in gene expression and DNA repair. 
THF also plays an important role in the biosynthesis of deoxyuridine monophosphate, dUMP, into 
TMP (Thymidylate Synthetase). TMP is important in DNA replication, playing a key role in the 
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biosynthesis of the pyrimidine ring that is a vital structural component of purine amino acids; 
carbons 2 and 8 are transferred to the structure via a single carbon transfer reaction (Stockstad and 
Jukes, 1987; o’Brien, 1966). 
Bearing these facts in mind, the mechanisms by which the growth and cellular function of the 
microbial community were likely to have been inhibited become apparent. Firstly, a number of 
factors relating to cell division (mitosis) would likely have been repressed. The main factor in this 
would have been the inability of intoxicated bacteria to produce purine nucleic acids. Purine 
nucleic acids (adenine and guanine) play a key role in the formation of DNA bases. In addition to 
this, the reduced ability of the microbial community to methytlate DNA has several implications. 
Firstly, methylated DNA is a mechanism by which bacteria recognise native DNA. Foreign DNA 
that has not been methylated is degraded so that phage DNA for example is not expressed. 
Inhibition of this process could therefore result in expression of foreign DNA and degradation of 
host bacterial DNA. Secondly, the timing of DNA replication is affected by methylation in relation 
to other cell-cycle events. A lack of methylation therefore results in cell cycling becoming out of 
sync. Thirdly, DNA methylation plays a crucial role in DNA strand repair. Inhibition of this 
process has been shown to result in an increased rate of DNA strand mis-matches. In mutants that 
lack DNA adenine methyl transferases (DAM, the main enzymes that methylated bacterial DNA) 
cell viability has been shown to have been lowered (Reisenauer et al., 1999).  
There are also implications for the microbial community if the ability to synthesise methionine is 
reduced. fMet molecules signal the start of translation during protein synthesis in bacteria. Without 
this “translation initiation codon” the first peptide in a newly forming nascent polypeptide chain 
cannot form (Sherman et al., 1985). In addition to this, methionine is an amino acid constituent in 
polypeptide chains and is therefore required for the production of certain proteins. Recent evidence 
has suggested that methionine-containing proteins play a crucial role in the cellular defense against 
oxidative stress, indicating that that an inhibition of this could also have affected the microbial 
community that were exposed to SMX in the current study (Luo and Levine, 2009). 
The microbial communities that were exposed to 0.32 and 1 mg/L
 
SMX on day 1 could also have 
experienced a reduction in the pool of available polyamines due to the inhibition of SAM. The role 
of polyamines in microbial cells is cell wall incorporation, siderophore biosynthesis and 
functioning relating to microbial growth (Wortham et al., 2007). If the microbial community 
cannot form key components of the cell wall then wall integrity could potentially be reduced. The 
production of siderophores by the microbial community is crucial to cellular biochemistry since 
siderophores are the main mechanism by which Gram negative bacteria scavenge metal ions 
(especially iron) from their environment (Neilands, 1995). Metals often form key prosthetic groups 
within bacteria enzymes that are crucial for cellular function such alcohol dehdrogenases, a group 
of enzymes that are involved in a multitude of catabolic microbial pathways. These metals are 
usually zinc, iron or magnesium (Clark, 1992). The inhibition of polyamine synthesis therefore 
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provides another potential explanation for why the utilisation of total substrates may have been 
affected in terms of growth of and the retardation of key cellular biochemical function.  
The inhibition of SAM production as a result of SMX exposure could also have reduced bacterial 
glutathione production. Glutathione is the main thiol-containing compound present in bacteria 
(Fahey et al., 1978). For years their role in cellular function was a mystery until Chesney et al. 
(1997) implicated their role in the sacrificial defence against intracellular chlorinated compounds 
and hydrogen peroxide. It can be suggested therefore that the reduced ability of the microbial 
community to synthesise glutathiol may potentially result in free radical intoxication. Free radicals 
have been shown to cause DNA damage in microbial cells (Ross, 1988). This may result in the 
death of some members of the microbial community via apoptosis (cell death) which often follows 
DNA damage (Rich et al., 2000). Indeed Chesney et al. (1997) reported that glutathione-deficient 
E. coli were twice as likely to die as a result of chlorine and hydrogen peroxide poisoning. It is 
possible therefore that the growth of the microbial community in microcosms exposed to 0.32 and 
1 mg/L
 
on day 1 of the exposure may have had a reduced growth rate and therefore reduced total 
substrate utilisation as a result of free radical intoxication (due to metabolic free radicals not being 
scavenged efficiently). 
In terms of looking at the growth of the microbial community, CFU counts were performed. These 
did not yield any significant differences in cell density (and therefore microbial growth) by dose 
group. It may be the case that this is because CFU counts are not always the best measure of 
microbial growth or, in the case of the current investigation may not be a reliable measure of what 
was occurring due to the use of different growth media in agar plates and Biolog GN2 plates. These 
have been discussed previously in section 3.4.1.  
A further increase in lag phase duration was observed on day 2 at 1 mg/L
 
SMX and on day 4 at 0.1 
mg/L SMX. In the microcosms that were exposed to the top two SMX concentrations, a recovery 
was suggested by the lack of further inhibition from days 2 and 3 onwards (for 0.32 and 1 mg/L 
SMX respectively). However, a significant effect on the max rate of total substrate utilisation was 
still occurring in microcosms exposed to these SMX concentrations up to day 3 (1 mg/L) and day 7 
(0.32 mg/L). In microcosms exposed to 0.1 mg/L
 
SMX significant effects on the max rate of total 
substrate utilisation were observed on days 2, 3, 4 and 7. These data would suggest three things. 
Firstly, there appears to have been a recovery in total substrate utilisation from day 4 onwards in 
microcosms treated with 1 mg/L SMX. Secondly, there didn’t appear to be any sort of recovery in 
microcosms treated with 0.32 mg/L SMX. Thirdly, there would appear to have been an intermittent 
recovery in microcosms treated with 0.1 mg/L SMX followed by another period of effects.  
Data was also analysed in terms of looking at the SWDI for each dose group over the exposure 
period. SWDI values were lower than control values at all SMX concentrations over all days of the 
exposure. On each day of the exposure, SWDI values were statistically significant in at least one 
dose group, apart from on day 5, when no significant changes could be observed. These data 
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indicate that SMX was having a negative impact on the functional diversity of total substrate 
utilisation over the entire exposure period. As such, SMX was resulting in SMX-exposed microbes 
not being able to utilise the same range of substrates that those present in control (unexposed) 
microcosms were able to. With the possible exception of a temporary recovery on day 5, no real 
recovery in terms of the functional diversity of substrate utilisation could be observed. The main 
reason for this is likely to be due to the reduced ability of the microbial community to synthesise 
folate. As discussed previously in this section, a number of consequences of impaired folate 
biosynthesis (such as reduced levels of SAM and methionine) include reduced growth and the 
inability of microbes to produce catabolic enzymes, such as alcohol dehydrogenases. It is therefore 
likely that certain bacteria which utilise a specific substrate or substrates are unable to grow to a 
sufficient abundance such that their substrate utilisation would be observable. In control 
microcosms, such members of the microbial community would be free to thrive and utilise a wider 
range of substrates. It is likely that a number of bacteria that utilise a wide array of substrates 
would have been inhibited in exposed microcosm. In addition, the reduced ability of the microbial 
community (or at least a portion of the microbial community) to produce essential catabolic 
enzymes (and other proteins vital for cellular function) would likely have resulted in the reduced 
ability of microbes to utilise a range of substrates. Kong et al. (2006) investigated the effect of 
exposing a soil microbial community to an antibiotic (CTC) at similar concentrations to the present 
investigation. They observed a general decrease in the diversity of Biolog substrates that could be 
utilised by the microbial community (or at least a portion of the microbial community). The results 
are however in general agreement with the current study, suggesting that antibiotics from different 
classes can have a negative impact on the range of substrates that both soil and aquatic microbial 
communities are able to utilise.  
PCA data (figure 4.2a) show that on day 1 all SMX-treated replicates showed distinct substrate 
utilisation profiles, suggesting that the way in which substrates were being utilised differ at all 
SMX concentrations. Day 4 PCA plots generally show the same trend. Day 5 PCA plots show that 
0.1 mg/L
 
SMX-treated replicates clustered independently from control replicates. By day 7 (figure 
4.2b), PCA plots show that significant mixing (of replicates on PC score plots) had occurred 
between 0.1 mg/L SMX and control replicates, but 0.32 and 1 mg/L replicates were still clustering 
distinctly from control replicates. These data suggests several things. Firstly, no overall temporal 
recovery occurred in microcosms exposed to 0.32 or 1 mg/L SMX, which is contrary to what was 
detected by kinetic analysis. Secondly, 0.1 mg/L
 
SMX was altering total substrate utilisation, which 
is also contrary to what kinetic data had shown. This could mean several things. Firstly, it could be 
the case that the kinetic and multivariate data show different things and that the kinetic response 
may be different from the actual “metabolic fingerprint.” As such, the actual pattern of substrate 
utilisation (PCA) and kinetic response could be considered as two different end-points. To expand 
on this, PCA data can be considered a measure of how differential metabolism occurs in the 
microbial communities and kinetic data may be an indicator as to the extent that specific substrate 
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utilisation occurred. This means that PCA data is a good indicator of how the microbial community 
structure is changing over time as the result of exposure to SMX. PCA data would therefore 
indicate that the microbial community structure (in terms of total substrate utilisation) was altered 
at all SMX concentrations throughout the vast majority of the exposure, with only a slight recovery 
being observed at the lower SMX dose group towards the end of the experiment.  It would 
therefore be an interesting future study to validate PCA data with molecular community analysis 
such as DGGE or TRFLP analysis to see if results from these analyses matched the finding of the 
present study.  
Assuming that the kinetic analysis did observe a recovery in microcosms exposed to 1 mg/L SMX 
but not 0.32 mg/L SMX (and to a lesser extent 0.1 mg/L SMX), this could potentially be explained 
by the selection of sulfonamide resistance. Sulfonamide resistance occurs via changes in the folate 
biosynthetic pathway (Perreten and Boerlin, 2002; Vedantam et al., 1998; Scholz et al., 1989). 
Moreover, sulfonamide resistance has been extensively detected in the aquatic environment (Zhang 
et al., 2009). The reason that this formed at the highest SMX concentration but not at other SMX 
concentrations could be that 0.32 mg/L
 
SMX
 
did not exert a strong enough selective pressure but 1 
mg/L
 
SMX did. Heuer et al. (2008) found that a sulfadiazine concentration of 0.15 mg/kg selected 
for sulfonamide resistance, although this was investigated in the soil environment and aquatic 
formation of resistance could well be selected by different sulfonamide concentrations. In addition, 
selection of sulfonamide resistance may be different with each sulfonamide type. It is not clear 
therefore if resistance formation is the key to explaining these particular results. Chapter 5 shall 
investigate the temporal formation of antibiotic resistance however, which may clarify what is 
occurring within the test systems.  
The tendency for intermittent effect and recovery in microcosms exposed to 0.1 mg/L
 
may have 
been due to the kinetic model not being sensitive enough to detect smaller changes in the max rate 
of substrate utilisation. Alternatively, it may be the case that transient communities with varying 
degrees of sulfonamide susceptibility were present. For example, on day 1 of the exposure period 
there could have been a large portion of the microbial community that exhibited resistance to 
sulfonamides. The presence of resistant bacteria in both natural rivers has been detected (Zhang et 
al., 2009), so it is entirely possible that resistant members of the microbial community were present 
at the start of the exposure. In addition, there may have been sulfonamide-resistant bacteria in the 
system that came from the treated sewage that was added to the microcosms (Zhang et al., 2009; 
Silva et al., 2006; Szczepanowski et al., 2004; Selvaratnam and Kunberger, 2004).  
It is also possible that there were transient portions of the microbial community that exhibited 
differential control of their internal pH. Tappe et al. (2008) demonstrated that bacteria that are poor 
regulators of pH will be less affected by sulfonamides at a pH of 7 or 8. The microcosm system 
used in the present study had an initial pH of 7.2. It is likely that the system was kept at this pH 
throughout the study by the presence of phosphate buffer (pH 7.2) in OECD synthetic sewage. 
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Therefore if transient communities of poor pH-regulating bacteria were present during the exposure 
period then the antimicrobial effects of SMX would have been reduced on days when such 
members of the microbial community were present at relatively higher densities.  
Other studies have also shown effects of sulfonamides on the growth of environmental bacteria. 
Isidori et al. (2005) and Kim et al. (2007) observed that various sulfonamide antibiotics inhibited 
the growth of the marine bacterium Vibrio fischeri. They observed EC50 values ranging from 23.3-
78.1 mg/L. Ando et al. (2007) investigated the effect of sulfonamides on cyanobacterial growth. 
EC50 values of between 2.3 and > 2000 mg/L
 
were recorded. Halling-Sorenson et al. (2002) found 
that sulfonamide antibiotics reduced CFU counts in sludge and soil studies. These results 
corroborate the findings of the current study which also observed effects of sulfonamides that may 
be linked (or partially linked) to the reduced growth of the microbial community as a result of 
exposing environmental bacteria to sulfonamides. In general however, the current study has 
observed that significant effects have occurred at lower concentrations compared with previous 
studies. 
Studies that have observed changes in total substrate utilisation as result of exposure to other 
antibiotics have also been reported. Maul et al. (2006) exposed leaf-bound microbial communities 
to the antibiotic ciprofloxacin. A significant variation in PC1 (principal component 1) and PC2 
(principal component 2) scores were observed at an exposure concentration of 0.1 mg/L, 
suggesting a change in total carbon utilisation profiles compared with controls. Schmitt et al. 
(2005) reported a shift in PCA scores on the second axis, suggesting a change in the total substrate 
utilisation profile had occured as a result of exposing soil microbial extracts to the antibiotic 
sulfachloropyridazine. The results of these and the present study suggest that a range of antibiotics 
can affect the metabolic physiology of microbial communities in a range of environments. As such, 
both the current and previous investigations have shown that sulfonamides can cause changes in 
microbial community structure in both soil and aquatic microbial communities and at similar 
concentrations. Landi et al. (1993) had already reported a significant decrease in soil respiration 
rates as a result of exposure to streptomycin. As the substrate being respired was SOM (soil organic 
matter), this pointed to the inhibition of multi substrate utilisation in soil microbial communities.  
The results of the present study therefore suggest that the presence of SMX may inhibit the ability 
of aquatic microbes to utilise and degrade this broad range of molecules contained within DOC. 
Tranvik and Hofle (1987) commented on the high efficiency with which microbes normally 
achieve this. If SMX inhibits the ability of aquatic microbes to utilise DOC then this could result in 
a reduced microbial biomass in aquatic environments. Although this may potentially increase 
oxygen levels in the aquatic environment (potentially making more oxygen available to aerobic 
organisms), the absence of certain bacteria may also result in key processes within nutrient cycles 
not being performed as efficiently. For example, a reduction in key nitrifying, denitrifying and 
xenobiotic-degrading bacteria may have adverse effects on nitrogen cycling and on the removal of 
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pollutants from the aquatic environment. In addition to this, bacteria provide a key food source for 
aquatic organisms such as heterotrophic flagellates and protozoa. In turn, these organisms are 
preyed upon and so on until energy is ultimately transferred to an apex predator (an organism that 
has no predator of its own). A reduction in bacterial numbers may therefore affect the normal 
transfer of energy through aquatic food chains. Blomqvist et al. (2001) demonstrated the 
importance of DOC in terms of its conversion into microbial biomass. This also means that, via the 
incorporation of DOC into bacterial biomass, aquatic bacteria act as important carbon sink. Carbon 
sinks play an important role in carbon sequestration from the atmosphere (removal or reduction in 
carbon dioxide levels). As such, bacterial biomass plays an important biogeochemical role in 
regulating the earth’s climate.    
The degradation of a wide array of autochthonous and allochtonous organic matter (such as humus, 
undigested food and dead animal material) in the aquatic environment requires microbial 
communities to be efficient organic multi substrate utilisers. Within the carbon cycle, bacterial 
breakdown of DOC can be liberated back into the environment via the release of carbon dioxide, 
which is commonly regarded as being the most critical greenhouse gas on the planet (Siegenthaler 
and Sarmiento, 1993). DOC degradation therefore plays an important role in releasing gasses 
which regulate the planet’s temperature over time (Berner, 1990). Other inorganic nutrients (such 
as nitrates and phosphates) are also liberated during microbial degradation of DOC. These may be 
taken up as nutrients by, for example, aquatic plants, or they may enter another nutrient cycle (such 
as the nitrogen cycle) for further processing. Any effect on DOC degradation in the aquatic 
environment therefore has the potential to interfere with climate and nutrient cycling.  
Previous studies have shown that antibiotics may inhibit the ability of bacteria to break down the 
broad range of volatile organic substances in manure.  Biogass production was therefore reduced. 
Inhibition of biogass production (both aerobic and anaerobic) as a result of exposing microbial 
communities to oxytetracycline ranged from 27-50% across three studies (Sankvist, 1984; Gamal-
El-Din, 1986; Arikan Rital et al., 2006).  Landi et al. (1993) also reported a significant decrease in 
soil respiration rates as a result of exposure to streptomycin. As the substrate being respired was 
SOM (soil organic matter), this pointed to the inhibition of multisubstrate utilisation by soil 
microbial communities. The inhibition of organic substrate utilisation by different antibiotics has 
therefore been reported in both the aquatic and terrestrial environment.  
4.4.2. Effect of Sulfamethoxazole on Substrate Guild Utilisation 
The present study also investigated the effect of three concentrations of sulfamethoxazole (0.1, 
0.32 and 1 mg/L) on
 
the utilisation of 5 distinct substrate “guilds”; amines and amides, amino 
acids, carbohydrates, carboxylic acids and polymers (Preston-Mafham et al., 2002). The following 
sections shall discuss these effects and the implications of these effects with regards to the 
available literature.  
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4.4.2.1. Amines and Amides Utilisation 
Kinetic model plots show that amine and amide utilisation was significantly inhibited on days 1 
and 2 in terms of lag phase duration before utilization at the highest SMX concentration (1 mg/L). 
There were no effects on amine and amide utilisation in terms of lag phase duration at any other 
SMX treatments on any other day of the exposure. Although there was no significant effects of 
SMX on the max rate of amine and amide utilisation on any day of the study at the higher SMX 
concentration a significant reduction in the max rate of amine and amide utilisation was observed 
on day 4 as a result of exposing microbial communities to 0.1 and 0.32 mg/L.   
In terms of PCA analysis, there was considerable mixing of replicates (on PC score plots) from all 
SMX treatments on day 1. There was also significant mixing of replicates from microcosms 
exposed to all SMX concentrations. There was also significant separation of replicates from all 
SMX treatments from control replicates. This trend continued up until the end of the exposure 
period, suggesting that all concentrations of SMX caused differential amine and amide utilisation 
across the exposure period. Once again the results obtained using multivariate analysis show 
different effects data from kinetic analysis. These data show that the community structure of amine 
and amide utilizing bacteria was different from control communities in microcosms exposed to all 
SMX concentrations. As discussed in section 3.4.2, these results suggest that the compositions of 
certain aquatic nitrogen cycling communities are altered as a result of SMX exposure. Specifically, 
it is highly likely that communities involved in ammonification will be different (see also section 
3.4.2).  
Although there are no studies from the literature that have investigated amine and amine utilization 
by microbial communities that been exposed to SMX, Kong et al. (2006) observed a decrease in 
amine and amide utilisation (quantified by maximum colour development) as a result of exposing 
Biolog GN2 plates (inoculated with soil extract) to different oxytetracycline concentrations. 
Although the study exposed microbial communities to a tetracycline, the present study and this 
study both show effects of bacteriostatic antibiotics on amine and amide utilisation.  
Amines and amides can be utilised in a number of ways by environmental bacteria. They may enter 
the nitrogen cycle where they are first subject to the process of ammonification. When ammonia 
has been produced via this reaction it is then subject to further biogeochemical processing in the 
process of nitrification, whereby nitrite and nitrate are formed. Nitrogen in these forms can be 
utilised by bacteria (Paul and Clark, 1996). Amines and amides can therefore act as an important 
nitrogen source for environmental microbes.  
 
Inhibition of amine and amide utilisation as a result of SMX exposure could indicate a potential 
inhibitory effect on the processes of ammonification and nitrification in the aquatic environment. 
Although no other previous work has detected inhibitory effects of specific aspects of the nitrogen 
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cycle as a result of exposure to sulfonamides, work has been conducted on other antibiotics. 
Halling-Sorensen et al. (2000) detected an inhibition of the growth of the aquatic nitrifying 
cyanobacterial species Microcystis aerugenosa as a result of exposure to CTC and tetracycline. In 
the case of both compounds an EC50 value of < 0.1 mg/L
 
was observed. Halling-Sorensen (2000) 
also detected a significant inhibition of nitrification as a result of exposing activated sludge 
communities to CTC, oxytetracycline and tetracycline. The data in these studies are a link between 
inhibition of nitrogen utilisation and exposure to antibiotics, providing a degree of corroboration 
with the present study. 
4.4.2.2. Amino Acid Utilisation 
Kinetic analysis showed that on day 1 of the exposure period amino acid utilisation was 
significantly inhibited by 0.32 and 1 mg/L SMX in terms of an increased lag phase duration. This 
trend continued into day 4 in microcosms treated with 1 mg/L. A significant inhibition of the max 
rate of amino acid utilisation was only observed on day 1 of study at an SMX concentration of 1 
mg/L
 
and on day 4 at a lower SMX concentration of 0.1 mg/L.  
Day 1 PCA analysis revealed much mixing of replicates from different microcosms, although 
replicates from microcosm spiked with 1 mg/L
 
SMX tended to separate from control replicates, 
suggesting that these replicates were utilising amino acids in a distinct manner than compared with 
control replicates. On day 4 all replicates could be separated almost by dose, while on day 7 only 
replicates from microcosms exposed to 0.32 and 1 mg/L
 
could be separated from controls. This 
would again suggest that effects in amino acid utilisation showed different results from what the 
kinetic response displayed. The data also suggest that the structure of the microbial community that 
is composed of bacteria which utilise amino acids was different in control communities than 
compared with exposed microcosms throughout the exposure. The lowest SMX concentration to 
have caused this change was 0.1 mg/L. Specifically, these data indicate that exposure to SMX can 
cause changes in the community structure of bacteria which are involved in deamination, a key step 
in the nitrogen cycle (see also section 3.4.3).   
Other studies have also observed the inhibition of amino acid uptake by sulfonamides. Some of 
these studies were conducted on pure cultures in the mid-20
th
 century when a number of research 
teams were investigating the sulfonamide mechanism of resistance and mode of action. Sevag and 
Green (1944) for example demonstrated that tryptophan utilisation by sulfonamide susceptible 
Staphylococcus aureus was inhibited by 6888 mg/L sulfanilamide and 1699 mg/L sulfathiazole. 
Although the doses used in these studies were much higher than those used in the current 
investigation, the results still infer that these mechanisms may occur, possibly at lower doses. This 
would require further experimentation however. These studies could investigate relevant 
biochemical pathways by techniques such HPLC or GC analysis of biochemical.   
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Other studies have looked at the inhibition of amino acid uptake in the environment. Brandt et al. 
(2009) also showed a reduction in bacterial growth using 
3
H leucine incorporation. This was 
significantly reduced by exposing a soil microbial community to 0.1 µg sulfadiazine/g. The order 
of magnitude of this environmental study is therefore within the order of magnitude of the LOEC 
(lowest observable effects concentration) that was observed during the present study. Effects on 
amino acid uptake have also been seen as a result of exposing environmental bacteria to other 
antibiotics. Wheeler and Kirchman (1986) had previously reported a > 58% decrease in amino acid 
uptake as a result of exposing marine bacteria to the protein synthesis inhibitor chloramphenicol. 
Verma et al. (2007) observed a significant reduction in leucine incorporation rates by river water 
microbial communities as result of exposure to 5 μg/L tetracycline. In another study, Kong et al. 
(2006) observed a significant reduction in amino acid utilisation as a result of exposing soil 
microbial communities to oxytetracycline. Exposure concentrations were similar to those that were 
employed during the present study. These results are in agreement with the current study.  
In the case of amino acid utilisation it is possible to make some tentative judgments that link the 
sulfonamide mode of action with inhibition of amino acids. Amino acids are metabolised by a 
range of dehydrogenase enzymes. The most documented of these is glutamate dehydrogenase, 
which catalyses the reaction that converts glutamate into α-ketoglturate and ammonia.  Ammonia 
can be then be easily utilized as a nitrogen source by environmental bacteria. These reactions rely 
heavily upon using NADP (nicotineamide adenine phosphate dinucleotide) as a cofactor. However 
since NADP is composed of the purine base adenine, it is likely that there were reduced levels 
present in intoxicated microbial communities. This is because the synthesis of adenine is dependent 
on the one carbon transfer capabilities of THF, as discussed earlier. The inhibition of NADP by 
sulfonamides (sulfanilamide) has been observed previously  in cell free microbial enzyme systems 
as far back as 1946, providing evidence that reactions involving NADP can be significantly 
inhibited by sulfonamides (Altman, 1946).  
4.4.2.3. Carbohydrate Utilisation 
Kinetic analysis showed that carbohydrate utilisation was significantly inhibited in terms of an 
increased lag phase duration on day 1 of the study at all SMX doses. Lag phase was also 
significantly increased on day 3 in microcosms exposed to 0.32 mg/L. On day 4, significant lag 
phase increases were observed as a result of exposing the microbial community to 0.1 and 0.32 
mg/L SMX. An increase in the max rate of carbohydrate utilisation was observed in microcosms 
exposed to 0.32 and 1 mg/L
 
on day 1 and at all SMX concentrations on day 2. Indeed, the max rate 
of carbohydrate utilisation was significantly inhibited for the duration of the study in microcosms 
exposed to 0.32 mg/L SMX. Further significant reductions in the max rate of carbohydrate duration 
were observed on days 4 and 5 (1 mg/L) and on days 3, 4 and 7 (0.1 mg/L).  
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Multivariate analysis also showed that replicates exposed to 0.1 mg/L
 
SMX were similar to control 
replicates on day 1 of the exposure period. However by days 3 and 4 replicates were clustering 
almost by dose; this continued until day 7. It can therefore be suggested that the microbial 
community were utilizing carbohydrates in a different manner in treated replicates compared with 
control replicates. In the case of carbohydrate utilisation therefore kinetic and multivariate analysis 
was more similar than had been seen with other utilisation scenarios. From these data, it can be 
suggested that exposure of aquatic microbial communities to SMX results in changes to certain 
portions of the microbial community that are able to utilise/metabolise carbohydrates. These data 
suggest that all doses of SMX were causing a change in the structure of the portion of the microbial 
community that was utilizing carbohydrates. The influence of SMX on the community structure of 
carbohydrate utilisers lasted throughout the exposure period. It is likely therefore that microbes 
involved in the cycling of carbon are affected in terms of having an altered community structure 
compared with unaffected (control) communities. As mentioned previously, these community 
shifts could be confirmed by molecular techniques such as PCR-DGGE.  
Several laboratory experiments have also found that sulfonamides inhibit carbohydrate utilisation. 
These have mainly found that sulfonamide compounds inhibited the utilisation of glucose (Clinton 
and Loeuringer, 1942; Dorfman and Koser, 1942; Sevag and Shelburne, 1942). 
Other studies have also looked at the effect of sulfonamides on microbial respiration in the 
environment. Thiele-Bruhn and Beck (2005) for example tracked the effect of sulfapyridine on 
substrate induced respiration (SIR). They observed EC50 values of 6.2 and 11.5 μg/L for two soils. 
In another experiment, Zielezny et al. (2006) tracked SIR rates in soils spiked with sulfadiazine. 
They also observed an inhibition in respiration rates. Vaclavik et al. (2004) recorded a 0.8 fold 
decrease in respiration rate as a result of exposing soil mesocosms to sulfachloropyridazine. The 
results of these studies are therefore in agreement with the present study.  
Work has also been completed that shows the effects of other antibiotics on carbohydrate 
utilisation. Kong et al. (2006) tracked carbohydrate utilisation in Biolog plates and observed an 
inhibition in the maximum level of carbohydrates utilised as a result of increasing CTC 
concentration. Maul et al. (2006) observed a 2.7-3.5-fold reduction in carbohydrate utilisation as a 
result of exposing leaf-bound microbial communities to the antibiotic ciprofloxacin (at 0.1 mg/L). 
The main consequence of a reduction in carbohydrate utilisation is the reduced ability of the 
microbial community to gain energy from a range of preferential sources. In the absence of a 
suitable energy source, the growth of certain portions of the microbial community will be inhibited. 
This has been demonstrated by whole-lake DOC addition experiments, in which a significant 
increase in aquatic microbial biomass was observed as a result of adding increased DOC 
(Blomqvist et al., 2001). The high degree with which aquatic microbes are able to convert glucose 
into biomass (20% of total DOC) highlights the importance of carbohydrate utilisation to aquatic 
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microbial communities (Tranvik and Hofle, 1987).  In addition, a wide range of biochemical 
processes are reliant upon the energy that microbial communities gain from carbohydrates, such as 
active transport of molecules in and out of cells and maintenance of buoyancy systems in 
cyanobacterial cells (Chu et al., 2007).  
The effect that SMX exerted on bacterial utilisation of carbohydrates can potentially be explained 
by the reduced ability of aquatic microbial cells to produce the metabolic cofactor NAPD as a 
direct result of the cells not being able to produce the purine base adenine. NADP is an essential 
cofactor in carbohydrate metabolism, ultimately acting as an electron acceptor during their 
oxidative metabolism. At the end of this process electrons are passed onto cytochrome c where 
energy from carbohydrates is ultimately liberated in mitochondria (Krebs, 1953).  
4.4.2.4. Carboxylic Acid Utilisation 
Kinetic results showed a significant increase in lag phase duration on day 1 (at 0.32 and 1 mg/L
 
SMX) and on day 4 (0.1 mg/L SMX). A significant decrease in the max rate of carboxylic acid 
utilisation was observed on days 1 and 2 in microcosm exposed to 1 mg/L SMX. From day 2 
onwards there were no further effects. In microcosms exposed to 0.32 mg/L
 
there was a significant 
reduction in the max rate of carbohydrate utilisation from day 2 until the end of the exposure. 
Significant reductions in the max rate of carboxylic acid utilisation in microcosms spiked with 0.1 
mg/L
 
SMX were observed on days 3, 4 and 7.  
PCA analysis of carboxylic acid utilisation shows that there was significant mixing of replicates on 
day 1 of the study, although replicates from microcosms spiked with the two highest concentrations 
of SMX (0.32 and 1 mg/L) clustered more distinctly. This would suggest that the microbial 
community was utilizing carboxylic acids differently from the control at these SMX doses on day 
1. By day 7 replicates from 0.1 and 1 mg/L
 
displayed distinct clustering from control replicates 
suggesting that the microbial communities were utilizing carboxylic in a different manner from 
control communities. These data suggest that SMX concentrations as low as 0.1 mg/L were causing 
changes in the microbial community structure of microbes that were utilizing carboxylic acids. 
These effects were apparent throughout the duration of the exposure. It is likely therefore that a 
portion of the microbial community that utilise carboxylic acids had a different community 
structure due to exposure to all SMX doses throughout the exposure period. Such communities are 
likely to preform biogechemical processes within the carbon cycle.  
Previous studies have demonstrated the inhibition of carboxylic utilisation by sulfonamide 
antibiotics in laboratory studies. Specifically, sulfonamides have been shown to inhibit the 
microbial utilisation of pyruvate (Sevag et al., 1942), lactate, (Macleod, 1939) and succinate 
(Gerundo, 1950) in pure culture studies involving various susceptible bacterial species. There have 
not been any studies exploring the effects of sulfonamides on carboxylic utilisation in the 
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environment though. Kong et al. (2006) did however detect the inhibitory effect of oxytetracycline 
on soil carboxylic acid utilising microbial communities, indicating the potential for a number of 
antibiotics to affect carboxylic acid utilisation, as well as sulfonamides.  
Carboxylic acids represent an important energy source for environmental microbes. Molecules 
such as citric acid, pyruvic acid, succinic acid and lactic acid can enter energy liberating 
biochemical pathways such as the tricarboxylic acid cycle directly (Reactome, 2010). Carboxylic 
acids are also formed from the cleavage of fatty materials in the environment in the form of fatty 
acids. These reactions are dependent on adenine based electron transfer systems (NADP).  
In addition, sulfonamides have been shown to reduce microbial carboxylase activity in pure 
cultures of Staphylococcus aureus and E.coli (Sevag et al., 1942). Carboxylase enzymes (such as 
carboxyl transferase) play a key role in metabolising carboxylic acids so that they can enter the 
energy-liberating citric acid cycle. For example, pyruvate decarboxylase catalises the reaction that 
transforms pyruvate into oxaloacetate. Oxaloacetate can then enter the citric acid cycle where 
energy is ultimately liberated via electron transfer systems. 
Naumann (1918) first showed the utilisation of humic materials by aquatic microorganisms. Humic 
acids contain high carboxylic acid content (Kawahigashi and Sumida, 2006). These form an 
important part of the carbon cycle in terms of the recycling of dead animal and plant material. 
Inhibition of carboxylic acid utilisation as result of SMX exposure in the environment could 
therefore inhibit the ability of environmental microbes to produce energy and degrade certain 
molecules within the carbon cycle.  
Guven et al. (2005) demonstrated the ability of certain Archaea (such as Candidatus Brocadia and 
Canditus Kuenemia) to utilise organic acids (such as propionate) using nitrite/nitrate instead of 
oxygen as a terminal electron acceptor. The important role of these organisms in the nitrogen cycle 
was therefore shown. Inhibition of carboxylic acid utilisation could possibly affect this part of the 
nitrogen cycle, although it is unclear if these types of reactions are taking place on Biolog GN2 
plates.  
4.4.2.5. Polymer Utilisation 
Kinetic analysis revealed that the lag phase prior to polymer utilisation was significantly increased 
on day 1 in microcosms exposed to 0.32 and 1 mg/L. On day 3 of the exposure, lag phase duration 
was also significantly at these SMX concentrations. Max rate values were significantly decreased 
on days 1, 2 and 4 at an SMX concentration of 1 mg/L. Significant reductions in the max rate of 
polymer utilisation were also observed on days 2, 3, 4, 6 and 7 in microcosm that were exposed to 
0.32 mg/L SMX. In microcosms exposed to 0.1 mg/L SMX,
 
a significant reduction in the max rate 
of polymer utilisation was shown to have occurred on days 2 and 4 of the exposure.  
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PCA analysis of polymer utilisation data on day 1 showed that the microbial community present in 
microcosms spiked with 0.32 and 1 mg/L SMX generally clustered separately from control 
replicates whereas replicates from microcosms spiked with 0.1 mg/L
 
SXM clustered more similarly 
to control replicates. This would suggest differential polymer utilisation was occurring as a result 
of exposure to 0.32 and 1 mg/L SMX. By day 7 replicate clustering was more mixed, suggesting 
replicates from all treatments were utilising polymers more similarly. These data would suggest 
that exposure of microcosms to 0.32 and 1 mg/L SMX were causing changes in the microbial 
community structure that was utilising polymeric compounds. These effects were seen until day 6 
at an SMX concentration of 0.32 mg/L. These results suggest that the portion of the microbial 
community that is able to utilise/biodegrade polymeric compounds has a different microbial 
community structure at SMX concentrations as low as 0.1 mg/L SMX. The structure of these 
communities is also different as the result of exposure to 0.32 mg/L SMX when the community is 
exposed for a slightly longer time period (6 days).  
Although no environmental studies have investigated the effect of sulfonamides on polymer 
utilisation, Kong et al. (2006) used Biolog plates to show an inhibitory effect of oxytetracycline on 
polymer utilisation by soil microbial communities at concentrations similar to those that were used 
in the current investigation.  
The main source of the inhibitory effect of sulfonamides on polymer utilisation may be an artefact 
of the inhibition of glutathione production by the microbial community. Although no literature is 
available on the effect of glutathione, it is clear that the enzyme glutathione-s-transferase plays a 
key role in the degradation of many polymeric compounds. Perhaps the best example of this is the 
role glutathione-s-transferases in the biodegradation of lignin and atrazine. In fact, glutathione-s-
tranferases are important in the microbial degradation of a huge array of unrelated polymeric and 
often xenobiotic compounds (Allocati et al., 2009). In addition to this, the degradation of 
polymeric compounds is heavily reliant on electron transfer mechanisms such as NADP which, as 
discussed earlier in this chapter, is likely to be present at much reduced concentrations in 
sulfonamide-inhibited microbial communities. An example of the role NADP in polymer utilisation 
is biodegradation of lignin (Kirk and Farrell, 1987).  
Environmental microorganisms are responsible for the degradation of polymers within ecosystems 
as result of biosynthesis of lipases, ureases, esterases and proteases (Fleming, 1998; Lugauskas, 
2003). Microorganisms also secrete enzymes into their environment to progressively reduce their 
molecular weight, producing oligomers, dimmers and monomers (Lucas et al., 2008). They have 
also been shown to be capable of degrading polymers that are widely regarded as being recalcitrant 
(Shimano, 2001; Howard, 2002; Szostac-Kotowa, 2004; Shah et al., 2008). Microrganisms 
ultimately assimilate polymers as cellular biomass and energy (Lucas et al., 2008). Any inhibition 
of the microbial community in terms of polymer utilisation could therefore result in the reduced 
functioning of such processes within the aquatic environment.  
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4.4.3. CFU Counts 
In the present study no significant effects were seen on CFU counts as a result of exposing aquatic 
microbial communities to three concentrations of SMX. In other studies, Halling-Sorensen et al. 
(2002) observed an EC50 value of 0.03 mg/L for CTC and 5a, 6-CTC when studying the effect of 
these compounds on CFU counts. In this study activated sludge microbial communities were 
exposed to antibiotics, indicating that the growth of activated sludge communities may be more 
sensitive to antibiotics than river water communities. Colinas et al. (1993) also showed a 
significant decrease in CFU counts in soils exposed to oxytetracycline, with a 20% reduction in 
CFU count being observed. It is possible that the growth of soil microbial communities is more 
sensitive to tetracyclines than aquatic communities are to sulfonamides. 
 
Alternatively, it may be the case that the portion of the aquatic microbial community that is 
affected by SMX is not culturable using traditional culturing techniques. A final possibility for not 
seeing any inhibition of microbial growth in the present study could be the presence of more 
resistant members of the aquatic microbial community than in other studies. One piece of evidence 
that supports this view is the high increase in CFU between days 1 and 7 as a result of exposure to 
1 mg/L SMX. Although this change was not statistically significantly different compared with CFU 
changes in the control, the variation between agar plates was extremely high. This reduces the 
chances of gaining a significantly different value. Other possibilities to explain why CFU counts 
did not detect any potential effects of SMX are discussed in section 3.4.1.  
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5. Presence and Development of Antimicrobial Resistance in Aquatic 
Microcosms 
Experiments that were conducted in previous chapters had suggested that varying degrees of 
recovery had taken place within microcosms that had been spiked with CTC and, to a lesser extent, 
SMX. Several publications point to the fact that this may have been a result of antibiotic resistance 
forming as a result of selective pressure being exerted by CTC and SMX. There have also been 
reports of the presence of antibiotic resistance in treated sewage and natural river waters. As such, 
a degree of antibiotic resistance may hve already been present within microcosm systems at the 
start of the exposure. A review of antibiotic resistance and antibiotic resistence in the environment 
shall be presented before the presence and development of antibiotic resistance in laboratory 
microcosms is evaluated experimentally.  
5.1. Specific Antibiotic Resistance 
5.1.1. Tetracycline Resistance  
Tetracycline resistance mechanisms are phenotypic traits whereby bacteria are able grow in 
otherwise inhibitory tetracycline concentrations. Tetracycline resistance is the result of bacteria 
possessing one or more copies of a range of genetic determinants, of which there are at least 38 tet 
genes and three otr genes (Roberts, 2005; Thompson et al., 2007). Each gene codes for a specific 
mechanism of resistance which can be categorised into distinct groups. The most abundant of these 
groups are the efflux proteins. Tetracycline efflux proteins actively transport tetracycline-divalent 
metal complexes across modified regions of the microbial cell membrane in exchange for protons 
or potassium ions (Krulwich et al., 2001).  
Tetracycline efflux pumps belong to the Major Facilitator Superfamily (MFS) of efflux pump 
classes (Marger and Siaer, 1993). Interestingly, tetracycline efflux pumps also play a key role in 
non-antibiotic efflux such as alkali efflux (Padan and Krulwich, 2000; Alekshun and Levy, 2000). 
The genes tet A, A (41), B, C, D, E, G, H, J, Y, Z, 33, 35, 38, 39 and otr C are all genetic 
determinants for tetracycline efflux pumps.  
Another major group of tetracycline resistance mechanisms are those that act as ribosomal 
protection proteins. These are coded by the tetracycline resistance genes tet M, O, S, W, Q, T, 32, 
36, B (P) and otr (A). With the exception of tet (M) and tet (O) ribosomal protection proteins 
display a high degree of homology with elongation factors EF-Tu and EF-G. As such they are able 
to bind to bacterial ribosomes and cause a conformational change that prevents tetracycline binding 
(and therefore reduces its inhibitory effects). Tet (M) and tet (O) display ribosome-dependent GTP-
ase (guanosine triphosphate-ase) activity. The energy liberated by the hydrolysis of GTP provides 
the energy required for conformational changes within the structure of the ribosome (Speer et al., 
1992; Roberts, 2005).  
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Two more tet genes, tet (X) and tet (37) code for mechanisms that enzymatically inactivate 
tetracycline molecules (Lambert, 2005). Tet X for example codes for a flavoprotein that catalyses 
the monohydroxylation of the Tetracycline-Mg
2+
 binding domain. After several hours the 
tetracycline molecule degrades into several degradation products (Wright, 2005). The enzymatic 
activity of tet (37) is very similar to tet (X) in that a monohydroxylation reaction is catalysed which 
is NADPH-dependent (Diaz-Torres et al., 2003). Another tet gene, tet (U) has also been discovered, 
although the function of its product has yet to be deciphered (Ridenhour et al., 1996).  
5.1.2. Sulfonamide Resistance 
Sulfonamide resistance is genetically encoded by just three acquired sul genes, sul I, sul II and sul 
III. Each genetic determinant codes for a modified DHPS enzyme that has a higher affinity for 
PABA than the sulfonamide analogue. Each protein is similar to the original 263 amino acid form 
with only slight substitutions (Perreten and Boerlin, 2002). The phylogenetic origins of sul genes 
are unknown due to their clear distinction from all known chromosomal DHPS genes (Radstrom 
and Swedberg, 1988). The most recent sulfonamide resistance gene (sul III) was described in 2002 
in Swiss pig farms. This gene accounts for 30% of environmental sulfonamide resistance alongside 
an unrelated mutation to the folA gene. Again, a single amino acid substitution is responsible 
(proline to serine at position 68). This mechanism is restricted to mutations in chromosomal DNA. 
Sul genes however have been detected on chromosomes and highly mobile elements called 
transposons (Huovinen et al., 1995).  
5.1.3. Environmental Monitoring of Tetracycline and Sulfonamide 
Resistance Genes 
Tet and sul genes have been discovered in all environmental matrices. The aquatic environment 
represents an important environmental gene-pool for tet and sul genes with several studies having 
detected specific tetracycline and sulfonamide resistance determinants. The results of these studies 
are summarised in table 5.1. This table highlights the variety of aquatic sources that sul and tet 
genes have been discovered in. These include a diverse array of natural matrices, such as natural 
waters and sediment and also a range of anthropogenic sources such as hospitals and STPs. Table 
5.1 also shows that sul and tet genes have been detected in drinking water. Also included is 
information on whether specific genes are located on a plasmid or chromosome. Genes found on 
plasmids are generally very mobile and transferable. Chromosomal resistance genes are much less 
likely to be transferred, although it has been speculated that some genes may have been transferred 
via gene transduction, the process whereby genes are transferred between cells virally (Thompson 
et al., 2007). The transfer of genetic elements shall be discussed later in this chapter.  
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Table 5.1: Reported occurrence of tet and sul resistance genes in the aquatic environment. 
     
Gene Biological Source 
Environmental 
Source 
Plasmid or 
Chromosomal? 
Reference(s) 
tetA  
Aeromonas, Alcaligenes, 
Arthrobacter, 
Comamonas, Escherichia, Listeria, 
Pseudomonas, Salmonella and 
Vibrio; 
Plasmids pB10, pTB11 and 
pRSB101 
AS, DW, EW, 
NW, SD, SW, US 
Plasmid 
Szczepanowski et al., 2004; Agersø and Sandvang 
2005; Srinivasan et al., 2005; Tennstedt et al., 2005; 
Poppe et al., 2006; Rodríguez et al., 2006; Cernat 
et al. 2007; Dang et al., 2007; Macauley et al., 2007; Hu et al., 2008 
tetA(41) Serratia NW Chromosomal Thompson et al., 2007 
tetB 
Afipia, Alcaligenes, Arthrobacter, 
Burkholderia, Escherichia, 
Pseudomonas, Serratia, 
Staphylococcus and Vibrio 
AS, DW, EW, 
NW, SW, US 
Chromosomal or 
plasmid 
Agersø and Sandvang 2005; Cernat et al., 2007; 
Dang et al., 2007; Jacobs and Chenia 2007; 
Kim et al., 2007; Kobashi et al., 2007, Macauley et al., 2007 
tetC 
Aeromonas, Alcaligenes, 
Arthrobacter, 
Brevibacterium and Pseudomonas 
AS, EW, SW, US Plasmid Agersø and Sandvang, 2005; Akinbowale et al., 
2007a; Macauley et al., 2007 
tetD 
Aeromonas, Escherichia; 
microbial community 
AS, DW, EW, 
SW, US 
Plasmid 
Schmidt et al., 2001; Auerbach et al., 2007a; 
Cernat et al., 2007 
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Table 5.1 (cont). 
Gene Biological Source 
Environmental 
Source 
Plasmid or 
Chromosomal? 
Reference(s) 
tetE 
Aeromonas, Pseudoalteromonas 
and Vibrio 
AS, EW, SD, 
SW, US 
Chromosomal and 
plasmid 
Schmidt et al., 2001; Dang et al., 2006; 
Agersø and Petersen 2007 
tetG 
Pseudomonas;  microbial 
community 
AS, EW, SW, US Plasmid Auerbach et al., 2007; Macauley et al., 2007; 
Jacobs and Chenia 2007; Macauley et al., 2007 
tetJ Pseudomonas SW Plasmid Macauley et al., 2007 
tetY 
Acidiovorax, Acinetobacter, 
Comamonas, 
and Proteus 
SW Plasmid Macauley et al., 2007 
tetZ 
Actinomycetales, Afipia, 
Brevibacterium, 
Burkholderia, Dietzia, Leucobacter 
and 
Microbacterium 
SW Plasmid Tauch, 2000; Kobashi et al., 2007; Macauley et al., 2007 
tet33 
Alcaligenes, Arthrobacter and 
Pseudomonas 
SW Plasmid Agersø and Sandvang, 2005 
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Table 5.1 (cont). 
Gene Biological Source 
Environmental 
Source 
Plasmid or 
Chromosomal? 
Reference(s) 
tet39 Acinetobacter SD, SW Plasmid Agersø and Petersen 2007 
tetA(41)   Serratia NW Chromosomal Thompson et al., 2007 
otrB Streptomycete AS, NW, SW 
 
Nikolakopoulou et al., 2005 
tetB(P) Microbial community SD, SW Plasmid Chee-Sanford et al., 2001; Pei et al., 2006 
tetM 
Aeromonas, Bacillus, Escherichia, 
Lactococcus, 
Pseudoalteromonas and Vibrio 
AS, EW, NW, SD, 
SW, US 
Chromosomal and 
plasmid 
Mackie et al., 2006; Akinbowale et al., 2007b; 
Auerbach et al., 2007; Dang et al., 2007; 
Kim et al., 2007; Nonaka et al., 2007; Hu et al., 
2008; Rahman et al., 2008; Suzuki et al., 2008 
tetO 
Paenibacillus, 
Pseudoalteromonas, Shewanella, 
Sporosarcina and Vibrio; 
microbial 
community 
AS, EW, NW, SD, 
SW, US 
Chromosomal and 
plasmid 
Chee-Sanford et al., 2001; Smith et al., 2004; 
Mackie et al., 2006; Pei et al., 2006; 
Auerbach et al., 2007; Nonaka et al., 2007 
tetQ Microbial community 
AS, EW, NW, 
SW, US 
Chromosomal Smith et al., 2004; Auerbach et al., 2007; 
Mackie et al., 2006 
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Table 5.1 (cont). 
Gene Biological Source 
Environmental 
Source 
Plasmid or 
Chromosomal? 
Reference(s) 
tetS 
Lactococcus and Vibrio; microbial 
community 
AS, EW, SD, 
SW, US 
Chromosomal or 
plasmid 
Chee-Sanford et al., 2001; Kim et al., 2004; 
Auerbach et al., 2007; Suzuki et al., 2008 
tetT Microbial community SD, SW Plasmid Chee-Sanford et al., 2001; Pei et al., 2006 
tetW Microbial community SD, NW, SW Plasmid Chee-Sanford et al., 2001; Mackie et al., 2006; 
Pei et al., 2006; Suzuki et al., 2008 
otrA 
Streptomycete; microbial 
community 
AS, NW, SW Plasmid Chee-Sanford et al., 2001; Nikolakopoulou et al., 2005 
sulI 
Aeromonas, Escherichia and 
Listeria; 
Plasmids pB2, pB3, pB8, and 
pB10; 
Microbial community 
AS, DW, NW, SD, 
SW 
Plasmid 
Heuer et al., 2004; Lin and Biyela 2005; Schlüter et al., 2005; 
Srinivasan et al., 2005; Akinbowale et al., 2007a; 
Cernat et al., 2007; Hu et al., 2008 
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Table 5.1 (cont). 
Gene Biological Source 
Environmental 
Source 
Plasmid or 
Chromosomal? 
Reference(s) 
sulII 
Acinetobacter, Escherichia, 
Salmonella, 
and Vibrio; Microbial community 
DW, NW, SD, SW 
Chromosomal or 
plasmid 
Pei et al., 2006; Agersø and Petersen 2007; Cernat et al., 2007; Hu et al., 
2008; Mohapatra et al., 2008; Michael et al., 2012 
sulIII Escherichia; Microbial community NW, SD Plasmid Pei et al., 2006; Hu et al., 2008 
 
a
 SW: special wastewater from hospital, animal production and aquaculture areas; US: untreated sewage; AS: activated sludge of STP; EW: effluent water of STP: NW: 
natural water; SD: sediments: DW: drinking water 
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5.1.4. Multidrug Resistance (MDR) in the Environment 
As well as a high reported occurrence of single tetracycline and sulfonamide resistance in the 
environment, there have also been a number of reported occurrences of environmental bacteria 
possessing more than one resistant gene, a process that shows features of positive epistasis 
(Trindade et al., 2009). This is a process whereby the effects of one gene are modified by the 
effects of another. In such cases members of the aquatic microbial community that have acquired 
multiple resistance genes are able to negate the inhibitory effect of a number of biocidal 
compounds that may be present in their habitat. Several authors have reported a surprisingly low 
fitness cost of obtaining antibiotic resistance (Ward et al., 2009; Trindade et al., 2009); it is 
therefore an evolutionarily sound strategy for environmental microbes to be resistant to several 
antibacterial toxicants.  
The benefit of possessing a range of resistant genotypes is reflected in the wealth of literature that 
reports multidrug resistance in a range of environmental matrices. Methods for detection of MDR 
in the environment include phenotypic techniques (mainly agar disk–diffusion) and molecular 
methods, including PCR and electrophoresis gels and qPCR.  
5.1.5. MDR in the Aquatic Environment  
A range of phenotypic MDR studies have been conducted in the aquatic environment. As early as 
1991, Magee and Quinn tested the MDR profiles of 183 heterotrophic aquatic isolates. They 
observed that 40% of isolates showed phenotypic resistance to 8 antibiotics and 35% of isolates 
tested were resistant to at least 2 of the 8 antibiotics tested. Ozgumus et al. (2009) also tested the 
susceptibility of a mixed aquatic microbial community (from 10 Turkish rivers) to a range of 
antibiotics. Of the 183 isolates tested, the most resistance was detected to ampicillin (58% 
resistance) and streptomycin (51.9%), with decreasing resistance shown to tetracycline (28.4%), 
trimethoprim (24%) and chloramphenicol (12.5%).  
Other studies have targeted studying the MDR profiles of specific portions of a microbial 
community. Park et al. (2003) tested 1400 coliform isolates for resistance to sulfamethoxazole, 
aminoglyosides and β–lactams. They observed that 53.6% of isolates were resistant to one or more 
of their test compounds. Zhang et al. (2009) targeted Acinetobacter sp. and found that 28.6% of 
samples (from an STP) showed MDR using a phenotypic approach.  
Jianying et al. (2008) observed the MDR profile of E.coli strains from a Beijing river in summer 
and winter. They showed that the MDR index was slightly higher in the winter (0.14) than in the 
summer (0.11). They found that a maximum of 48.7% of isolates showed resistance to one or more 
antibiotics, with sulfonamide, tetracycline and ampicillin resistance being the most frequent. Lima 
Bittencourt et al. (2007) studied the susceptibility of a range of Enterbacteriaceae isolates to 
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several antibiotics in a pristine riverine environment. They found that 61% of isolates tested were 
resistant to multiple antimicrobial compounds. They additionally observed that resistance to one or 
more antibiotics was higher in rainy (100%) than it was in dry seasons (89%).  
There are also several reported occurrences of genotypic MDR in the aquatic environment. 
Jianying et al. (2008) complemented phenotypic MDR data with specific resistance gene detection. 
They found high levels of the ampicillin resistance gene TEM. 90% of tetracycline resistance and 
96% of sulfonamide resistance could be explained by combinations of different tet (tet (A), Tet (B) 
and Tet (M)) and sul genes (Sul I, Sul II and Sul III). The different combinations of distinct 
resistance genes showed a wide diversity of MDR. Verner–Jeffreys et al. (2009) investigated MDR 
in ornamental fish carriage water. 47 of 94 isolates that were tested were resistant to more than 15 
antibiotics. This could be explained by the detection of several genetic resistance determinants 
including qnrS2, blaTEM, tet (A), Tet (E), Tet (D), qacE2, sul I and an aminoglycoside transferase 
gene.  
5.1.6. MDR in the Marine and Estuarine Environment 
Several studies have quantified phenotypic MDR in the marine and estuarine environment. The 
majority of these studies have focused on MDR in E. coli strains. Florian-Fricke et al. (2008) 
observed that an E. coli SMS 3–5 that had been isolated from a tidal harbor system showed 
resistance to a range of antibiotic classes (fluoroquinolones, β–Lactams, aminoglycosides, 
quinolones, macrolides, sulfonamides and tetracyclines). The isolate was resistant to a number of 
specific compounds within each class, with MICs reaching as high as 10 000 µg/ml. Parveen et al. 
(1997) also demonstrated MDR profiles of marine E .coli strains. A wide range of MDR profiles 
were observed, the most prominent one being resistance conferred to CTC and sulfathiazole, 
followed by CTC, penicillin and sulfamethoxazole. 2% of E. coli isolates showed resistance to all 
antibiotics tested. 
Laroche et al. (2009) also found multidrug resistance profiles in E. coli isolates of marine origin. 
The authors reported that the frequency of isolates being resistant to between 2 and 12 of 
antibiotics tested was between 60.5–80%. Chandran et al. (2008) also studied E. coli MDR isolates 
in an Indian tropical estuary. A relatively large proportion of cultured isolates (95%) were resistant 
to all 12 of the antibiotics that were tested. Fernandez–Delgado and Suarez (2009) also observed 
relatively high MDR profiles of E. coli that had been cultured from a warmer marine environment. 
They demonstrated that E. coli isolates were resistant to 9 out of 10 antibiotics tested. The also 
observed that 21 isolates were resistant to at least 5 antibiotics and one isolate (Enterococcus 
durans) was resistant to all 20 antibiotics tested.  
Molecular characterisation of marine isolates has also shown MDR profiles. Dang et al. (2007) 
analysed mariculture isolates from China. Oxytetracycline resistance was commonly found along 
with chloramphenicol and ampicillin resistance. The genes tet (A), tet (B), tet (M) and tet (D) were 
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often found in conjunction with other genetic resistance determinants such as cat II and floR. 
McIntosh et al. (2008) detected resistant gene cassettes in the marine isolate Aeromonas 
salmonicida. One of these cassettes containined floR, tetA, suIII and strA / strB sequences and 
another coded for a bla (CMY-2) beta-lactamase in association with sugE and blc sequence.  
5.1.7. MDR in the Soil Environment 
Phenotypic MDR profiles of isolates that have been cultured from the soil environment have also 
been investigated. It is noteworthy that all of these studies have been conducted in areas where 
livestock were being reared or agricultural activity was taking place. Hayes et al. (2004) studied 
MDR profiles of isolates that had been cultured from a commercial poultry farm. MDR profiles 
were observed for all but one species of Enterococcus. One species (E. faecium) was resistant to 18 
out of the 20 antibiotics that were tested. Santos et al. (2007) also examined phenotypic MDR 
profiles in soils that had been sampled from 12 North Carolina poultry farms. The study found that 
5% of all isolates were resistant to all of the antibiotics that were tested. Other isolates were 
resistant to 9 (2%), 6 (5%), 7 (12%), 4 (10%), 3 (21%), 2 (24%) and 1 antibiotic (10%).  
Peron et al. (2008) looked at the phenotypic MDR profile of swine production isolates. 362 
Salmonella strains were tested for resistance to 12 antibiotics. They observed that more than 25% 
of isolates displayed MDR, with the most common MDR isolate being Salmonella typhimurium, a 
serotype with links to public health concerns. Singh et al. (2007) studied the presence of MDR 
Salmonella strains in two Indian vegetable farms. They observed that 82.9% of the isolates that 
were screened displayed MDR. Of these, 25% were resistant to all 10 of the antibiotics tested. 
Byrne-Bailey et al. (2009) investigated cross–resistance of soil isolates that were resistant to 
sulfonamides to other antibacterial compounds. It was observed that the 12 isolates were resistant 
to 3 of the 12 antibiotics tested, including nalidixic acid, tetracycline, neomycin and trimethoprim. 
One study has provided evidence in favor of multiple resistance genes being present in the soil 
environment. Burgos et al. (2005) tested the resistance profiles of a range of soil–dwelling 
microbial species in the presence and absence of salicylate, a known promoter of the mar (multiple 
antibiotic resistance) operon. They observed a widespread increase in MIC values of all four of the 
antibiotics that had been tested in the presence of salicylate, in some cases up to 30 times the 
control values. These results indicated the expression of a wide array of resistance genes that the 
mar operon carries. Frequently these were resistance determinants of the antibiotics that had been 
tested (chloramphenicol, nalidixic acid, penicillin and tetracycline).  
5.1.8. Multidrug Efflux in the Environment 
A common strategy of Gram negative environmental microbes in becoming resistant to antibiotics 
(along with other toxic waste products and xenobiotics) is to express a multidrug efflux pump 
phenotype (MEPP). Gram negative efflux pumps exhibit a tripartite structure comprising a 
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transporter, an adapter and exit duct proteins. A typical Gram negative pump comprises an AcrB / 
MexB–Acr/ Mex A–Tol C/OprM structure (Symmons et al., 2009). MEPPs allow environmental 
microbes to expel a huge number of unrelated toxins and drugs out of their cytoplasm (Koronakis 
et al., 2004). Despite their ability to export anthropogenic xenobiotics out of their intracellular 
space, bacteria are likely to have evolved MEPPs to export natural chemicals out of their cell such 
as plant root exudates (Bais et al., 2006). It has been hypothesised that MEPPs may ultimately have 
played a key role in initiating microbe–plant interactions which would not have been possible if 
plant defenses were effective against microorganisms (Espinosa-Urgel et al., 2002).  There are 
several main classes of MEPPs. These are the RND (Resistance Nodulation–Cell Division) family, 
the MFS (Major Facilitator Superfamily), ABC (ATP-Binding Cassette) superfamily, the SMR 
(Small Multidrug Resistance) family and the MATE (Multi Antimicrobial Extrusion) family 
(Martinez et al., 2009). 
5.1.9. Reported Incidences of MEPPs in the Environment 
In addition to specific resistance mechanisms, MEPPs have been detected in the environment. 
Species such as Stenotrophomonas maltophilia for example are known to be extremely tolerant to a 
range of antimicrobial compounds and much of this is thought to be due to the presence of MEPPs 
such as smeDEF efflux mechanisms (Hernandez et al., 2009). Florian-Frike et al. (2008) conducted 
recombinant studies to see if MDR phenotype profiles could be explained by MEPPs in the aquatic 
MDR isolate E. coli SMS 3–5. Their results implicated the role of AcrAB-TolC, together with 
MarA as being responsible for conferring resistance to tetracycline, chloramphenicol, ampicillin, 
nalidixic acid, and rifampin. In the same study it was also suggested that expression of the fsr gene 
(the product of which is an efflux pump) conferred resistance to both ofloxacin and ciprofloxacin.  
Long et al. (2008) also studied MEPPs in E .coli as well as Neisseria gonorrhoeae. The study was 
able to demonstrate that the proteins NorM (from N. gonorrhoeae) and YdhE (from E .coli) greatly 
increased resistance to several compounds including antimicrobials (fluoroquinolones, ethidium 
bromide, rhodamine 6G, acriflavine, crystal violet, berberine, doxorubicin, novobiocin, enoxacin, 
and tetraphenylphosphonium chloride). 
Groh et al. (2006) investigated the presence of MEPPS in the aquatic sediment–dwelling isolate 
Shewanella oneidensis. Knockout studies revealed the importance of the MexF MEPP in conferring 
resistance to chloramphenicol and tetracycline, suggesting the role of MexF in multidrug efflux in 
this isolate. Further studies also revealed the importance of a mutated TetR regulatory protein (a 
protein that is involved in tetracycline resistance) that interacts with the MexAB operon to confer 
multidrug resistance in Shewanella oneidensis. In addition, Szezepanowski et al. (2004) found 
MEPPs in bacterial plasmids in an STP that conferred genotypes to two MEPPs, an ABC–binding 
cassette efflux pump and an efflux membrane fusion protein (EMF) associated with the RND 
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family of MEPPs.  It is also notable that that these genes were plasmid-based, suggesting that they 
may be highly transferrable.  
5.1.10. Transfer of Genetic Elements between Environmental 
Microbes 
So far in this review multidrug resistance has been discussed with regard to environmental 
microorganisms possessing multiple genotypes that have lead to the expression of multiple 
resistant phenotypes. A major mechanism by which bacteria can possess a range of resistance 
profiles is by the transfer of genetic elements from other bacteria, regardless of genera or species. 
Gene transfer can occur via three processes, transduction (DNA is taken up by cells into their 
genome from phage DNA), conjugative transfer (which relies upon mobile genetic elements) and 
transformation (when DNA is taken up by competent cells) (Droge et al., 1999). A wealth of 
literature has described both single and multiple gene transfer. Such studies are frequently 
combined with the detection of mobile genetic elements called intergrons or transposons which are 
responsible for carrying transferred genetic material. Such mobile elements may carry single 
resistance or so called multiple gene cassettes. Interestingly though, mobile genetic elements seem 
to have origins from before the “antibiotic era”, suggesting that bacteria are using evolutionarily–
conserved mechanisms to cope with a relatively modern environmental stressor of anthropogenic 
origin (Stokes et al., 2006). 
5.1.11. Direct Experimental Evidence for Gene Transfer between 
Environmental Bacteria 
Several studies have attempted to show the occurrence of gene transfer experimentally by 
conducting microbial “mating” experiments. Mating experiments have revealed that resistance 
gene transfer can occur in both an intragenic (transfer between same species) and intergenic 
(transfer between different species) manner (Zahid et al., 2008). Silva et al. (2006) for example 
were able to successfully show the transfer of multidrug resistance phenotypically between donor 
coliform isolates and a recipient E. coli K-12 strain by observing an increase in MIC values post–
mating. Nagachinta and Chen (2008) also used a phenotypic approach in mating experiments. After 
mating an MDR donor (a shiga toxin producing strain of E. coli) with a multidrug sensitive E. coli 
K-12 strain, they observed that the sensitive K-12 transconjugant had developed resistance to 
sulfathiazole, streptomycin and oxytetracycline.  
In another study that had been utilizing E. coli as a recipient (Agerso and Sandvang, 2005), various 
MDR soil strains acted as donors. This study used molecular techniques to quantify gene transfer. 
They observed co–transfer of various tet resistance determinants and class 1 intergrons, suggesting 
that tetracycline resistance was transferred via a gene region that was present on a mobile genetic 
element. Mukhergee et al. (2005) also utilized molecular techniques to study MDR transfer. They 
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found that three plasmids associated with MDR (D1QN–9, D2QN–14 and MR-1) were transferable 
between aquatic MDR isolates and an E. coli DH-5α recipient. Byrne–Bailey et al. (2009) 
conducted mating experiments between 12 MDR soil isolates (as donors) using both E. coli and P. 
putida as recipients. The transfer of sul I, sul II and sul III were investigated. They observed 64% 
successful transfer of sul I between soil isolates and recipients and a 36% transfer success to both 
recipients of sul II. Sul III was shown to be non-transferrable. These data would suggest that the sul 
III gene is not transferrable between bacteria that are present in the soil environment.  
5.1.12. Reported Transfer of Single Drug Resistance Determinants in 
the Environment  
A number of studies have conducted molecular genetic studies that have demonstrated the transfer 
of genetic determinants that confer resistance to a single compound. Knapp et al. (2008) 
demonstrated that a range of tetracycline resistance genes were transferrable in aquatic mesocosm 
studies. They observed an indirect association between the frequency of tetracycline resistance 
genes and Tn916/1545 genes, genes that code for transferable genetic structures called transposons. 
The results of this study had therefore suggested that certain tet genes can be transferred between 
bacteria in the aquatic environment. 
Peterson et al. (2000) investigated the presence of a transferrable trimethoprin gene cassette in the 
aquatic isolate Acenetobacter. They were able to detect a dhfr1 gene (linked to trimethoprin 
resistance) which was associated with an open frame sequence (orf) orfC which had previously 
been linked with a class 1 intergron of a clinical enterobacterial isolate. 
Byrne–Bailey et al. (2009) investigated the transfer of various sul genes (sul I, sul II and sul III) 
via class I intergrons in soil studies. They found that 8% of isolates carried the sul I gene alongside 
the gene that encodes for class 1 intergrons (int1), compared with 17.9% of sul II containing 
isolates. Interestingly, very few isolates possessed the int2 gene (which codes for class 2 
intergrons), implying that class 1 integrons may be more significant resistance gene carrying 
elements. 
In another study, McIntosh et al. (2008) showed that a gene cassette containing an aminoglycoside 
–3-transferase (conferring aminoglycoside resistace) was present on a class 1 intergron in 
Aeromonas strains that had been isolated from the marine environment. They found that the 
intergron/gene cassette was present on a conjugative incA/C plasmid. It has also been demonstrated 
that resistance to other antimicrobial compounds can be transferred. Gillings et al. (2009) for 
example were able to associate quaternary ammonium compounds (QAC) with transferrable 
elements in freshwater biofilm bacteria. They observed that the qac gene (which codes QAC 
resistance) could be detected on class 1 intergrons in a similar manner to which antibiotics can.  
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5.1.13. Reported Transfer of Multiple Drug Resistance Determinants 
in the Environment  
In addition to the transfer of genetic elements that confer resistance to a single antibiotic (or other 
compound or element) in the environment, there have been several reports of multiple gene transfer 
or transfer of MEPPs. This has mainly been studied in the aquatic environment and has been 
observed in several countries. Laroche et al. (2009) studied MDR transfer in the River Seine in 
France. They detected int1 and int2 in 11% of their isolates. When these regions were further 
investigated two dominant gene cassettes were discovered, aadA and dfr. These gene cassettes are 
known to confer resistance to a number of antibiotics, including some of those that the isolates in 
the study were resistant to, such as CTC, kanamycin and amoxicillin. Ozgumus et al. (2008) 
examined the potential for MDR isolates to transfer multiple resistance genes in Northern Turkish 
rivers. In addition to reporting nalidixic acid strains that harboured quinolone resistance, the study 
also found class 1 and class 2 intergrons on 15 and 4% of coliform isolates respectively. Sequence 
analysis of the gene cassettes revealed the presence of dfrA1, dfr2d, dfrA7, dfrA16, dfrA17, aadA1, 
aadA5, bla (oxA-30), and sat1. These resistance determinants were all transferrable.  
Park et al. (2003) also detected the presence of class I intergrons in aquatic isolates (24%), this 
time in South Korea. They also observed multiple resistance determinants on mobile gene 
cassettes. These included dfrA5, dfrA7, dfrA12, dfrA17, aaA2, aaA5, and aad (3'). Mukherjee and 
Chakraborty (2006) studied multidrug gene transfer in Indian rivers. As well as finding class 1 
intergrons on 40% of isolates tested, they were also able to show a statistically significant 
correlation between MAR and presence of class 1 intergrons. The study also found the genes dfrA1, 
dfrA5, dfrA7, dfrA17 and dfrA12. They additionally detected variant gene sequences conferring 
resistance to amikacin, tobramycin, streptomycin and spectinomycin.  
The transfer of MDR has also been studied in the marine environment. McIntosh et al. (2008) 
studied MDR gene transfer elements in the marine species Aeromonas salmonicida. They 
examined the structure of class 1 intergrons that were present in MDR isolates. One of these gene 
cassettes coded for an inA/C plasmid that carried the resistance determinants floR, tetA, suIII and 
strA/strB. Jacobs and Chenia (2007) investigated MDR transferrable genes in South African 
aquaculture systems. They found that 37.8% of isolates carried multiple resistance plasmids. Upon 
sequencing they discovered that class 1 intergrons (and related structures) carried different 
combinations of the genes ant (3'') Ia, aac (6) Ia, dhfr1, oxa2a and/or pse1. Interestingly, no 
variable resistance gene cassettes could be found on class 2 intergrons providing more evidence 
that antibiotic resistance gene transfer is mediated mainly by class 1 intergrons in the environment.   
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5.1.14. Development of Antibiotic Resistance in the Environment 
5.1.14.1. External Sources of Resistance Genes in the Environment 
Several studies have investigated the potential for external sources of resistance genes to become 
part of environmental resistance gene reservoirs. Most studies have focused their attention on 
studying the fate of resistance genes from highly polluted environments into relatively less polluted 
ones. Lu et al. (2010) for example looked at the clonal relatedness between MDR bacteria from 
different origins (animals, workers and environment) in a range of farms. They observed a high 
degree of homology between samples. The results of this study suggested that resistance genes had 
been exchanged between animals, the environment and farm workers, although the exact pathways 
were not investigated. Heuer and Smalla (2007) produced data that supported some of these 
findings. Their study investigated the effects of manuring on the abundance of sul genes in soil 
samples. They found that sul1 and sulII genes could be transferred from manure to soil, suggesting 
the role of animal intestinal bacteria in contributing to the soil resistome (a collection of all of the 
antibiotic resistance genes that are present in an environment) (Wright, 2007).  
Byrne–Bailey et al. (2009) also provided evidence that manure application onto soils can increase 
the sul gene reservoir in the environment. Their work tracked sul gene levels in soils that had been 
amended and that had not been amended with pig slurry. They observed that the sulIII genotype 
was only present in soil samples that had been treated with pig slurry. In addition, it was reported 
that soil columns that had received a post-application of slurry contained a higher number of sul 
genes. These two results would suggest that sul genes in pig slurry can enter the terrestrial 
environment.  Sul genes could also be detected in soil leachate, suggesting a possible reservoir of 
sul genes that may be further transported into different matrices, such as groundwater.  
Schmitt et al. (2006) also investigated the effect of manuring soil on the number of sul gene copies 
that were present in microcosm and field studies. They also detected possible increases in tet gene 
copy numbers. In manure amended microcosms a large increase in tet and sul gene copies were 
observed. It was further demonstrated that the genes tet (Y), tet (S), tet (C), tet (Q), and tet (H) were 
only present in soil as a result of manuring. Field studies were slightly less conclusive, as the sites 
that were investigated had a considerable number of tet and sul gene copies that were already 
present. These results did indicate however that the soil environment contains a considerable 
resistance gene reservoir.  
Knapp et al. (2010) investigated the fate of erythromycin and β–lactamase genes from swine 
lagoon waste into the aquatic environment using mesocosms. They observed that resistance genes 
disappeared from the water column rapidly. After 2 days they were able to detect a variety of genes 
in aquatic biofilms, although these genes disappeared over time. Interestingly, the transfer of 
specific genes was altered by different light and darkness regimes, suggesting that the transfer of at 
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least some resistance genes had depended upon specific abiotic factors. Mackie et al. (2006) 
conducted field studies to investigate the impact of manure management practices on the number of 
tet gene copies in nearby groundwater. They found a greater detection frequency of tet genes in 
groundwater underlying or slightly down–stream of the facility than in wells that were further 
away. The authors concluded that tet genes from farming represent a persistent environmental 
contaminant.  
STPs as a source of antibiotic resistance genes into the environment have also been investigated.  
Szczepanowski et al. (2004) investigated the possibility of bacteria in STPs transferring genetic 
material into the aquatic environment. They analysed a range of plasmids that were harbouring 
antibiotic resistant genotypes. They observed that one of these plasmids, pRSB1 01 contained a 
number of resistance genes that were contained on a class I intergron associated with a highly 
mobile Tn–402 transposon-like sequence. This region of DNA also contained a number of genetic 
resistance determinants that potentially conferred resistance to β–lactams, trimethoprim, 
macrolides, tetracyclines and sulfonamides. A mobile region coding for two types of tripartite 
MEPPs was also detected, suggesting the possibility that these could be transferred also.  
Silva et al. (2006) showed that STP effluent contained elevated levels of antibiotic resistant 
coliform bacteria. Such bacteria therefore act as a source of resistance genes into the aquatic 
environment. Zhang et al. (2009) also investigated the release of resistant isolates into the aquatic 
environment from STPs. The study tracked the presence of multidrug resistant Acinetobacter 
strains throughout the sewage treatment process. They observed an increase in multidrug resistant 
isolates that were present in effluent compared with raw influent samples. They also observed that 
isolates downstream of an STP showed greater multidrug resistance than isolates sampled from 
upstream. The results of these studies therefore show the potential of STPs to contribute to the 
natural resistome of aquatic habitats. 
As mentioned in chapter 1, sewage sludge is often applied to land as a fertilizer. Selvaratnam and 
Kunberger (2004) studied this as a source of resistance genes into surface water via run–off from 
sludge–amended fields. They observed that AmpR (conferring ampicillin resistance) frequency 
could be positively correlated with AmpR input from agricultural run–off. 
The transfer of resistance genes from land to seas has also been observed. Chandrasekaran et al. 
(1998) were able to successfully mate the soil isolate P. flourescens with a halophilic and halo–
tolerant marine species. They observed that mating was successful even when P fluorescens was in 
a viable but non–culturable state and in a variety of nutrient levels. The potential for terrestrial 
influence of the marine resistome was thus exhibited. 
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5.1.14.2. Antibiotics as a Selective Pressure for the Formation of 
Antibiotic Resistance in the Environment  
For some time it has been hypothesized that antibiotic residues in the environment may select for 
antibiotic resistance. The concept is based upon Darwin’s theory of Natural Selection (Darwin, 
1859) and has long been used as an example of the concept. With regard to antibiotic resistance it 
has been theorized that the members of the microbial community that can tolerate antibiotic 
exposure will survive and replicate; the microbial community will then contain more antibiotic-
resistant genetic material. It has also been theorized that this scenario will be greatly helped by the 
ability of the microbial community to mutate at a rapid rate due to their short generation time (20–
30 minutes). This has been observed with mutations to the folA gene that can confer sulfonamide 
resistance. As discussed in the previous section, the ability of environmental microbes to exchange 
genetic material also acts to increase the total microbial resistome in the environment.  
In a recent study, Knapp et al. (2010) examined the presence of resistance genes in archived Dutch 
soils (from 1940–1968). This represented a gradient of antibiotic discovery and usage, ranging 
from low in the 1940s to high in 2008. The results indicated that the antibiotic resistance profile of 
the soils had increased over time. The abundance of tetracycline resistance genes showed a 
particularly sharp rise, with a > 15 times increase between 1970 and 2008. The authors commented 
on the fact that the abundance of resistance genes had risen despite improvements in waste 
management. These results show a global temporal trend of antibiotic use resulting in an increase 
in antibiotic resistance. 
5.1.14.3. Selection of Single–Drug Resistance 
The extent to which tetracyclines act as selecting agents for resistant genotypes in the environment 
has been the subject of a large body of literature. Kim et al. (2007) used activated sludge that had 
been spiked with tetracycline concentrations of 1–250 µg/L. As the tetracycline concentration 
increased, an increase in the number of resistant cells was observed. It was also observed that 
resistant isolates showed higher growth rates at higher tetracycline concentrations.  
Rhysz and Alverez (2004) conducted aquifer studies to study the effects of tetracycline on the 
formation of resistance in run–off from agricultural land. A tetracycline concentration of 50 mg/L 
reduced the number of heterotrophic bacteria in the system while also increasing the number of 
tetracycline resistant bacteria. Interestingly, the study also observed the effects of removing 
tetracycline from the system (depuration period). It was observed that the system had completely 
recovered in terms of the bacterial community structure returning to that of the control as shown by 
16S RNA profiles becoming more similar during the depuration period.  
Kanpp et al. (2008) also used a simulated environment (mesocosm studies) when looking at 
oxytetracycline as a selector for resistance. They observed that an oxytetracycline concentration of 
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20 µg/L resulted in an increase in the ratio of tet genes: total 16S RNA. In addition, an increased 
abundance of tet (M) was positively correlated to all tetracycline concentrations, suggesting that 
this gene is particularly sensitive to the selective pressure exerted by tetracyclines. The results of a 
study by Yu et al. (2009) agree with these findings. In this investigation it was found that an 
oxytetracycline concentration of 5 mg/L resulted in elevated tetracycline resistance levels in the 
indicator species Enterococcus faecalis in an aquatic test system. The study also concluded that 
selection for resistance was highest when tetracycline was added with animal feed. 
The ability of tetracyclines to act as a selecting agent for antibiotic resistance has also been 
investigated in the marine environment. Using marine microcosms, Kerry et al. (1996) observed a 
> 90% frequency in resistant CFU counts at an oxyteracycline concentration of 25 µg/g compared 
with a < 7% frequency at an oxytetracycline concentration of 6.25 µg/g or less. When the effect of 
adding oxytetracycline after 3 days of microcosm incubation was tested, oxytetracycline lost its 
selective pressure, perhaps suggesting that marine resistance may form more readily in a microbial 
community that is growing quicker and is able to establish itself within an environment.  
Several studies have also investigated sulfonamides as selective agents for resistance in the 
terrestrial environment. Brandt et al. (2009) examined the effect of sulfadiazine on pollution 
induced community tolerance profiles. They found that sulfadiazine and nutrient amendment 
showed a tendency to increase the tolerance of the microbial community. The authors commented 
that these results showed that resistance to sulfonamides could proliferate in certain soil “hotspots.” 
Heuer and Smalla (2007) investigated the effect of sulfadiazine that had beenamendment to soil. 
They showed that sulfadiazine, along with manure amendment, had an effect on sulI and sulII 
abundance in soils over time, suggesting that a synergistic effect occurred. Heuer et al. (2008) 
further investigated the effect of sulfadiazole on the selection of sulfonamide resistance, using a 
modeling approach. They concluded that a selective effect of sulfathiazole was observed on sulII 
selection at concentrations as low as 0.15 mg/Kg.  
A Chinese study recently investigated the effect of several sulfonamides (sulfamethoxazole, 
sulfadiazine and sulfachloropyridazine) on the selection of sulfonamide resistance selection in the 
aquatic environment (Yi et al., 2010). They found a positive correlation between total sulfonamide 
concentration and the total abundance of resistance genes in aquatic sediment. Interestingly, the 
authors detected 120–2000 more sul gene copies in sediment then in the water column, implicating 
aquatic sediments as an important sul gene reservoir in the environment (Yi et al., 2010). 
The influence of other antibiotics as selective agents of resistance formation has been investigated 
to a much lesser extent. Cermak et al. (2008) observed an increased selection of lmrB homologues 
in soils that had been treated with lincomycin compared with untreated soils. Lu et al. (2004) 
investigated the effect of vancomycin–exposed soils on the long term selection of the vanHAX 
genotype in animal commensal bacteria. The authors concluded that exposure to vancomycin had 
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selected for vancomycin resistance in animal commensal bacteria based on gene cluster analysis. 
They further reported that humans faced exposure to animal bacteria that had become vancomycin–
resistant. Yu et al. (2009) studied the effect of ciprofloxacin on the formation of resistance in the 
aquatic environment. They observed that 2 mg/L
 
of ciprofloxacin administered in animal feed 
resulted in the selection of resistant bacteria.  
5.1.14.4. Co–Selection of Antibiotic Resistance: Development of 
Multidrug Resistance 
As well as antibiotics acting as a selective agent for single drug resistance in the environment, a 
number of studies have examined co–selection of a number of resistance profiles. Peterson et al. 
(2002) tracked resistance levels to a number of antibiotics over time in aquatic systems that been 
amended with farming animal waste. Although the exact antibiotic composition in the waste were 
unknown they were likely to contain mainly tetracyclines based upon normal farming procedures. 
The authors observed co–selection of chloramphenicol, ciprofloxacin, erythromycin, 
oxytetracycline, sulfamethizine and trimethoprim over the study period.  
Wright et al. (2008) investigated the effect of heavily polluted water (containing antibiotic and 
metals) on the abundance of class 1 intergrons in microcosm experiments. The results of this study 
therefore suggested that polluted microcosms had a greater potential for gene transfer and possibly 
the formation of multidrug resistance.  
Heuer et al. (2007) investigated the effect of exposing soils to sulfadiazole on the composition of 
class 1 intergrons. They observed that sulfadiazine had a synergistic effect with manure on 
increasing the number int1 gene copies in soil. Sulfadiazine was thus shown to play at least some 
role in increasing the number of mobile elements that could (in theory) lead to a rise in MDR in 
manure soils.  
From the available literature, it is evident that the exposure of microbial communities to general 
contaminants (that may not be antibiotic compounds) may also result in the proliferation of 
antibiotic resistance. A major reason for this is likely to be the movement of several genetic 
elements on mobile elements such as gene cassettes on integrons and transposons (eg: Ozgumus et 
al., 2008). The presence of multidrug efflux pumps and the possibility for these to be transferred on 
mobile genetic elements also increases the likelihood that co-selection of resistance will occur in 
the presence of a general environmental stressor (such as heavy metal pollution).  
5.1.15. Fears over Antibiotic Resistance in the Environment: The 
Broader Issues 
There has been widespread media coverage concerning antibiotic resistance in clinical settings, 
such as the spread of MRSA (methicillin-resistant Staphylococcus aureus) and the rise of so called 
278 
 
“superbugs.” For some time now the propensity for these microorganisms to exchange genetic 
material and mutate has been known. Scientists therefore understand that clinical isolates can (and 
do) rapidly adapt to conventional antibiotic chemotherapy. The next question the scientific 
community are asking themselves is whether or not antibiotic resistance in the environment can 
have an impact on human health. Or more specifically, can resistance that started in the 
environment be transferred to bacteria that are human pathogens? On the same note, can 
environmental resistance be transferred to pathogens of animals that are economically important?  
There has already been some research that provides an insight into some of these issues. Kruse and 
Sorum (1994) investigated resistance gene transfer (a multidrug resistant R plasmid) between 
bacteria that been isolated from different microhabitats. They found that multidrug resistance was 
transferrable between the human pathogen Vibrio cholera and a previously susceptible fish 
pathogen, Aeromonas salmonicida. The fish pathogen could also act as a recipient to pathogenic 
bovine E. coli. In addition, MDR bovine pathogenic E. coli could also transfer multidrug resistance 
to a previously susceptible human pathogenic E. coli. Transfer of resistance from animal (pocine 
and fish) pathogens to human pathogens was also demonstrated during this study. Lu et al. (2004) 
described a study in which they saw vancomycin resistance form in animal feed. The gene cluster 
involved was then passed to animal commensal bacteria and eventually to bacteria that humans 
regularly came into contact with. It had therefore been demonstrated that vancomycin resistance 
determinants (and therefore vancomycin resistance) had been transferred between different gene 
pools. Opegaard et al. (2001) found genetic homology between R plasmids from cattle and humans 
associated with farm work. The authors speculated that the spread of the MDR R plasmid was due 
to antibiotic residues on in the farm environment acting as a selective pressure for resistance 
formation. 
Mukherjee and Chakraborty (2005) studied multidrug resistant gene transfer in Indian rivers. They 
isolated a Margonella sp. that harbored a multidrug resistant gene cassette that shared homology to 
a multidrug resistant gene cassette that was associated with the human pathogenic bacteria V. 
cholerae. The results of this study indirectly suggested that exchange of genetic material between 
pathogenic and non–pathogenic bacteria is possible. 
Gillings et al. (2009) found more direct evidence that suggested gene transfer had taken place 
between environmental bacteria and a clinical isolate. They found identical gene cassettes 
(encoding for QAC resistance) associated with aquatic proteobacteria and clinical human 
pathogens. Rhodes et al. (2000) investigated resistance gene transfer between an aquaculture 
location and bacteria found in a nearby hospital. They observed significant genetic similarities 
between Aeromonas sp. and E. coli, suggesting that the aquaculture and human environmental 
compartments can act as one resistance reservoir. 
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5.1.16. The Biolog PM11C and PM12B Assays as a Phenotypic 
Reporter of Multidrug Resistance 
Biolog PM11C and PM12B arrays are comprised of a 96 well microplate format. Each well 
contains a coating of a specific antibiotic at set a concentration; each antibiotic is present at 4 
different concentrations. Low cellular suspensions of a particular isolate are prepared then 
inoculated onto PM plates. The inoculating solution is also prepared with a redox dye which is 
reduced and changes colour when microbial growth occurs. This colour change can be measured 
spectrally at 595 nm. The system therefore acts a “phenotypic reporter” of microbial growth in the 
presence of antibiotics. Figure 5.1 and 5.2 show the configuration of antibiotic compounds that are 
present on PM11C and PM12B plates respectively.  
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Figure 5.1:  Schematic configuration of different antibiotics on a Biolog PM11C plate (Biolog, 2007). 
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Figure 5.2:  Schematic configuration of different antibiotics on a Biolog PM11B plate (Biolog, 2007). 
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5.1.17. Aims and Objectives 
1) To investigate the formation of CTC and SMX resistance as a result of the selective pressure 
exerted by the  exposure of aquatic microbial communities to CTC and SMX and to examine the 
hypothesis that this influenced the functional recoveries that were observed in Chapters 3 and 4. 
2) To investigate whether exposure to CTC and SMX selects for a wider resistance profile.  
3) To investigate the extent to which antibiotic resistance is already present in test systems and to 
what extent antibiotic resistance forms in the absence of antibiotics as a selective pressure.  
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5.2. Materials and Methods 
5.2.1. Reagents 
All reagents and chemicals were purchased and prepared according to section 2.5.1. Biolog PM11C 
and PM12B plates and all associated equipment were purchased from Biolog (Hayward, CA).  
5.2.2. Preparation of R2A/CTC and Sulfamethoxazole Agar Plates 
R2A agar (11.5g) was mixed with 1 liter of deionised water. The R2A agar/deionised water 
suspension was then slowly heated while being stirred on a magnetic infrared hotplate. When the 
mixture was completely melted it was autoclaved at 121°C for 15 minutes. Following cooling (~ 15 
minutes), CTC or sulfamethoxazole stock solutions were pipetted into the melted R2A agar to 
achieve a final [CTC] / [SMX] of 1 mg/L. The spiked melted R2A agar was then poured into sterile 
Petri dishes leaving an air space of ~0.25cm. 
5.2.3. Preparation of Biolog BUG B Media 
Biolog BUG B media (15 g) was mixed with 1 liter of deionised water. The agar / water suspension 
was then slowly heated and stirred on a magnetic infrared hotplate. When the mixture was 
completely melted it was autoclaved at 121°C for 15 minutes. Following cooling the melted agar 
was poured into sterile petri dishes in a class II Hera cabinet. 
5.2.4. Preparation of Biolog PM Media 
Biolog IF-10a inoculating fluid (a proprietary nutrient broth used for inoculating Biolog PM Plates) 
was prepared by mixing 125 ml 1.2 x Biolog IF-10a fluid with 37.5 ml deionised H20. Biolog IF-
10a inoculating fluid was prepared by mixing 125 ml of 1.2 x IF-10a fluid with 36 ml deionised 
H20 and 1.5 ml Biolog Dye Mix A (an aqueous tetrazolium dye). All media was prepared in a Hera 
class II flow cabinet to minimize contamination. 
5.2.5. CFU Counts of CTC and Sulfamethoxazle–Resistant Bacteria 
Serial dilutions (0, 10
-1
, 10
-2
 and 10
-3
) of microcosm liquid were prepared using sterile water. 
Triplicate R2A -CTC / sulfamethoxazole agar plates were spread-plated with each 0.1 ml of each 
dilution factor using a sterile plate spreader. 
 
Plates were then incubated at 20°C for 72 hours. After 
incubation, the numbers of individual CFUs on each plate were enumerated by eye on each agar 
plate. Only counts of 30-300 CFU were considered as being valid. This process was repeated on 
days 1 and 7 of the exposure period. CFU counts of each CTC and SMX resistant morphotype was 
also taken in plates spread from control microcosms following the same procedure. 
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5.2.6. Preparation of R2A Slopes 
11.5g R2A agar was weighed on a calibrated balance and mixed with 1 litre of deionised water. 
The R2A agars / deionised water suspension was then slowly heated while being stirred on a 
magnetic infrared hotplate. When the mixture was completely melted it was autoclaved at 121°C 
for 15 minutes. Following a period of cooling, 5.5 ml melted R2A agar was poured into a sterile 
sample tube at an angle of 25º - 35º and allowed to set. Slopes were prepared and seeded in a Hera 
class II flow cabinet to minimise contamination of R2A slopes. 
5.2.7. Morphotyping and Storage of Antibiotic Resistant Bacteria 
Each R2A + CTC/SMX agar plate (plated on day 1 and 7 of each corresponding exposure and 
including inoculations of control microcosm liquid) that contained visible colony growth was 
screened for individual morphtypes.  Each morphotype is considered as being a distinct isolate 
during the current investigation. Morphotypes were harvested from R2A plates that had been 
spiked with both treated and dosed microcosms liquid. Criteria for individual morphotypes was 
based on colony colour, size, shape, translucence and other features that made them different from 
other colonies such as distinct patterns (such as veined colony). Each morphotype description was 
noted. Each individual morphotype was then picked up with a flamed loop and streak–plated onto a 
new sterile R2A plate. If pure cultures were not obtained then the desired colony was re–streaked 
onto a new sterile R2A plate. When a pure culture was obtained a single colony was picked up with 
a sterile loop and a pre–poured slope was seeded. Slopes were stored at 20ºC for 72 hours to allow 
growth then transferred to a 4ºC cold–store to slow growth until future use of cultures.  
5.2.8. Biolog PM11C and PM12B Array Procedure 
A Biolog IF–10a / pure culture suspension was prepared by swirling a Biolog longswab covered in 
a pure morphotype culture in a sterile tube containing IF–10a. Cultures were grown on Biolog 
BUG B agar plates. A sample of the suspension (~1 ml) was then read at 600 nm with a 
spectrophotometer. Depending on the absorbance reading, the suspension was amended with either 
more pure culture or IF-10a until an absorbance of 0.85 was obtained. A 1:5 ratio of the final cell 
suspension was then prepared using fresh IF–10a. A further dilution of 1:200 was made in IF–10a 
+ Biolog Dye Mix A solution to obtain the final diluted culture suspension. 100 µl of 1:200 pure 
culture / IF-10a + dye mix A suspension was used to seed Biolog PM11C or PM12B plates, 
depending on the antibiotic the individual morphotype was resistant to (CTC-resistsnt isolates were 
used to seed PM11C plates, sulfamethoxazole- resistant isolates were used to seed PM12B plates as 
corresponding plates contained the original antibiotic that these microbes were resistant to). This 
was seen as being a trade-off between relevance and cost as all isolated morphotypes could not 
feasibly be plated on both types of plate. Plates were then incubated at 20ºC for at least 94 hours. 
During this period, plates were read spectrally at 595 nm periodically. This procedure was repeated 
for each isolated morphotype (from day 1 and day microcosms) that could be isolated during the 
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exposure. Blank wells on a standard 96–well plate were also inoculated with 100 µl 1.2 x diluted 
IF–10a fluid to obtain blank readings. All procedures were performed in a Hera Class II flow 
cabinet to minimise contamination.  
5.2.9. Resistant CFU Counts 
Serial dilutions (0, 10
-1
, 10
-2
 and 10
-3
) of microcosm liquid (all doses and control) were prepared 
using sterile water. Triplicate R2A-SMX and R2A-CTC agar plates were spread-plated with each 
0.1 ml of each dilution factor using a sterile plate spreader.  Plates were then incubated at 20°C for 
72 hours. After incubation, the numbers of individual CFUs on each plate were enumerated by eye 
on each agar plate. Only CFU counts of between 30 and 300 were accepted for further analysis.  
5.2.10. Data Analysis  
5.2.10.1. Total Resistant CFU Counts over Time: Formation of 
Culturable Resistance 
Total resistant CFU count data were treated in an identical manner as described in section 3.2.8. 
5.2.10.2. Morphotype Data 
The total number of distinct resistant morphotypes was enumerated for each antibiotic resistance 
profile (CTC and SMX resistance) on days 1 and 7 of the exposure. These data were then graphed 
using Microsoft Excel. Morphotypes from control and dosed microcosms were included. The 
profile of each morphotype that was inoculated onto each R2A + CTC/SMX plate was then cross 
referenced using the descriptions of each unique morphotype. The presence of each specific 
morphotype at each dose group could therefore be ascertained qualitatively. The specific features 
of each morphotype could also be compared. This also allowed for a comparison of which 
antibiotic resistant morphotypes were present at the start of the exposure and which specific 
antibiotic resistant morphotypes had appeared in miocrocosms after day 1.  In addition, a total CFU 
count of each specific morphotype that had been plated onto control microcosm inoculated R2A + 
CTC/SMX agar plates was conducted. Counts of between 30 and 300 CFU were considered valid. 
Log CFU/ml values for each specific morphotype were then graphed using Microsoft Excel. This 
analysis allowed the relative presence of each morphotype in control microcosms to be calculated.  
If a distinct morphotype was not present in control microcosms at the start of the exposure and 
could not be cross referenced to a specific day 1 resistant morphtype then it was assumed that such 
a morphotype had developed antibiotic resistance during the exposure as the result of selective 
pressure of the corresponding antibiotic that microcosms had been dosed with (CTC or SMX). If a 
specific morphotype could only be detected in day 7control microcosms only but could not be cross 
referenced with a specific day 1 morphotype, then it was assumed that the resistance of this 
morphotype had formed due to a mechanism other than the selective pressure of dosed SMX or 
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CTC. Day 7 resistant morphotypes that could be detected in day 1 control microcosms and could 
also be cross referenced to a specific day 1 morphotype were considered to be resistant 
morphotypes that were added to a specific microcosm via river water of treated sewage. Finally, if 
a specific morphotype could be detected in day 1 microcosms but could not be cross-referenced 
with a day 7 morphotype, then it was assumed that these morphotypes had not thrived beyond the 7 
day exposure (they were all dead and had possibly been degraded themselves by other bacteria).  
5.2.10.3. Biolog PM Data: MDR Profiling of SMX/CTC-Resistant 
Morphotypes 
A total growth value for each morphotype that could be grown on Biolog PM plates was calculated 
by subtracting the initial well values against the final well values using Microsoft Excel (ΔDAY 1 – 
DAY 7). If an absorbance value of > 0.1 was recorded (~ 2 x background noise) a positive growth 
outcome was noted. All values < 0.1 were noted as having no significant growth and therefore the 
isolate had been inhibited by the corresponding antibiotic. The number of isolates that could grow 
in x number of antibiotic–containing wells was then graphed for days 1 and 7 and the frequency 
distribution was graphed using Microsoft Excel. The number of incidences of resistance to each 
antibiotic was also graphed against antibiotic–type using Microsoft Excel.  
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5.3: Results 
5.3.1: Total Resistant CFU Counts: Formation of Single Drug 
Resistance over Time 
The data shown in figure 5.3 highlight the temporal change in the total number (log cells/ml) of 
culturable CTC-resistant bacteria (figure 5.3a) and SMX-resistant bacteria (figure 5.3b) that were 
present in microcosms that had been spiked with 3 antibiotic doses. It can be seen that resistant 
CFU counts showed a large rise over time at each dose group, including in controls. These data 
indicate that the density of resistant bacterial cells increased regardless of antibiotic dose. In CTC-
treated microcosms, the resistant CFU count showed an increase with increasing CTC 
concentration. Each resistant CFU count was significantly higher than the control CFU count value 
(P < 0.01). These data indicate that a statistically significant rise in resistance formation had 
occurred as a result of exposing microbial communities to all CTC doses. There was however no 
statistically significant rise in resistant CFU counts at any SMX dose group. These data suggest 
that exposing microbial communities to these SMX concentrations has no significant effect on the 
formation of SMX resistance.   
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a) 
 
b) 
 
 
Figure 5.3: Total resistant CFU counts of a) CTC-resistant bacteria and b) SMX-resistant bacteria 
that could be cultured from microcosms from each dose group on day 1 and day 7. Statistical 
significance is represented by asterisk notation (*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P 
≤ 0.0001). 
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5.3.2. Total CFU Counts of CTC and SMX-Resistant Isolates: Day 1 
versus Day 7 
The data in figure 5.3 show the combined (control plus dosed) total number of distinct 
morphotypes that could be harvested from each microcosm on day 1 and day 7 of the exposure. 
Note that these data are an initial indication of how many distinct morphotypes could be isolated 
from combined microcosms before further cross-referencing had been conducted. This initial 
analysis revealed that 52.6 % more CTC-resistant morphotype could be isolated on day 7 compared 
with day 1. It was additionally revealed that 57.1 % more SMX-resistant morphotypes could be 
isolated on day 7 compared with day 1. It can be concluded therefore that a temporal rise in CTC 
and SMX-resistant morphotypes occurred over the 7 day exposure in combined microcosms.  
 
 
Figure 5.4: Total number of distinct morphotypes that could be harvested from combined 
microcosms on day 1 (CTC Day 1 and SMX Day 1) and day 7 (CTC Day 7 and SMX Day 7) of the 
exposure.  
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5.3.3. CFU Counts and Morphotyping of Resistant Bacteria in Control 
Microcosms on day 1 and 7 
The data in figure 5.5 show CTC-resistant CFU counts in control microcosms on a) day 1 and b) 
day 7. The data shown by figure 5.6 show SMX-resistant CFU counts in control microcosms on a) 
day and b) day 7. The information in table 5.2 shows which other microcosms each CTC-resistant 
morphotype could be isolated from. It additionally shows which day 1 and day 7 CTC-resistant 
morphotypes could be cross referenced with each other based on their distinct characteristics. 
Detailed CTC-resistant morphotype characteristics can be found in appendix 1. The information in 
table 5.3 shows which other microcosms each SMX-resistant morphotype could be isolated from. It 
additionally shows which day 1 and day 7 SMX-resistant morphotypes could be cross-referenced 
with each other based on their distinct characteristics. Detailed SMX-resistant morphotype 
characteristics can be found in appendix 1.  
It can be seen form the data in figure 5.5a and the information in table 5.2 that every distinct CTC-
resistant morphotype that was isolated from day 1 control microcosms could be cross-referenced 
with a corresponding day 7 CTC-resistant morphotype, with two exceptions (CTCD1RES4 and 
CTCD1RES10). It can therefore be suggested that the majority of day 1 CTC-resistant morphotypes 
could be accounted for on day 7. This was also the case for SMX-resistant morphtypes that were 
isolated from day 1 control microcosms (figure 5.6a and table 5.3). Each of these morphotypes 
could be cross-referenced with a similar day 7 morphotype, with the exception of two distinct 
isolates (SMXD1RES2 and SMXD1RES6). It is likely that all day 1 CTC and SMX-resistant 
morphotypes that were found in control microcosms (and day 7 isolates that could be cross 
referenced with these morphotypes) were added to each microcosm (control and dosed) via river 
water, treated sewage or both due to the fact that they were expressing CTC/SMX resistance at the 
start of the exposure in unexposed microcosms. It also likely that CTCD1RES4, CTCD1RES10, 
SMXD1RES2 and SMXD1RES6 were also present at the start of the exposure, but disappeared from 
microcosms at some point during the seven day exposure. Data shown by figures 5.5b and 5.6b 
also confirm that each CTC and SMX-resistant day 7 morphotype that was successfully cross-
referenced with a corresponding day 1 morphotype could be accounted for in terms of varying cell 
densities (as shown by CFU data).  
Further data shown by figures 5.5b and 5.6b demonstrate that a number of day 7 CTC and SMX-
resistant morphotypes could not be accounted for in day 1control microcosms, as demonstrated by 
a zero CFU count. These data suggest that such morphotypes were not added to microcosms via 
river water or treated sewage at the start of each exposure. It is likely that these isolates developed 
antibiotic resistance during the exposure period. The next section (5.3.4) shall present more data 
regarding these morphotypes.  
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a) 
 
b) 
 
Figure 5.5: Resistant CFU counts for CTC-resistant bacteria that were present in control 
microcosms on a) day 1 and b) day 7. 
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a) 
 
b) 
 
Figure 5.6: Resistant CFU counts for SMX-resistant bacteria that were present in control 
microcosms on a) day 1 and b) day 7. 
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Table 5.2: Matching CTC-resistant morphotypes that could be detected on day 1 and day 7 following cross referencing of their morphotype characteristics. The dose 
groups in which they could be detected in are also listed. 
            Successful or Unsuccessful Detection (+/-)   Successful or Unsuccessful Detection (+/-) 
Day 1 
Morphotype 
0 mg/L 
CTC 
0.1 mg/L 
CTC 
0.32 mg/L 
CTC 
1 mg/L 
CTC 
Corresponding Similar 
Day 7 Morphotype 
0 mg/L 
CTC 
0.1 mg/L 
CTC 
0.32 mg/L 
CTC 
1 mg/L 
CTC 
CTCD1RES1 + + + - CTCD7RES14 + + + + 
CTCD1RES2 + + + + CTCD7RES28 + - - + 
CTCD1RES3 + + + + CTCD7RES7 + + + + 
CTCD1RES5 + + + + CTCD7RES26 + + + + 
CTCD1RES6 + + + + CTCD7RES3 + + + - 
CTCD1RES7 + + - + CTCD7RES4 + + - - 
CTCD1RES8 + + + + CTCD7RES6 + + + + 
CTCD1RES9 + + + + CTCD7RES20 + + + + 
CTCD1RES11 + + + + CTCD7RES22 + + + + 
CTCD1RES12 + + + + CTCD7RES10 + - - + 
CTCD1RES13 + + + + CTCD7RES12 + + + - 
CTCD1RES14 + + + + CTCD7RES19 + + + + 
CTCD1RES15 + + + - CTCD7RES8 + + + - 
CTCD1RES16 + + + + CTCD7RES15 + + + + 
CTCD1RES17 + + + + CTCD7RES21 + - - + 
CTCD1RES18 + + + + CTCD7RES24 + + + + 
CTCD1RES19 + + + + CTCD7RES11 + + + + 
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Table 5.3: Matching SMX-resistant morphotypes that could be detected on day 1 and day 7 following cross referencing of their morphotype characteristics. The dose 
groups in which they could be detected in are also listed. 
            Successful or Unsuccessful Detection (+/-)   Successful or Unsuccessful Detection (+/-) 
Day 1 
Morphotype 
0 mg/L 
SMX 
0.1 mg/L 
SMX 
0.32 mg/L 
SMX 
1 mg/L 
SMX 
Corresponding Similar 
Day 7 Morphotype 
0 mg/L 
SMX 
0.1 mg/L 
SMX 
0.32 mg/L 
SMX 
1 mg/L 
SMX 
SMXD1RES1 + + + + SMXD7RES21 + + - + 
SMXD1RES3 + + + + SMXD7RES11 + + + + 
SMXD1RES4 + + + + SMXD7RES2  + + + + 
SMXD1RES5 + + + - SMXD7RES10 + - + + 
SMXD1RES7 + + + + SMXD7RES20 + + + - 
SMXD1RES8 + + - + SMXD7RES18 + + - + 
SMXD1RES9 + + + + SMXD7RES6 + + + + 
SMXD1RES10 + + + - SMXD7RES13 + + + - 
SMXD1RES11 + + + + SMXD7RES19 + + + + 
SMXD1RES12 + + + + SMSD7RES17 + - + + 
SMXD1RES13 + + + + SMXD7RES5 + + + - 
SMXD1RES14 + + + + SMXD7RES9 + + + + 
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5.3.4. Analysis of Day 7 Isolates that could not be Cross-Referenced 
with a Day 1 Control Morphotype 
The information in tables 5.4 and 5.5 indicate the microcosms from which resistant morphotypes 
that were not detected in day 1 control microcosms, or cross-referenced with these morphotypes 
could be detected in. Table 5.4 shows that one morphotype could only be detected in a day 7 
control microcosm, two could be detected in both control and treated microcosms and nine could 
be detected only in microcosms that had been exposed to CTC. Table 5.5 also shows that only one 
unique day 7 SMX-resistant morphotype was present in exclusively day 7 control microcosms. In 
addition, four unique day 7 SMX-resistant morphotypes were found in both control and treated 
microcosms, while another five SMX-resistant morphotypes were found only in microcosms that 
had been exposed to SMX. By looking at tables 5.4 and 5.5 there is no obvious link between the 
presence of a resistant morphotype and antibiotic concentration. Indeed, antibiotic resistant 
morphotypes were detected at every antibiotic dose. 
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Table 5.4: Microcosms in which unique day 7 CTC-resistant morphotypes were detected in with an indication of whether resistance developed in control or treated 
microcosms. 
        Successful or Unsuccessful Detection (+/-)   
Morphotype 0 mg/L CTC 0.1 mg/L CTC 0.32 mg/L CTC 1 mg/L CTC 
Formation of Resistance in Treated (Tr) or 
Control (C) Microcosms 
CTCD7RES1 + - - - C 
CTCD7RES2 - - + + Tr 
CTCD7RES5 + + - - C + Tr 
CTCD7RES9 - + + - Tr 
CTCD7RES13 - + + + Tr 
CTCD7RES16 - + + + Tr 
CTCD7RES17 - + - - Tr 
CTCD7RES18 - + + - Tr 
CTCD7RES23 - - + + Tr 
CTCD7RES25 + + + - C + Tr 
CTCD7RES27 - + - - Tr 
CTCD7RES29 - + + + Tr 
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Table 5.5: Microcosms in which unique day 7 SMX-resistant morphotypes were detected in with an indication of whether resistance developed in control or treated 
microcosms. 
        Successful or Unsuccessful Detection (+/-)   
Morphotype 0 mg/L SMX 0.1 mg/L SMX 0.32 mg/L SMX 1 mg/L SMX 
Formation of Resistance in Treated (Tr) or Control 
(C) Microcosms 
SMXD7RES1 + + + + C + Tr 
SMXD7RES2 + + + + C + Tr 
SMXD7RES3 + - + + C  
SMXD7RES7 - + - - Tr 
SMXD7RES8 - + + + Tr 
SMXD7RES12 + + - + C + Tr 
SMXD7RES14 - + + - Tr 
SMXD7RES15 + + + + C + Tr 
SMXD7RES16 - - + - Tr 
SMXD7RES22 - + + + Tr 
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5.3.5. Temporal Expression of MDR by the Total Microbial 
Community (Control and Exposed) 
5.3.5.1. Frequency of MDR Phenotypes on Day and Day 7 of CTC and 
SMX Exposures 
Previous experiments have shown that morphotypes that are resistant to either CTC or SMX were 
either present at the start and throughout the exposure or have been detected at the end of the 
exposure. The data in figure 5.7 show the frequency different antibiotic resistant phenotypes were 
expressed by CTC-resistant morphotypes (isolated from all microcosms, control and treated) on a) 
day 1 and b) day 7 of the exposure. As antibiotic resistance was observed at all CTC and SMX 
concentrations, control morphotypes were also included in this study. On day 1 of the exposure, 
isolates expressed resistance to either a low number of antibiotics (or none at all) or a high number 
of antibiotics. Indeed on day 1 six morphotypes did not show resistance to any of the antibiotics 
that were tested, whereas six morphotypes were found to be resistant to between 21 and 24 
antibiotics. On day 7 the resistance distribution profile of all morphotypes tested showed a marked 
shift. Six morphotypes were shown to express between 2 and 21 resistant phenotypes and only two 
morphotypes expressed a resistant phenotype to no antibiotics at all.  Conversely, nine instances of 
morphotypes being resistant to between 21 and 24 antibiotics were recorded.   
The data in figure 5.8 show the frequency different antibiotic resistant phenotypes were expressed 
by SMX-resistant morphotypes (isolated from all microcosms, control and treated) on a) day 1 and 
b) day 7 of the exposure. On day 1 of the exposure, the number of resistance incidences was shown 
to be relatively more dispersed compared with the resistance frequency distribution on day 1 of the 
CTC exposure. At the lower end of the frequency scale, a total of 4 incidences of morphotypes 
expressing between zero and four resistant phenotypes was recorded. Conversely, there were eight 
incidences of isolates expressing between 18 and 24 resistant phenotypes. On day 7 there was a 
massive shift in the distribution of resistant phenotype occurrences. In fact, all day 7 SMX-resistant 
morphotypes expressed resistance to all 24 antibiotics.   
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a) 
 
b) 
 
 
Figure 5.7: Number of resistant phenotypes that were expressed to number of specific antibiotics 
by CTC-resistant morphotypes on day 1 (a) and 7 (b) of the CTC exposure period. 
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Figure 5.8: Number of resistant phenotypes that were expressed to number of specific antibiotics 
by SMX-resistant morphotypes on day 1 (a) and 7 (b) of the SMX exposure period. 
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5.3.5.2. Temporal Change of MDR Profile of the Total Microbial 
Community 
Section 5.3.5.1 demonstrated changes in the number of specific antibiotic resistance phenotypes 
that CTC and SMX-resistant bacteria expressed over time. The data in figure 5.9a show the number 
of morphotypes that were resistant to each antibiotic on PM11C plates on day 1 and day 7 of the 
exposure. The data shown by figure 5.9b show the number of morphotypes that were resistant to 
each antibiotic on PM12B plates on day 1 and day 7 of the exposure.  
On day 1 between five and six morphotypes were resistant to each antibiotic. There was little 
difference in the number of morphotypes that were resistant to each compound however; the 
number of incidences was always five or six. The data representing day 7 incidences of resistance 
to each antibiotic showed that the number of morphotypes that expressed resistance to every 
compound had increased. The greatest increases in resistance could be recorded for enoxacin, 
capreomycin and gentimycin. The lowest increases in resistance could be observed in the case of 
cloxacillin, nafcillin and lincomycin. The overall trend therefore showed that the exposure of the 
microbial community to CTC generally resulted in an increase in resistance to a number of 
different antibiotics, in most cases from a different class altogether to the test compound.   
The data representing day 1 resistance profiles for SMX-resistant morphotypes (figure 5.9b) 
indicate that resistance was expressed to between four and eleven individual antibiotics. The most 
resistance on day 1 was expressed to enoxacin, capreomycin and gentimycin. On day 7, there was a 
marked increase in the number of morphotypes that expressed resistance to each of the antibiotics 
tested. In fact, the data show that by day 7 of the exposure all morphotypes were resistant to every 
compound tested. In general, the data illustrate that exposure of the microbial community to SMX 
resulted in all of the SMX-resistant morphotypes expressing resistance to an increased number of 
compounds present on Biolog PM12B plates.      
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Figure 5.9: Number of isolates that expressed specific resistance to particular antibiotics as a result 
of exposure to a) CTC and b) SMX on day 1 and day 7 of the exposure. 
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5.3.6. Co-Selection of MDR in CTC and SMX-Resistance Microbes by 
CTC and SMX Exposure 
Previous sections in this chapter have demonstrated that a general increase in the incidence of 
MDR can be detected over time. It has also been demonstrated that nine CTC-resistant 
morphotypes (CTCD7RES2, CTCD7RES9, CTCD7RES13, CTCD7RES16, CTCD7RES17, 
CTCD7RES18, CTCD7RES23, CTCD7RES27 and CTCD7RES29) and six SMX-resistant 
morphotypes (SMXD7RES1, SMXD7RES2, SMXD7RES3, SMXD7RES7, SMXD7RES8, 
SMXD7RES12, SMXD7RES14, SMXD7RES15, SMXD7RES16 and SMXD7RES22) developed 
single drug resistance (to CTC and SMX) only in microcosms that had been exposed to antibiotics. 
The information in table 5.6 and 5.7 shows the MDR resistance profile of those isolates that could 
be grown in Biolog media for CTC and SMX-resistant morphotypes respectively. It should be 
noted that several isolates could not be transferred from R2A to Biolog PM Medium. These were 
CTCD7RES9, CTCD7RES17, CTCD7RES23, CTCD7RES27, SMXD7RES2, SMXD7RES2, 
SMXD7RES3, SMXD7RES7, SMXD7RES12, SMXD7RES14, SMXD7RES15 and SMXD7RES16. It 
can be seen that each morphotype that developed single drug resistance exclusively in the presence 
of CTC and SMX also expressed a much wider resistance profile. CTC-resistant morphotypes 
expressed resistance to between 14 and 24 distinct antimicrobial compounds. SMX-resistant 
morphotypes all expressed resistance to 24 antimicrobial compounds. It can be concluded therefore 
that morphotypes that have developed single drug resistance under the selective pressure of CTC 
and SMX are likely to also express a wider MDR profile. It is possible that these additional 
resistance phenotypes may be co-selected.  
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Table 5.6: MDR profile of CTC-resistant morphotypes that formed single drug resistance only in CTC-treated microcosms. 
   
Morphotype Name Total MDR Profile 
Total AB Resistance 
Count 
CTCD7RES2 
amoxicillin, cefazolin, erythromycin, potassium tellurite, minocycline, neomycin, enoxacin, amikacin, CTC, 
cloxacillin, lomefloxacin, bleomycin, colistin, capreomycin, demeclocycline, nafcillin, nalidixic acid,  
chloramphenicol, ceftrixone, gentimicin, cephalothin, kanamycin, ofloxacin 
23 
CTCD7RES13 
lincomycin, amoxicillin, cefazolin, erythromycin, potassium tellurite, minocycline, neomycin, enoxacin, 
amikacin, CTC, cloxacillin, lomefloxacin, bleomycin, colistin, capreomycin, demeclocycline, nafcillin, 
nalidixic acid, ceftrixone, gentimicin, cephalothin, kanamycin, ofloxacin 
23 
CTCD7RES16 
lincomycin, amoxicillin, cefazolin, erythromycin, potassium tellurite, minocycline, neomycin, enoxacin, 
amikacin, CTC, cloxacillin, lomefloxacin, bleomycin, colistin, capreomycin, demeclocycline, nafcillin, 
nalidixic acid,  chloramphenicol, ceftrixone, gentimicin, cephalothin, kanamycin, ofloxacin 
24 
CTCD7RES18 
amoxicillin, cefazolin, erythromycin, neomycin, enoxacin, amikacin, CTC, cloxacillin, lomefloxacin, 
capreomycin, chloramphenicol, gentimicin, kanamycin, ofloxacin 
14 
CTCD7RES29 
lincomycin, amoxicillin, cefazolin, erythromycin, potassium tellurite, minocycline, neomycin, enoxacin, 
amikacin, CTC, cloxacillin, lomefloxacin, bleomycin, colistin, capreomycin, demeclocycline, nafcillin, 
nalidixic acid,  chloramphenicol, ceftrixone, gentimicin, cephalothin, kanamycin, ofloxacin 
24 
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Table 5.7: MDR profile of SMX-resistant morphotypes that formed single drug resistance only in SMX-treated microcosms. 
   
Morphotype Name Total MDR Profile 
Total AB Resistance 
Count 
SMXD7RES1 
penecillin G, tetracyline, cabenicillin, oxacillin, penimepicycline, polymyxin B, paromomycin, vancomycin, 
D, L-serine hydroxymate, sisomycin, sulfamethazine, novobiocin, 2,4-diamino-6,7-diisopropylpteridine, 
sulfadiazine, benzethonium chloride, tobrmycin, sulfathiazole, 5-fluoroorotic acid, spectinomycin, 
sulfamethoxazole, L-aspartic-beta-hydroxamate, spiramycin, rifampicin, dodecyltrimethyl ammonium 
bromide 
24 
SMXD7RES8 
penecillin G, tetracyline, cabenicillin, oxacillin, penimepicycline, polymyxin B, paromomycin, vancomycin, 
D, L-serine hydroxymate, sisomycin, sulfamethazine, novobiocin, 2,4-diamino-6,7-diisopropylpteridine, 
sulfadiazine, benzethonium chloride, tobrmycin, sulfathiazole, 5-fluoroorotic acid, spectinomycin, 
sulfamethoxazole, L-aspartic-beta-hydroxamate, spiramycin, rifampicin, dodecyltrimethyl ammonium 
bromide 
24 
SMXD7RES22 
penecillin G, tetracyline, cabenicillin, oxacillin, penimepicycline, polymyxin B, paromomycin, vancomycin, 
D, L-serine hydroxymate, sisomycin, sulfamethazine, novobiocin, 2,4-diamino-6,7-diisopropylpteridine, 
sulfadiazine, benzethonium chloride, tobrmycin, sulfathiazole, 5-fluoroorotic acid, spectinomycin, 
sulfamethoxazole, L-aspartic-beta-hydroxamate, spiramycin, rifampicin, dodecyltrimethyl ammonium 
bromide 
24 
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5.4. Discussion 
A series of experiments were conducted to determine the extent to which SMX and CTC selected 
for single and multidrug resistance in the aquatic environment. The influence of resistance which 
was likely to have been added to microcosms (via treated sewage and river water) was also 
evaluated. A range of culture based approaches were utilised, including selective plating and 
multidrug susceptibility tests. Initial experiments revealed that CTC but not SMX exposure caused 
a significant increase in the number of resistant bacterial cells over time. All CTC doses caused this 
effect. A general increase in CTC and SMX-resistant morphotypes was observed over time in 
microcosms that had been exposed to both antibiotics. It was also observed that several antibiotic-
resistant morphotypes were present in day 1 control and dosed microcosms in both exposures (CTC 
and SMX), as well as being present in day 1 dosed microcosms. Some of these isolates were also 
present at the end of the exposure (day 7). It was also observed that several SMX and CTC-
resistant morphtypes emerged over time in both control and treated microcosms, in control only 
microcosms and exclusively in dosed microcosms. In general, the entire microbial community 
showed an increase in MDR over the exposure period. Morphotypes that had formed single drug 
resistance over time also mirrored the trend of the total microbial community by expressing a wider 
MDR profile on day 7 of the exposure.  
5.4.1. Culture of CTC / SMX - Resistant Morphotypes from Aquatic 
Microcosms 
 
Resistant isolates could be selectively cultured from microcosm contents that had been plated on 
R2A agar + 1 mg/L
 
CTC or SMX. However, when stored isolates were grown on Biolog BUG B 
agar the agar could not sustain the growth of all isolates. In addition to this, there were some Biolog 
PM11C and PM12B plates that did not show any growth at all when inoculated. The result of this 
was that a reduced resistance profile of culturable bacteria. The most likely cause of this is that 
some isolates were nutrient (media) shocked having been transferred from R2A agar to glycerol 
deep freeze then to Biolog BUB B agar. The cells were also subjected to a different growth 
medium in the form of Biolog IF-10a inoculating fluid. It is highly likely that all Biolog media was 
too nutrient–rich for aquatic isolates as it is a general medium and is not specifically designed for 
oligotrophic bacteria. Future experiments should investigate this. Azevedo et al. (2004) observed 
the shocking of aquatic H. pylori by increasing the nutrient content of growth medium. Reasoner 
and Geldreich (1985) observed that a wider array of aquatic microorganisms were able to grow on 
R2A media compared with a standard plate count media. Straskravoba (1983) demonstrated that 
starved aquatic organisms (simulating natural conditions) that were transferred to a more nutrient 
rich media showed a short term loss in viability and a long term loss of biochemical function. 
Accordingly, a repeat of the study should be conducted using R2A agar only and R2A broth should 
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be used as inoculating fluid. Both of these measures would potentially reduce any media–specific 
growth factors.  
In the present study it was however possible to isolate a number of morphotypes that expressed 
resistance to CTC and SMX. It was possible to culture more morphotypes on day 7 compared with 
day 1 of the study. It was shown that a portion of the microbial community that was present in 
aquatic microcosms were already resistant to CTC and SMX. The microcosm contained both river 
water from a “pristine” location and 5% treated sewage, so these are the two possible sources of 
resistant bacteria. Other studies have detected the presence of antibiotic resistance in pristine 
aquatic environments (Lima-Bittencourt et al., 2007). In addition to this, there has been a wealth of 
literature reporting the presence of resistant isolates in sewage effluent. Many of these studies have 
detected tet and sul genes (Zhang et al., 2009).  It is highly likely therefore that a significant pool of 
antibiotic resistance was added to every microcosms system at the start of each exposure.  
The addition of resistance genes to an aquatic system via an STP has also been reported in the 
aquatic environment, acting to increase the natural resistance gene reservoir (Szczepanowski et al., 
2004; Silva et al., 2006; Zhang et al., 2009). The aquatic microcosms that were developed in the 
current study therefore provide a realistic simulation of natural aquatic habitats. The 1:20 dilution 
of surface water: treated sewage used in aquatic microcosms is likely to vary between different 
rivers and different aquatic systems within different countries however. Accordingly, the contents 
of the microcosm system could be changed. This would allow site and geographically–specific 
simulations. The resistome of aquatic systems can also be influenced by other additional factors, 
such as manure amendment (Mackie et al., 2006) and surface run–off from agricultural areas 
(Selvaratnam and Kunberger, 2004). Again, the contents of the microcosm system presented in the 
current study could be altered accordingly to simulate a range of variables. 
Wide arrays of resistance mechanisms are likely to be responsible for conferring tetracycline and 
sulfonamide resistance in aquatic microcosms. In the case of tetracycline resistance, genes have 
been detected from each of the mechanistic groups of tetracycline resistance (efflux, ribosomal 
protection and enzymatic modification) in sewage effluent and surface water. All three sul genes 
(sul I, sulII and sulIII) have also been detected in the same matrices (Zhang et al., 2009). The 
resistance genotypes that were expressed in the present study are therefore likely to be comprised 
of a wide and diverse array of genetic resistance determinants.  
5.4.2 Development of CTC and SMX Resistance over Time in Aquatic 
Microcosms 
The fact that more resistant morphotypes could be isolated on day 7 compared with day 1 indicates 
that the portion of the culturable microbial community had developed tetracycline or sulfonamide 
resistance during the exposure period. This was further shown by the emergence of SMX and CTC- 
resistant morphotypes exclusively in microcosms that were dosed with CTC and SMX. Resistant 
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CFU counts also showed that each CTC concentration caused a significantly higher resistant-cell 
density compared with control values on day 7 of the exposure. A similar result was not repeated 
during the SMX exposure however, with no significant increase in day 7 resistant CFU counts 
being observed compared with control values. In both exposures a large increase in CTC and SMX-
resistant CFU counts was observed on day 7 compared with day 1 at all CTC and SMX 
concentrations (including controls).   
Other studies have also observed an increase in CFU counts as a result of antibiotic exposure. Kim 
et al. (2007) observed an increase in cell density and production rate of tetracycline–resistant 
activated sludge bacteria as a result of exposing the microbial community to 250 µg/L tetracycline. 
Kanpp et al. (2008) found that a lower oxytetracycline concentration of 20 µg/L caused an increase 
in the ratio of tet genes: total 16S RNA, inferring that tetracycline resistance had developed over 
time in a series of aquatic microcosm experiments. Other investigations have observed the 
formation of tetracycline resistance in systems that were exposed to higher tetracycline 
concentrations. Yu et al. (2009) showed that an oxytetracycline concentration of 5 mg/L
 
resulted in 
an increased resistant cell density of Enterococcus faecalis. Rhysz and Alverez (2004) found that 
50 mg/L
 
tetracycline (in agricultural run–off) resulted in an increased concentration of resistant 
bacteria in the aquatic environment. Kerry et al. (1996) investigated tetracycline resistance 
formation in the marine environment. Their findings indicated that oxytetracycline concentrations 
of 6.25 and 25 µg/g resulted in an increase of resistant CFU frequencies (7% and 90% 
respectively). The literature therefore agrees with the findings of the present study, with some 
higher and lower inputs of selective pressure (tetracycline concentration) having resulted in the 
formation of tetracycline resistance.  
Other studies have investigated the formation of sulfonamide resistance in the environment. Brandt 
et al. (2009) observed that soil microbial communities had become tolerant to a sulfadiazine 
concentration of 1 µg/g after 15 weeks of exposure to the compound based on PICT experiments. 
Heuer et al. (2008) were able to show a direct correlation between the formation of sulfonamide 
resistance (indicated by a temporal increase in sulII gene abundance) following sulfadiazole 
application to soil over time. Modeling approaches suggested that a sulfadiazole concentration of 
0.15 mg/kg acted as a sufficient selective pressure for resistance to form. Heuer and Smalla (2007) 
concluded that sulfadiazine (10 and 100 mg/kg) had a synergistic effect with manuring of soils on 
the formation of sulfonamide resistance over time. A recent aquatic study concluded that 
sulfonamide resistance in aquatic sediments (measured as sul gene abundance) could be positively 
correlated with higher total sulfonamide concentrations down a 72 km stretch of river (Yi et al., 
2010). The results of these studies generally agree with the findings of the present investigation in 
terms of resistant morphotypes emerging in SMX-exposed microcosms; the concentrations 
observed to have selected for sulfonamide resistance are generally in the same magnitude also. 
CFU counts could detect a significant rise in resistance compared with control values on day 7 of 
the exposure however. It is possible that a greater portion of SMX-resistant bacteria (than CTC-
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resistant bacteria) are not culturable. This could be confirmed by a molecular technique such whole 
community sequencing or PCR-DGGE.  
In general though, the findings of Knapp et al. (2010) that antibiotic resistant gene abundance 
(especially tet genes) has increased in the environment over the last few decades of heavy antibiotic 
usage is perhaps the greatest insight into how antibiotics residues in the environment have 
increasingly selected for resistance in the environment.  
Interestingly, distinct resistant morphotypes also emerged in control microcosms over the 7 day 
period. A total rise in CTC and SMX-resistant CFU counts was also observed between day 1 and 
day 7. These findings could perhaps be explained by the increasing presence of mechanisms that 
are responsible for the general efflux of toxic/waste materials from microbial cells (Koronakis et 
al., 2004). General efflux mechanisms such RND and MATE family efflux systems can expel a 
massive range of unwanted but unrelated compounds from a bacterial cell. Hernandez et al. (2009) 
for example reported the presence of the general efflux mechanism smeDEF in the aquatic isolate 
Stenotrophomonas maltophilia.  
In general however it is possible to explain the increase in resistance in tetracycline and 
sulfonamide resistance in terms of natural selection, in the sense that only those members of the 
microbial community that could genetically code for resistance mechanisms could survive 
antibiotic treatment. Some of the microbial community may have acquired resistance by horizontal 
gene transfer. The transfer of tetracycline and sulfonamide resistance has been shown 
experimentally by mating studies (Nagachinta and Chen, 2008; Byrne–Bailey et al., 2009; Agerso 
and Sandvang, 2005). Moreover, transfer of tetracycline and sulfonamide resistance has also been 
shown to occur in specific environmental matrices. Knapp et al. (2008) for example detected a link 
between tet gene transfer and the presence of transposons in aquatic studies. Byrne–Bailey et al. 
(2009) found a possible link between sulI gene transfer and class 1 integrons. It is therefore 
possible that certain sul and tet genes were transferred from resistant members of the microbial 
community to non–resistant members. The total resistance within a microcosm would thus be 
increased (which could be detected by selective plating).  
5.4.3. Presence of Multidrug Resistance on Day 1 of Aquatic 
Microcosm Experiments 
The results of the present study have indicated that a degree of multidrug resistant isolates were 
present in both microcosms (exposed to CTC and SMX) on day 1 of the exposure period (6 MDR 
profiles in CTC microcosms and 8 MDR profiles in SMX microcosms). From the available 
literature it is clear that multidrug resistant bacteria have been isolated from various environmental 
matrices including the soil (Peron et al., 2008; Byrne-Bailey et al., 2009; Singh et al., 2007; Santos 
et al., 2007; Burgos et al., 2005; Hayes et al., 2004) and the marine and estuarine environment 
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(Fernandez–Delgado and Suarez, 2009; Laroche et al., 2009; Fricke et al., 2008; Chandran et al., 
2008; Dang et al., 2007; Parveen et al., 1997).  
There have also been several reported occurrences of multidrug resistance in the aquatic 
environment. This has been reported as far back as 1991, when Magee and Quinn isolated 73 
aquatic isolates that were resistant to 8 antibiotics. Since then several more investigations have 
detected MDR in the aquatic environment (Ozgumus et al., 2009; Zhang et al., 2009; Verner–
Jeffreys et al., 2009; Jianying et al., 2008; Lima-Bittencourt, 2007; Park et al., 2003). When the 
individual resistance profiles were analysed, there did not appear to be any particular pattern 
however. It is likely therefore that MDR profiles in the environment are dependent upon sample 
site and geographical location. Indeed MDR profiles have been shown to depend on other factors, 
such as season (Jianying et al., 2008). The results of the current study are therefore consistent with 
other studies that have detected MDR in the environment.  
It is also possible that MEPPs were present in aquatic microcosms. These mechanisms have also 
been detected in various environments including surface water (Hernandez et al., 2009; Frike et al., 
2008; Long et al., 2008), aquatic sediment (Groh et al., 2006) and also in STPs (Szczepanowski et 
al., 2004). Such resistance mechanisms are not compound–specific and as such are capable of 
expunging a huge number of toxicants out of a bacteria cell (Koronakis et al., 2004). Interestingly, 
one study reported the presence of multiple resistance genotypes and MEPPs (Florian–Fricke et al, 
2008). The possibility of multidrug resistance being present on day 1 in aquatic microcosms as a 
result of multiple general mechanisms and general efflux mechanisms is therefore presented.  
5.4.4. Development of Multidrug Resistance in Aquatic Microcosms 
The results of the current study have indicated that multidrug resistance forms over time in the 
aquatic environment. Some of this MDR formation was not due to exposing the microbial 
community to CTC or SMX it would appear. However, the presence of several MDR isolates were 
not detected in control microcosms, suggesting that the selective pressure exerted by CTC and 
SMX selected for the formation of MDR also. With the exception of one isolate that was screened 
for MDR, resistant morphotypes expressed between 22 and 24 different resistant phenotypes. These 
data would suggest that antibiotic resistance can be co-selected in aquatic systems.  
There have been other reported incidences of co–selection of antibiotic resistance in the 
environment. Peterson et al. (2002) observed co–selection of chloramphenicol, ciprofloxacin, 
erythromycin, oxytetracycline, sulfamethizine and trimethoprim as a result of exposing an aquatic 
system to farm animal waste (likely to contain tetracyclines).  
Other studies have concentrated on detecting an increase in mobile genetic elements (that are 
highly likely to carry multiple transferrable genotypes) as a result of the exposure of microbial 
communities to antibiotics and metals (Wright et al., 2008) and sulfonamides in particular (Heuer 
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et al., 2007). The literature therefore provides some corraboration although the current study 
potentially provides novel evidence of tetracycline and sulfonamide–mediated co–selection of 
antibiotic agents.  
The available literature also presents a number of reported occurrences of multiple gene transfer in 
the environment. It is possible that these processes provide the explanation for why MDR 
characteristics were co–selected by exposure to CTC and SMX in the aquatic microcosms studied 
in the current investigation. 
The transfer of multiple resistance genes is a possible explanation to explain why there was an 
increase in multiple resistance phenotypes over the 7 days of exposure to both compounds. Many 
studies have shown that multiple genetic resistance determinants can be transferred between 
environmental microbes. A number of these studies have additionally identified the role of mobile 
genetic elements such as class 1 integrons and transposons in the transfer of multiple resistance 
genes.  
Ozgumus et al. (2009) reported that ampicillin, tetracycline, trimethoprim, streptomycin, and 
nalidixic acid resistance traits were all transferrable between isolates that had been cultured from 
Turkish rivers. PM11C studies in the current investigation showed that CTC resistance can 
potentially be co–transferred with nalidixic acid resistance. Both studies have therefore 
demonstrated that tetracycline and nalidixic acid resistance mechanisms can be co–selected. The 
same study also detected class 1 and class II integrons that were carried by many of the isolates 
tested. This provides some evidence that tetracycline and nalidixic acid genes may be co–
transferrable of these mobile genetic elements. 
Laroche et al. (2009) investigated the presence of multidrug resistance profiles in aquatic isolates 
in relation to the presence of class I and class II integrons. They observed that the presence of both 
tetracycline and sulfonamide resistance were often accompanied by several other resistance 
profiles. One isolate for example showed resistance to amoxicillin, kanamycin, CTC, tetracycline 
and nalidixic acid and sulfamethoxazole. In the present study CTC resistance was co–selected with 
amoxicillin, nalidixic acid and kanamycin resistance. In addition, sulfamethoxazole resistance was 
co–selected with tetracycline resistance. Tetracycline and sulfonamide resistance could also be co 
selected with cephlalosporin resistance and tetracycline resistance could also be transferred with 
chloramphenicol resistance; these selection patterns were also observed in the present study. This 
investigation therefore shows some similar results to the present study. The int2 gene was also 
present suggesting the possibility that resistance genes could be horizontally transferred. It is 
noteworthy however that sequence analysis of the variable intgeron regions could not explain the 
multitude of resistance profiles. 
Zahid et al. (2008) investigated the co–transfer of tetracycline resistance (the gene was not 
specified and only referred to as “tetR”) in a series of mating experiments involving aquatic 
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bacteria. They found that tet
R 
could be co–transferred with sulfamethoxazole, trimethoprim, 
erythromycin and streptomycin. The present study has shown that tetracycline and erthythromycin 
resistance were co-transferrable also. It was additionally shown that sulfamethoxazole and 
tetracycline resistance were co–selected. The two data sets therefore demonstrated some agreement 
in their findings.  
In another study, Park et al. (2003) found that sulfamethoxazole resistance had been co–selected 
alongside resistance to aminoglycosides and β–lactam resistance. In the present study 
sulfamethoxazole resistance was co–selected with aminoclycoside resistance. One example of this 
was the co–selection of tobramycin resistance. Co–selection of β–lactam resistance was also 
witnessed in the present study, in the case of penicillin G resistance co–selection for example. The 
findings of this study therefore provide more corraborating evidence with the present investigation.  
Mukherjee and Chakraborty (2006) also detected co–selection of antibiotic resistance. Their 
investigation revealed the presence of a variable gene cassette (found on class I integrons) that 
contained sequences for several resistance genes, including sequences that coded for β–lactam and 
aminoglycoside resisance determinants. Although the study did not show co–selection of resistance 
along with tetracycline or sulfonamide resistance studied in the present investigation, it still 
provided more evidence of the occurrence of co–selection of antibiotic resistance in the 
environment.  
It also possible that MDR formed in aquatic microcosms due to the transfer of genes that code for 
MEPPs. To the best of my knowledge this has not yet been studied in the environment or in mating 
studies. If genes coding for MEPPs were shown to be transferrable this would provide more 
evidence to explain why MDR was formed in the present study. Alternatively, it is also possible 
that MEPPs were present in one or more resistant isolates all along but were only expressed when 
antimicrobial compounds were added to their habitat (ie: gene expression was being induced). 
Another scenario could be that a portion of the aquatic microbial community was expressing 
MEPPs in response to the build-up of toxic waste products within the microcosm system. In this 
scenario, antibiotic molecules could potentially have been expelled from microbial cells as general 
toxicants. Bacteria that would have produced these systems may not have been affected by 
selective pressure as they would have been able to avoid antimicrobial toxicity. It is conceivable 
that such bacteria would also have been able to thrive equally as well in control microcosm and 
spiked microcosms. In this scenario, antibiotic exposure may have been of reduced significance. 
Several studies have reported the apparently low fitness cost of developing MDR (Ward et al., 
2009; Trindade et al., 2009). It is therefore in a microbe’s best interest (in an evolutionary sense) to 
become resistant to as many antibiotics as possible considering the low risks involved. The current 
investigation detected the presence of morphotypes that had developed resistance in control only 
systems (over the seven day exposure). As antibiotics were not added to these microcosms one 
must seek an alternative selective pressure which selected resistance. It is however possible that a 
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cocktail of antimicrobial compounds already have existed within the river water and treated sewage 
that comprised the majority of microcosm liquid (see table 1.3). It is possible that these compounds 
may have been selecting and co-selecting for the expression of specific and general resistance 
mechanisms. In the scenario that the build-up of toxic waste (such as ammonia) was causing an 
increased expression of general efflux mechanisms (which will expel toxic waste from bacterial 
cells) it is also possible that antibiotics will be expunged inadvertently. If toxic waste products are 
present within microcosms then it possible that toxic waste products are acting as a selective 
pressure for general efflux genes being horizontally transferred. It has been previously 
demonstrated that toxic compounds can co-select for mechanisms that also protect microbes from 
other, unrelated toxic compounds (eg: Burgos et al., 2005). Also, given the presence of bacteria 
that were resistant to more than one antibiotic at the start of the exposure, it is clear that a resistant 
gene pool was available from which a range of resistance genotypes (possibly general and specific) 
could be transferred to previously susceptible bacteria. It is also worth mentioning that class 1 
integron genes have been detected (in sediment-dwelling bacteria) which lacked the type of 
transposons (Tn402-like) that would normally be associated with the spread of antibiotic resistance. 
These integrons also lacked any antibiotic resistance genes.  This study therefore demonstrates that 
genetic determinants were being transferred bfore the “antibiotic era” and that transfer of genetic 
antibiotic reistance determinants may occur in the absence of a positive selective pressure such the 
presense of antibiotic resistance (Stokes et al., 2006).  
It remains unclear as to whether resistance developed in control microcosms due to a particular 
selective pressure (such as exposure to ammonia for example) or occurred passively due to the 
microbial developing antibiotic resistance at a low fitness cost. The only way to study this would 
be to follow temporal resistance formation in truly pristine test systems. One option would be to 
utilize synthetic media (such as synthetic pond water or mineral medium) and study the 
formation/donation of resistance by pure cultures with known resistance profiles.  
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Chapter 6: General 
Discussion 
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6. General Discussion 
Antibiotics are specifically targeted to kill pathogenic bacteria in both human and veterinary 
medicine. As a result of the necessary usage of antibiotics they may enter the aquatic environment 
via a number exposure routes such as STP effluent and surface run-off from agricultural areas. As a 
result, antibiotics have been detected in several aquatic environmental matrices, such as surface 
water (e.g.: Kolpin et al., 2002), sediment (e.g.: Lalumera et al., 2004) and groundwater (e.g.: 
Karthikeyan and Bleam, 2003). Several studies have demonstrated that antibiotics exert a targeted 
effect on the soil microbial community, such as inhibiting microbial respiration (e.g.: Thiele-Bruhn 
and Beck, 2005). 
Despite this, there is a lack of data on how antibiotics may affect aquatic microbial communities. 
This is reflected in the current environmental risk assessment of antibiotics, which relies on tests 
that are ecologically irrelevant for the aquatic environment as well as being conducted in too brief a 
time period.  
To address these issues, a series of experiments were conducted that initially focused on 
developing a more ecologically relevant test system that could detect the effects of two antibiotics 
from classes that have been frequently detected in the environment due to their heavy global usage 
(sulfamethoxazole and CTC).  A microcosm system was developed that contained 90% river water 
as a basic test medium, 5% treated sewage to increase biomass and provide environmental 
relevance and 5% OECD synthetic sewage as a nutrient source. As such, the test system provided a 
“bridge between theory and nature” (Fraser, 1999).  In addition to this, a multisubstrate utilisation 
assay (Biolog GN2) was optimized for use in aquatic microbial ecotoxicological studies and some 
issues that had been raised in the literature were resolved (Preston-Mafham et al., 2002; Garland, 
1996; Haack et al., 1995).  These were concerning relating to inoculum density, detection of 
substrate utilization rates in relation to lag times, nutrient carryover, taking multiple time-point 
readings and adding equal volumes of inoculum to each well. The current investigation 
demonstrated methods that should ultimately take away these concerns. The combined microcosm-
GN2 system was shown to be repeatable in the absence of a toxicant and could be validated against 
the OECD reference toxicant 3, 5-DCP. In addition, the system could detect the effects of and 
recovery to 3, 5-DCP.  
The present study has therefore developed an approach that is arguably more environmentally 
relevant than the current standard test battery. As pointed out in section 2.4, laboratory test systems 
will never fully recreate a natural aquatic environment in terms of its full complexity; there are far 
too many variables to take into consideration. Having said this, conducting the current investigation 
under field conditions would have been logistically and financially infeasible. The current test 
system has also been shown to be capable of detecting the effects of environmental toxicants on 
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aquatic microbial communities. Further, the system also allows the removal of contents for further 
analysis with minimum disruption. As such, A “one system fits all” was developed.  
A test system was now in place that could test the effects of antimicrobial compounds on microbial 
function in a simulated aquatic environment. As the Biolog GN2 assay can assess a range of carbon 
and nitrogen sources belonging to 5 ecologically relevant “guilds” (Preston-Mafham, 2002) the 
system can detect carbon and nitrogen turnover in the aquatic environment. The system can 
therefore detect many more ecologically relevant end-points than the current range of microbial 
toxicity tests. The current test system can track the effects of pharmaceuticals on aquatic microbial 
communities, not sludge communities (as the ASRIT does) or single algal or marine species (as the 
Microtox or other single species testing do). In addition, the system is generally equallyas sensitive 
than these tests, with a LOEC of 0.1 mg/L having been detected. Table 6.1 summarises the toxicity 
of CTC and SMX that have been previously reported, alongside the results of other published 
standard test information. Toxicity values obtained in the present study are generally comparable. 
However, this generally holds true for Microtox only when the test duration is increased (Backhaus 
et al., 1997).  
This test system was then used to test the effects of two antibiotics on microbial function. Acute 
effects were observed on total substrate utilisation for both compounds in terms of lag phase, max 
rate and multivariate analysis. This was in accordance with other studies that had tested the effects 
of antibiotics on total substrate utilisation in Biolog plates in other environmental matrices (Kong et 
al., 2006; Maul et al., 2006; Schmitt et al., 2005). The mode of action of each antibiotic could 
explain these effects; tetracyclines inhibit protein synthesis and sulfonamides prevent the 
biosynthesis of folic acid. Both of these compounds would therefore be expected to prevent 
microbial growth and therefore reduce the extent to which bacteria can utilize substrates. 
Jankhe and Craven (1995) report the ability of aquatic microorganisms to utilise a broad range of 
molecules contained within DOC (dissolved organic carbon). Blomqvist et al. (2001) demonstrated 
the importance of DOC in terms of its conversion into microbial biomass while Tranvik and Hofle 
(1987) commented on the efficiency with which microbes achieve this. Landi et al. (1993) have 
already reported a significant decrease in soil respiration rates as a result of exposure to 
streptomycin. The results of the present study therefore raise concerns over the ability of aquatic 
bacteria to utilize a wide range of substrates in their environment.  
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Table 6.1: Reported toxicity by microbial standard tests. 
   Test  Result Reference 
Microtox 
oxytetracycline: EC50 = 64.5 mg/L; sulfamethoxazole: EC50 = 
23.3 mg/L; oflaxacin: 25% growth inhibition at 100 mg/L 
Isidori et al., 
2005 
Microtox 
oxytetracycline, erythromycin, ofloxacin and oxolinic acid: EC50 
= 66-550 mg/L 
Christensen 
et al., 2006 
Microtox 
sulfamethoxazole: EC50 (15 and 30 mins) = 74.2 and 78.1 mg/L; 
sulfachloropyridizine: EC50 (15 and 30 mins) = 53.7 and 26.4 
mg/L 
Kim et al., 
2007 
Microtox 
flumequine: EC50 = 12.12-15.24 mg/L; oxytetracycline: EC50 = 
121.01 - 139.31 mg/L 
Lalumera et 
al., 2004 
Microtox 
nalidixic acid: EC50 (24 hour) = 0.21 mg/L; streptomycin 
sulphate: EC50 (24 hour) = 20.6 mg/L; chloramphenicol: 0.074 
mg/L 
Froehner et 
al., 2000 
Microtox 
nalidixic acid: EC50 (24 hour) = 0.184 mg/L; tetracycline: EC50 
(24 hour) = 0.024 mg/L 
Backhaus et 
al., 1997 
Microtox 
chloramphenicol, tetracycline, nalidixic acid, norfloxacin and 
norfloxacin: EC50 (24 hour) < 1 mg/L 
Backhaus 
and Grimme, 
1999 
Pseudomonas 
putida 
Growth 
Inhibition 
Test 
ciprofloxacin: EC50 = 80 µg/L; ofloxacin: EC50 = 10 µg/L 
Kummerer et 
al., 2000 
Pseudomonas 
putida 
Growth 
Inhibition 
Test 
tetracycline: MIC50 = 2 mg/L; CTC: MIC50 = 0.5 mg/L; 
oxytetracycline: MIC50 = 1 mg/L 
Halling 
Sorensen et 
al., 2002 
Microcystis 
aeruginosa 
Growth 
Inhibition 
Test 
levofloxacin: EC50 = 7.9 µg/L; ciprofloxacin: EC50 = 17 µg/L; 
ofloxacin: EC50 = 21 µg/L; enrofloxacin: EC50 = 49 µg/L; 
flumequine: EC50 = 1960 µg/L 
Robinson et 
al., 2005 
Microcystis 
aeruginosa 
Growth 
Inhibition 
Test 
mecillinam: EC50 = 0.06 mg/L; ciprofloxacin: EC50 = 0.005 mg/L 
Sorensen et 
al., 2000 
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Both antibiotics also exerted significant effects on substrate guild utilisation. For both antibiotics 
acute effects could be detected for amine and amide, amino acid, carbohydrate, carboxylic acid and 
polymer utilisation. Each of these end-points indicated the inhibition of key ecological processes 
within the aquatic environment. These can be generally categorized as effects on the nitrogen cycle 
(amines and amides and amino acids), the carbon cycle (carbohydrate and carboxylic acids) and on 
degradatative processes (polymer utilisation).  
The nitrogen cycle is responsible for recycling inorganic nitrogen from nitrogenous compounds 
such as amines and amino acids. Any disruption of this process could lead to a reduction in key 
processes such as the ammonification, deamination and nitrification. Other studies have also 
gathered data that points to the potential disruption of nitrogen cycling by antibiotics (Brandt et al., 
2009; Verma et al., 2007; Kong et al., 2006; Halling Sorensen et al., 2000; Halling Sorensen, 2000; 
Klaver and Mathews, 1994; Wheeler and Kirchman, 1986; Sevag and Green, 1944). This area 
therefore warrants further investigation. This should start with the testing of as many antibiotics as 
possible as a range of compounds from different classes have shown potential toxicity towards 
nitrogen cycling. The effects of various antibiotics on microorganisms that perform key distinct 
roles within the nitrogen cycle should also be investigated using molecular techniques such DGGE 
and TRFLP for community analysis and q-RT-PCR for specific gene analysis. Interestingly, there 
is a suite of nitrogen metabolizing end-points within a specially designed Biolog plate for 
investigating the utilisation of nitrogenous compounds (PM3B), nitrogen peptide compounds 
(PM6, PM7 and PM8) and also an array for testing the utilisation of nitrogen sources at different 
pHs (PM10) (Biolog 2010). A combination of these approaches could potentially be employed 
within the context of microcosm studies similar to the one used in the current investigation.  
Carbon turnover (which can be linked to processes that occur within the carbon cycle) is also a key 
ecological process. The importance of aquatic bacteria in the utilization of DOC constituents has 
been previously reported (Blomqvist et al., 2001; Tranvik and Hofle, 1987). Specifically, 
carbohydrates are an important energy source for aquatic microorganisms. Carboxylic acids are an 
important constituent of humic material in the environment (Kawahigashi and Sumida, 2006). The 
importance of carboxylic acid utilisation to the functioning of microbial function has also been 
reported (eg: Naumann, 1918). The current study saw that both antibiotics inhibited the utilisation 
of both carbohydrates and carboxylic acids. Interestingly, the mode of action of each antibiotic can 
be linked to this inhibitory effect in terms of retardation of protein synthesis and the inhibition of 
purine base biosynthesis (Tritton, 1977; Gale et al., 1981; Chopra, 1985; Rasmussen et al., 1991; 
Altman, 1946).   
Other studies have also found that a range of antibiotics tend to interfere with carbon turnover by 
microorganisms (Kong et al., 2006; Maul et al., 2006; Zielezny et al., 2006; Boleas et al., 2005; 
Thiele-Bruhn and Beck, 2005; . Vaclavik et al., 2004; Sevag et al., 1945; Clinton and Loeuringer, 
1942; Dorfman and Koser, 1942; Sevag and Shelburne, 1942). The results of these studies, as well 
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as those presented in the current investigation therefore raise concerns over the tendency of 
antibiotics to interfere with carbon turnover in the environment. Consequently, the issue merits 
further investigation. This could take the form of testing as wide a range of antibiotics as possible, 
in particular new antibiotics such as fourth generation cephelosporins and tigecycline (a new 
tetracycline antibiotic). In addition to this, detailed metabolomics technology could tease out 
specific biochemical alterations in the microbial metabolome. Specific gene analysis of important 
enzymes involved in the utilisation of carbohydrates could also be conducted.  
Polymer utilisation was another specific end point that was affected by both antibiotics. The current 
study has suggested that this could have consequences for degradative processes that occur in the 
aquatic environment. Microorganisms play a key role in degrading natural polymers in the 
environment, such as lignin for example (Kirk and Farrell, 1987), but have also been shown to be 
able to degrade a huge array of polymeric compounds some of which were once thought to be 
recalcitrant to degradation (Shimano, 2001; Howard, 2002; Szostac-Kotowa, 2004; Shah et al., 
2008). Microrganisms ultimately assimilate polymers as cellular biomass and energy (Lucas et al., 
2008). In addition, environmental microorganisms play a key role in the degradation of a wide 
array of xenobiotic compounds (Allocati et al., 2009).   
Other studies have also detected the inhibition of polymer utilisation by antibiotics (Kong et al., 
2006). Other studies have also demonstrated that antibiotics inhibit the degradation of a number of 
xenobiotic compounds such as synthetic hormones (Chun et al., 2005), pesticides (Allen and 
Walker 1987) and pharmaceuticals (Montiero and Boxall, 2009). Montiero and Boxall also point 
out that pharmaceuticals are rarely present by themselves in the environment. Not only is this a 
concern in terms a possible additive antibacterial effect (Christensen et al., 2006) but also raises 
concerns that a potentially huge array of degradative processes are being inhibited by antibiotics in 
the environment. Future work is therefore warranted. The effect of antibiotics on the degradation of 
both naturally occurring and xenobiotic polymeric compounds should be investigated. This is a 
daunting thought considering how many possible polymers and xenobiotic compounds are present 
in the environment. High-throughput methods would therefore have to be developed to save time 
and labour intensity. In addition to this, molecular techniques such as q-RT-PCR should be utilized 
to investigate the specific genes that code for degradative enzymes (both specific and general) and 
how the expression of these are affected by antibiotics. Another approach could be to 
biochemically assay specific degradative systems. For example the current investigation suggested 
that sulfonamides may interfere with the glutathione-s-transferase degradative mechanism. This 
also leads to the conclusion that more care should be taken to properly evaluate not just the mode 
of action of an antibiotic but also take into account the knock-on effects of what this will cause. 
This could lead to the development of more rigid hypotheses and targeted test design. The current 
investigation for example has highlighted the knock on effects of folate deficiency as result of 
sulfonamide intoxication, such as inhibiting crucial metabolic cofactors (Altman, 1946). This can 
often involve the review of complex biochemical pathways. 
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As well as detecting a range of specific acute effects of CTC and SMX, the current investigation 
also showed that effects can show later on in study period. It was interesting to speculate why this 
may have happened. In the case of CTC, it was hypothesized that there may have been a toxic 
effect of a CTC metabolite or transformation product, as was observed by Halling-Sorensen in 
2002. This certainly merits further investigation. This could possibly take the form of specific 
metabolite analysis with mass spectrometry to identify the presence of any toxic metabolites and 
toxicity testing of the actual metabolites. However, this would not be easy in the case of CTC 
considering the 64 possible tautomer conformations, five protonation sites and four dissociation 
constants (Duarte et al., 1998; Jin et al., 2007). Degradation studies have suggested that the half-
lives of tetracyclines are between 1 and 4 days (Verma et al., 2007; Sanderson et al., 2005).  
However these studies took place in the presence of light. Tetracyclines are known to 
photodegraded (Thiele-Bruhn and Peters, 2007; Bautitz and Nogueira, 2007; Sanderson et al., 
2005). When studies in the absence of light have been investigated, half-lives of between 13 and 18 
days have been reported (Verma et al, 2007). During the present study samples were taken and 
stored for specific analysis. Given the variation in degradation rate that have been reported, it 
would be wise to perform specific analysis in future exposures. Due to time and financial 
limitations during the present project, it was not possible to conduct the analytical procedures that 
were required.  
In the case of SMX, it was hypothesized that microbial communities that were intermittently 
inhibited later in the study may have been an artifact of transient communities displaying a variable 
ability to regulate their internal pH (Tappe et al., 2008). Due to the likely buffering effect of the 
phosphate buffer present in OECD synthetic sewage, an increase in sulfonamide activity as the 
result of a 1 unit drop in pH (1997 Zarfl et al., 2008; Madigan et al., 2003; Mengelers et al., 1997 
Roland et al., 1979) was tentatively ruled out. It is likely however that SMX did not degrade in the 
aquatic microcosm, as has been suggested by closed bottle tests (Alexy et al., 2004; Al-Amad et 
al., 1999) and studies in the aquatic environment (Bartsch, 2009;  Radke et al., 2009; Benotti and 
Brownawell, 2008; Conkle et al., 2008; Tamtam et al., 2008; Bendz et al., 2005). The compound 
was therefore likely to persist and exert an effect upon susceptible microbial communities over the 
7 day period investigated in the present study.  
In the aquatic environment therefore, both CTC and SMX are likely to exert an inhibitory effect on 
susceptible aquatic microbial communities and affect several effects on ecologically relevant end-
points. Studies have shown that both compounds are present in the environment and were 
transported there via a number of exposure routes, as has been discussed extensively throughout the 
current investigation. More studies are therefore warranted to further investigate the effects of 
antibiotics on microbial function in the aquatic environment as suggested during this section.  
Another key observation during the current investigation was that a degree of recovery occurred in 
microcosm exposed to both CTC and SMX. The recovery was much more pronounced in 
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microcosms exposed to CTC than with SMX. A degree of recovery was however observed at the 
highest SMX concentration. This may suggest that an SMX concentration of between 0.32 and 1 
mg/L
 
is required to select for sulfonamide resistance. A more widespread recovery was observed in 
microcosms spiked with CTC. This could be observed in microcosms spiked with 0.1 mg/L CTC, 
suggesting that a lower CTC concentration might select for antibiotic resistance. It is noteworthy 
that the effect of SMX on the functional diversity of total substrate utilisation could still be 
observed on day 7 of the exposure. No effect of CTC on functional diversity was observed after 
day 1. These data therefore highlight the differential recoveries of microbial communities to both 
compounds that were tested. 
To test the hypothesis that CTC and SMX selected for antibiotic resistance a series of culture-based 
resistance experiments were conducted. It was initially shown that a greater number of distinct 
CTC and SMX-resistant bacteria could be cultured on day seven compared with day one. In 
addition, more resistant morphotypes could be cultured from microcosms that had been exposed to 
CTC than SMX. Total CFU counts of resistant bacteria were shown to significantly increase in all 
microcosms, including controls that had not been spiked with either CTC or SMX. Moreover, day 7 
CTC resistant CFU counts indicated that exposure to all CTC concentrations resulted in a 
significantly higher increase in resistance formation compared to controls. SMX exposed 
microcosms did not result in a significantly higher development of SMX resistance however. 
CFU counts of resistant bacteria from control microcosms and cross referencing thee with day 7 
SMX and CTC-resistant morphotypes revealed that several resistant isolates had been added to 
microcosms via river water and treated sewage (“background’ resistance). In addition, some 
resistant morphotypes had formed in exclusively control microcosms, some in control and treated 
microcosms and some had only formed resistance as the result of exposure to CTC and SMX. 
Multidrug resistance profiles were established for those CTC and SMX-resistant isolates that could 
be sub-cultured. This revealed that a wider resistance profile was formed on day seven compared 
with day one. For the resistant morphotypes that formed due to selective pressure, multidrug 
resistance profiles could be established for five CTC-resistant and three SMX-resistant isolates. It 
was found that these resistant morphotypes generally displayed a much wider resistance profile. 
The results therefore suggested that both single and multidrug resistance could form in both the 
presence and absence of CTC and SMX. The reduction in resistant bacteria that could be cultured 
was attributed to media (nutrient) shock.  
The presence of “background” resistance in microcosms could be attributed to the resistant bacteria 
that were already present in river water and treated sewage within microcosms. Several studies 
have shown that STP effluent and river water contain antibiotic-resistant bacteria (Xiang Zhang et 
al., 2009; Zhang et al., 2009; Szczepanowski et al., 2004; Silva et al., 2006). Other studies have 
shown that exposure of microbial communities to tetracyclines can result in the formation of single 
drug resistance (Yu et al., 2009; Kanpp et al., 2008; Kim et al., 2007; Rhysz and Alverez, 2004; 
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Kerry et al., 2006). Exposure to sulfonamides has also been shown to result in selection of 
antibiotic resistance (Yi et al., 2010; Brandt et al., 2009; Heuer et al., 2008; Heuer and Smalla, 
2007). Knapp et al. (2010) have reported an increase in antibiotic resistance (especially tetracycline 
resistance) with increasing usage over longer time periods.  
The current investigation also suggests that the formation of both single and multidrug resistance 
may have been due to the presence of multidrug efflux systems that were also expelling toxic waste 
products that were likely to have been produce in all microcosms, including controls (Koronakis et 
al., 2004). Aquatic bacteria have previously been shown to possess such mechanism (Hernandez et 
al., 2009; Hernandez et al., 2009; Frike et al., 2008; Long et al., 2008; Groh et al., 2006). 
Multidrug resistance mechanisms have also been detected in STPs (Szczepanowski et al., 2004). It 
is possible therefore such genetic resistance determinants were added to microcosms via treated 
sewage.  
The presence of multidrug resistance has been reported in aquatic systems (Ozgumus et al., 2009; 
Zhang et al., 2009; Verner–Jeffreys et al., 2009; Jianying et al., 2008; Lima-Bittencourt, 2007; 
Park et al., 2003; Magee and Quinn, 1991). Day one results showed that a certain amount of 
multidrug resistance was also present in the aquatic microcosms studied in the present 
investigation. It is likely therefore that this contributed significantly to the multidrug resistance 
profile of the microbial community in the aquatic microcosm investigated during the present study.  
The mechanism behind the formation of both single and multidrug resistance is likely to be the 
transfer of genetic material between environmental bacteria. This has been shown to occur by 
several mating studies that have observed the exchange of resistance genes (Nagachinta and Chen, 
2008; Byrne–Bailey et al., 2009; Agerso and Sandvang, 2005). Moreover, this has been shown to 
occur in an intergenic and intragenic manner (Zahid et al., 2008).  
Chapters 3 and 4 revealed very different recovery profiles. It was hypothesized that a recovery may 
have occurred (at least partially) due to the formation of antibiotic resistance. In the case of the 
functional recovery shown by microbial communities during CTC exposure experiments, analysis 
of resistant CFU formation demonstrated that a significant temporal rise in resistant CFU counts 
occurred at all CTC doses. These data support the hypothesis that a recovery was observed due to 
development of antibiotic resistance. This is not to say that other factors, such as degradation of 
CTC, were also taking place. Interestingly, several tet genes code for tetracycline 
degradation/transformation mechanisms. Both degradation rates and formation of CTC resistance 
may therefore be linked. Future studies should employ specific analysis for tet genes and CTC 
concentration also.  
In the case of SMX exposure, although a certain degree of recovery could be observed, a wide 
range of functional effects could still be observed on day 7 of the exposure, even at the lowest 
SMX dose (0.1 mg/L). In addition, a significantly greater rise in the temporal formation of SMX 
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resistance as the result of exposure to SMX could not be detected by culture-based methods. A rise 
in resistance was however detected at all SMX doses including controls. It must be concluded 
though that SMX did not seem to act as much as a selective pressure for resistance as CTC did. It is 
possible therefore that the less pronounced recovery that was observed in SMX exposures could 
have been caused by lack of significant formation of temporal resistance as the result of exposure 
to SMX.  
To conclude, single resistance and co-selection of multidrug resistance were shown to have 
occurred as the result of “background” and selective processes. This would suggest that antibiotic 
resistance in the aquatic environment can be a naturally occurring process or can be influenced by 
the anthropogenic discharge of antimicrobial compounds. The current investigation would like to 
apply a cautionary message however. It is highly likely that control microcosms were not entirely 
free of antibiotic residues due to the occurrence of CTC, SMX and other antibiotics in both natural 
river systems and treated sewage. To investigate the formation of single and multidrug resistance 
formation in a truly pristine environment (whether this takes the form of filed or simulated 
environment study) may not be easy. This deserves a high degree of consideration in the view of 
the current study. Saying that however, it would perhaps not be surprising that single or multiple 
drug resistance did form in the absence of antibiotics due to the apparently low fitness cost of 
bacteria exchanging genetic information MDR (Ward et al., 2009; Trindade et al., 2009).  
What were not investigated during the current investigation were the concentrations of CTC and 
SMX that were required to exert a selective pressure on the formation of single and multidrug 
resistance. Time constraints did not allow more extensive CFU counts of each resistant morphotype 
that were present in each microcosm on each day of the study. However, samples were kept aside 
for molecular analysis; this should reveal changes in the microbial community and complement 
phenotypic data well. Further molecular analysis (q-RT-PCR) would allow the detection of specific 
genes and when they were expressed during the exposure period. Moreover, metagenomic analysis 
of stored samples would give an even more detailed picture of genetic events during the study.  
The results regarding antibiotic resistance studies during the present investigation raise some 
concerns over human and animal health. Antibiotic resistance has been reported to spread from the 
environment to bacteria that both humans and animals come into contact with (Mukherjee and 
Chakraborty, 2005; Opegaard et al., 2001; Kruse and Sorum 1994). Moreover, other studies have 
suggested that antibiotic resistance may be transferable between the environment and 
humans/animals (Gilling et al., 2009; Kruse and Sorum 1994). This seems worthy of further 
investigation. One method of achieving this would be to spike aquatic microcosms with human or 
animal pathogens that are susceptible to a range of antibiotics and detect changes in their resistance 
profile over a time period. Resistance could be detected by either molecular or phenotypic 
methods.  
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6.1. General Conclusions of Thesis 
1)  A test system was developed that was validated with an OECD reference toxicant and could 
detect functional and structural changes in microbial communities.  
2)  CTC had an inhibitory effect on various aspects of ecologically relevant structural and 
functional aspects of microbial communities in aquatic microcosms at a lower dose of 0.1 mg/L on 
the first two days of the exposure period. 
3)  SMX also had an inhibitory effect on various aspects of ecologically relevant structural and 
functional aspects of microbial communities in aquatic microcosms at a lower dose of 0.1 mg/L on 
the first two days of the exposure period.  
4) The microbial community showed a variable degree of recovery to both antibiotics at certain 
concentrations, whereas at other concentrations less or no recovery was exhibited. More recovery 
was observed by microbial communities that were exposed to CTC.  
5) Single and multidrug resistance was formed in the presence and absence of CTC and SMX, 
indicating that resistance can form due to the selective pressure of antibiotics or due to naturally 
occurring processes. A significantly greater rise in CTC resistance was observed at all CTC doses 
but not as the result of exposure of microbial communities to SMX.  
6) A functional recovery to the effects of CTC could have have occurred due to the formation of 
CTC resistance over time, as suggested by the significant increase in CTC-resistant CFU counts 
over time. It is less clear as to whether the same may have happened during SMX exposures due to 
the lack of significant SMX-resistant CFU counts over time.  
7) In general, CTC and SMX show signs that they may pose a risk to the environment and possibly 
the wider health of humans and animals.  
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Appendix 1a: Morphotyping of CTC-resistant isolates and their presence in microcosms - Day 1.  
    
       
  
Presence of Distinct Morphotype at Different CTC 
Concs 
Similar To / 
Formed
2 
Morphotype 
ID Morphotype Description 
0 mg/L 
CTC 
0.1 mg/L 
CTC 
0.32 mg/L 
CTC 
1 mg/L 
CTC 
CTCD7RES14 CTCD1RES1 
White colonies. 1-2 mm diameter. Irregular edges. Non-translucent. 
Non-swarming 
+ + + - 
CTCD7RES28 CTCD1RES2 Orange colonies. 10-12 mm diameter. Translucent. Swarming.  + + + + 
CTCD7RES7 CTCD1RES3 
Purple colonies. 4-6 mm diameter. Pulvonated. Translucent. Non-
swarming. 
+ + + + 
UNIQUE CTCD1RES4 White colonies. 5-7 mm diameter. Non-translucent. Non-swarming. + + + - 
CTCD7RES26 CTCD1RES5 White colonies. 1-2 mm diameter. Translucent. Non-swarming.  + + + + 
CTCD7RES3 CTCD1RES6 Orange colonies. 5-6 mm diameter. Non-translucent. Non-swarming. + + + + 
CTCD7RES4 CTCD1RES7 White colonies. 20 mm diameter. Non-translucent. Swarming.  + + - + 
CTCD7RES6 CTCD1RES8 Yellow colonies. 5-7 mm diameter. Non-translucent. Non-swarming. + + + + 
CTCD7RES20 CTCD1RES9 
White colonies. 25-27 mm diameter. Non-translucent. Swarmed to 
form dense plaque. 
+ + + + 
UNIQUE CTCD1RES10 Purple colonies. 2-3 mm diameter. Non-translucent. Swarming.  + + + + 
CTCD7RES22 CTCD1RES11 White colonies. 10-12 mm diameter. Translucent. Non-swarming.  + + + + 
CTCD7RES10 CTCD1RES12 
Bright pink colony. 3-4 mm diameter. Opaque. Non-translucent. 
Non-swarming. 
+ + + + 
CTCD7RES12 CTCD1RES13 Yellow colonies. 2-3 mm diameter. Translucent. Non-swarming. + + + + 
CTCD7RES19 CTCD1RES14 White colonies. 10-12 mm diameter. Non-translucent. Swarming.  + + + + 
CTCD7RES8 CTCD1RES15 
Orange colonies. 10-12 mm diameter. Non-translucent. Non-
swarming. 
+ + + - 
CTCD7RES15 CTCD1RES16 
Light pink colonies. 15-18 mm diameter. Non-translucent. Swarmed 
to form dense plaque. 
+ + + + 
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Appendix 1a (cont). 
    
   
Presence of Distinct Morphotype at Different CTC 
Concs 
Similar to/Formed
2
 
Morphotype 
ID 
Morphotype Description 
0 mg/L 
CTC 
0.1 mg/L 
CTC 
0.32 mg/L 
CTC 
1 mg/L 
CTC 
CTCD7RES21 CTCD1RES17 
Orange colony with veins. 14-16 mm diameter. Translucent. 
Swarming.  
+ + + + 
CTCD7RES24 CTCD1RES18 
White raised colony. 8-10 mm diameter. Non-translucent. Non-
swarming.  
+ + + + 
CTCD7RES11 CTCD1RES19 White veined colony. 18-20 mm diameter. Translucent. Swarming.  + + + + 
       
 
    
 
    
 
    
 
 
 
 
 
 
 
 
 
 
 
 
                                                          
2
 C = Formed in control microcosms only; Tr = Formed in treated microcosm only; C + Tr = Formed in treated and control microcosms 
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Appendix 1b: Morphotyping of CTCresistant isolates and their presence in microcosms - Day 7.  
       
  
Presence of Distinct Morphotype at 
Different CTC Concs 
Similar To / 
Formed
2 
Morphotype 
ID Morphotype Description 
0 mg/L 
CTC 
0.1 mg/L 
CTC 
0.32 mg/L 
CTC 
1 mg/L 
CTC 
C  CTCD7RES1 White colonies. 50-55 mm diameter. Non-translucent. Non-swarming. + - - - 
Tr CTCD7RES2 Raised pink colonies. 3-5 mm diameter. Translucent. Non-swarming.  - - + + 
CTCD1RES6 CTCD7RES3 Orange colonies. 4-6 mm diameter. Non-translucent. Non-swarming. + + + - 
CTCD1RES7 CTCD7RES4 White colonies. 18-20 mm diameter. Non-translucent. Swarming.  + + - - 
C + Tr CTCD7RES5 
Light blue colonies. 2-3 mm diameter. Non-translucent. Non-swarming. 
Relativey rare isolate.  
+ + - - 
CTCD1RES8 CTCD7RES6 Yellow colonies. 5-7 mm diameter. Non-translucent. Non-swarming. + + + + 
CTCD1RES3 CTCD7RES7 Purple colonies. 4-6 mm diameter.  Pulvonated. Translucent. Non-swarming. + + + + 
CTCD1RES15 CTCD7RES8 Orange colonies. 10-12 mm diameter. Non-translucent. Non-swarming. + + + - 
Tr CTCD7RES9 
White, veined colonies. 10-12 mm diameter. Translucent. Non-swarming. 
Grows near to other colonies 
- + + - 
CTCD1RES12 CTCD7RES10 Bright pink colony. 3-5 mm diameter. Non-translucent. Opaque. Non-swarming. + - - + 
CTCD1RES19 CTCD7RES11 White veined colony. 19-21 mm diameter. Translucent. Swarming.  + + + + 
CTCD1RES13 CTCD7RES12 Yellow colonies. 2-3 mm diameter. Translucent. Non-swarming. + + + - 
Tr CTCD7RES13 
Raised white colonies. 22-24 mm diameter. Non-translucent. Swarming; forms 
dense plaque. 
- + + + 
CTCD1RES1 CTCD7RES14 
White colonies. 1-2 mm diameter. Irregular edges. Non-translucent. Non-
swarming 
+ + + + 
CTCD1RES16 CTCD7RES15 
Light pink colonies. 16-19 mm diameter. Non-translucent. Swarmed to form 
dense plaque. 
+ + + + 
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Appendix 1b (cont). 
   
 
   
Presence of Distinct Morphotype at Different 
CTC Concs 
Similar To / 
Formed
2 
Morphotype 
ID Morphotype Description 
0 mg/L 
CTC 
0.1 mg/L 
CTC 
0.32 mg/L 
CTC 
1 mg/L 
CTC 
Tr CTCD7RES16 
Raised off-white colonies. 4-5 mm diameter. Rough surface. Non-
translucent. Non-swarming.  
- + + + 
Tr CTCD7RES17 White raised colonies. 1-2 mm diameter. Translucent. Non-swarming.  - + - - 
Tr CTCD7RES18 
Raised purple colonies. 9-11 mm diameter. Non-translucent. Non-
swarming.  
- + + - 
CTCD1RES14 CTCD7RES19 White colonies. 10-12 mm diameter. Non-translucent. Swarming.  + + + + 
CTCD1RES9 CTCD7RES20 
White colonies. 26-29 mm diameter. Non-translucent. Swarmed to form 
dense plaque. 
+ + + + 
CTCD1RES17 CTCD7RES21 Orange colony with veins. 14-16 mm diameter. Translucent. Swarming.  + - - + 
CTCD1RES11 CTCD7RES22 White colonies. 12-14 mm diameter. Translucent. Non-swarming.  + + + + 
Tr CTCD7RES23 
Puplle colonies. 14-16 mm diameter. Shiny surface. Translucent. Non-
swarming.  
- - + + 
CTCD1RES18 CTCD7RES24 White raised colony. 8-10 mm diameter. Non-translucent. Non-swarming.  + + + + 
C + Tr CTCD7RES25 Yellow veined colonies. 10-13 mm diameter. Translucent. Swarming.  + + + - 
CTCD1RES5 CTCD7RES26 White colonies. 1-2 mm diameter. Translucent. Non-swarming.  + + + + 
Tr CTCD7RES27 
Off-white colonies. 40-42 mm in diameter. Filiform edges. Non-translucent. 
Non-swarming.  
- + - - 
CTCD1RES2 CTCD7RES28 Orange colonies. 10-12 mm diameter. Translucent. Swarming.  + - - + 
Tr CTCD7RES29 
Orange raised veined colonies. 30-32 mm diameter. Translucent. 
Swarming. Mainly found by themselves on plates. 
- + + + 
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Appendix 1c: Morphotyping of SMX-resistant isolates and their presence in microcosms – day 1.  
    
       
   
Presence of Distinct Morphotype at 
Different SMX Concs 
Similar To / 
Formed
2 
Morphotype 
ID 
Morphotype Description 
0 mg/L 
SMX 
0.1 mg/L 
SMX 
0.32 mg/L 
SMX 
1 mg/L 
SMX 
SMXD7RES21 SMXD1RES1 White colonies. 1-2 mm diameter. Non-translucent. Non-swarming + + + + 
UNIQUE SMXD1RES2 Veined purple colonies. 23-25 mm diameter. Translucent. Non-swarming. + + + - 
SMXD7RES11 SMXD1RES3 
White colonies. 50-55 mm diameter. Non-translucent. Rough surface. Non-
swarming. 
+ + + + 
SMXD7RES2  SMXD1RES4 Yellow colonies. 2-3 mm diameter. Opaque. Non-translucent. Non-swarming. + + + + 
SMXD7RES10 SMXD1RES5 
Light brown colonies. 3-4 mm diameter. Filiform margins.Translucent. Non-
swarming.  
+ + + - 
UNIQUE SMXD1RES6 Purple colonies. 3-4 mm diameter. Non-translucent. Swarming.  + + + + 
SMXD7RES20 SMXD1RES7 White veined colony. 18-20 mm diameter. Translucent. Swarming.  + + + + 
SMXD7RES18 SMXD1RES8 White raised colony. 8-10 mm diameter. Non-translucent. Non-swarming.  + + - + 
SMXD7RES6 SMXD1RES9 Bright pink colony. 1-3 mm diameter. Translucent. Non-swarming. + + + + 
SMXD7RES13 SMXD1RES10 Orange colonies. 20-25 mm diameter. Translucent. Swarming.  + + + + 
SMXD7RES19 SMXD1RES11 
Light blue colonies. 2-3 mm diameter. Convex. Non-translucent. Non-swarming. 
Relativey rare isolate.  
+ + + + 
SMSD7RES17 SMXD1RES12 Orange colonies. 5-6 mm diameter. Pulvonated. Non-translucent. Non-swarming. + + + + 
SMXD7RES5 SMXD1RES13 Off-white colonies. 15-17 mm diameter. Translucent. Swarming.  + + + + 
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Appendix 1d: Morphotyping of SMX-resistant isolates and their presence in microcosms - day 7 isolates.  
    
       
   
Presence of Distinct Morphotype at Different 
SMX Concs 
Similar To / 
Formed
2 
Morphotype 
ID 
Morphotype Description 
0 mg/L 
SMX 
0.1 mg/L 
SMX 
0.32 mg/L 
SMX 
1 mg/L 
SMX 
SMXD7RES9 SMXD1RES14 Raised white colonies. 1-2 mm diameter. Translucent. Non-swarming.  + + + + 
Tr SMXD7RES1 White colonies. 30-33 mm diameter. Non-translucent. Non-swarming.  + + + + 
C  SMXD7RES2 Off-white veined colonies. 3-4 mm diameter. Opaque. Filamentous edges. 
Non-swarming. 
+ + + + 
C + Tr SMXD7RES3 Raised, veined orange colomnies. Non-translucent. Non-swarming.  + - + + 
SMXD1RES6 SMXD7RES4 Purple colonies. 2-3 mm diameter. Non-translucent. Swarming.  + + + - 
SMXD1RES13 SMXD7RES5 Off-white colonies. 15-17 mm diameter. Translucent. Swarming.  + + + - 
SMXD1RES9 SMXD7RES6 Bright pink colony. 1-3 mm diameter. Translucent. Non-swarming. + + + + 
Tr SMXD7RES7 Red colonies. 2-3 mm. Non-translucent. Non-swarming.  - + - - 
Tr SMXD7RES8 Raised white colonies. 9-11 mm. Translucent. Non-swarming.  - + + + 
SMXD1RES14 SMXD7RES9 Raised white colonies. 1-2 mm diameter. Translucent. Non-swarming.  + + + + 
SMXD1RES5 SMXD7RES10 Light brown colonies. 3-4 mm diameter. Filiform margins.Translucent. Non-
swarming.  
+ - + + 
SMXD1RES3 SMXD7RES11 
White colonies. 52-56 mm diameter. Rough surface. Non-translucent. Non-
swarming. 
+ + + + 
C + Tr SMXD7RES12 Purple colonies. 4-6 mm diameter. Translucent. Non-swarming. + + - + 
SMXD1RES10 SMXD7RES13 Orange colonies. 20-25 mm diameter. Translucent. Swarming.  + + - - 
Tr SMXD7RES14 Off-white colonies. 10-15 mm diameter. Translucent. Non-swarming.  - + + - 
C + Tr SMXD7RES15 
Raised purple colonies. 10-12 mm diameter. Non-translucent. Non-
swarming.  
+ + + + 
Tr SMXD7RES16 Veined, off-white colonies. 5-6 mm diameter. Translicent. Non-swarming. - - + - 
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Appendix 1d (cont).  
    
   
Presence of Distinct Morphotype at Different 
SMX Concs 
Similar 
To/Formed
2 
Morphotype 
ID 
Morphotype Description 
0 mg/L 
SMX 
0.1 mg/L 
SMX 
0.32 mg/L 
SMX 
1 mg/L 
SMX 
SMXD1RES12 SMXD7RES17 
Orange colonies. 5-6 mm diameter. Pulvonated. Non-translucent. Non-
swarming. 
+ - + + 
SMXD1RES8 SMXD7RES18 White raised colony. 8-10 mm diameter. Non-translucent. Non-swarming.  + + - + 
SMXD1RES11 SMXD7RES19 
Light blue colonies. 2-3 mm diameter. Convex. Non-translucent. Non-
swarming. Relativey rare isolate.  
+ + + + 
SMXD1RES7 SMXD7RES20 White veined colony. 19-21 mm diameter. Translucent. Swarming.  + + + - 
SMXD1RES1 SMXD7RES21 White colonies. 1-2 mm diameter. Non-translucent. Non-swarming. + + - + 
Tr SMXD7RES22 
Pink colonies. 20-22 mm diameter. Non-translucent. Swarms to form solid 
plaque. 
- + + + 
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